march 2009

03/2009

‫התשס"ט‬/'‫ט‬

‫רשומות‬ ISRAEL STATE RECORDS ‫ד' בתשרי התש"ע‬

September 22, 2009

‫יומן הפטנטים והמדגמים‬

PATENTS AND DESIGNS JOURNAL PATENTS Applications filed Applications accepted Patents granted Patents renewed Patents not in force Patents renewed for 20 years Applications patent for extension Notices Changes in particulars entered in register Corrigenda Country codes Indices of applications accepted DESIGNS Designs registered Designs renewed Designs void

‫עמוד‬ Page 3 205 436 437 439 440 441 442

‫פטנטים‬

446 447 i

‫בקשות שהוגשו‬ ‫בקשות שקובלו‬ ‫פטנטים שניתנו‬ ‫פטנטים שחודשו‬ ‫פטנטים שתוקפם פקעו‬ ‫פטנטים שחודשו לעשרים שנה‬ ‫בקשות להארכת פטנטים‬ ‫הודעות‬ ‫שינויים בפרטים רשומים‬ ‫בפנקס‬ ‫תיקוני טעויות‬ ‫קודים למדינות‬ ‫מפתחות לבקשות שקובלו‬

449 460 461

‫מדגמים‬ ‫מדגמים שנרשמו‬ ‫מדגמים שחודשו‬ ‫מדגמים שבוטלו‬

445

‫ידיעות כלליות‬ :‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬ ‫ ירושלים‬,‫ מלחה‬,5 ‫ בנין‬,‫ ירושלים‬,‫ גנים טכנולוגיים‬,‫רשם הפטנטים והמדגמים‬ ‫ ירושלים והיא פתוחה‬,‫ מלחה‬,5 ‫ בנין‬,‫לשכת הפטנטים נמצאת בגנים טכנולוגיים ירושלים‬ .12:30 -‫ ו‬8:30 ‫לציבור בימי חול שאינם ערבי שבת או מועד בין השעות‬ ‫ שקלים בעד כל‬2.50 ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬ .‫עמוד או חלק ממנו‬ '‫א גרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬ ‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. 0-24145-2 .‫שולמה‬

GENERAL INFORMATION Letters, documents, etc. concerning Patents and Designs should be addressed to: The Commissioner of Patents and Designs, Jerusalem Technology Park, Building 5, Malcha, Jerusalem The Patent Office is located at Jerusalem Technology Park, Building 5, Malcha, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs. The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof. Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid. Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office.

‫זכות היוצרים בתקצירים אלה שמורה‬ ‫ אין להעתיק מת‬,‫למדינת ישראל‬ ‫קצירים‬ .‫אלה אלא ברשות לשכת הפטנטים‬

Price per single issue (incl. VAT) : NIS 96.

.₪ 96 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬

Annual subscription (incl. VAT): NIS 1,152. Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv.

2

.₪ 1,152 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬ :‫אפשר להשיג אצל‬ '‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬ .‫אביב‬-‫ תל‬,‫ הקריה‬,29 '‫מס‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

NOTICE UNDER SECTION 16 OF THE PATENTS LAW, 5727-1967 In the following there are listed new Applications complying with the Provisions of rule 32(a) of the Patent Regulations, 5728-1968

‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬ 1967 - ‫תשכ"ז‬ ‫להלן רשימת בקשות חדשות‬ ‫הממלאות אחר הדרישות שנקבעו‬ ,‫(א) לתקנות הפטנטים‬32 ‫בתקנה‬ :1968–‫תשכ"ח‬

Particulars of the applications are given in the following order:

‫פרטי הבקשות מובאים לפי‬ :‫סדר זה‬

Number and date of application And the first four symbols of the International Classification

‫מספר הבקשה – ותאריך הגשתה‬ ‫וארבעה הסמנים הראשונים של‬ ‫הסיווג הבינלאומי‬

Title of invention (as proposed by applicant)

‫שם האמצאה (כפי שהוצע ע"י‬ )‫המבקש‬ ‫המבקש‬

Applicant Priority right: Convention country – Number and date of Foreign application

– ‫ מדינת האיגוד‬:‫דין קדימה‬ ‫תאריך ומספר‬ ‫בקשת החוץ‬

International Application Number

‫מספר בקשה בינלאומית‬

International Publication Number

‫מס' פרסום בינלאומי‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

3

16/07/2007

DIVIDER/COMBINER WITH COUPLED SECTION WERLATONE, INC. US 11/458332 18/07/2006

16/07/2007

H03K )2009.01(

184629

‫ מאחד עם חלק מקושר‬/‫מחלק‬

A47D )2009.01(

184630

‫לוח זיכרון‬ ‫נסים עובדיה‬

MEMORIAL SCREEN NISSIM OVADIA

17/01/2006

PHARMACEUTICAL COMPOSITIONS CONTAINING A Wht3a PROTEIN KYOTO UNIVERSITY 2005JP 18/01/2005 010189 PCT/JP/2006/300517 WO/2006/077824

16/07/2007

A SLIDING GATE SYSTEM NOAM RIMON

4

Wht3a ‫תכשירי רוקחות המכילים חלבון‬

A61N )2009.01(

184632

SYSTEMS AND METHODS FOR REMOVAL OF URINE MED-I-DYNAMIX FLUID MONITORING LTD.

16/07/2007

A61K )2009.01(

184631

‫מערכות ושיטות לסילוק שתן‬ ‫דינמיקס ניטור נוזלים בע"מ‬-‫י‬-‫מד‬

E06B )2009.01(

184633

‫מערכת שער הזחה‬ ‫נעם רימון‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

07/02/2006

H04K )2009.01(

184634

INTELLIGENT DEMODULATION SYSTEMS AND METHODS IN AN OFDMA MULTICELL NETWORK ADAPTIX, INC. US 11/062890 22/02/2005 PCT/US/2006/004350 WO/2006/091373

26/01/2006

‫מערכות דה–אפנון חכמות ושיטות ברשת‬ ‫ רב תאית‬OFDMA

184635

‫מכונת תערובת ציר אנכי לעיבוד‬ ‫תערובות‬

VERTICAL-AXIS MIXING MACHINE FOR PROCESSING MIXES TONCELLI DARIO IT TV2005A000020 08/02/2005 PCT/EP/2006/050463 WO/2006/084792

26/01/2006

184636

METHOD FOR PRODUCING ARTICLES WHICH ARE NOT FLAT USING AGGLOMERATES OF INORGANIC AGGREGATES AND HARDENING RESINS AND RESULTANT ARTICLES TONCELLI DARIO IT TV2005A000019 08/02/2005 PCT/EP/2006/050470 WO/2006/084794

12/09/1997

184637

RECOMBINANT HUMAN ? GALACTOSIDASE SHIRE HUMAN GENETIC THERAPIES, INC. US 08/712614 13/09/1996 PCT/US/1997/016603 WO/1998/011206

September 22, 2009

–‫ד' בתשרי התש"ע‬

B01F )2009.01(

B28B )2009.01( ‫שיטה לייצור פריטים לא שטוחים‬ ‫באמצעות ערמה של הצטברות‬ ‫אנאורגני ושרף מקשיח ופריטים‬ ‫הנובעים מכך‬

C12N )2009.01( ‫ריקומביננט אנושי ? – גאלאקטוסידאז‬

5

16/07/2007

CONTROLLED BLEEDER FOR POWER SUPPLY MICROSEMI CORP - ANALOG MIXED SIGNAL GROUP LTD US 60/807503 17/07/2006

20/02/2006

H02M )2009.01(

184638

‫נגד עומס מבוקר לספק כח‬ ‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬ ‫גרופ בע"מ‬

PROCESS FOR THE PRODUCTION OF 2-(2-AMINOPHENYL)BICYCLOPROPANE DERIVATIVES SYNGENTA PARTICIPATIONS AG CH 0302/05 21/02/2005 PCT/EP/2006/001508 WO/2006/087223

24/01/2006 SUPERMARKET TROLLEY WIETH FRANZ DE 202005001770.1 PCT/DE/2006/000105 WO/2006/081793

16/02/2006

–2(–2 ‫תהליך לייצור תולדות של‬ ‫אמינופניל)–ביציקלופרופן‬

G07F )2009.01(

184640

‫עגלת סופרמרקט‬ 03/02/2005

C12Q )2009.01(

184641

HUMAN AUTISM SUSCEPTIBILITY GENE ENCODING A KINASE AND USES THEREOF INTEGRAGEN US 60/653502 17/02/2005 PCT/IB/2006/000469 WO/2006/087634

6

C07C )2009.01(

184639

‫גן אנושי לרגישות לאוטיזם המקודד לקינאז‬ ‫ושימוש בו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

16/07/2007

184642

PROCESS FOR THE PREPARATION OF NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS PFIZER PRODUCTS, INC. US 60/243873 27/10/2000

30/01/2006

‫תהליך להכנת מודולטורים של רצפטור‬ ‫לא–סטרואידלי של גלוקוקורטיקואיד‬

184643

INHIBITORS OF OF DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) F. HOFFMANN-LA ROCHE AG US 60/650671 07/02/2005 PCT/EP/2006/000786 WO/2006/082010

16/01/2006

September 22, 2009

184645

–‫ד' בתשרי התש"ע‬

G06F )2009.01( ‫תקשורת בעזרת איקונים‬ ‫זלנגו בע"מ‬

ICONIC COMMUNICATION ZLANGO LTD IL 166322 16/01/2005 60/644021 18/01/2005 US PCT/IL/2006/000061 WO/2006/075334

COMMUNICATIONS NETWORK SYSTEM AND METHODS FOR USING SAME ZLANGO LTD IL 166322 16/01/2005 60/644021 18/01/2005 US PCT/IL/2006/000062 WO/2006/075335

C07C )2009.01(

‫מעכבים של דיאצילגליצרול אצילטרנספרז‬ )DGAT(

184644

16/01/2006

C07C )2009.01(

H04L )2009.01(

‫מערכת תקשורת רשתית ושיטות שימוש‬ ‫בה‬ ‫זלנגו בע"מ‬

7

06/09/2005

A61H )2009.01(

189826

‫מכונה לבניית כושר עם תמיכה בולמת‬ ‫רעידות‬

FITNESS MACHINE HAVING A VIBRATION ABSORBING SUPPORT POWER PLATE INTERNATIONAL LTD PCT/NL/2005/000642 WO/2007/030000

15/09/2006

SULPHONAMIDE DERIVATIVES BIOTIE THERAPIES CORPORATION FI 20055498 16/09/2005 PCT/FI/2006/050395 WO/2007/034035

22/09/2005

C07C )2009.01(

190012

‫נגזרות סולפונאמיד‬

A61K )2009.01(

190024

STABILIZED PROTEASE COMPOSITION TROBIO AB

‫תרכובת פרוטואזה מאוזנת‬

PCT/SE/2005/001391 WO/2007/035143

15/09/2005

INTEGRATED COIL APPARATUS AND METHOD FOR USING SAME IVIVI TECHNOLOGIES, INC. US 11/223073 10/09/2005 PCT/US/2005/032974 WO/2007/030122

8

A61N )2009.01(

190036

‫התקן סליל מוכלל ושיטה לשימוש בו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

12/09/2006

190102

‫עיבוד תמונה רפואי‬ ‫ טכנולוגיות בע"מ‬.‫פי‬.‫וי‬.‫די‬

MEDICAL IMAGE PROCESSING D.V.P. TECHNOLOGIES LTD. US 60/715572 12/09/2005 PCT/IB/2006/053243 WO/2007/031946

22/09/2005

G06T )2009.01(

190108

H04N )2009.01( ‫גלישה טלוויזיונית‬

TELEVISION SURFING NDS LIMITED PCT/IL/2005/001019 WO/2007/034467

14/09/2006

190143

CONTAINER AND BLANK FOR THE PRODUCTION THEREOF SEDA S.P.A. DE 202005014738.9 19/09/2005 PCT/EP/2006/008983 WO/2007/033794

14/09/2006

190193

REINFORCED PLASTIC PIPE HONEYWELL INTERNATIONAL INC. US 11/228935 16/09/2005 PCT/US/2006/035878 WO/2008/033134

September 22, 2009

–‫ד' בתשרי התש"ע‬

B65D )2009.01( ‫מיכל והתקן לייצורו‬

B32B )2009.01( ‫צינור פלסטיק מחוזק‬

9

28/09/2006

C07D )2009.01(

190225

PYRAZOLO [1,5-ALPHA]PYRIMIDINYL DERIVATIVES USEFUL AS CORTICOTROPIN-RELEASING FACTOR (CRF) RECEPTOR ANTAGONISTS

]‫–אלפא‬1,5[‫תולדות פירזולו‬ ‫פירימידיניל השימושיות‬ ‫כאנטגוניסטים של הרצפטור‬ ‫לפקטור שחרור קורטיקוטרופין‬ )CRF(

SMITHKLINE BEECHAM (CORK) LIMITED GB 0519957.5 30/09/2005 US PCT/US2005/37576 19/10/2005 PCT/EP/2006/009531 WO/2007/039264

26/09/2006

ORGANOMETALLIC COMPOUNDS AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. US 60/721804 29/09/2005 11/501075 09/08/2006 US PCT/US/2006/037414 WO/2007/041089

26/09/2006

‫תרכובות אורגנומטליות ושיטות לשימוש‬ ‫בהן‬

C07D )2009.01(

190227

PHENYL-[1,2,4]-OXADIAZOL-5-ONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI AVENTIS EP 05021235.6 29/09/2005 PCT/EP/2006/009304 WO/2007/039178

10

C07F )2009.01(

190226

‫–און‬5–‫]–אוקסאדיאזול‬1,2,4[–‫נגזרות פניל‬ ‫ תהליכים להכנתן‬,‫עם קבוצה פנילית‬ ‫ושימוש שלהן כתכשירים רפואיים‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

26/09/2006

C07D )2009.01(

190228

– 1 ,2 ,4–‫נגזרות פניל–ופירינידיל‬ ,‫אוקסאדיאזולון עם קבוצה פנילית‬ ‫תהליכים להכנתן ושימוש שלהן‬ ‫כתכשירים רפואיים‬

PHENYL-AND PYRIDYL-1,2,4OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI AVENTIS EP 05021235.6 29/09/2005 PCT/EP/2006/009298 WO/2007/039172

13/09/2006

190229

METHOD FOR AMIDATING POLYPEPTIDES WITH BASIC AMINOACID C- TERMINALS BY MEANS OF SPECIFIC ENDOPROTEASES SANOFI-AVENTIS DEUTSCHLAND GMBH DE 102005046113.1 27/09/2005 PCT/EP/2006/008903 WO/2007/036299

18/03/2008

190262

A GAS PHAS SYNTHESIS METHOD OF MONO CRYSTALLINE NANOSIZED SUPER HARD MATERIALS AND RESULTING PRODUCTS ZARUEV VASILY

18/03/2008

A61B )2009.01( ‫מתקן עזר לאיש מוגבל‬ ‫עוזי עזרא חבושה‬

190264

–‫ד' בתשרי התש"ע‬

H01F )2009.01(

‫פרופסור אולג פיגובסקי‬

A DEVICE TO AID THE DISABLED UZI EZRA HAVOSHA

September 22, 2009

–C ‫שיטה למרכוז פוליפפטידים עם‬ ‫טרמינלים של חומצה אמינית בסיסית‬ ‫באמצעות אנדופרוטאזות ספציפיות‬

‫שיתת הסינתזה בפזה גזית של חומרים‬ ‫מונו בדולחיים קשים במיוחד בגודל ננו‬ ‫ותוצרת סופית‬

190263

18/03/2008

C07K )2009.01(

H01R )2009.01(

11

‫ נייח הכולל תאורת חירום‬/‫שקע נייד‬ ‫ולילה ומערכות הגנה והתרעה‬ ‫עצמון דקל‬

‫אאאאאאאאאאאאאאאאאאאאאאאאאאאאאא‬ DAN KATZ

21/09/2006

SYSTEM AND METHOD FOR SOLUBILITY CURVE AND METASTABLE ZONE DETERMINATION AVANTIUM INTERNATIONAL B.V. NL PCT/NL2005/000688 21/09/2006 PCT/NL/2006/000466 WO/2007/025087

18/03/2008

12

H01L )2009.01( ‫בקרת צבע לתאורה סורקת דינמי‬ ‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬ ‫גרופ בע"מ‬

G09F )2009.01(

190269

PATHWAY MARKER, ESPECIALLY FIRE ESCAPE MARKER IN A FLOOR OR WALL JORMA PARKKARI FI 20055539 06/10/2005 PCT/FI/2006/050430 WO/2007/039673

14/03/2000

‫מערכת ושיטה לקביעה של עקומת‬ ‫מסיסות ואזור מטא–יציב‬

190268

COLOR CONTROL FOR DYANMIC SCANNING BACKLIGHT MICROSEMI CORP - ANALOG MIXED SIGNAL GROUP LTD US 60/908709 29/03/2007

05/10/2006

G01N )2009.01(

190266

‫ במיוחד סמן נתיב ברצפה או‬,‫סמן של נתיב‬ ‫בקיר למילוט מאש‬

C12N )2009.01(

190270

September 22, 2009

–‫ד' בתשרי התש"ע‬

AKT NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF AVENTIS PHARMACEUTICALS INC. US 60/125108 19/03/1999 PCT/US/2000/006574 WO/2000/056866

22/09/2005

‫ פוליפפטידים‬AKT ‫חומצות נוקלאיות של‬ ‫ושימושים שלהם‬

190271

METHOD FOR TRANSFERRING ONE OR MORE GENETIC TRAITS FROM A PLANT OF THE PURPLE-FLOWERED CAPSICUM SPECIES TO A PLANT OF THE WHITE-FLOWERED CAPSICUM SPECIES ENZA ZADEN BEHEER B.V.

A01H )2009.01(

‫שיטה להעברת תכונה גנרית אחת או יותר‬ ‫מצמחי פלפלת מזנים בעלי פרחים סגולים‬ ‫לצמחי פלפלת מזנים בעלי פרחים לבנים‬

PCT/EP/2005/054759 WO/2007/038980

07/09/2006

190272

PRINTED THERMOFORMABLE LAMINATE WITH INCREASED SECURITY AGAINST FORGERY ALCAN TECHNOLOGY & MANAGEMENT LTD. EP 05405560.3 27/09/2005 PCT/EP/2006/008739 WO/2007/036289

27/09/2006 September 22, 2009

‫ציפוי מודפס הניתן לעצוב בחום עם‬ ‫הבטחה מוגברת למניעת זיוף‬

190273

–‫ד' בתשרי התש"ע‬

B32B )2009.01(

C07D )2009.01(

13

BENZOTHIADIAZOLYPHENYLALKYLAMINE DERIVATIVES FOR USE IN THE TREATMENT OF CONDITIONS AMELIORATED BY MONOAMINE REUPTAKE WYETH US 60/721693 PCT/US/2006/037962 WO/2007/041258

28/09/2006

29/09/2005

14

‫מכשיר ושיטה להחלפת מפרק באופן‬ ‫פולשני מינימלי‬

C07D )2009.01(

190275

7-[2-[4-(6-FLUORO-3-METHYL-1,2BENZISOXAZOL-5-YL)-1PIPERAZINYL]ETHYL]-2-(1PROPYNYL)-7H-PYRAZOLO-[4,3-e][1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN5 AMINE SCHERING CORPORATION US 60/720027 23/09/2005 PCT/US/2006/037003 WO/2007/038284

12/09/2006

A61B )2009.01(

190274

APPARATUS AND METHOD FOR MINIMALLY INVASIVE TOTAL JOINT REPLACEMENT ALEXANDRIA RESEARCH TECHNOLOGIES LLC US 60/721450 28/09/2005 11/535916 27/09/2006 US PCT/US/2006/038434 WO/2007/038776

21/09/2006

‫נגזרות של‬ ‫בנוזיתיאדיאזוליפנילאלקילאמין‬ ‫לשימוש בטיפול במצבים‬ ‫המשתפרים ע"י ספיגת מונואמין‬

–2,1–‫–מתיל‬3–‫–פלואורו‬6(–4[–2[–7 –]‫–פיפרזיניל]אתיל‬1–)‫–איל‬5–‫בנזיסוקסאזול‬ e–[–3,4[–‫–פירזולו‬H7–)‫–פרופיניל‬1(–2 ‫ אמין‬5–‫]–פירימידין‬c–5,1[–‫[]–טריאזולו‬4,2,1

G06M )2009.01(

190276

September 22, 2009

–‫ד' בתשרי התש"ע‬

MECHANICAL DOSES COUNTER FOR A POWDER INHALER AVENTIS PHARMA LIMITED GB 0519151.5 20/09/2005 PCT/GB/2006/050287 WO/2007/034237

28/09/2006

‫מונה מנות מכאני למשאף המיועד לשימוש‬ ‫עם אבקה‬

190277

ARIL-SUBSTITUTED NITROGENCONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. 2005JP 30/09/2005 288545 PCT/JP/2006/319912 WO/2007/037513

22/09/2006

‫תרכובת הטרוציקלית בעלת חנקן מותמר‬ ‫באריל‬

190278

TETRAHYDRO-CYCLOPENTYL PYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV US 60/720029 23/09/2005 PCT/US/2006/037348 WO/2007/035945

27/09/2006

190279

THIENO[2,3-B]PYRIDINE-5CARBONITRILES AS PROTEIN KINASE INHIBITORS WYETH US 60/720821 27/09/2005 PCT/US/2006/037502 WO/2007/038519 22/09/2006 September 22, 2009

190280

–‫ד' בתשרי התש"ע‬

C07D )2009.01(

C07D )2009.01( ‫מודולטורים של טטרהידרו–ציקלופנטיל‬ ‫פירזול קנאבינויד‬

C07D )2009.01( ‫–קרבוניטרילים‬5–‫ פירידין‬B[ –3 ,2[‫תיאנו‬ ‫כמעכבים לפרוטאין קינאז‬

C07D )2009.01(

15

FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS BRISTOL-MYERS SQUIBB COMPANY US 60/719519 22/09/2005 11/524996 21/09/2006 US PCT/US/2006/037056 WO/2007/038314

19/09/2006

16

‫מודולציה של ביטוי של רצפטור‬ ‫לגלוקוקורטיקויד‬

C07D )2009.01(

190282

ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS MERCK & CO. INC. US 60/721678 29/09/2005 PCT/US/2006/037196 WO/2007/041052

19/09/2006

C12N )2009.01(

190281

MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH &DEVELOPMENT, LLC US 60/718685 19/09/2005 PCT/US/2006/036527 WO/2007/035759

25/09/2006

‫תרכובות הטרוציקליות מאוחות‬ ‫המשמשות כמודולטורים לקינאז‬

‫נגזרות ספירופיפרידין שעברו אצילציה‬ 4–‫כווסתים לקולטן מלאנוקורטין‬

C12N )2009.01(

190283

September 22, 2009

–‫ד' בתשרי התש"ע‬

MODULATION OF GLUCAGON RECEPTOR EXPRESSION JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH &DEVELOPMENT, LLC US 60/718684 19/09/2005 PCT/US/2006/036545 WO/2007/035771

27/09/2006

‫מודולציה של ביטוי של רצפטור לגלוקגון‬

190284

MILNACIPRAN FOR THE LONGTERM TREATMENT OF FIBROMYALGIA SYNDROME CYPRESS BIOSCIENCE, INC. US 60/721722 28/09/2005 PCT/US/2006/037714 WO/2007/038620

18/07/2006

‫מילנציפראן לטיפול ארוך טווח בתסמונת‬ ‫פיברומיאלגיה‬

190285

SUPPORT ARM, CYLINDRICALPARABOLIC SOLAR COLLECTOR SUPPORT AND METHOD OF PRODUCING SAID ARM SENER, INGENIERIA Y SISTEMAS, S.A. ES 200502280 19/09/2005 PCT/ES/2006/000414 WO/2007/034008

26/10/2006

NEW CYCLIC PEPTIDE COMPOUNDS ASTELLAS PHARMA INC. US 60/730011 26/10/2005 60/751204 19/12/2005 US PCT/JP/2006/321924 WO/2007/049803

September 22, 2009

190287

–‫ד' בתשרי התש"ע‬

F24J )2009.01(

‫זרוע תמיכה לקולט שמש צילינדרי מעוגל‬ ‫והשיטה לייצורו‬

190286

29/09/2006

C07C )2009.01(

C07K )2009.01( ‫תרכובות פפטיד ציקליות חדשות‬

F26B )2009.01(

17

A METHOD OF AND SYSTEM FOR CONTROLLING A KILN AUSTRALIAN CHOICE TIMBER SUPPLIES PTY LTD AU 2005905414 30/09/2005 PCT/AU/2006/001424 WO/2007/035995

04/10/2006

18

C12N )2009.01( ‫שיטה לקבלת תאי שריר אנושיים‬ ‫ושימושיהם‬

A61M )2009.01(

190290

SAFETY NEEDLE WITH LOCKOUT MECHANISM TYCO HEALTHCARE GROUP LP US 60/719761 22/09/2005 PCT/US/2006/037278 WO/2007/035923

22/09/2006

‫פיגמנטים פולטי אור הסגורים בקפסולה‬

190289

METHOD FOR OBTAINING HUMAN SMOOTH MUSCULAR CELLS AND USES THEREOF INSTITUT DES VAISSEAUX ET DU SANG OF FR 0509557 19/09/2005 PCT/FR/2006/002144 WO/2007/034069

22/09/2006

C09B )2009.01(

190288

ENCAPSULATED LUMINESCENT PIGMENTS CIBA SPECIALTY CHEMICALS HOLDING INC. EP 05109465.4 12/10/2005 PCT/EP/2006/067037 WO/2007/042438

19/09/2006

‫שיטה ומערכת לשליטה בתנור‬

‫מחט בטיחותית עם מנגנון השבתה‬

A61M )2009.01(

190291 September 22, 2009

–‫ד' בתשרי התש"ע‬

NON-AXIAL RETURN SPRING FOR SAFETY NEEDLE TYCO HEALTHCARE GROUP LP US 60/719762 22/09/2005 PCT/US/2006/037288 WO/2007/035924

09/10/2006

‫קפיץ נסיגה שאינו צירי למחט בטיחותית‬

190292

PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka EXELIXIS, INC. US 60/724571 07/10/2005 60/743719 23/03/2006 US PCT/US/2006/039734 WO/2007/044813

02/10/2006

190293

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF ONO PHARMACEUTICAL CO., LTD. 2005JP 03/10/2005 289542 2006-093266 30/03/2006 JP PCT/JP/2006/319732 WO/2007/040208

05/10/2006

September 22, 2009

190294

–‫ד' בתשרי התש"ע‬

C07D )2009.01( Ka13P ‫פירידופירימידינונים מעכבי‬

C07D )2009.01( ‫תרכובת הטרוציקלית המכילה חנקן‬ ‫ויישומיה הרוקחיים‬

A01N )2009.01(

19

–3 ‫תכשירים קוטלי עשבים המבוססים על‬ ‫–[ציקלו פרופיל‬N–[[4–‫פניל אוראצילים ו‬ ‫–מתוקסי‬2–]‫אמינו)–קרבוניל]פניל]סולפוניל‬ ‫בנזואיד‬

HERBICIDAL COMPOSITIONS BASED ON 3-PHENYLURACILS AND N-[[4[(CYCLOPROPYLAMINO)CARBONYL]PHENYL]SULFONYL]-2METHOXYBENZAMIDE BASF SE EP 05022222.3 12/10/2005 PCT/EP/2006/067061 WO/2007/042447

22/09/2006

COMBINATION THERAPY COMPRISING SUBSTITUTED OXAZOLIDINONES FOR THE PREVENTION AND TREATMENT OF CEREBRAL CIRCULATORY DISORDERS BAYER HEALTHCARE AG DE 102005047558.2 04/10/2005 PCT/EP/2006/009204 WO/2007/039134

04/10/2006

‫תרופה משולבת המכילה‬ ‫אוקסאזולידונינים מותמרים למניעה‬ ‫וטיפול באי סדרים של זרימת דם מוחית‬

20

A24D )2009.01(

190296

CIGARETTES HAVING HOLLOW FIBERS PHILIP MORRIS PRODUCTS S.A. US 11/241978 04/10/2005 PCT/IB/2006/003884 WO/2007/054826

29/09/2006

C07D )2009.01(

190295

‫סיגריות בעלות סיבים חלולים‬

A01N )2009.01(

190297

September 22, 2009

–‫ד' בתשרי התש"ע‬

FUNGICIDES AND BIOREGULATORY MIXTURES BASF SE DE 102005048430.1 07/10/2005 PCT/EP/2006/066870 WO/2007/042404

02/11/2006

190298

DISPENSING DEVICE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 05026285.6 02/12/2005 06000276.3 09/01/2006 EP PCT/EP/2006/010536 WO/2007/062726

19/03/2008

190299

190300

SYSTEM AND METHOD FOR WATER DESALINATION AND OTHER USES S.D.E. LTD.

19/09/2006

September 22, 2009

190301

–‫ד' בתשרי התש"ע‬

B05B )2009.01( ‫מתקן חלוקה‬

A47K )2009.01( ‫מערכת ושיטת ניקוי‬ ‫אבירם מן‬

CLEANING SYSTEM AND METHOD AVIRAM MANN

19/03/2008

‫קוטלי פטריות ותערובות לבקרה‬ ‫ביולוגית‬

B01D )2009.01( ‫מערכת ושיטה להתפלת מים ושימושים‬ ‫אחרים‬ ‫ אנרגיה בע"מ‬.‫אי‬.‫די‬.‫אס‬

A61K )2009.01(

21

‫מודולטורים להתמיינות של תאי‬ ‫אוסטאוקלסט‬ ‫ניצוצות ייזום והשקעות בע"מ‬

MODULATION OF OSTEOCLAST DIFFERENTIATION NITZOZOT LTD US 60/717762 19/09/2005 PCT/IL/2006/001095 WO/2007/034477

19/09/2006

PROCESS FOR SEPARATING SOLUTES AND WATER FROM AQUEOUS SOLUTIONS WITH GAS RECYCLING WATER SCIENCE LIMITED GB 0519087.1 19/09/2005 PCT/GB/2006/050296 WO/2007/034241

19/03/2008

C02F )2009.01(

190302

‫תהליך להפרדת מומסים ומים מתמיסות‬ ‫מיימיות יחד עם מיחזור גז‬

A PAINLESSLY HAND-HELD APPARATUS USEFUL FOR DETECTION AND QUANTIZATION OF AN ANALYTE AND METHODS THEREOF SINDOLOR MEDICAL LTD

19/03/2008

22

‫מכשיר ידני לזיהוי וכימות של חומרים‬ ‫שונים ללא כאב‬ ‫סינדולור מדיקל בע"מ‬

H04M )2009.01(

190304

METHOD OF FORWARDING ETHERNET PACKETS IN TELECOMMUNICATIONS NETWORKS ECI TELECOM LTD.

29/09/2006

A61B )2009.01(

190303

‫שיטה למסירת מנות נתונים מסוג‬ ‫ ברשתות תקשורת‬ETHERNET ‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬

A61K )2009.01(

190305

September 22, 2009

–‫ד' בתשרי התש"ע‬

CONTROLLED RELEASE, PHARMACEUTICAL COMPOSITION OF VENLAFAXINE HYDROCHLORIDE, AND PROCESS FOR PREPARATION THEREOF VALPHARMA S.A. IT FI2005A000206 30/09/2005 PCT/EP/2006/066906 WO/2007/039569

10/10/2006

‫תכשיר רפואי של שחרור מבוקר של‬ ‫ ותהליך להכנתו‬,‫ונלפקסין הידרוכלוריד‬

C07D )2009.01(

190306

‫מעכבי קינאז‬

KINASE INHIBITORS TAKEDA SAN DIEGO, INC. US 60/724619 07/10/2005 PCT/US/2006/039667 WO/2007/044779

21/09/2006

190307

BULLET-PROOF STRUCTURE COSIMO CIOFFI IT FI2005A000210 07/10/2005 PCT/IB/2006/002622 WO/2007/042877

07/08/1998

190308

USE OF ANTIBODY THAT BINDS INTEGRIN av ? 6 TO PREPARE A MEDICAMENT FOR TREATING KIDNEY FIBROSIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA US 60/055060 08/08/1997 PCT/US/1998/016439 WO/1999/007405 05/10/2006

September 22, 2009

190309

–‫ד' בתשרי התש"ע‬

F41H )2009.01( ‫מבנה חסין כדורים‬

C07K )2009.01( av ?6 ‫שימוש בנוגדן שקושר אינטגרין‬ ‫להכין תרופה לטיפול בלייפת הכליה‬

H01J )2009.01(

23

OPTICAL FIBER ASSEMBLY WRAPPED ACROSS GIMBAL AXES RAYTHEON COMPANY US 11/243562 05/10/2005 PCT/US/2006/039426 WO/2007/044684

15/10/2006

‫הרכבת סיבים אופטיים עטופים על פני ציר‬ ‫מאוזן‬

COMPOSITIONS FOR SILENCING THE EXPRESSION OF VDAC1 AND USES THEREOF BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY US 60/724794 11/10/2005 PCT/IL/2006/001176 WO/2007/043049

21/09/2006

24

VDAC1 ‫תכשירים להשתקת הביטוי של‬ ‫והשימוש בהם‬ ‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬ ‫למחקר ופיתוח‬

C12N )2009.01(

190311

NUCLEIC ACID CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME FOR TREATING CANCER YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/719178 22/09/2005 PCT/IL/2006/001110 WO/2007/034487

21/09/2006

C12N )2009.01(

190310

‫ תכשירים‬,‫קונסטרקטים של חומצות גרעין‬ ‫רוקחיים ושימוש בהם לטיפול בסרטן‬ ‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים‬

A61K )2009.01(

190312

September 22, 2009

–‫ד' בתשרי התש"ע‬

IMMUNOGENIC FRAGMENTS OF TCELL RECEPTOR CONSTANT DOMAINS AND PEPTIDES DERIVED THEREFROM QUINTANA FRANCISCO J. US 60/719342 22/09/2005 PCT/IL/2006/001112 WO/2007/034489

19/03/2008

‫מקטעים אימונוגניים של המתחם הקבוע‬ ‫ ופפטידים הנגזרים מהם‬T ‫בקולטני תאי‬ .‫קווינטנה פרנסיסקו ח‬

190313

ACTUATOR POSITION CONTROL DEVICE USING A FAIL FREEZE SERVO-VALVE HISPANO-SUIZA FR 0753960 21/03/2007

26/09/2006

‫התקן לשליטה על מיקום מפעיל בעל‬ ‫שסתום מנוע סרוו עם מנגנון כשל–קפיאה‬

190314

MODIFIED SHOTGUN AND MODIFIED SHOTGUN SHELL AMMUNITION RACHO,JEFF US 60/720791 27/09/2005 60/740946 30/11/2005 US 60/742413 05/12/2005 US 11/526446 25/09/2006 US PCT/US/2006/037782 WO/2007/120180

27/09/2006

ILLUMINATED GOLF FLAGPOLE WILLETT, RICHARD US 60/721561 28/09/2005 PCT/US/2006/037969 WO/2007/038711

September 22, 2009

190316

–‫ד' בתשרי התש"ע‬

F41A )2009.01(

‫רובה ציד מותאם ותחמושת מותאמת עבור‬ ‫רובה ציד‬

190315

19/03/2008

F16K )2009.01(

A63B )2009.01( ‫מוט–דגל מואר לגולף‬

B23B )2009.01(

25

CUTTER TOOL AND CUTTER INSERT THEREFOR NO SCREW LTD IL 183721 06/06/2007 184091 20/06/2007 IL 184742 19/07/2007 IL 186569 10/10/2007 IL

23/09/2006

‫כלי לחיתוך ותוספת חיתוך בתוכו‬ ‫בלי בורג בע"מ‬

SUSTAINED-RELEASE ANTIMICROBIAL PLASTIC COMPOSITION WITH LOW RATE OF ELUTION BAYER INNOVATION GMBH DE 102005048131.0 06/10/2005 PCT/EP/2006/009265 WO/2007/039156

23/10/2006

26

‫תכשיר פלסטי אנטי–מיקרוביאלי בעל‬ ‫שחרור מושהה עם קצב השטפה איטי‬

A61M )2009.01(

190318

DISPENSING DEVICE, STORAGE DEVICE AND METHOD FOR DISPENSING A FORMULATION BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 05026286.4 02/12/2005 06000866.1 17/01/2006 EP PCT/EP/2006/010197 WO/2007/062721

20/09/2006

C08K )2009.01(

190317

‫ התקן אחסון ושיטה לנתינת‬,‫התקן נתינה‬ ‫פורמולציה‬

A61K )2009.01(

190319

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ננו חלקיקים לנשיאה מכוונת של חומרים‬ ‫פעילים‬

NANOPARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/718333 20/09/2005 PCT/IL/2006/001098 WO/2007/034479

25/10/2006

‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים‬

190320

SYRINGE ASSIST FOR INFUSION PUMP CURLIN MEDICAL INC. US 11/262258 28/10/2005 PCT/US/2006/041595 WO/2007/053387

28/09/2006

‫מזרק עזר למשאבת אינפוזיה‬

190321

COMPOSITIONS CONTAINING SARATIN BIOVASCULAR, INC. US 60/721754 28/09/2005 PCT/US/2006/038141 WO/2007/038749

08/09/2006

NUTRIENT MEDIUM FOR THE CULTIVATION OF A CELL CULTURE CELLCA GMBH DE 102005046225.1 28/09/2005 PCT/EP/2006/008761 WO/2007/036291

September 22, 2009

190323

–‫ד' בתשרי התש"ע‬

C08L )2009.01( ‫תכשירים המכילים סראטין‬

190322

29/09/2006

A61M )2009.01(

C12N )2009.01( ‫מצע תזונתי לתרבות תרבית תאים‬

A61K )2009.01(

27

‫ערכה לנתינת תרופות שלא דרך‬ ‫המעיים‬

KIT FOR THE PARENTERAL ADMINISTRATION OF DRUGS INFA S.A. IT MI2005A001826 29/09/2005 PCT/IB/2006/002702 WO/2007/036792

22/09/2006

MODULAR CLONING VECTOR PLASMIDS INTREXON CORPORATION US 11/233246 22/09/2005 PCT/US/2006/036992 WO/2007/038276

21/09/2006

‫פלסמידי וקטור שיבוט מודולריים‬

VEHICULAR WINDOW SYSTEM

28

‫תהליך להכנת הלופינט‬

A46B )2009.01(

190326

DENTAL TOOL FOR CREATING GAP BETWEEN TEETH, WITH DEVICE TO TRANSPORT FLUIDS AND TOOTH PASTE YEHOSHOUA TABOR

20/03/2008

C07D )2009.01(

190325

A PROCESS FOR THE PREPARATION OF HALOFENATE METABOLEX, INC. US 60/720300 23/09/2005 11/525200 20/09/2006 US PCT/US/2006/036928 WO/2007/038243

20/03/2008

C12N )2009.01(

190324

‫מפסק שיניים בעל מנגנון להובלת נוזלים‬ ‫ומשחות שיניים‬ ‫יהושע תבור‬

B60J )2009.01(

190327

‫מערכת חלון לרכב‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

‫רומן רשקובן‬

ROMAN RASHKOVAN

20/03/2008

190328

,‫ חד פעמי‬,‫אלמנט מכסה רב שימושי‬ ‫למאפרה‬ ‫אלי כהן‬

A MULTI-USE DISPOSABLE ASHTRAY COVER ELEMENT ELI COHEN

20/03/2008

190329

190330

3-ALKYL-5-(4-ALKYL-5-OXOTETRAHYDROFUTRAN-2YL)PYRROLIDIN-2-ONE DERIVATIVES AS INTERMEDIATES IN THE SYNTHESIS OF RENIN INHIBITORS NOVARTIS AG GB 0521083.6 17/10/2005 PCT/EP/2006/009970 WO/2007/045420

04/10/2006

September 22, 2009

C07D )2009.01(

–‫–אוקסו‬5–‫–אלקיל‬4(–5–‫–אלקיל‬3 ‫תולדות‬ ‫–און‬2–‫–יל)פירולידינ‬2–‫טטרהידרופוטראנ‬ ‫כחומרי ביניים בסינתזה של מעכבי רנין‬

190331

–‫ד' בתשרי התש"ע‬

H02M )2009.01( ‫קבל להספק גבוה המקורר באמצעות‬ ‫הולכה לצדדים‬ ‫סלם פאסיב קומפוננטס בע"מ‬

SIDEWAYS CONDUCTION COOLED HIGH-POWER CAPACITOR CELEM PASSIVE COMPONENTS LTD

16/10/2006

B67B )2009.01(

C07D )2009.01(

29

DEUTERATED INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES AUSPEX PHARMACEUTICALS, INC. US 60/724160 06/10/2005 60/741316 01/12/2005 US PCT/US/2006/038819 WO/2007/041630

19/10/2006

30

‫ ושימושים‬IL13 ‫נוגדנים של בני אדם כנגד‬ ‫טיפוליים‬

C07K )2009.01(

190333

PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF CASPOFUNGIN SANDOZ AG EP 05024961.4 15/11/2005 PCT/EP/2006/010867 WO/2007/057141

13/11/2006

C07K )2009.01(

190332

HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES NOVARTIS AG GB 0521509.0 21/10/2005 0616666.4 22/08/2006 GB PCT/EP/2006/010098 WO/2007/045477

13/11/2006

H, +K–+–‫מעכבים שעברו דיוטרציה ל‬ ‫ של מערכת העיכול בעלי תכונות‬ATPase ‫טיפוליות מוגברות‬

‫תהליך ותוצרי ביניים לסינטזת קספופונגין‬

C07D )2009.01(

190334

September 22, 2009

–‫ד' בתשרי התש"ע‬

PYRIDYLSULFONAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS ANTINEOPLASTIC AGENTS F. HOFFMANN-LA ROCHE AG EP 05025733.6 25/11/2005 PCT/EP/2006/010847 WO/2007/059872

20/03/2008

‫ ייצורן ושימושן‬,‫תולדות פירידילסולפונאמיד‬ ‫כחומרים למניעת גדילת תאים סרטניים‬

MINIATURE DISPOSABLE OR PARTIALLY REUSABLE DOSING PUMPS THOMAS PHILIP

05/10/2006

‫משאבות מנה מיניאטוריות חד פעמיות או‬ ‫ברות שימוש חוזר חלקי‬ ‫טומס פיליפ‬

C07D )2009.01(

190336

IMIDAZOPYRIDINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS LABORATORIOS ALMIRALL, S.A. ES P200502433 06/10/2005 PCT/EP/2006/009620 WO/2007/039297

02/06/2006

‫תולדות אימידאזופירידין כאנטגוניסטים‬ ‫ אדנוזין‬B2A ‫לרצפטור של‬

190337

AXIAL FLOW PUMP WITH MULTIGROOVED ROTOR HEARTWARE, INC. US 11/243722 05/10/2005 US PCT/US2005/35964 06/10/2005 US PCT/US2005/42495 22/11/2005 PCT/US/2006/021544 WO/2007/040663

05/10/2006 September 22, 2009

F04B )2009.01(

190335

190338

–‫ד' בתשרי התש"ע‬

A61M )2009.01( ‫משאבה צירית בעלת רוטור מחורץ‬

C07C )2009.01(

31

BIPHENYLOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB GB 0520324.5 06/10/2005 0525082.4 09/12/2005 GB 0602800.5 11/02/2006 GB PCT/GB/2006/003697 WO/2007/039741

03/10/2006

–1 ,2–)‫–כלורופניל‬2(–5–‫משטר מתן ל‬ –‫–מתיל‬3–‫–מתוקסי‬8–‫–פלואורו‬7–‫דיהידרו‬ ‫]בנזודיאזפין‬B][1,4–3,4[‫פיראזולו‬

32

C07D )2009.01(

190340

HETEROCYCLIC AMIDE DERIVATIVES USEFUL AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG EP 05023222.2 25/10/2005 06004191.0 02/03/2006 EP PCT/EP/2006/010185 WO/2007/048556

14/10/2003

C07D )2009.01(

190339

REGIMEN OF ADMINISTRATION FOR 5-(2-CHLOROPHENYL)-1,2-DIHYDRO7-FLUORO-8-METHOXY-3-METHYLPYRAZOLO [3,4B][1,4]BENZODIAZEPINE F. HOFFMANN-LA ROCHE AG US 60/727020 14/10/2005 PCT/EP/2006/067005 WO/2007/042430

23/10/2006

‫תולדות חומצה ביפנילאוקסיאצטית‬ ‫לטיפול במחלה נשימתית‬

‫תולדות אמיד הטרוציקלי השימושיות‬ ‫כקוטלי מיקרובים‬

C07D )2009.01(

190341

September 22, 2009

–‫ד' בתשרי התש"ע‬

HETEROCYCLOCARBOXAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG GB 0224316.0 18/10/2002 PCT/EP/2003/011388 WO/2004/035589

12/10/2006

‫נגזרות של הטרוציקלוקרבוקסמיד‬

B24B )2009.01(

190342

‫ליטוש כימי–מכני של מצעי‬ ‫רותניום‬/‫נחושת‬

CMP OF COPPER/RUTHENIUM SUBSTRATES CABOT MICROELECTRONICS CORPORATION US 11/259645 26/10/2005 PCT/US/2006/039956 WO/2007/050313

20/03/2008

G01B )2009.01(

190343

SYSTEM AND METHOD FOR HEIGHT MEASUREMENT CAMTEK LTD. US 60/895988 21/03/2007

20/03/2008

‫שיטה ומערכת למדידת גובה‬ ‫קמטק בע"מ‬

190344

POWER-ELECTRONIC CIRCUIT ARRANGEMENT FOR A ROTATING FIELD MACHINE RENK AKTIENGESELLSCHAFT DE 102007013462.4 21/03/2007

20/03/2008

September 22, 2009

190345

–‫ד' בתשרי התש"ע‬

G06F )2009.01(

‫מערך מעגל כח–אלקטרוני עבור מכונת‬ ‫שדה מסתובבת‬

G08B )2009.01(

33

THEFT-PROTECTING ASSEMBLY FOR RECHRGEABLE HAND-HELD ELECTRONIC DEVICES MEIR AVGANIM

30/10/2006

‫מיכלול להגנה בפני גניבות של מכשירים‬ ‫אלקטרוניים ניידים נטענים‬ ‫מאיר אבגנים‬

PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY NISSAN CHEMICAL INDUSTRIES, LTD. 2005JP 31/10/2005 316758 PCT/JP/2006/321632 WO/2007/052592

18/09/2006

‫תכשיר רפואי בעל פוטוסטאביוליות‬ ‫מצויינת‬

34

–‫מודולטורים של הקסאהידרו‬ ‫ציקלוהפטאפירזול קנבינויד‬

C07D )2009.01(

190348

HEXAHYDRO CYCLOOCTYL PYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV US 60/719884 23/09/2005 PCT/US/2006/037350 WO/2007/044215

18/09/2006

C07D )2009.01(

190347

HEXAHYDROCYCLOHEPTAPYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV US 60/720253 23/09/2005 PCT/US/2006/036158 WO/2007/038036

22/09/2006

A61K )2009.01(

190346

‫מודולטורים של הקסאהידרו ציקלואוקטיל‬ ‫פירזול קנבינויד‬

C07D )2009.01(

190349 September 22, 2009

–‫ד' בתשרי התש"ע‬

‫מודולטורים של טטראהידרו–אינדזוליל‬ ‫קנבינויד‬

TETRAHYDRO-INDAZOLYL CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV US 60/719772 23/09/2005 PCT/US/2006/036248 WO/2007/038045

19/09/2006

190350

BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES AND THEIR USE AS HISTAMINE-3 RECEPTORS LIGANDS ABBOTT LABORATORIES US 60/719516 22/09/2005 11/518132 08/09/2006 US PCT/US/2006/036422 WO/2007/038074

19/09/2006

‫נגזרות של בנזותיאזול ציקלובוטיל אמין‬ ‫והשימוש בהן כליגנדים של רצפטורים של‬ 3–‫היסטמין‬

190351

METHOD AND ANGLED SHEET MATERIAL AND JOINT INDUSTRIAL ORIGAMI, INC. US 60/720417 23/09/2005 PCT/US/2006/036698 WO/2007/038154

20/03/2008

METHOD FOR CONSOLIDATING BLOCKS OR SLABS MADE OF BUILDING MATERIAL

E04B )2009.01( ‫שיטה לגיבוש לבנים או אריחים‬ ‫העשויים מחומר בנייה‬

12/04/2007

20/03/2008

190353

C06B )2009.01( ‫התקן‬

DEVICE September 22, 2009

B21D )2009.01( ‫שיטה וחומר מלווח זוויתי ומחבר‬

190352

AROS S.R.L. IT VR2007A000054

C07D )2009.01(

–‫ד' בתשרי התש"ע‬

35

RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

22/09/2006

‫רפאל מערכות לחימה מתקדמות בע"מ‬

A61B )2009.01(

190354

‫מערך אלקטרודה‬

ELECTRODE ARRAY BRAINSCOPE COMPANY, INC. US 60/719943 23/09/2005 PCT/US/2006/037045 WO/2007/038305

12/09/2006

CONTROL SYSTEM FOR AN ARC FURNACE ADVANCED MINERAL RECOVERY TECHNOLOGIES LTD GB 0519163.0 20/09/2005 PCT/GB/2006/003357 WO/2007/034138

23/09/2005

F27B )2009.01(

190355

‫מערכת בקרה עבור כבשן‬

B32B )2009.01(

190356

COMPOSITIONS FOR IMPREGNATING PAPER PRODUCTS AND NATURAL FABRICS AND METHODS, PROCESSES AND ASSEMBLAGES THEREFOR ECOLOGY COATING, INC.

‫תכשירים להספגת מוצרי נייר ומרקמים‬ ‫ תהליכים והרכבים עבורם‬,‫טבעיים ושיטות‬

PCT/US/2005/034299 WO/2007/040493

21/09/2006

36

H04H )2008.04(

190357

September 22, 2009

–‫ד' בתשרי התש"ע‬

METHOD AND DEVICE FOR PROCESSING A DVB-H (DIGITAL, VIDEO BROADCASTINGHANDHELD) COMPLIANT TRANSPORT STREAM UDCAST, EP 05291979.2 23/09/2005 PCT/EP/2006/066603 WO/2007/039479

22/09/2006

190358

INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION US 60/719552 23/09/2005 PCT/US/2006/037142 WO/2007/038367

25/09/2006

190359

CONJUGATES OF THERAPEUTICALLY ACTIVE COMPOUNDS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/719175 22/09/2005 PCT/IL/2006/001118 WO/2007/034495

20/03/2008

190360

BALLISTIC ARMOR September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ התואם‬H–DVB ‫שיטה ומערכת לעיבוד‬ ‫לרצף שנשלח‬

C07D )2009.01( ,‫ בנזותיאזולים‬,‫אינדאזולים‬ ,‫ בנזאיזוקסאזולים‬,‫בנזואיזותיאזולים‬ ,‫ איזותיאזולופירידינים‬,‫פיראזולופירידינים‬ ‫הכנתם ושימושים בהם‬

A61K )2009.01( ‫צימודים של חומרים תראפויטים פעילים‬ ‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים‬

F41H )2009.01( ‫שריון בליסטי‬

37

‫פלסן סאסא בע"מ‬

PLASAN SASA LTD.

21/09/2006

A61B )2009.01(

190361

‫התקן‬

A DEVICE SMART SURGICAL APPLIANCES LTD GB 0519259.6 21/09/2005 PCT/GB/2006/003533 WO/2007/034203

21/09/2006

‫בלון מסועף ותומכן‬ ‫בלון בע"מ‬-‫בי‬

BIFURCATED BALLOON AND STENT B-BALLOON LTD US 60/719737 21/09/2005 60/750024 12/12/2005 US PCT/IL/2006/001111 WO/2007/034488

22/09/2006

A SYSTEM AND METHOD TO TRANSLATE EMAILS AND SMS

38

C12N )2009.01(

190363

CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION USES CELLERIX, S.L. EP 05077186.4 23/09/2005 PCT/EP/2006/009244 WO/2007/039150

23/03/2008

A61F )2009.01(

190362

‫אוכלוסיות תאים שלהם פעילות‬ ‫ שיטה לבידוד ושימושים‬,‫אימונורגולוטורית‬

G06F )2009.01(

190364

‫מערכת ושיטה לתרגום אימיילים‬ ‫ומיסרונים‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שלמה ארן‬

SHLOMO ARAN

23/03/2008

190365

INFLATABLE REFRIGERATOR AND FREEZER AVRAHAM KLANSS

23/03/2008

‫מקרר ומקפיא מתנפח‬ ‫אברהם קלאנס‬

190366

A DEVICE FOR POCKETS IN FOOTWEAR UZI EZRA HAVOSHA

20/09/2006

‫עוזי עזרא חבושה‬

FOOD ROASTING DEVICE, METHOD AND KIT GREEN GROWTH COFFEE, INC. US 60/718977 21/09/2005 60/726426 13/10/2005 US PCT/US/2006/036601 WO/2007/038113

190368

PATTERN DIVERSITY TO SUPPORT A MIMO RECEIVER AND ASSOCIATED METHODS September 22, 2009

–‫ד' בתשרי התש"ע‬

A43B )2009.01( ‫מתקן לכיסים בהנעלה‬

190367

22/09/2006

A47J )2009.01(

A47J )2009.01( ‫ שיטה וערכה לצליית מזון‬,‫התקן‬

G01S )2009.01( ‫מגוון תבניות לתמיכה במקלט רב–קלט‬ ‫ ) ושיטות קשורות‬MIMO( ‫ופלט‬

39

INTERDIGITAL TECHNOLOGY CORPORATION US 11/233329 22/09/2005 11/326042 05/01/2006 US PCT/US/2006/037074 WO/2007/038326

20/09/2006

WIRELESS COMMUNICATION METHOD AND SYSTEM FOR SUPPORTING CALL CONTINUITY INTERDIGITAL TECHNOLOGY CORPORATION US 60/720270 23/09/2005 PCT/US/2006/036986 WO/2007/038272

25/09/2006

B67D )2009.01(

‫שיטה ומערכת להושטה של מוצר ממיכל‬ ‫שומר צורה‬

B65B )2009.01(

190371

DEVICE FOR WINDING TAPES SHLOMO ESHED GB 0519367.7 23/09/2005

40

‫שיטה לתקשורת אלחוטית ומערכת‬ ‫לתמיכה ברצף שיחה‬

190370

METHOD AND ASSEMBLY FOR DISPENSING A PRODUCT FROM A FORM-RETAINING CONTAINER AFA POLYTEK B.V. NL 1030018 23/09/2005 06010958.4 28/05/2006 EP PCT/EP/2006/009268 WO/2007/039158

21/09/2006

H04Q )2008.04(

190369

‫התקן לליפוף סרטים‬ ‫שלמה אשד‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

PCT/IL/2006/001114 WO/2007/034491

23/06/2006

190372

BIARYL SUBSTITUTED HETEROCYCLE INHIBITORS OF LTA4H DECODE GENETICS EHF US 60/719016 21/09/2005 PCT/US/2006/024393 WO/2007/040682

27/12/2005

‫ הטרוצ'יקלים מותמרים‬LTA4H ‫מנועי‬ ‫ביארילים‬

190373

IMPROVED PROCESS FOR THE RECOVERY OF SULPHATE OF POTASH (SOP) FROM SULPHATE RICH BITTERN COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN 3014DEL2005 10/11/2005 PCT/IN/2005/000441 WO/2007/054953

21/09/2006

23/03/2008

September 22, 2009

–‫ד' בתשרי התש"ע‬

B43L )2009.01(

‫מכשיר–תיאום ומערכת המספקים ממשק‬ ‫למדייה להעברת חומרים חינוכיים‬

190375

METHOD AND APPARATUS FOR UTILIZATION OF LOCATION DETERMINING SIGNAL SAMPLES IN NOISY ENVIRONMENTS

C01D )2009.01( ‫תהליך משופר להפקת גפרית אשלג‬ ‫מאנפית עשירת גפרית‬

190374

ADAPTABLE DEVICE AND SYSTEM TO PROVIDE AN INTERFACE FOR MEDIA IMPARTING EDUCATIONAL MATERIAL EDU BARKAI US 60/719190 22/09/2005 PCT/IL/2006/001109 WO/2007/034486

C07D )2009.01(

‫אדו ברקאי‬

G01S )2009.01( ‫שיטה ומערכת לניצול דוגמיות אותות‬ ‫הגדרת מיקום בסביבה רועשת‬

41

‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬

MARVELL ISRAEL(M.I.S.L.) LTD. US 60/896104 21/03/2007

23/03/2008

‫שיטה ומערכת להגדרת מיקומם העושה‬ ‫שימוש בפתרונות היבריד‬

METHOD AND APPARATUS FOR DETERMINING LOCATION USING A HYBRID SOLUTION

‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬

MARVELL ISRAEL(M.I.S.L.) LTD. US 60/896098 21/03/2007 60/912551 18/04/2007 US

23/03/2008

POOL CLEANER WITH INTEGRAL CHLORINE GENERATOR AQUATRON, INC.

42

‫שיטה ומערכת להגדרת מיקומם העושה‬ ‫שימוש בפתרונות היבריד‬ ‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬

G07F )2009.01(

190378

SAFE DEVICE FOR COLLECTING COINS AND SAFE METHOD FOR TRANSFERRING AND EMPTYING COIN BOXES THALES FR 0509775 23/09/2005 PCT/EP/2006/066646 WO/2007/033996

23/09/2005

G06F )2009.01(

190377

METHOD AND APPARATUS FOR DETERMINING LOCATION USING A HYBRID SOLUTION MARVELL ISRAEL(M.I.S.L.) LTD. US 60/896098 21/03/2007 60/912551 18/04/2007 US

22/09/2006

G06F )2009.01(

190376

‫אמצעי בטוח לאיסוף מטבעות ושיטה‬ ‫בטוחה להחלפת וריקון קופסאות מטבעות‬

E04H )2009.01(

190379

‫מנקה בריכה עם גנרטור כלור אינטגרלי‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

PCT/US/2005/034233 WO/2007/040490

21/09/2006

190380

METHOD AND APPARATUS FOR MANAGING CACHE PARTITIONING QUALCOMM INCORPORATED US 11/233575 21/09/2005 PCT/US/2006/036938 WO/2007/035904

28/09/2006

‫שיטה ומערכת לניהול חלוקת אזורי אחסון‬

190381

MIXTURE OF IRON AND COPPER SALTS MASKING METTALIC TASTE BAYER CONSUMER CARE AG. EP 05292120.2 11/10/2005 PCT/EP/2006/009434 WO/2007/042153

24/03/2008

190382

DETECTING PROSTATE CANCER VERIDEX, LLC US 11/734763 12/04/2007

24/03/2008

190383

LOCAL VASCULAR DELIVERY OF PROBUCOL ALONE OR IN COMBINATION WITH SIROLIMUS TO TREAT RESTENOSIS, VULNERABLE PLAQUE, AAA AND STROKE September 22, 2009

–‫ד' בתשרי התש"ע‬

G06F )2009.01(

A61K )2009.01( ‫תערובת מלחי ברזל ונחושת הממסכים‬ ‫טעם מתכתי‬

A61B )2009.01( ‫אבחון סרטן הפרוסטטה‬

A61K )2009.01( ‫נתינה מקומית וסקולרית של פרובוקול‬ ‫לבד או בשילוב עם סירולימוס לטיפול‬ ‫ ושבץ‬AAA ,‫ פלק פגיע‬,‫ברסטנוסיס‬

43

CORDIS CORPORATION US 11/692744

24/03/2008

28/03/2007

THE MAGNETIC-FIELD METHOD FOR PROPULSIVE FORCE ACTIVATION AND MAGNETIC- FIELD PROPULSIVE DEVICES KHMELNIK SOLOMON

29/09/2006

‫חמלניק סולומון‬

A61K )2009.01(

‫שיטות להכנת פולימרים עם קבוצות אמינו‬ ‫קצוניות תוך כיד שימוש במלחי אמין‬ ‫מוגנים‬

C12N )2009.01(

190521

NUCLEIC ACIDS ENCODING MODIFIED CYTOCHROME P450 ENZYMES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

44

‫שיטת השדה המגנטי לזירת כח הינא‬ ‫והמגנטי לזירת מכשיר הינא‬

190415

METHODS FOR PREPARING POLYMERS HAVING TERMINAL AMINE GROUPS USING PROTECTED AMINE SALTS ENZON PHARMACEUTICALS, INC. US 11/242656 04/10/2005 PCT/US/2006/038562 WO/2007/044319

05/10/2006

B63H )2009.01(

190384

‫חומצות גרעין המקודדות לאנזימי צ'טוכרום‬ ‫ משונים ושיטות לשימוש בהן‬P450

September 22, 2009

–‫ד' בתשרי התש"ע‬

US 60/724525 60/762700 US PCT/US/2006/039433 WO/2007/044688

07/10/2005 27/01/2006

15/10/2006

190562

METHOD AND SYSTEM FOR TREATING ORGANICALLY CONTAMINATED WASTE WATER RONI WEISSMAN US 60/723986 06/10/2005 PCT/IL/2006/001172 WO/2007/039910

15/11/2006

‫שיטה ומערכת לטיפול בשפכים המכילים‬ ‫זיהום אורגני‬ ‫רוני ויסמן‬

190705

190706

ISOLATED NUCLEIC ACID WHICH ENCODES A SUCROSE FLUORESCENT INDICATOR, SUCROSE BIOSENSORS AND METHODS OF USING THE SAME CARNEGIE INSTITUTION OF WASHINGTON September 22, 2009

–‫ד' בתשרי התש"ע‬

C12N )2009.01( ‫תהליך להכנת שורת תאים אנושיים‬ ‫קבועה‬

A METHOD FOR THE PRODUCTION OF A PERMANENT HUMAN CELL LINE CEVEC PHARMACEUTICALS GMBH DE 102005054628.5 16/11/2005 PCT/DE/2006/002004 WO/2007/056994

14/10/2005

C02F )2009.01(

A01H )2009.01(

‫חומצת גרעין מבודדת המקודדת אינדקטור‬ ‫ חיישן מן החי‬,‫לפלוארנות של סוכרוז‬ ‫לסוכרוז ושיטות לשימוש בהם‬

45

PCT/US/2005/036951 WO/2007/046786

13/10/2006

DIURETIC-LIKE COMPOUND ANALOGS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS CONTAINING THE SAME NEUROTHERAPEUTICS PHARMA, INC US 60/727564 17/10/2005 PCT/US/2006/040108 WO/2007/047447

19/10/2006

‫אנולוגים דמיוו תרכובת משתנת ותכשירי‬ ‫רוקחות לויסות אי–סדרים של מערכת‬ ‫העצבים המרכזית המכילים אותם‬

‫כרומנונים ושימושם כמאפנני רצפטורים‬ ‫של גלוטמט מטבוטרופי‬

C07J )2009.01(

190743

IMPROVED METHOD FOR THE PRODUCTION OF BETULINIC ACID BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 05109482.9 12/10/2005 PCT/EP/2006/067309 WO/2007/042542

46

C07D )2009.01(

190740

CHROMENONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA US 60/729312 21/10/2005 PCT/GB/2006/003888 WO/2007/045876

12/10/2006

C07D )2009.01(

190710

‫שיטה משופרת ליצור חומצה בטולינית‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

09/11/2006

190920

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS WELLSTAT THERAPEUTICS CORPORATION US 60/734803 09/11/2005 PCT/US/2006/060727 WO/2007/567714

18/10/2006

190921

ANTENNA ARRANGEMENT BLUESKY POSITIONING LIMITED EP 05109729.3 19/10/2005 PCT/FI/2006/050448 WO/2007/045725

30/05/2006

190922

INPUT-DEVICE MOVEMENT TO CURSOR MOVEMENT CORRELATOR AVOCENT HUNTSVILLE CORP. US 11/250406 17/10/2005 PCT/US/2006/021181 WO/2007/046879

25/10/2006

190924

METHOD FOR COLLATING DOCUMENTS AND DEVICE FOR CARRYING OUT THIS METHOD MEGASPIREA PRODUCTION S.A.S. FR 0510923 26/10/2005 PCT/FR/2006/002394 WO/2007/048923 September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫תרכובות לטיפול בהפרעות מטבוליות‬

H01Q )2009.01( ‫סידור אנטנה‬

G06F )2009.01( ‫מתאם של תנועות מכשיר הזנה עם‬ ‫תנועות סמן‬

B65B )2009.01( ‫שיטה למיון מסמכים והתקן לבצע את‬ ‫השיטה‬

47

16/11/2006

A PHARMACEUTICAL COMPOSITION CONTAINING A TISSUE PROTEIN THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION US 60/737194 16/11/2005 PCT/US/2006/044344 WO/2007/059211

24/10/2006

B65B )2009.01( ‫מכשירים ושיטות השימושיות לאישור‬ ‫קניות הקשורות עם כלי רכב‬ ‫פטרהטק אינטרנשיונל בע"מ‬

A61K )2009.01(

190935

4-(3-AMINOPYRAZOLE)PYRIMIDINE DERIVATIVES FOR USE AS TYROSINE KINASE INHIBITORS IN THE TREATMENT OF CANCER ASTRAZENECA AB US 60/731299 28/10/2005 60/803061 24/05/2006 US PCT/GB/2006/003978 WO/2007/049041

48

‫תכשיר רוקחות המכיל חלבון רקמה‬

190934

DEVICES AND METHODS USEFUL FOR AUTHORIZING PURCHASES ASSOCIATED WITH A VEHICLE PETRATEC INTERNATIONAL LTD US 60/729215 24/10/2005 60/762498 27/01/2006 US 60/790533 10/04/2006 US PCT/IL/2006/001222 WO/2007/049274

26/10/2006

A61K )2009.01(

190926

‫–אמינופיראזול)פירימידין‬3(–4 ‫נגזרות‬ ‫לשימוש כמעכבי טירוזין קינאז בטיפול‬ ‫בסרטן‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

20/10/2006

190936

IAP BIR DOMAIN BINDING COMPOUNDS AEGERA THERAPEUTICS INC. US 60/729727 25/10/2005 60/830662 14/07/2006 US PCT/CA/2006/001721 WO/2007/048224

16/10/2006

190939

APPARATUS FOR DELIVERY OF PRESSURISED GAS COMPUMEDICS LIMITED AU 2005905836 21/10/2005 PCT/AU/2006/001513 WO/2007/045017

19/10/2006

190944

APERTURED CONDITIONING BRUSH FOR CHEMICAL MECHANICAL PLANARIZATION SYSTEMS TBW INDUSTRIES, INC. US 60/728126 19/10/2005 11/582711 18/10/2006 US PCT/US/2006/041166 WO/2007/047996

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( BIR IAP ‫תרכובות קושרות‬

A61M )2009.01( ‫מתקן לאספקת גז בלחץ‬

B24B )2009.01( ‫מברשת התאמה עם פתח למערכות‬ ‫פלנריזציה כימיות מכניות‬

49

12/10/2006

‫זיהוי תוך גופי של מוות תאי‬

JN VIVO DETECTION OF APOPTOSIS IMMUNOCHEMISTRY TECHNOLOGIES, LLC US 60/729227 21/10/2005 PCT/US/2006/040047 WO/2007/050319

19/10/2006

‫מוחק לדיסק קשיח‬

A61K )2009.01(

190951

METHOD OF ACTING UPON ORGANISM BY TARGETED DELIVERY OF BIOLOGICALY ACTIVE SUBSTANCES INTO MITOCHONDRIA, PHARMACEUTICAL COMPOSITION FOR CARRYING OUT SAID METHOD, AND COMPOUND USED FOR THE PURPOSE

50

G06F )2009.01(

190950

HARD DRIVE ERASER ENSCONCE DATA TECHNOLOGY, INC. US 60/728320 20/10/2005 PCT/US/2006/040805 WO/2007/047802

24/07/2006

G01N )2009.01(

190949

‫שיטה להכוונת חומר פעיל ביולוגית לתוך‬ ‫ תכשיר רוקחי המיישם‬,‫המיטוכונדריה‬ ‫שיטה זו ותרכובות למטרה זו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

LIMITED LIABILITY COMPANY "MITOTECHNOLOGY" RU 2005132217 18/10/2005 PCT/RU/2006/000394 WO/2007/046729

20/10/2006

PIPERAZINE DERIVATIVES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD. WO IB05/53457 21/10/2005 PCT/IB/2006/053868 WO/2007/046075

09/10/2006

‫תולדות פיפראזיניות כגורם נגד מלריה‬

190953

CYCLOPROPYLACETIC ACID DERIVATIVES AND USE THEREOF BAYER HEALTHCARE AG DE 102005050498.1 21/10/2005 PCT/EP/2006/009723 WO/2007/045367

20/10/2006

190954

MODIFIED PROTEASES THAT INHIBIT COMPLEMENT ACTIVATION CATALYST BIOSCIENCES, INC. US 60/729817 21/10/2005 PCT/US/2006/041165 WO/2007/047995

September 22, 2009

C07D )2009.01(

190952

–‫ד' בתשרי התש"ע‬

C07C )2009.01( ‫תולדות חומצה ציקלו פרופיל אצטית‬ ‫ושימושיה‬

A61K )2009.01( ‫פרוטיאזות שונות המעכבות שפעול‬ ‫משלים‬

51

17/10/2006

DICARBOXYLIC ACID DERIVATIVES AND THEIR USE BAYER HEALTHCARE AG DE 102005050376.4 21/10/2005 PCT/EP/2006/009996 WO/2007/045433

20/10/2006

‫תולדות חומצות דיקרבוקסיליות‬ ‫ושימושיהן‬

F16L )2009.01(

190956

FITTING FOR TUBE AND PIPE SWAGELOK COMPANY US 11/255499 20/10/2005 11/375843 14/03/2006 US PCT/US/2006/041214 WO/2007/048021

23/10/2006

C07C )2009.01(

190955

‫מתאם עבור שפופרת וצינור‬

H01M )2009.01(

190958

‫סוללות יוני ליתיום‬

LITHIUM ION BATTERIES ALTAIRNANO, INC. US 60/729100 21/10/2005 60/748124 06/12/2005 US PCT/US/2006/060164 WO/2007/048142

09/11/2006

MOLDED SHAVING AID COMPOSITIONS, COMPONENTS AND METHOD OF MANUFACTURE THE GILLETTE COMPANY US 60/735758 09/11/2005 PCT/US/2006/043611 WO/2007/056509

52

B26B )2009.01(

190959

‫ רכיבים ושיטה‬,‫תכשיר מעוצב לגילוח‬ ‫ליצורו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

08/11/2006

C07K )2009.01(

190960

‫אנטגוניסטים של ניורופילין‬

NEUROPILIN ANTAGONISTS GENENTECH, INC. US 60/734798 08/11/2005 60/820561 27/07/2006 US PCT/US/2006/043516 WO/2007/056470

30/10/2006

C07D )2009.01(

190961

SUBSTITUTED CYCLOALKYLPYRROLONES AS ALLOSTERIC MODULATORS OF GLUCOKINASE JANSSEN PHARMACEUTICA NV US 60/732414 01/11/2005 PCT/US/2006/042925 WO/2007/053765

27/04/2008

‫ציקלואלקילפירולונים מותמרים‬ ‫המשמשים כמודולטורים אלוסטרים של‬ ‫גלוקוקינאז‬

191062

ANGULAR DISPLACEMENT DERIVATIVE METHOD FOR ULTRASOUND SEQUENCE ANALYSIS BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

06/11/2006

‫שיטה הנגזרת מזווית ציר לניתוח רצף‬ ‫אולטראסוני‬ ‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬ ‫למחקר ופיתוח‬

191488

AQUEOUS HERBICIDAL COMPOSITION BASED ON A SUSPENSION CONCENTRATE COMPRISING HERBICIDES AND SAFENER BAYER CROPSCIENCE AG EP 05025149.5 17/11/2005 102006030326.1 30/06/2006 DK PCT/EP/2006/010591 WO/2007/057107 September 22, 2009

–‫ד' בתשרי התש"ע‬

G01N )2009.01(

A01N )2009.01( ‫תכשירים קוטלי עשבים מימיים‬ ‫מבוססים על תרכיז של תרחיף המכיל‬ ‫חומרים קוטלי עשבים ומגן‬

53

09/11/2007

INTRAUTERINE ULTRASOUND AND METHOD FOR USE GYNESONICS, INC. US 60/758727 12/01/2006 60/821009 01/08/2006 US PCT/US/2007/060285 WO/2007/112144

12/06/2007

A61B )2009.01(

191526

‫אולטרסאונד תוך–רחמי ושיטה לשימוש‬

F16D )2009.01(

191638

ELECTRICALLY-OPERATED SHAFT BRAKE WITH MANUAL POSITIVE LOCK AND ROTARY RELEASE AND AUTOMATIC RESET FEATURE MOOG INC

‫מוט עצר המופעל על–ידי חשמל בעל‬ ‫ שחרור סיבובי‬,‫נעילה פוזיטיבית ידנית‬ ‫ומאפיין איפוס אוטומטי‬

PCT/US/2007/013722

27/11/2006

B66F )2009.01(

191689

‫מגבה‬

A SCISSOR JACK QUADDRO TECHNOLOGIES (PTY) LTD ZA 2005/09554 28/11/2005 2006/01531 22/02/2006 ZA 2006/02326 22/03/2006 ZA 2006/02455 27/03/2006 ZA PCT/IB/2006/054465 WO/2007/096714

54

September 22, 2009

–‫ד' בתשרי התש"ע‬

29/11/2006

191710

GLUCOCORTICOID RECEPTOR MODULATORS AS ANTIINFLAMMATORY AGENTS F. HOFFMANN-LA ROCHE AG US 60/749180 09/12/2005 PCT/EP/2006/069059 WO/2007/065828

22/11/2006

12/12/2006

27/11/2006

C12N )2009.01(

‫ ודהפיגמנטציה של העור‬VA siRNA ‫רצפי‬

191735

–‫ד' בתשרי התש"ע‬

G06F )2009.01(

‫ מערכות ומוצרים המשלבים תוכנת‬,‫שיטות‬ ‫מחשב לאספקת סידרת ניהול‬

191728

ANTI-MYOSIN VA siRNA AND SKIN DEPIGMENTATION PIERRE FABRE DERMOCOSMETIQUE FR 0512553 12/12/2005 PCT/EP/2006/069618 WO/2007/068704

September 22, 2009

‫מאפננים לרצפטור לגלוקוקורטיקואיד‬ ‫כסוכנים אנטידלקתיים‬

191727

METHODS, SYSTEMS, AND COMPUTER INTEGRATED PROGRAM PRODUCTS FOR SUPPLY CHAIN MANAGEMENT THE BOEING COMPANY US 60/740356 29/11/2005 11/343425 30/01/2006 US PCT/US/2006/045232 WO/2007/064549

C07D )2009.01(

G02B )2009.01(

55

OPTICAL INSTRUMENT COMPRISING AN INPUT CAVITY WHEREIN IS ARRANGED A MIRROR THALES FR 0553620 28/11/2005 PCT/FR/2006/051234 WO/2007/060376

28/11/2006

‫מערכת ושיטה למניעת רכישת מידע ללא‬ ‫הרשאה‬

G21F )2009.01(

191901

CERAMIC RADIATION SHIELDING COMPOSITION CONTAINING AN OXIDE-PHOSPHATE CERAMIC CEMENT MATRIX CO-OPERATIONS, INC US 11/295708 06/12/2005 11/441833 26/05/2006 US PCT/US/2006/046722 WO/2008/060292

56

G06F )2009.01(

191799

[SVC] SYSTEM AND METHOD FOR PREVENTING UNAUTHORIZED ACQUISITION OF INFORMATION IBM CORPORATION 2005JP 28/11/2005 341712 PCT/JP/2006/323748 WO/2007/061119

06/12/2006

‫מכשיר אופטי המכיל חלל מקבל אשר בו‬ ‫נמצאת מראה‬

‫תכשיר קרמי מגן קרינה המכיל מטריצת‬ ‫מלט קרמי תחומצתית–פוספטית‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

23/11/2006

A61P )2009.01(

191971

POLYMORPHS OF A C-MET/HGFR INHIBITOR PFIZER PRODUCTS INC. US 60/742676 05/12/2005 PCT/IB/2006/003383 WO/2007/066185

04/01/2007

HGFR/MET–C ‫פולימורפים של מעכב‬

SYSTEM AND METHOD FOR LOW POWER WORDLINE LOGIC FOR A MEMORY QUALCOMM INCORPORATED US 60/756100 04/01/2006 60/756856 06/01/2006 US 11/402483 11/04/2006 US PCT/US/2007/060117 WO/2007/012093

22/03/2007

‫מערכת ושיטה ללוגיקת קו–מילולי בכוח‬ ‫נמוך לזיכרון‬

192297

BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX NEUROSEARCH A/S DK PA200600426 24/03/2006 DK PA200601327 12/10/2006 PCT/EP/2007/052766 WO/2007/110374

25/12/2006 September 22, 2009

G11C )2009.01(

191973

‫תולדות בנזימידאזול והשימוש בהן לאפנון‬ AA GABA ‫קומפלקס קולטן‬

192298

–‫ד' בתשרי התש"ע‬

C07D )2009.01(

A61P )2009.01(

57

HETEROCYCLIC JANUS KINASE 3 INHIBITORS ASTELLAS PHARMA INC. 2005JP 28/12/2005 378858 PCT/JP/2006/326327 WO/2007/077949

27/12/2006

58

‫גורם טיפולי לסוכרת‬

C07D )2009.01(

192387

DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS OR BKCA CHANNEL MODULATORS NEUROSEARCH A/S DK PA200600360 14/03/2006 PCT/EP/2007/052243 WO/2007/104719

05/01/2007

A61P )2009.01(

192369

THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED JP 379407/2005 28/12/2005 061722/2006 07/03/2006 JP PCT/JP/2006/326141 WO/2007/074884

09/03/2007

‫ הטרוציקליים‬JAK3 ‫מעכבי‬

‫תולדות דיפניל אוריאה ושימושן כחסמי‬ BKCA ‫ערוץ כלורידי או מאפנני ערוץ‬

A01N )2009.01(

192422

September 22, 2009

–‫ד' בתשרי התש"ע‬

AGROCHEMICAL FORMULATIONS BASED ON MOLECULARLY IMPRINTED ACRYLATES BASF SE EP 06100263.0 12/01/2006 PCT/EP/2007/050112 WO/2007/082802

19/12/2006

192465

GENIUS ADAPTIVE DESIGN KAYS, STEVEN US 60/755291 30/12/2005 60/756607 05/01/2006 US 60/778313 01/03/2006 US 60/783018 15/03/2006 US 60/786906 28/03/2006 US 60/852794 18/10/2006 US PCT/US/2006/048704 WO/2007/081519

21/12/2006

192482

FITTING FOR METAL PIPE AND TUBING SWAGELOK COMPANY US 11/324882 04/01/2006 PCT/US/2006/048786 WO/2007/081527

18/01/2007

September 22, 2009

192514

–‫ד' בתשרי התש"ע‬

‫הרכבים אגרוכימיים המבוססים על‬ ‫אקרילטים המוטבעים באופן מוליקולרי‬

G06Q )2008.04( ‫תכנון גאונות הניתן להתאמה‬

F16L )2009.01( ‫אביזר עבור צנור מתכת וצנרת‬

G06F )2009.01(

59

SEMI-TRANSPARENT HIGHLIGHTING OF SELECTED OBJECTS IN ELECTRONIC DOCUMENTS MICROSOFT CORPORATION US 11/344396 31/01/2006 PCT/US/2007/001545 WO/2007/089461

17/02/2006

‫הדגשה שקופה למחצה של חפצים‬ ‫נבחרים במסמכים אלקטרוניים‬

A61F )2008.04(

192543

‫תותבת אנדולומינלית‬

ENDOLUMINAL PROSTHESIS INVATEC S.R.L. PCT/IT/2006/000086 WO/2007/094020

21/09/2006

DNT-SUCCINATE AND METHODS OF PREPARATION THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. US 60/761585 23/01/2006 60/771162 06/02/2006 US PCT/US/2006/036974 WO/2007/084193

18/12/2006

‫דולקסטין סוקצינט ותהליכים להכנתם‬ ‫טבע תעשיות פרמצבטיות בע"מ‬

A61K )2009.01(

192593

COMBINATION OF TRIAZINE DERIVATIVES AND PPAR? AGONISTS POXEL SAS FR 06/00345 13/01/2006 PCT/EP/2006/012186 WO/2007/079918

60

C07D )2009.01(

192552

‫קומבינציה של נגזרות טריאזין ואגוניסטים‬ ?PPAR ‫של‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

18/12/2006

192594

COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS POXEL SAS FR 06/00343 13/01/2006 PCT/EP/2006/012184 WO/2007/079916

18/12/2006

‫קומבינציה של נגזרות טריאזין ומעכבים‬ COA–HMG ‫של רדוקטאז‬

192596

COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SECRETION STIMULATORS POXEL SAS FR 06/00342 13/01/2006 PCT/EP/2006/012182 WO/2007/079914

22/12/2006

USE OF TIOTROPIUM SALTS IN THE TREATMENT OF MODERATE PERSISTENT ASTHMA BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 06100055.0 04/01/2006 PCT/EP/2006/070135 WO/2007/077162

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫שימוש במלחי טיאוטרופיום לטיפול‬ ‫באסטמה מתונה מתמדת‬

192613

CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS SEPRACOR INC. US 60/756550 06/01/2006 PCT/US/2007/000376 WO/2007/081857

A61K )2009.01( ‫קומבינציה של נגזרות טריאזין ומעוררי‬ ‫הפרשת אינסולין‬

192602

05/01/2007

A61K )2009.01(

A61K )2009.01(

‫ציקלואלקילאמינים כמעכבי ספיגה מחדש‬ ‫של מונואמינים‬

61

04/01/2007

STEAM CIRCUIT IN A POWER STATION SIEMENS AKTIENGESELLSCHAFT EP 06000183.1 05/01/2006 PCT/EP/2007/050081 WO/2007/077248

03/01/2007

PESTICIDAL MIXTURES BASF SE US 60/760532 PCT/EP/2007/050280 WO/2007/082841

07/02/2007

A61K )2009.01(

‫ הריאות או דרך‬,‫תכשיר לנתינה דרך הריר‬ ‫הפה‬

A01N )2009.01(

192658

‫תערובות קוטלות מזיקים‬ 20/01/2006

H04J )2009.01(

192669

AN APPARATUS AND METHOD FOR FAST ACCESS IN A WIRELESS COMMUNICATION SYSTEM QUALCOMM INCORPORATED US 60/771093 07/02/2006 PCT/US/2007/061793 WO/2007/092896

62

‫מסלול קיטור בתחנת כוח‬

192642

A COMPOSITION FOR MUCOSAL, PULMONARY OR ORAL ADMINISTRATION THOMAS SKOLD US 60/756359 05/01/2006 11/616658 27/12/2006 US PCT/IB/2007/000027 WO/2007/077529

12/01/2007

F22G )2009.01(

192620

‫התקן ושיטה לגישה מהירה במערכת‬ ‫תקשורת אלחוטית‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

22/01/2007

192678

COMPOSITIONS AND KITS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS GENZYME CORPORATION US 60/760377 20/01/2006 PCT/US/2007/001599 WO/2007/084743

10/01/2007

‫תכשירים וערכות לטיפול לטרשת לטרלי‬ ‫עמיוטרופי‬

192693

UROTENSIN II RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV US 60/757692 10/01/2006 PCT/US/2007/000644 WO/2007/081995

17/01/2007

192696

NEURONAL NICOTINIC RECEPTOR LIGANDS AND THEIR USE ABBOTT LABORATORIES US 60/759314 17/01/2006 PCT/US/2007/001193 WO/2007/084535

17/01/2007

192700

USE OF ELDERBERRY EXTRACT HEALTHCARE BRANDS INTERNATIONAL LIMITED IL 173207 17/01/2006 PCT/GB/2007/000150 WO/2007/083123

18/01/2007 September 22, 2009

192718

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

A61K )2009.01( II ‫אנטגוניסטים לרצפטור אורוטנסין‬

A61K )2009.01( ‫ליגנדים של רצפטור ניקוטיני נוירונלי‬ ‫ושימוש שלהם‬

A61K )2008.04( ‫שימוש בתמצית פרי הסמבוק‬

A61F )2009.01(

63

HARNESS FOR STRETCHING THE PENIS CVETANOVIC, MIODRAG P19/01/2006 2006/0030 PCT/RS/2007/000001 WO/2007/084022

04/03/2007

‫ריתמה למתיחת הפין‬

METHOD AND APPARATUS FOR LIGHT-BASED HAIR REMOVAL USING INCOHERENT LIGHT PULSES ALMA LASERS LTD US 60/778403 03/03/2006 60/853428 23/10/2006 US PCT/IL/2007/000275 WO/2007/099546

20/09/2006

‫שיטה ומתקן להסרת שיער בעזרת אור על‬ ‫ידי פולסים של אור אינקוהרנטי‬ ‫אלמה לייזרס בע"מ‬

64

‫מוצר לריכוך מים וניקוי צבע‬

D03J )2009.01(

192938

METHOD AND APPARATUS FOR WEAVING UNIVERSITY OF BRIGHTON GB 0601376.7 24/01/2006 PCT/GB/2007/050035 WO/2007/085872

01/02/2007

C11D )2009.01(

192887

DYE SCAVENGING AND WATER SOFTENING PRODUCT ORLANDI S.P.A. IT MI2006A000096 20/01/2006 PCT/IT/2006/000667 WO/2007/083335 23/01/2007

A45D )2009.01(

192784

‫מכשיר ושיטה לאריגה‬

H05K )2009.01(

192986

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ שיטה‬,‫מערכת הדמיה אופטימלית‬ ‫ומדפסת שיכפול‬

OPTIMAL IMAGING SYSTEM AND METHOD FOR A STENCIL PRINTER SPEEDLINE TECHNOLOGIES, INC. US 11/345727 02/02/2006 PCT/US/2007/002925 WO/2007/092325

29/01/2007

193020

DRUG DELIVERY SYSTEMS CONTAINING WEAKLY BASIC SELECTIVE SEROTONIN 5-HT3 BLOCKING AGENT AND ORGANIC ACIDS EURAND, INC. US 60/762750 27/01/2006 PCT/US/2007/061217 WO/2007/090082

31/01/2007

‫מערכות לנתינת תרופות המכילות גורם‬ ‫ בסיסי חלש‬HT–53 ‫חוסם ברירתי סרוטנין‬ ‫וחומצות ארוגניות‬

193137

METHOD OF CHARACTERIZING A BIOLOGICALLY ACTIVE COMPOUND REGENETECH, INC. US 60/764524 02/02/2006 PCT/US/2007/002626 WO/2007/092222

23/02/2006

A61K )2009.01(

193189

A SURGICAL ISOLATOR OVAGEN INTERNATIONAL LIMITED

C12N )2009.01( ‫שיטה לאיפיון חומר פעיל ביולוגית‬

A61D )2009.01( ‫מבודד כירוגי‬

PCT/EP/2006/060241 WO/2007/095998

30/11/1998

September 22, 2009

193245

–‫ד' בתשרי התש"ע‬

G01N )2009.01(

65

PHARMACEUTICAL COMPOSITIONS CONTAINING AN A? FRAGMENT NEURALAB LIMITED US 60/067740 02/12/1997 60/080970 07/04/1998 US PCT/US/1998/025386 WO/1999/027944

22/12/2003 RADIATION CURABLE INK SERICOL LIMITED GB 0229825.5 GB PCT/GB03/0028.34 PCT/GB/2003/005619 WO/2003/015988

23/03/2006

?A ‫תכשירי רוקחות המכילים קטע‬

B41M )2009.01(

193263

‫דיו הניתן לריפוי באמצעות קרינה‬ 20/12/2002 01/07/2003

G06T )2009.01(

193290

SYSTEM FOR ANALYSIS OF MOTION NDS LIMITED

‫מערכת לניתוח תנועה‬

PCT/GB/2006/001070 WO/2007/107685

09/02/2007

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC GB 0602767.6 10/02/2006 0617737.2 08/09/2006 GB 0623984.2 30/11/2006 GB PCT/GB/2007/050056 WO/2007/091107

66

A61K )2009.01(

193314

‫טיפול במחלת ניוון שרירים דושן‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

09/02/2007

193315

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC GB 0602768.4 10/02/2006 0614690.6 24/07/2006 GB 0619281.9 29/09/2006 GB 0623983.4 30/11/2006 GB PCT/GB/2007/050055 WO/2007/091106 21/02/2007

193356

USE OF RASAGILINE FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY TEVA PHARMACEUTICAL INDUSTRIES LTD. US 60/775147 21/02/2006 60/874341 12/12/2006 US PCT/US/2007/004884 WO/2007/098264

20/02/2007

193372

PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR PHOSPHATE

A61K )2009.01( ‫טיפול במחלת ניוון שרירים דושן‬

A61K )2009.01( ‫רסג'לין כטיפול באטרופיה רב מערכתית‬ ‫טבע תעשיות פרמצבטיות בע"מ‬

A61K )2009.01( ‫תכשיר רוקחות המכיל אוסלטמיביר‬ ‫פוספט‬

F. HOFFMANN-LA ROCHE AG 2006JP 20/02/2006 042178 PCT/JP/2007/053081 WO/2007/097325

September 22, 2009

–‫ד' בתשרי התש"ע‬

67

07/03/2007

SYSTEM FOR THE EXPRESSION OF ORTHOGONAL TRANSLATION COMPONENTS IN EUBACTERIAL HOST CELLS THE SCRIPPS RESEARCH INSTITUTE US 60/780973 09/03/2006 60/783497 17/03/2006 US 60/855336 29/10/2006 US PCT/US/2007/005914 WO/2007/103490

15/02/2006

G06Q )2008.04(

193394

‫מערכת לביטוי רכיבי תרגום אורתוגונליים‬ ‫בתאים פונדקאיים אובקטריאליים‬

B07C )2009.01(

193409

‫התקן מיון‬

SORTING INSTALLATION PPG AG PERNER PUBLISHING GROUP AG PCT/EP/2006/001372 WO/2007/093189

13/08/2008 STORAGE FOR RADIOACTIVE WASTE NOVARENA TECHNOLOGIES LTD

20/02/2007

‫איחסון של חומר רדיו אקטיבי‬ ‫נוברנה טכנולוגיות בע"מ‬

G06F )2009.01(

193436

DEVICE, SYSTEM AND METHOD OF ACCESSING A SECURITY TOKEN K.K. ATHENA SMARTCARD SOLUTIONS US 60/774660 21/02/2006 PCT/IL/2007/000226 WO/2007/096871

68

G21F )2009.01(

193434

‫ מערכת ושיטה לגישה לטוקן‬,‫התקן‬ ‫אבטחה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

21/03/2007

193467

SUBSTITUTED INDAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG EP 06006008.4 23/03/2006 PCT/EP/2007/002487 WO/2007/107346

27/02/2007

‫ ייצורן‬,‫נגזרות מותמרות של אינדאזול‬ ‫ושימושן כחומרי רוקחות‬

193483

193649

A SYSTEM AND METHOD OF MANAGING ABSENTEEISM IN AN ORGANISATION DISCOVERY HOLDINGS LIMITED ZA 2006/01934 07/03/2006 PCT/IB/2007/000541 WO/2007/102077 28/02/2007

September 22, 2009

–‫ד' בתשרי התש"ע‬

G06Q )2008.04( ‫מערכת ושיטה לניהול היעדרות בארגון‬

193664

STENT WITH VARIABLE FEATURES TO OPTIMIZE SUPPORT AND METHOD OF MAKING SUCH STENT MEDINOL LTD. US 11/366365 01/03/2006 PCT/IB/2007/000482 WO/2007/099439

C07D )2009.01( ‫– אונים‬2 – ‫– דיהידרו–אימידאזול‬1,5 5–‫ ו‬1 ‫ – אמינו בעמדות‬4 –‫המותמרים ב‬

4-AMINO-1,5-SUBSTITUTED 1,5 DIHYDRO - IMIDAZOL -2- ONES F. HOFFMANN-LA ROCHE AG EP 06110812.2 08/03/2006 PCT/EP/2007/051824 WO/2007/101802

07/03/2007

C07D )2009.01(

A61F )2009.01(

‫סטנט בעל מאפיינים הניתנים לשינוי על‬ ‫מנת לייעל תמיכה ושיטה לייצור הסטנט‬ ‫מדינול בע"מ‬

69

15/03/2007

VARENICLINE STANDARDS AND IMPURITY CONTROLS PFIZER PRODUCTS INC. US 60/786543 27/03/2006 60/828142 04/10/2006 US PCT/IB/2007/000722 WO/2007/110730

14/03/2007

‫סטנדרטים ובקרות אי–נקיונות של ורניקלין‬

‫שיטות ותכשירים למניעת ניצול רע של‬ ‫מוצרים פרמצבטיים המיועדים למתן‬ ‫פומית‬

‫תכשיר רוקחות המכיל אמינוסליצילת‬ ‫כחומר פעיל‬

A61P )2009.01(

193799

NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCOTIC DISORDERS WYETH US 60/785449 24/03/2006 60/788392 31/03/2006 US PCT/US/2007/007210 WO/2007/111983

70

A61K )2009.01(

193776

A PHARMACEUTICAL COMPOSITION CONTAINING AN AMINOSALICYLATE ACTIVE AGENT AGI THERAPEUTICS RESEARCH LTD. US 11/371958 10/03/2006 PCT/IB/2007/002029 WO/2007/119177 23/03/2007

A61K )2009.01(

193766

METHOD AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS ACURA PHARMACEUTICALS, INC. US 60/782448 15/03/2006 PCT/US/2007/006519 WO/2007/106550

07/03/2007

A61K )2009.01(

193688

‫צירופים טיפוליים חדשים לטיפול או מניעה‬ ‫של אי סדרים פסיכוטיים‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

23/03/2007

A61P )2009.01(

193800

ENDOTHELIN AND ENDOTHELIN RECEPTOR AGONISTS IN THE TREATMENT OF METABOLIC DISEASES AMYLIN PHARMACEUTICALS, INC. US 60/785447 23/03/2006 PCT/US/2007/007376 WO/2007/112069

23/03/2007

‫אגוניסטים של קולטן אנדותאלין‬ ‫ואנדותאלין לטיפול במחלות חילוף חומרים‬

A61P )2009.01(

193841

METHODS FOR MODULATING BLADDER FUNCTION WYETH US 60/785451 24/03/2006 PCT/US/2007/007387 WO/2007/112073

28/03/2007

‫שיטות לויסות פעילות שלפוחית השתן‬

193842

DIAGNOSTICS AND TREATMENTS FOR TUMORS GENENTECH, INC. US 60/787720 29/03/2006 PCT/US/2007/065377 WO/2007/115045 07/03/2007

‫אבחונים וטיפולים עבור גידולים‬

193885

NEW AMINES ACTELION PHARMACEUTICALS LTD. WO PCT/IB06/050724 08/03/2006 PCT/IB/2007/050758 WO/2007/102127

02/10/2006 September 22, 2009

193894

–‫ד' בתשרי התש"ע‬

C07K )2009.01(

C07D )2009.01( ‫אמינים חדשים‬

A61K )2009.01(

71

PHARMACEUTICAL COMPOSITIONS CONTAINING LULICONAZOLE FOR EXTERNAL USE POLA PHARMA INC 2006JP 08/03/2006 062079 2006-215871 08/08/2006 JP PCT/JP/2006/319708 WO/2007/102242

28/03/2007

A23K )2009.01( ‫תכשירי מדוראמיצין ושיטות‬

A23G )2008.04(

193946

PROTEIN-ENRICHED FROZERN DESSERT NESTEC S.A. EP 06006298.1 27/03/2006 PCT/EP/2007/002495 WO/2007/110182

72

‫הרכבים בעלי עמידות לאור שלילית‬

193921

MADURAMICIN COMPOSITIONS AND METHODS ALPHARMA, INC. US 60/909969 04/04/2007 PCT/US/2008/000576 WO/2008/123898

21/03/2007

G03F )2009.01(

193903

NEGATIVE PHOTORESIST COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP US 11/390716 28/03/2006 PCT/IB/2007/000899 WO/2007/110773

17/01/2008

‫תכשירי רוקחות המכילים לוליקונאזול‬ ‫לשימוש חיצוני‬

‫לפתן קפוא מועשר בחלבון‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

23/03/2007

C07F )2009.01(

193948

2'-FLUORONUCLEOSIDE PHOSPHONATES AS ANTIVIRAL AGENTS RFS PHARMA, LLC US 60/785356 23/03/2006 PCT/US/2007/007304 WO/2007/112028

27/02/2007

‫'–פלואורונוקליאוזיד פוספונאטים‬2 ‫כחומרים אנטי וירליים‬

193971

‫ננוחלקיקים מועשרים בחומר‬ ‫המבוססים על חלבונים הידרופיליים‬

AGENT-ENRICHED NANOPARTICLES BASED ON HYDROPHILIC PROTEINS LTS LOHMANN THERAPIE-SYSTEME GMBH DE 102006011507.4 14/03/2006 PCT/EP/2007/001675 WO/2007/104422

14/03/2007

193973

BIORESORBABLE CONTROLLEDRELEASE COMPOSITION LIDDS AB DK PA200600361 14/03/2006 PCT/EP/2007/002250 WO/2007/104549

17/04/2007

193984

COMPUTERIZED CROP GROWING MANAGEMENT SYSTEM AND METHOD NETAFIM LTD US 11/417263 04/05/2006 PCT/IL/2007/000481 WO/2007/129295

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

A61K )2009.01(

‫תכשיר בעל שחרור מבוקר הנספג בגוף‬

G06Q )2009.01( ‫שיטה ומערכת ממוחשבת לניהול גידול‬ ‫יבול‬ ‫נטפים בע"מ‬

73

23/03/2007

MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES BIOALLIANCE PHARMA EP 06290480.0 24/03/2006 PCT/IB/2007/001662 WO/2007/110778

20/03/2007

‫נשא רירי דביק ביולוגית המשתחרר לאט‬ ‫למתן חומרים פעילים‬

08/03/2007

‫תרכובות‬ ‫טטראהידרופירידותיאנופירימידיניות‬ ‫ושיטות לשימוש בהן‬

20/03/2006

A01N )2009.01(

194036

METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/782516 16/03/2006 PCT/IL/2007/000297 WO/2007/105203

74

C07D )2009.01(

194028

TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF BAYER HEALTHCARE AG US 60/784146 PCT/US/2007/006927 WO/2007/109279

A61K )2009.01(

193987

‫שיטה ותכשיר להגנה על רקמה עצבית‬ ‫מנזק שנגרם מרמות גבוהות של גלוטמאט‬ ‫מור יישום מחקרים בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

14/03/2007

194044

TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION ACTELION PHARMACEUTICALS LTD. WO PCT/IB06/050812 15/03/2006 PCT/IB/2007/050868 WO/2007/105177

15/03/2007

‫תולדות טטראהידרואיזוקווינולין‬ ‫להגברת פעילות הזכרון‬

194066

THERAPEUTIC COMPOSITION FOR TREATMENT OF TINNITUS UWE STOLDT DE 102006011922.3 15/03/2006 PCT/EP/2007/002294 WO/2007/104566

16/03/2007

16/09/2008

September 22, 2009

–‫ד' בתשרי התש"ע‬

CO7D )0(

‫תרכובות אימידזולותיאזול לטיפול במחלה‬

194136

CITRUS JUICE APPARATUS WITH UNDESIRED MATERIAL RELEASE DETECTOR AND RELATED METHODS JOHN BEAN TECHNOLOGIES CORPORATION US 11/859232 21/09/2007

A61K )2008.04( ‫תכשיר תרופתי לטיפול בטיניטוס‬

194076

IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE AMBIT BIOSCIENCES CORPORATION US 60/743543 17/03/2006 PCT/US/2007/006613 WO/2007/109120

A61K )2009.01(

A47J )2009.01( ‫מסחטת פרי הדר עם גלאי שחרור חומר‬ ‫בלתי רצוי ושיטות קשורות‬

75

02/04/2007

TREATMENT USING CITRULLINE NESTEC S.A. US 60/789330 04/04/2006 60/747493 17/05/2006 US PCT/US/2007/008143 WO/2007/114903

21/03/2007

C07K )2009.01( ‫שיטות למניעה וטיפול במחלות‬ ‫אמילוידוגניות‬

C07D )2009.01(

194237

SUBSTITUTED IMIDAZOLE 4CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS MERCK & CO. INC. US 60/791961 14/04/2006 PCT/US/2007/008832 WO/2007/120655

76

‫טיפול בשימוש בציטרולין‬

194235

METHODS FOR PREVENTING AND TREATING AMYLOIDOGENIC DISEASES WYETH US 60/784575 21/03/2006 60/895303 16/03/2007 US PCT/US/2007/064571 WO/2007/109749

10/04/2007

A61K )2009.01(

194202

‫קרבוקסאמידים מותמרים באימידאזול‬ ‫ המשמשים כמודולטורים‬4 ‫בעמדה‬ 1–‫לרצפטור כולציסטוקינין‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

11/04/2007

‫אנטגוניסטים לתעלות סידן מסוג פירידיל‬ T–‫אמיד סוג‬

PYRIDYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO, INC. US 60/791372 12/04/2006 PCT/US/2007/008977 WO/2007/120729

08/08/2006

194254

SOLID ORAL COMPOSITIONS BASED ON S-ADENOSYL METHIONINE AND/OR NADH AND PROCESS FOR OBTAINING THEM GNOSIS SPA IT MI2006A000629 31/03/2006 PCT/IT/2006/000610 WO/2007/113885

22/03/2007

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

‫הרכבים פומיים מוצקים המבוססים על‬ ‫ ותהליך‬NADH ‫או‬/‫–אדנוזיל מתיונין ו‬S ‫להשגתם‬

194257

PROCESS FOR THE PREPARATION OF A HOT-MELT EXTRUDED LAMINATE AUXILIUM PHARMACEUTICALS, INC. US 60/785590 24/03/2006 PCT/US/2007/064713 WO/2007/112285

September 22, 2009

C07D )2009.01(

194238

B32B )2008.04(

)‫שיטה להכנת לוחיות מרוקעות (למינטות‬ ‫בחום‬

77

25/03/2007

S-ALKYLISOTHIOURONIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES MEDITOR PHARMACEUTICALS LTD. US 60/784766 23/03/2006 PCT/IL/2007/000385 WO/2007/108004

22/03/2007

78

‫מדיטור פרמצבטיקה בע"מ‬

A61K )2009.01( ‫שימוש בחומרים דמויי דיגיטליס לטיפול‬ ‫בהפרעות רגשיות‬ ‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים‬

A61K )2009.01(

194277

SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER MERRION RESEARCH III LIMITED US 60/791231 07/04/2006 PCT/US/2007/008935 WO/2007/117706

05/04/2007

‫נגזרות של אס–אלקילאיזותיואורוניום‬ ‫לטיפול במחלות דלקתיות‬

194275

USE OF DIGITALIS-LIKE COMPOUNDS IN THE TREATMENT OF AFFECTIVE DISORDERS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/784782 23/03/2006 PCT/IL/2007/000379 WO/2007/108002

09/04/2007

A61K )2009.01(

194261

‫צורת מינון אוראלית מוצקה המכילה‬ ‫מגדיל‬

A61K )2009.01(

194292 September 22, 2009

–‫ד' בתשרי התש"ע‬

SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION US 60/790416 06/04/2006 11/696585 04/04/2007 US PCT/US/2007/066071 WO/2007/118151

28/03/2007

‫תולדות ספירוציקליים הטרוציקליים‬ ‫ושיטות לשימוש בהן‬

194293

PHARMACEUTICAL COMPOSITIONS CONTAINING A CHOLEST-4-EN-3ONE DERIVATIVE TROPHOS FR 0602799 31/03/2006 PCT/FR/2007/000530 WO/2007/118967

22/03/2007

September 22, 2009

‫תכשירי רוקחות המכילים תולדה של‬ ‫–און‬3–‫–אין‬4–‫כולסט‬

194308

METHOD AND APPARATUS FOR MAINTAINING UPLINK SYNCHRONIZATION AND REDUCING BATTERY POWER CONSUMPTION INTERDIGITAL TECHNOLOGY CORPORATION US 60/785491 24/03/2006 PCT/US/2007/007117 WO/2007/111941

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

H04B )2009.01(

‫שיטה ומערכת לשמירה על סינכרוניזציה‬ ‫של קשר בין הארץ ללוויין והקטנת צריכת‬ ‫כח סוללה‬

79

11/04/2007

BATTERY INCLUDING A FLUID MANAGER THE TECHNOLOGY PARTNERSHIP PLC OF US 60/790876 11/04/2006 60/817199 28/06/2006 US 60/860175 20/11/2006 US PCT/US/2007/066404 WO/2007/121226

11/04/2007

H01M )2009.01( ‫סוללה הכוללת ניהול נוזלים המורכב‬ ‫חיצונית לתא‬

H01M )2009.01(

194349

BATTERY INCLUDING A FLUID MANAGER MOUNTED INTERNAL TO CELL THE TECHNOLOGY PARTNERSHIP PLC OF US 60/790876 11/04/2006 60/817199 28/06/2006 US 60/860175 20/11/2006 US PCT/US/2007/066437 WO/2007/121244

80

‫סוללה המכילה מנהל נוזלים‬

194348

BATTERY INCLUDING A FLUID MANAGER MOUNTED EXTERNAL TO CELL THE TECHNOLOGY PARTNERSHIP PLC OF US 60/790876 11/04/2006 60/817199 28/06/2006 US 60/860175 20/11/2006 US PCT/US/2007/066415 WO/2007/121232

11/04/2007

H01M )2009.01(

194347

‫סוללה המכילה מנהל נוזלים המורכב‬ ‫פנימית לתא‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

28/09/2008

194408

SYSTEM AND METHOD FOR CONTROLLED OUTPUT OF A DIFFERNCE FREQUNECY GENERATOR RAMOT AT TEL-AVIV UNIVERSITY LTD.

28/09/2008

‫מערכת ושיטה לתפוקה מבוקרת ממחולל‬ ‫הפרש תדרים‬ ‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬

194411

TECHNIQUE FOR SELECTIVELY CHANGING DISPERSION IN OPTICAL COMMUNICATION CHANNELS ECI TELECOM LTD.

28/09/2008 TECHNIQUE FOR COMBATING LOOPS IN COMMUNICATION NETWORK ECI TELECOM LTD.

194570

–‫ד' בתשרי התש"ע‬

H04L )2009.01(

‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬

REPETITIVE STROKE WORK SYSTEM ASSAF MALUL US 60/939372 22/05/2007 60/979873 15/10/2007 US PCT/IL/2008/000009 WO/2008/142670

September 22, 2009

‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬

‫טכנולוגיה להתגברות על לולאות ברשת‬ ‫תקשורת‬

194418

15/05/2007

H04L )2009.01(

‫טכנולוגיה לשינוי סלקטיבי של דיספרסיה‬ ‫בערוצי תקשורת אופטיים‬

194412

01/01/2008

H01H )2009.01(

B23D )2009.01( ‫מערכת עבודה בתנועה חוזרת‬

C07D )2009.01(

81

SUBSTITUTED PYRAZOLOPYRIMIDINES CEPHALON, INC. US 60/800375 15/05/2006 11/803320 14/05/2007 US PCT/US/2007/011619 WO/2008/063232

12/04/2007

‫ שיטה‬,‫נגזרות של אמינומתיל פירידין‬ ‫להכנתן ושימושיהן הרפואיים‬

A61K )2009.01(

194694

METHODS FOR BONE REGENERATION USING ENDOTHELIAL PROGENITOR CELL PREPARATINS HEPACORE LTD. US 60/792341 17/04/2006 PCT/IL/2007/000485 WO/2007/119240

82

C07D )2009.01(

194573

AMINOMETHYL PYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS FR 0603382 14/04/2006 PCT/FR/2007/000620 WO/2007/119001

17/04/2007

‫תרכובות פיראזולופירימידין מותמרות‬

‫שיטות לבנייה מחדש של עצמות על ידי‬ ‫שימוש בתכשירי תאי אב אנדותליאליים‬ ‫הפאקור בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

18/04/2007

194722

A47C )2009.01( ‫מודול להשראת תנועה‬ ‫אקטיב צ'ר בע"מ‬

MOVEMENT INDUCING MODULE ACTIVE CHAIR LTD PCT/IL/2007/000491 WO/2007/119242

30/05/2007

194746

TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR INTARCIA THERAPEUTICS, INC. US 60/809451 30/05/2006 PCT/US/2007/069990 WO/2007/140416

01/03/2007

‫מווסת זרם בעל שני חלקים עבור מערכת‬ ‫אוטומטית למתן תרופות בערוץ פנימי‬

194797

VIDEO SEGMENTATION USING STATISTICAL PIXEL MODELING OBJECTVIDEO, INC. US 60/792313 17/04/2006 PCT/US/2007/005238 WO/2007/126525

13/04/2007

A61K )2009.01(

194798

G06K )2009.01( ‫סגמנטציה של ווידאו באמצעות מודל‬ ‫סטטיסטי של פיקסלים‬

A61K )2009.01(

TREATMENT OF MELANOMA SCICLONE PHARMACEUITCALS, INC. US 60/793243 20/04/2006 PCT/US/2007/009049 WO/2007/123847

‫טיפול במלנומה‬

20/03/2007

F25D )2009.01(

September 22, 2009

194801

–‫ד' בתשרי התש"ע‬

83

INSTALLATION FOR THE TEMPERATURE TREATMENT OF PRODUCTS STORED ON PALLETS OR SIMILAR FROMFROID FR 0603570 21/04/2006 0752825 23/01/2007 FR PCT/FR/2007/050955 WO/2007/122334

29/03/2007

‫התקן עבור טיפול בטמפרטורה למוצרים‬ ‫המאוחסנים על גבי משטחים או דומיהם‬

C09D )2009.01(

194802

COATING COMPOSITION FOR PRODUCING MAGNETICALLY INDUCED IMAGES SICPA HOLDING S.A. EP 06113891.3 12/05/2006 PCT/EP/2007/052993 WO/2007/131833

25/06/2007

‫תכשיר ציפוי ליצור דמויות מושרות‬ ‫מגנטיות‬

PROCESS FOR PREPARING TRIALLYL CYANURATE EVONIK DEGUSSA GMBH DE 102006034257.7 21/07/2006 PCT/EP/2007/056316 WO/2008/009540 11/05/2007

‫תהליך להכנת טריאליל ציאנוראט‬

C07D )2009.01(

194804

HETEROAROYL-SUBSTITUTED ALANINES WITH A HERBICIDAL ACTION BASF SE EP 06114239.4 19/05/2006 PCT/EP/2007/054562 WO/2007/134984

84

C07D )2009.01(

194803

‫אלאנינים מותמרים בהטרוארואיל בעלי‬ ‫פעילות קוטלת עשבים‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

09/05/2007

194806

ANTI-VIRAL PYRIMIDINE NUCLEOSIDE DERIVATIVES UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED GB 0609178.9 09/05/2006 PCT/GB/2007/001677 WO/2007/129083

13/04/2007

‫תולדות פירימידין–נוקלאוזיד אנטי–וירליות‬

194807

CONFIGURABLE PARALLEL COMPUTATION OF CYCLIC REDUNDANCY CHECK (CRC) CODES THE QUEEN'S UNIVERSITY OF BELFAST GB 0607976.8 22/04/2006 PCT/GB/2007/001371 WO/2007/122384

23/04/2007

INHIBITORS OF 11-BETAHYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY & CO. US 60/745475 24/04/2006 PCT/US/2007/067182 WO/2007/127688

September 22, 2009

–‫ד' בתשרי התש"ע‬

C07D )2009.01( ‫–בטא–הדרוקסיסטרואיד‬11 ‫מעכבים של‬ 1 ‫דהידרוגנאז‬

194818

COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM LLC US 60/797949 05/05/2006 PCT/US/2007/068292 WO/2007/131201

H03M )2009.01( ‫חישוב מקבילי ניתן להתאמה של קוד‬ ‫יתירות מחזורי‬

194810

04/05/2007

C07D )2009.01(

C07D )2009.01(

‫תרכובות ותכשירים כמאפננים של שביל‬ ‫קיפוד‬

85

23/04/2007

METHOD AND APPARATUS FOR COORDINATING TIMING IN A WIRELESS LOCAL AREA NETWORK INTERDIGITAL TECHNOLOGY CORPORATION US 60/794463 24/04/2006 PCT/US/2007/009884 WO/2007/127185

27/10/2008

‫שיטה ומערכת לתיאום תזמון ברשת‬ ‫מקומית אלחוטית‬

G06F )2009.01(

194943

VERIFICATION OF DATA TRANSMITTED BY COMPUTER HUMAN INTERFACE SECURITY LTD.

05/05/2006

H04L )2009.01(

194903

‫אימות נתונים המשודרים ע"י מחשב‬ ‫היומן אינטרפייס סקיוריטי בע"מ‬

C07C )2009.01(

194977

PROCESS FOR PREPARING GABAPENTIN PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED

‫תהליך להכנת גאבאפנטין‬

PCT/IE/2006/000049 WO/2007/129286

30/10/2008 ARTLLERY PROJECTILE WITH SEPERATELY CONTROLLED BOOSTER ACTUATION AND FRAGMENT DISPERSION RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

02/11/2008

86

F42B )2009.01(

195003

‫קליע ארטילרי עם פיקוד נפרד של הפעלת‬ ‫מאיץ ופיזור רסיסים‬ ‫רפאל מערכות לחימה מתקדמות בע"מ‬

G02F )2009.01(

195050 September 22, 2009

–‫ד' בתשרי התש"ע‬

MODULATION OF FIBER LASER PUMPED DIFFERENCE FREQUENCY GENERATOR ELBIT SYSTEMS ELECTRO-OPTICAL ELOP LTD.

03/05/2007

‫אפנון של מחולל הפרש תדרים נשאב‬ ‫בלייזר סיבי‬ ‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬ ‫בע"מ‬

195065

MULTIBAND RADIO WITH TRANSMITTER OUTPUT POWER OPTIMIZATION HARRIS CORPORATION US 11/429837 08/05/2006 PCT/US/2007/010780 WO/2007/133474

04/11/2008

195090

A METHOD AND A DEVICE FOR PRESTRESSED ARMOR GIGI SIMOVICH

04/11/2008

195091

AIR VEHICLE, AND SYSTEM AND METHOD THEREFOR ISRAEL AEROSPACE INDUSTRIES LTD.

04/11/2008

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫רדיו רב–פסי עם אופטימיזצית כח שידור‬ ‫פלט‬

F41H )2009.01( ‫שיריון דרוך ושיטה ליצורו‬ ‫ג'יג'י סימוביץ‬

F41H )2009.01( ‫ ומערכת ושיטה עבורו‬,‫רכב אויר‬ ‫התעשייה האוירית לישראל בע"מ‬

195099

ASYNCHRONOUS DYNAMIC NETWORK DISCOVERY FOR LOW POWER SYSTEMS

H01Q )2009.01(

H04L )2009.01( ‫גילוי אסינכרוני של מערכות תקשורת‬ ‫עבור מערכות בעלות עוצמה נמוכה‬

87

HARRIS CORPORATION US 11/937015

08/11/2007

03/05/2007

METHODS AND SYSTEMS FOR BANDWIDTH ADAPTIVE N-TO-N COMMUNICATION IN A DISTRIBUTED SYSTEM CITRIX ONLINE, L.L.C. US 11/381702 04/05/2006 PCT/US/2007/010729 WO/2007/130511

26/04/2007

‫ ברוחב‬N–‫–ל‬N ‫שיטות ומערכות לתקשורת‬ ‫פס ניתן להתאמה המערכת מבוזרת‬

REAL-TIME DETECTION OF INFLUENZA VIRUS THERANOS, INC.

88

‫ מכשיר ושיטה לאספקה של‬,‫התקן‬ ‫פרסומות תוך שימוש ביישומי פרוטוקול‬ ‫אלחוטי‬ ‫אמוביי בע"מ‬

A61K )2009.01(

195107

APTAMERS DIRECTED TO MUC1 UNIVERSITY OF TORONTO GB 0608778.7 04/05/2006 PCT/GB/2007/050234 WO/2007/129114

10/05/2007

G06F )2009.01(

195105

DEVICE, SYSTEM AND METHOD OF DELIVERING TARGETED ADVERTISEMENTS USING WIRELESS APPLICATION PROTOCOL AMOBEE LTD. US 11/417143 04/05/2006 PCT/IL/2007/000514 WO/2007/129298

02/05/2007

G06F )2009.01(

195103

MUC1–‫אפטמרים מכוונים ל‬

B65D )2009.01(

195108

‫גילוי בזמן אמת של נגיף שפעת‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

US 60/799442 60/800939 US 11/746535 US PCT/US/2007/068665 WO/2007/134166

10/05/2006 16/05/2006 09/05/2007

29/04/2007

195109

RETURN AND LIMITED MOTION IN ENERGY CAPTURE DEVICES DANIEL FARB US 60/746375 04/05/2006 60/805875 22/06/2006 US 60/807489 16/07/2006 US 60/826927 26/09/2006 US 60/866070 16/11/2006 US 60/908693 29/03/2007 US PCT/IL/2007/000523 WO/2007/129299

04/05/2007

195110

SUBSTITUTED SPIROCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK & CO. INC. US 60/799071 09/05/2006 PCT/US/2007/010952 WO/2007/133491

23/05/2007

195111

METHOD OF PREPARING 4HALOGENATED QUINOLINE INTERMEDIATES September 22, 2009

–‫ד' בתשרי התש"ע‬

F03B )2009.01( ‫תנועת החזר ותנועה מוגבלת במתקני‬ ‫קליטת אנרגיה‬

A61K )2009.01( ‫ספירוציקליים מותמרים המשמשים‬ CGRP ‫כאנטגוניסטים לרצפטור‬

C07D )2009.01( ‫שיטה להכנת תוצרי ביניים של קווינולין‬ ‫ עם הלוגן‬4 ‫המותמר בעמדה‬

89

WYETH US 60/802759 PCT/US/2007/012211 WO/2007/139797

14/05/2007

23/05/2006

METHOD AND DEVICE FOR CONTROLLING A REMOTE VEHICLE IROBOT CORPORATION US 60/747183 12/05/2006 PCT/US/2007/068911 WO/2008/060690

25/05/2007

90

‫שיטה והתקן עבור שליטה על רכב מרוחק‬

A61K )2009.01(

195113

PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA GB 0610680.1 31/05/2006 PCT/GB/2007/050295 WO/2007/138351

04/05/2007

H04B )2009.01(

195112

‫נגזרות של פירידינון ופירידאזינון‬ )‫–ריבוז‬ADP(‫המשמשות כמעכבים של פולי‬ )PARP( ‫פולימרז‬

C12N )2009.01(

195114 September 22, 2009

–‫ד' בתשרי התש"ע‬

PANCREATIC ISLET-LIKE CELLS OPEXA THERAPEUTICS US 60/746584 05/05/2006 PCT/US/2007/068303 WO/2007/131209

04/05/2007

195115

T-CELL VACCINE OPEXA THERAPEUTICS US 60/746611 60/747903 US PCT/US/2007/068304 WO/2007/131210

G01N )2009.01( T–‫תרכיב תא‬

05/05/2006 22/05/2006

04/05/2007

195116

ACTUATION OF PARALLEL MICROFLUIDIC ARRAYS CYTONOME, INC. US 60/798154 05/05/2006 PCT/US/2007/010959 WO/2007/130647

17/06/2007

195117

SUPER-PYROELECTRIC FILMS AND PROCESS OF THEIR PREPARATION YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/813692 15/06/2006 PCT/IL/2007/000731 WO/2007/144892

30/04/2007

September 22, 2009

‫תאים לבלביים דומים לתאי אי‬

195118

–‫ד' בתשרי התש"ע‬

B07C )2009.01( ‫הנעה של מערכים מיקרופלואידים‬ ‫מקבילים‬

H01L )2009.01( ‫פילמים בעלי תכונות פירואלקטריות‬ ‫מצויינות ותהליך להכנתם‬ ‫ידע חברה למחקר ופיתוח בע"מ‬

H04L )2009.01(

91

RADIO LINK FAILURE DETECTION PROCEDURES IN LONG TERM EVOLUTION UPLINK AND DOWNLINK AND APPARATUS THEREFOR INTERDIGITAL TECHNOLOGY CORPORATION US 60/798119 05/05/2006 PCT/US/2007/010394 WO/2007/130324

07/05/2007

‫שיטה להפעלת מסוף‬

A61B )2009.01(

195122

INTRAMEDULLARY TRANSILLUMINATION APPARATUS, SURGICAL KIT AND METHOD FOR ACCURATE PLACEMENT OF LOCKING SCREWS IN LONG BONE INTRAMEDULLARY RODDING JG MEDICAL PRODUCTS LLC US 60/797986 05/05/2006 11/744844 05/05/2007 US PCT/US/2007/068387 WO/2007/131231

92

H04L )2009.01(

195121

TERMINAL ACTIVATION METHOD SAGEM MONETEL FR 06/04195 11/05/2006 PCT/EP/2007/054410 WO/2007/131905

07/05/2007

‫פרוצדורות לגילוי כשל בקישור רדיו‬ ‫בהתפתחות לטווח רחוק של קישור‬ ‫מהארץ ללוויין וקישור מהלוויין לארץ‬ ‫ומערכת עבורן‬

‫ ערכת כלי‬,‫התקן לשיקוף תוך העצם‬ ‫ניתוח ושיטה למיקום מדויק של ברגי‬ ‫קיבוע בתמיכה–תוך–עצמית של עצמות‬ ‫ארוכות‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

09/05/2007

195124

IMAGING SYSTEMS AND METHODS FOR RECOVERING OBJECT VISIBILITY TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. US 60/798737 09/05/2006 PCT/IL/2007/000560 WO/2007/129326

29/05/2007

‫מערכות ושיטות להדמיה לשחזור ראות‬ ‫של חפץ‬ ‫מוסד הטכניון למחקר ופתוח בע"מ‬

195125

195126

SUBSTITUTED 5-PHENYLAMINO1,3,4-OXADIAZOLE-2YLCARBONYLAMINO-4-PHENOXYCYCLOHEXANECARBOXYLIC ACID AS INHIBITOR OF ACETYL COENZYME A DIACYLGLYCEROL ACYLTRANSFERASE ASTRAZENECA AB US 60/809298 30/05/2006 PCT/GB/2007/001990 WO/2007/138311

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61P )2009.01( ‫–אוקסאדיאזול כמעכבי‬1,3,4 ‫נגזרות‬ DGAT1

1,3,4-OXADIAZOLE DERIVATIVES AS DGAT1 INHIBITORS ASTRAZENECA AB US 60/809297 30/05/2006 PCT/GB/2007/001981 WO/2007/138304

29/05/2007

G06T )2009.01(

A61P )2009.01(

–5 ‫חומצה קרבוקסילית מותמרת‬ –2–‫–אוקסאדיאזול‬1,3,4–‫פנילאמינו‬ ‫–פנוקסי–ציקלוהקסאן‬4–‫אילקרבונילאמינו‬ A ‫כמעכב של אצטיל קואנזים‬ ‫דיאצילגליצרול אצטילטרנספראז‬

93

02/05/2007

SECURING CARD TRANSACTIONS SECURANT INC US 60/746172 05/05/2006 60/892621 02/03/2007 US PCT/IL/2007/000535 WO/2007/129306

08/05/2007

E06B )2009.01( ‫נגזרות אזאספירו מותמרות‬

A61K )2009.01(

195135

USE OF FLIBANSERIN FOR THE TREATMENT OF POSTMENOPAUSAL SEXUAL DESIRE DISORDERS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG US 60/746817 09/05/2006 60/830987 14/07/2006 US PCT/EP/2007/054380 WO/2007/128802

94

‫אבטחת פעולות כרטיס אשראי‬

195132

SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION US 60/746680 08/05/2006 11/745448 07/05/2007 US PCT/US/2007/011135 WO/2007/133561

07/05/2007

G06Q )2008.04(

195127

‫שימוש בפליבנסרין לטיפול באי–סדרים‬ ‫של חשק מיני לאחר הבלות‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

02/05/2007

H04L )2009.01(

195136

SELECTING A COMMAND NODE IN A HETEROGENEOUS COMMUNICATION SYSTEM LUCENT TECHNOLOGIES INC. US 11/433835 12/05/2006 PCT/US/2007/010598 WO/2007/133453

02/05/2007

‫בחירת נקודת מפגש פקודתית במערכת‬ ‫תקשורת הטרוגנית‬

H04L )2009.01(

195137

EVENT CONTEXT TRANSFER IN A HETEROGENEOUS COMMUNICATION SYSTEM LUCENT TECHNOLOGIES INC. US 11/433754 12/05/2006 PCT/US/2007/010543 WO/2007/133448

03/05/2007

G01N )2009.01(

195139

DEHYDRATION TOILET HAVING AN INFUSION ODOR CAPTURING STEAM AND WATER RECOVERY SYSTEM STEVEN LUMBERT US 11/382336 PCT/US/2007/068131 WO/2007/133954

‫שירותים עם מנגנון להוצאת המים בעלי‬ ‫אדים ללכידת ריחות ומערכת לקבלת‬ ‫המים בחזרה‬

09/05/2006

26/04/2007

September 22, 2009

‫העברת תוכן אירוע במערכת תקשורת‬ ‫הטרוגניות‬

195140

–‫ד' בתשרי התש"ע‬

F03B )2009.01(

95

PRODUCTION OF ELECTRIC ENERGY FROM SEA WAVES CONSTANTINOS, A. HATZILAKOS GR 20060100482 08/05/2006 PCT/GR/2007/000023 WO/2007/129126

09/05/2007

‫ייצור אנרגיה חשמלית מגלי ים‬

‫שימוש בג'ינסנוסידים ומיצויים המכילים‬ ‫אותם‬

USE OF GINSENOSIDES AND EXTRACTS CONTAINING THEM BAYER CONSUMER CARE AG. EP 06290814.0 17/05/2006 PCT/EP/2007/004088 WO/2007/131677

21/05/2007

‫ארילאימידאזולון מותמר וטריאזולון‬ ‫כמעכבי קולטני וזופרסין‬

H04L )2009.01(

195146

BI-DIRECTIONAL RLC NONPERSISTENT MODE FOR LOW DELAY SERVICES TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) US 60/800760 16/05/2006 11/684020 09/03/2007 US PCT/EP/2007/054273 WO/2007/131880

96

A61K )2009.01(

195142

SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS BAYER HEALTHCARE AG DE 102006024024.3 23/05/2006 PCT/EP/2007/004615 WO/2007/134862

03/05/2007

A61K )2008.04(

195141

‫בקר חיבור רדיו דו–כיווני המופעל בצורת‬ ‫לא מתמיד עבור שירותי השהיה נמוכה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

22/05/2007

195147

PREPARATION OF POLYMER CONJUGATES OF THERAPEUTIC, AGRICULTURAL AND FOOD ADDITIVE COMPOUNDS ELAN PHARMACEUTICALS, INC. US 60/802349 22/05/2006 PCT/US/2007/069464 WO/2007/137260

23/05/2007

30/05/2007

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

–‫–טריהידרוקסי‬5,4,3–‫–אלקוקסי‬2 ‫ ושימוש‬,‫ הכנתם‬,‫אלקילאמיד–בנזאזפינים‬ ‫בהם והרכבים המכילים אותם‬

195149

CCR5 ANTAGONIST FOR ENHANCING IMMUNE RECONSTITUTION AND TREATING OPPORTUNISTIC INFECTION IN HIV PATIENTS PFIZER PRODUCTS INC. US 60/804480 12/06/2006 60/821974 10/08/2006 US 60/888387 06/02/2007 US PCT/IB/2007/001508 WO/2007/144720

September 22, 2009

‫הכנת קוניוגאטים של פולימרים‬ ‫ חקלאיות ושל תוספי‬,‫מתרכובות רפואיות‬ ‫מזון‬

195148

2-ALKOXY-3,4,5-TRIHYDROXYALKYLAMIDE-BENZAZEPINES, THE PREPARATION AND USE THEREOF AND COMPOSITIONS CONTAINING THE SAME SANOFI-AVENTIS FR 0604733 24/05/2006 PCT/FR/2007/000866 WO/2007/135293

A61K )2009.01(

A61K )2009.01( ‫ להגברת‬CCR5 ‫אנטגוניסט של‬ ‫הרקונסטיטוציה החיסונית וטיפול‬ HIV ‫בזיהומים אופורטוניסים בחולי‬

97

09/05/2007

USE OF SYK TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS NEW ERA BIOTECH LTD. US 60/799103 09/05/2006 PCT/IB/2007/002471 WO/2007/129226

08/05/2007

98

G06F )2009.01( ‫חיישני טמפרטורה עם אלמנט מגנטי‬

A61K )2009.01(

195155

DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE NITEC PHARMA AG US 60/835093 03/08/2006 PCT/EP/2007/006894 WO/2008/015018

06/06/2007

SYK ‫שימוש במעכבים של תירוזין קינאז‬ ‫לטיפול במחלות של התרבות תאים‬

195154

MAGNETIC ELEMENT TEMPERATURE SENSORS THERMAL SOLUTIONS, INC. US 60/798591 09/05/2006 60/818385 05/07/2006 US 60/836448 09/08/2006 US 11/619066 02/01/2007 US 60/919345 22/03/2007 US 11/745348 07/05/2007 US PCT/US/2007/068483 WO/2007/134061

03/08/2007

A61K )2009.01(

195152

‫טיפול במחלת שגרון באמצעות‬ ‫גלוקוקורטיקואיד בשחרור–מושהה‬

C07K )2009.01(

195156

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫פוליפפטידים מיוצבים של פקטור גידול‬ ‫דמוי–אינסולין‬

STABILIZED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES NOVARTIS AG US 60/812349 09/06/2006 60/862244 20/10/2006 US 60/897187 24/01/2007 US PCT/US/2007/070468 WO/2007/146689

10/05/2007

195157

USE OF NON-CATALYTIC FORM OF HEPARANASE AND PEPTIDES THEREOF FOR REVERSING THE ANTI-COAGULANT EFFECTS OF HEPARINOIDS 50% THE MEDICAL RESEARCH FUND AT THE TEL AVIV SOURASKY MEDICAL CENTER IL 175571 11/05/2006 PCT/IL/2007/000564 WO/2007/132445

06/11/2008

‫שימוש בתצורה לא–קטליטית של הפרנאז‬ ‫ופפטידים הנגזרים ממנו לביטול פעילות‬ ‫אנטי–קרישתית של הפרינואידים‬ ‫ קרן מחקרים ופיתוח תשתיות שליד‬50% ‫אביב ע"ש סוראסקי‬-‫המרכז הרפואי תל‬

195167

CABIN ATTACHMET DEVICE AND METHOD PLASAN SASA LTD. IL 192447 25/06/2008

11/05/2007

195216

PREPARATION OF ANTIBODY OR ANTIBODY FRAGMENT-TARGETED IMMUNOLIPOSOMES AND USES THEREOF September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

F42D )2009.01( ‫מכשיר ושיטה לחיבור תא נוסעים‬ ‫פלסן סאסא בע"מ‬

A61K )2009.01( –‫תהליכים להכנת נוגדנים או קטעי‬ ‫נוגדנים–מכוונים אימונוליפוסומים‬ ‫ושימושים בהם‬

99

GEORGETOWN UNIVERSITY US 60/800163 15/05/2006 60/844352 14/09/2006 US PCT/US/2007/011407 WO/2007/142781

10/05/2007

PROTEIN KINASE INHIBITORS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED US 60/799914 12/05/2006 PCT/US/2007/011285 WO/2007/133622

15/05/2007

‫מעכבי קינאזים חלבוניים וניצולם‬

‫–דיאמינו פירימידינים כמעכבי קינאז של‬4,2 ‫מחזור התא‬

100

D01F )2009.01(

195242

FIRE RETARDANT JACKET FOR TUBING OMEGA FLEX, INC. US 11/382960 12/05/2006 PCT/US/2007/011165 WO/2007/133574

15/05/2007

A61K )2009.01(

195218

2,4-DIAMINO PYRIMIDINES AS CELL CYCLE KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 06113967.1 15/05/2006 PCT/EP/2007/054723 WO/2007/132010 09/05/2007

A61K )2009.01(

195217

‫מעכבי בעירה לעטיפת צינורות‬

A61K )2009.01(

195243

September 22, 2009

–‫ד' בתשרי התש"ע‬

USE OF A FUSION MOLECULE FOR THE PREPARATION OF A MEDICAMENT FOR TREATING RHEUMATOID ARTHRITIS ZYMOGENETICS INC. US 60/747270 15/05/2006 PCT/US/2007/068982 WO/2007/134326

14/05/2007

‫שימוש במולקולה מאחדת להכנת תרופה‬ ‫לטיפול בדלקת פרקים שגרונית‬

195244

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG US 60/747311 16/05/2006 PCT/CA/2007/000845 WO/2007/131350

14/05/2007

September 22, 2009

‫מעכבי שכפול נגיף האיידס‬

195245

SUBSTITUTED PROLINAMIDES, PRODUCTION THEREOF AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 06113977.0 16/05/2006 07102566.2 16/02/2007 EP PCT/EP/2007/054631 WO/2007/131982

–‫ד' בתשרי התש"ע‬

B05B )2009.01(

C07D )2009.01(

‫ ייצורם ושימושם‬,‫פרולינאמידים מותמרים‬ ‫כתרופות‬

101

16/05/2007

A61M )2009.01(

195246

‫מרסס‬

ATOMISER BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DE 102006023657.2 18/05/2006 102006043637.7 18/09/2006 DE PCT/EP/2007/004418 WO/2007/134794

16/05/2007

A61M )2009.01(

195247

‫משאף‬

INHALER BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DE 102006023662.9 18/05/2006 PCT/EP/2007/004416 WO/2007/134792

16/05/2007

B05B )2009.01(

195248

‫מרסס‬

ATOMISER BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DE 102006023657.2 18/05/2006 102006043637.7 18/09/2006 DE PCT/EP/2007/004417 WO/2007/134793

17/05/2007

102

H04L )2009.01(

195263

September 22, 2009

–‫ד' בתשרי התש"ע‬

MAC ADDRESS LEARNING IN A DISTRIBUTED BRIDGE CORRIGENT SYSTEMS LTD. US 11/419444 19/05/2006 PCT/IL/2007/000601 WO/2007/135666

21/05/2007

195379

REVERSION OF OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVES ECOLE NORMALE SUPERIEURE DE CACHAN OF EP 06290822.3 22/05/2006 60/838860 21/08/2006 US PCT/IB/2007/001307 WO/2007/135538

13/06/2007

195382

IL-17 AND IL-23 ANTAGONISTS AND METHODS OF USING THE SAME ZYMOGENETICS INC. US 60/804602 13/06/2006 60/824665 06/09/2006 US 60/828277 05/10/2006 US 60/891410 23/02/2007 US PCT/US/2007/071152 WO/2007/147019

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫לימוד כתובת מקינטוש בגשר מבוזר‬ ‫קוריג'נט מערכות בע"מ‬

A61K )2009.01( ‫הפיכה של פנוטיפ ממאיר באמצעות‬ ‫–הידרוקסי אליפטיציניות‬9 ‫תולדות‬

C07K )2009.01( ‫ ושיטות‬IL–23–‫ ו‬IL–17 ‫אנטגוניסטים של‬ ‫לשימוש בהם‬

103

22/05/2007

‫גלאיי חום אינפרא–אדום הכוללים חלל‬ ‫שניתן לכוון בצורה מדויקת‬

TUNABLE FINESSE INFRARED CAVITY THERMAL DETECTORS REGENTS OF THE UNIVERSITY OF MINNESOTA, US 60/802751 23/05/2006 PCT/US/2007/012213 WO/2008/108784

11/06/2007

104

‫תולדות פניל–פיראזול כליגנדים לא‬ ‫סטרואידים של קולטן גלוקוקוריקואיד‬

G06F )2008.04(

195507

DEVICE TO SHIELD AGAINST INTERFERENCE FROM ELECTRICAL APPLIANCES SAGEM MONETEL FR 0604952 02/06/2006 PCT/FR/2007/000906 WO/2007/141410

25/05/2007

C07D )2009.01(

195492

PHENYL-PYRAZOLE DERIVATIVES AS NON-STEROIDAL GLUCOCORICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED GB 0611587.7 12/06/2006 0625457.7 20/12/2006 GB 0710217.1 29/05/2007 GB PCT/EP/2007/055724 WO/2007/144327

31/05/2007

G01J )2009.01(

195415

‫התקן להגנה נגד הפרעות נגרמות על ידי‬ ‫מכשירי חשמל‬

G06F )2009.01(

195523

September 22, 2009

–‫ד' בתשרי התש"ע‬

HANDOVER OF A BACKWARDCOMPATIBLE MOBILE UNIT LUCENT TECHNOLOGIES INC. US 11/421874 02/06/2006 PCT/US/2007/012531 WO/2007/142892

13/06/2007

‫העברה של יחידה ניידת המותאמת לאחור‬

195530

PROCESS FOR ENHANCING PLANT GROWTH CIBA HOLDING INC. EP 06115868.9 22/06/2006 PCT/EP/2007/055793 WO/2007/147758

08/06/2007

29/06/2007

30/11/2008

H04L )2009.01(

MIMO– ‫שיטה ומערכת למנגנון בחירה בין‬ SIMO–LFDM–‫ ו‬OFDM

195609

–‫ד' בתשרי התש"ע‬

C25D )2009.01(

‫אריזת אנודה מצופה בדיל לתאים בסיסיים‬

195606

METHOD AND APPARATUS FOR SELECTION MECHANISM BETWEEN OFDM-MIMO AND LFDM-SIMO QUALCOMM INCORPORATED US 60/818223 29/06/2006 PCT/US/2007/072538 WO/2008/003087

September 22, 2009

‫תהליך להגברת גדילה של צמח‬

195534

TIN-PLATED ANODE CASINGS FOR ALKALINE CELLS EVEREADY BATTERY COMPANY, INC. US 60/811825 08/06/2006 11/811092 08/06/2007 US PCT/US/2007/013628 WO/2007/146192

A01G )2009.01(

B01D )2009.01(

105

‫מיכל לתגובה במים‬

WATER REACTION TANK JERRY HANNA CA 2,634672 09/06/2008

02/12/2008

ESCAPE PARACHUTES & METHODS OF ESCAPE THERE THROUGH MICHA BLOCH

09/11/2006

‫מצנחי מילוט ושיטת מילוט באמצעותם‬ ‫מיכה בלוך‬

‫מערכת ושיטה להכנת לוחות המשמשים‬ ‫לקירות‬

106

H01P )2009.01(

195810

A BROADBAND SWITCHED MULTIPLEXER TELEDYNE DEFENCE LIMITED GB 0611445.8 09/06/2006 0613215.3 04/07/2006 GB PCT/GB/2007/002092 WO/2007/141528

12/06/2007

E04C )2009.01(

195714

SYSTEM AND METHOD FOR MAKING WALLBOARD JOHN CONBOY US 60/736123 09/11/2005 11/345349 01/02/2006 US PCT/US/2006/043757 WO/2007/056562

07/06/2007

B64D )2009.01(

195659

‫מרבב רחב פס עם מתג‬

C07D )2009.01(

195813 September 22, 2009

–‫ד' בתשרי התש"ע‬

SUBSTITUTED AMINOPYRAZOLOPYRIDINES AND SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM BAYER SCHERING PHARMA AG EP 06090109.7 13/06/2006 07090020.4 15/02/2007 EP PCT/EP/2007/005432 WO/2007/144204

05/07/2007

‫אמינופיראזולו פירידינים מותמרים‬ ‫ הכנתם ותכשירי רוקחות‬,‫ומלחיהם‬ ‫המכילים אותם‬

195819

MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. US 60/819500 06/07/2006 PCT/US/2007/015681 WO/2008/005576

08/06/2007

10/12/2008

–‫ד' בתשרי התש"ע‬

C12N )2009.01(

‫פלח שלייתי ושימוש בו עבור תרבית תאי‬ ‫גזע‬

195841

WATERCRAFT FLOATATION SYSTEM AND METHOD September 22, 2009

‫אפננים המשפיעים על מטבוליזם וטיפול‬ ‫במחלות הקשורות למטבוליזם‬

195826

PLACENTAL NICHE AND USE THEREOF TO CULTURE STEM CELLS ANTHROGENESIS CORPORATION US 60/812366 09/06/2006 PCT/US/2007/013507 WO/2007/146123

C07D )2009.01(

B63B )2009.01( ‫מערכת ושיטה להצפת כלי שיט‬

107

‫מאיר נורמונד בומן‬

MEIR NORMUND BUMAN

10/12/2008

A METHOD AND DEVICE FOR IDENTIFYING THE LOCATION OF A MOBILE TELEPHONE USER CLARITON NETWORKS LTD

15/06/2007

‫שיטה והתקן לזיהוי מיקומו של משתמש‬ ‫בטלפון נייד‬ ‫קלריטון נטוורקס בע"מ‬

H04L )2009.01(

‫שיטה לתקשורת ברשת אלחוטית המכילה‬ )LAN( ‫רשת מקומית‬ ‫אלווריון בע"מ‬

C07C )2009.01(

195958

PHENYLACETIC ACID DERIVATIVES AS COX-2 INHIBITORS NOVARTIS AG US 60/805784 26/06/2006

108

‫תכשירי רוקחות לטיפול בבעיות‬ ‫פסיכולוגיות המכילים אנטאגוניסטים‬ M1 ‫לקולטן מוסקריני‬

195918

A METHOD FOR COMMUNICATION IN A WIRELESS NETWORK COMPRISING A LOCAL AREA NETWORK (LAN) ALVARION LTD.

25/06/2007

A61K )2009.01(

195857

PHARMACEUTICAL COMPOSITIONS FOR TREATING PSYCHOLOGICAL CONDITIONS COMPRISING MUSCARINIC RECEPTOR M1 ANTAGONISTS THERACOS, INC US 60/805066 16/06/2006 60/829225 12/10/2006 US 11/763145 14/06/2007 US PCT/US/2007/071356 WO/2007/147123

14/12/2008

G08B )2009.01(

195847

–2 ‫תולדות חומצה פנילאצטית כמעכבי‬ COX

September 22, 2009

–‫ד' בתשרי התש"ע‬

PCT/US/2007/071979 WO/2008/002853

14/06/2007

195959

METFORMIN R-(+)LIPOATE AS AN ANTIDIABETIC AGENT FOR CONTROL OF DIABETIC HYPERGLYCEMIA AND DIABETIC COMPLICATIONS INDIGENE PHARMACEUTICALS, INC. US 60/814250 16/06/2006 PCT/US/2007/014034 WO/2007/149313

06/08/2007

196006

SYNCHRONIZATION BETWEEN WIRELESS DEVICES WHILE SAVING PORWER MICROSOFT CORPORATION US 60/835618 04/08/2006 11/529880 29/09/2006 US PCT/US/2007/017520 WO/2008/019140 29/06/2007

196034

METHOD AND SYSTEMS FOR EFFICIENT DELIVERY OF PREVIOUSLY STORED CONTENT CITRIX SYSTEMS INC. US 11/428058 30/06/2006 PCT/US/2007/072490 WO/2008/005840

21/06/2007

196039

INTERPRETATION OF GEOLOGIC DEPOSITIONAL SYSTEMS TERRASPARK GEOSCIENCES, L.P. September 22, 2009

–‫ד' בתשרי התש"ע‬

C07D )2009.01( ‫)ליפואט כגורם‬+(–R ‫מטפורמין‬ ‫אנטיסוכרתי לשליטה על היפרגליקמיה‬ ‫וסיבוכים סוכרתיים‬

H04L )2009.01( ‫סנכרון בין התקנים אל–חוטיים תוך כדי‬ ‫חסכון באנרגיה‬

H04L )2009.01( ‫שיטה ומערכות להעברה יעילה של תוכן‬ ‫שנשמר קודם לכן‬

G01V )2009.01( ‫אינטרפטציה למערכות של מרבצים‬ ‫גיאולוגיים‬

109

US 60/815630 60/815625 US 60/815961 US PCT/US/2007/071733 WO/2008/005690

18/06/2007

21/06/2006 21/06/2006 21/06/2006

AIR CLEANER WITH PULSE JET REVERSE CLEANING DONALDSON COMPANY, INC. US 60/814744 19/06/2006 60/848320 29/09/2006 US 60/921173 30/03/2007 US PCT/US/2007/014187 WO/2007/149388

18/06/2007

‫מנקה אוויר עם ניקוי פעימת סילון הפוכה‬

‫ רקמת‬,‫ במיוחד לעיסוי‬,‫מכשיר לטיפול‬ ‫החיבור של העור‬

H04L )2009.01(

196075

SYSTEMS AND METHODS FOR COORDINATING SUPPLEMENTARY SERVICES FOR VOICE TELEPHONE CALLS IN A CENTRALIZED FASHION

110

B01D )2009.01(

196063

DEVICE FOR TREATING, IN PARTICULAR MASSAGING, THE CONNECTIVE TISSUE OF THE SKIN LOUISIN RESEARCH AND DEVELOPMENT LIMITED FR 0605423 19/06/2006 PCT/FR/2007/001008 WO/2007/147964

20/07/2007

B01D )2009.01(

196061

‫מערכות ושיטות לתיאום שירותים‬ ‫משלימים עבור שיחות טלפון קוליות באופן‬ ‫מרוכז‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

QUALCOMM INCORPORATED US 60/832568 21/07/2006 11/780440 19/07/2007 US PCT/US/2007/074046 WO/2008/011610

18/12/2008

196079

SECURITY WITHIN INTEGRATED CIRCUITS NDS LIMITED

21/12/2008

‫בטחון במעגלים משולבים‬

196083

AN EAR CLEANING DEVICE AND METMOD YOTAM NADAM

21/12/2008

‫ישראל סוריאן פרידמן‬

CONFETTI AND METHOD FOR TOSSING NON-NEGLIGIBLE-WEIGHT OBJECTS ON CELEBRATORS DROR DAKAR KARAGULA

–‫ד' בתשרי התש"ע‬

H01H )2009.01(

‫קונפטי ושיטה לזריית חפצים בעלי מזקל‬ ‫זניח על חוגגים‬

196090

HANDHELD PHOTOCOSMETIC DEVICE PALOMAR MEDICAL TECHNOLOGIES, INC. US 60/816743 27/06/2006 60/857154 06/11/2006 US PCT/US/2007/014949 WO/2008/002625 September 22, 2009

A61B )2009.01( ‫מכשיר ושיטה לניקוי אוזניים‬

196084

27/06/2007

H01H )2009.01(

‫דרור דקר קרגולה‬

A61B )2009.01( ‫מתקן פוטוקוסמטי באחיזת יד‬

111

21/12/2008

A61B )2009.01(

196092

‫התקן ניקוי הגוף‬ ‫הידרו לוק בע"מ‬

BODY CLEANING IMPLEMENT HYDRO LOCK LTD.

22/06/2007

A METHOD OF CONTROLLING MOBILE UNIT RESPONSE MESSAGES ON AN ACCESS CHANNEL LUCENT TECHNOLOGIES INC. US 11/427639 29/06/2006 PCT/US/2007/014639 WO/2008/005206

22/12/2008

‫שיטה לבקרת מסר מענה של יחידה ניידת‬ ‫בערוץ גישה‬

‫שיטה ומערכת לחיפוש של מידע בנוגע‬ ‫למושאי מטרה‬ ‫עדי געש‬

112

G09F )2009.01(

196117

PROTECTION MEANS ON TRAFFIC WAYS OUTIMEX AG DE 102007063511.9 27/12/2007

23/12/2008

G06F )2009.01(

196115

METHOD AND SYSTEM OF SEARCHING FOR INFORMATION PERTAINING TARGET OBJECTS ILAN SIMON

22/12/2008

H04H )2009.01(

196104

‫אמצעי הגנה בדרכי תנועה‬

B41J )2009.01(

196125 September 22, 2009

–‫ד' בתשרי התש"ע‬

A METHOD AND SYSTEM FOR OPERATING A KEYBOARD WITH MULTI FUNCITIONAL KEYS, USING FINGERPINTS RECOGNITION BEJAMIN ZIMCHONI

23/12/2008

‫שיטה ומערכת להפעלה של לוח מקשים‬ ‫ באמצעות זיהוי טביעות‬,‫מרובי פעולות‬ ‫אצבעות‬

196126

196127

PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY US 60/816522 26/06/2006 PCT/US/2007/014832 WO/2008/002576

27/06/2007

196128

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY US 60/816730 27/06/2006 PCT/US/2007/014822 WO/2008/002569

27/06/2007

196129

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY September 22, 2009

–‫ד' בתשרי התש"ע‬

B65D )2009.01( ‫חפיסת סיגריות‬ ‫נור האש טכניקום בע"מ‬

CIGARETTE PACKAGE NUR HAESH TECHNICOM LTD.

26/06/2007

‫בנימין צמחוני‬

C07C )2009.01( ‫מעכבי פרוליל הידרוקסילאז ושיטות‬ ‫לשימוש בהם‬

C07D )2009.01( ‫מעכבי חלבון טירוזין פוספטאז אנושי‬ ‫ושיטות לשימוש בהם‬

C07D )2009.01( ‫מעכבי חלבון טירוזין פוספטאז אנושי‬ ‫ושיטות לשימוש בהם‬

113

US 60/816731 60/816730 US 60/816825 US PCT/US/2007/014823 WO/2008/002570

27/06/2007

27/06/2006 27/06/2006 27/06/2006

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY US 60/816825 27/06/2006 PCT/US/2007/014824 WO/2008/002571

26/06/2007

114

‫מעכבי חלבון טירוזין פוספטאז אנושי‬ ‫ושיטות לשימוש בהם‬

A61K )2009.01(

196132

ALPHANIZOMENON FLOS AQUAE PREPARATION, EXTRACTS AND PURIFIED COMPONENTS THEREOF FOR THE TREATMENT OF NEUROLOGICAL NEURODEGENERATIVE AND MOOD DISORDERS NUTRATEC S.R.L. US 60/816593 27/06/2006 PCT/EP/2007/005622 WO/2008/000430

27/06/2007

C07D )2009.01(

196130

‫ תמציות‬,‫תכשיר אלפאניזומנון פלוס אקווה‬ ‫ומרכיבים טהורים שלו לטיפול באי–סדרים‬ ‫ ניוונים–עצביים ומצבי–רוח‬,‫ניורולוגיים‬

A61K )2009.01(

196133

September 22, 2009

–‫ד' בתשרי התש"ע‬

EXTRACTS OF APHANIZOMENON FLOS AQUAE AND NUTRITIONAL, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME NUTRATEC S.R.L. US 60/816594 27/06/2006 PCT/EP/2007/005623 WO/2008/000431

13/07/2007

‫תמציות של אפהניזומנון פלוס אקווה‬ ‫ קוסמטיים ורוקחיים‬,‫ותכשירים מזינים‬ ‫המכילים אותן‬

C12N )2009.01(

196134

‫משרן מוות תאי‬

CELL DEATH INDUCER CHUGAI SEIYAKU KABUSHIKI KAISHA 2006JP 13/07/2006 193053 PCT/JP/2007/063946 WO/2008/007755

19/06/2007

196135

CHASSIS FRAME OF A RAIL VEHICLE BOMBARDIER TRANSPORTATION GMBH DE 102006029835.7 27/06/2006 PCT/EP/2007/056077 WO/2008/000657

17/07/2007

196136

AMINOINDANE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. 2006JP 18/07/2006 195307 PCT/JP/2007/064072 September 22, 2009

–‫ד' בתשרי התש"ע‬

B61F )2009.01(

‫מסגרת שלדה של כלי רכב על מסילה‬

C07C )2009.01( ‫נגזרת אמינואינדאן או מלח שלה‬

115

WO/2008/010481

11/06/2007

APPARATUS AND METHOD FOR CALIBRATION OF GAIN AND/OR PHASE IMBALANCE AND/OR DC OFFSET IN A COMMUNICATION SYSTEM SIERRA MONOLITHICS, INC. US 60/816240 23/06/2006 11/590278 30/10/2006 US PCT/US/2007/013634 WO/2008/002389

23/12/2008

B42D )2009.01(

‫התקן אלקטרוני נישא בעל תיפקוד‬ ‫היסטורי ומטרה להציג ערכי משתנים על‬ ‫בסיס מדידות הנעשות באמצעות חיישן‬

A61K )2009.01(

196141

OSMOTIC DELIVERY SYSTEMS AND PISTON ASSEMBLIES INTARCIA THERAPEUTICS, INC. US 60/821830 09/08/2006

116

‫או חוסר איזון‬/‫מערכת ושיטה לכיול רווח ו‬ ‫ במערכת תקשורת‬DC ‫או איזון‬/‫פאזי ו‬

196140

PORTABLE ELECTRONIC DEVICE HAVING A HISTORY FUNCTION AND INTENDED TO DISPLAY THE VALUE OF VARIABLES ON THE BASIS OF MEASUREMENTS MADE BY A SENSOR ETA SA MANUFACTURE HORLOGERE SUISSE EP 07150448.4 27/12/2007

08/08/2007

H04B )2009.01(

196139

‫מערכות למתן באופן אוסמטי ומכלולי‬ ‫בוכנה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

60/930205 US PCT/US/2007/017634 WO/2008/021133

15/05/2007

25/07/2007

196142

PROCESS FOR PREPARING AMIDRAZONES BASF SE EP 06118365.3 03/08/2006 PCT/EP/2007/057645 WO/2008/015133

13/08/2007

196143

THIOPHENE-SULFONIC ACID PICOLYL AMIDES BASF SE EP 06119331.4 22/08/2006 PCT/EP/2007/058348 WO/2008/022937

12/07/2007

196144

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG US 60/832482 21/07/2006 PCT/EP/2007/057155 WO/2008/009613

27/06/2007

196147

SYSTEM AND METHOD OF USING A MULTI-VIEW DISPLAY GULFSTREAM AEROSPACE CORPORATION US 60/817748 30/06/2006 11/648567 01/02/2007 US PCT/US/2007/014862 September 22, 2009

–‫ד' בתשרי התש"ע‬

C07C )2009.01( ‫תהליך להכנת אמידראזונים‬

C07D )2009.01( –‫פיקוליל אמידים של חומצה תיאופן‬ ‫סולפונית‬

C07C )2009.01( ‫מעכבי רברס טרנסקריפטאז שאינם‬ ‫נוקליאוזידים‬

G09G )2009.01( ‫מערכת ושיטה לשימוש בצג רב–מבטי‬

117

WO/2008/005247

28/06/2007

PHARMACEUTICAL COMPOSITIONS CONTAINING MONOCLONAL ANTI IDIOTYPIC ANTI-CA-125 ANTI-BODY AND ALUMINIUM DERIVATIVES MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. IT FI2006A000163 29/06/2006 PCT/EP/2007/056465 WO/2008/000789

27/06/2007

C07D )2009.01( ‫פיפרדינים מותמרים שמגבירים פעילות‬ ‫ ושימושים שלהם‬P53

C01B )2009.01(

196153

CARBON NITRIDE PREPARATION METHOD CARBODEON LTD OY FI 20060682 13/07/2006 PCT/FI/2007/000192 WO/2008/006935

118

–‫תכשירים רפואיים המכילים נוגדן חד‬ CA–125 ‫שבטי אנטי אידיוטייפי אנטי‬ ‫ונגזרות אלומיניום‬

196152

SUBSTITUTED PIPERIDINES THAT INCREASE P53 ACTIVITY AND THE USES THEREOF SCHERING CORPORATION US 60/817753 30/06/2006 PCT/US/2007/014958 WO/2008/005268

13/07/2007

A61K )2009.01(

196148

‫שיטה להכנת פחמן ניטרידי‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

05/05/2007

PHARMACEUTICAL PREPARATIONS FOR CONTRACEPTION AND FOR PREVENTING THE RISK OF CONGENITAL MALFORMATIONS BAYER SCHERING PHARMA AG EP 06014002.7 06/07/2006 06016950.5 14/08/2006 EP PCT/EP/2007/003982 WO/2008/003363

28/06/2007

‫תכשירי רוקחות למניעת היריון ולמניעת‬ ‫הסיכון של פגמים מולדים‬

196155

METHOD FOR TESTING THE REALTIME CAPABILITY OF A SYSTEM INCHRON GMBH DE 102006031013.6 03/07/2006 PCT/EP/2007/005732 WO/2008/003427

27/06/2007

196156

BEAD IMMOBILISATION METHOD AND BEAD ARRAYS MADE THEREBY SWINBURNE UNIVERSITY OF TECHNOLOGY AU 2006903471 28/06/2006 PCT/AU/2007/000895 WO/2008/000031

21/06/2007

196157

CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION COLGATE-PALMOLIVE COMPANY US 11/479679 30/06/2006 PCT/US/2007/071782 WO/2008/005693 September 22, 2009

A61K )2009.01(

196154

–‫ד' בתשרי התש"ע‬

G06F )2009.01(

‫שיטה לבחינת יכולת של מערכת בזמן‬ ‫אמת‬

G01N )2009.01( ‫שיטה להדממת אגל ומערכי אגלים‬ ‫המיוצרים באמצעות שיטה זו‬

C11D )2009.01( ‫הרכב מיקרו–כמוסה המיוצב בפולימר‬ ‫קטיוני‬

119

28/06/2007

GASTROINTESTINAL PROSTHESES SLIMEDICS LTD. US 60/817071 29/06/2006 PCT/IL/2007/000799 WO/2008/001381

19/07/2007

120

‫ שיטה ומערכת ניידת לעיבוד‬,‫מנגנון‬ ‫גורמים המשפיעים על הסוכר בדם‬

B62D )2009.01( ‫מתקן גרירת רכב הניתן להקטנה עבור‬ ‫איחסון ברכב‬

H04N )2009.01(

196161

REMOVAL OF SHADOWS FROM IMAGES IN A VIDEO SIGNAL RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

24/12/2008

A61B )2009.01(

196160

VEHICLE-TOWING APPARATUS WHICE IS COMPACTABLE FOR STORAGE IN A VEHICLE AVRAHAM ELKAYAM

24/12/2008

‫תותבים לדרכי העיכול‬ ‫סלימדיקס בע"מ‬

196159

MOBILE APPARATUS, METHOD AND SYSTEM FOR PROCESSING BLOOD SUGAR AFFECTING FACTORS CROSS TECHNOLOGY SOLUTIONS AB SE 0601580-4 19/07/2006 PCT/EP/2007/057495 WO/2008/009737

24/12/2008

A61F )2009.01(

196158

‫הורדת צל מתמונות בתוך אות וידאו‬ ‫רפאל מערכות לחימה מתקדמות בע"מ‬

H04N )2009.01(

196162

September 22, 2009

–‫ד' בתשרי התש"ע‬

A SYSTEM FOR USING THREEDIMENSIONAL MODELS TO ENABLE IMAGE COMPARISONS INDEPENDENT OF IMAGE SOURCE RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

25/05/2007

–‫מערכת המשתמשת במודלים תלת‬ ‫ממדיים לאפשר השוואת תמונות ללא‬ ‫תלות במקור התמונות‬ ‫רפאל מערכות לחימה מתקדמות בע"מ‬

196165

A METHOD FOR THE TARGETED EXECUTION OF A REACTION TAKING PLACE ALONGSIDE SEVERAL COMPETING CHEMICAL REACTIONS LONZA AG DE 102006031652.5 08/07/2006 PCT/EP/2007/004673 WO/2008/006420

25/12/2008

196166

PROCESS SYSTEM AND METHOD FOR REWARDING CUSTOMERS, COMPUTER-READABLE MEDIUM AND COMPUTER-IMPLEMENTED METHOD FOR CONTROLLING AND OPERATING SUCH PROCESS

C07C )2009.01( ‫שיטה להוצאה לפועל מכוונת של‬ ‫ראקציה המתרחשת לצד כמה‬ ‫ראקציות כימיות מתחרות‬

G07B )2009.01( ,‫ מערכת ושיטה לתגמול לקוחות‬,‫תהליך‬ ‫אמצעי נקרא–מחשב ושיטה מבוססת‬ ‫מחשב לבקרת והפעלת תהליך זה‬ ‫עו"ד מאיר דהאן‬

29/06/2007

196167

BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KINEX PHARMACEUTICALS, LLC US 11/480163 29/06/2006 September 22, 2009

–‫ד' בתשרי התש"ע‬

C07D )2009.01( ‫תרכובות ביציקליות ותכשירי רוקחות‬ ‫המכילים אותן‬

121

PCT/US/2007/015271 WO/2008/002674

29/06/2007

BIARYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KINEX PHARMACEUTICALS, LLC US 11/480174 29/06/2006 60/923496 13/04/2007 US PCT/US/2007/015273 WO/2008/002676

27/06/2007

C07J )2009.01( ‫תולדות חומצת מרה ותכשירי רוקחות‬ ‫המכילים אותן‬

A61K )2009.01(

196172

ACTIVATED MYELOID CELLS FOR PROMOTING TISSUE REPAIR AND DETECTING DAMAGED TISSUE YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/806055 28/06/2006 60/807264 13/07/2006 US

122

‫תרכובות ביאריל ותכשירי רוקחות‬ ‫המכילים אותן‬

196169

BILE ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME INTERCEPT PHARMACEUTICALS, INC. US 60/816635 27/06/2006 PCT/US/2007/014829 WO/2008/002573

28/06/2007

C07C )2009.01(

196168

‫תאי מיאלואיד משופעלים לעידוד תיקון‬ ‫רקמות ולגילוי רקמות פגועות‬ ‫ידע חברה למחקר ופיתוח בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

PCT/IL/2007/000797 WO/2008/001379

28/06/2007

196173

USE OF AGENTS THAT ACT ON T CELLS FOR TREATMENT OF AGERELATED MACULAR DEGENERATION YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/806041 28/06/2006 PCT/IL/2007/000798 WO/2008/001380

25/06/2007

196174

METHOD FOR ADSORPTION OF FLUID CONTAMINANTS AND REGENERATION OF THE ADSORBENT TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. US 60/816643 27/06/2006 PCT/IL/2007/000765 WO/2008/001354

03/07/2007

196175

PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2006JP 04/07/2006 184254 PCT/JP/2007/063289 September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( T ‫שימוש בתרכובות הפועלות של תאי‬ ‫לטיפול בניוון במקולה הקשור לגיל‬ ‫ידע חברה למחקר ופיתוח בע"מ‬

C02F )2009.01( ‫שיטה לספיחת מזהמים פלואידיים‬ ‫ולמיחזור החומר הסופח‬ ‫מוסד הטכניון למחקר ופתוח בע"מ‬

C07C )2009.01( ‫הליך לייצור תרכובת אלכוהול‬

123

WO/2008/004544

03/07/2007

PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2006JP 04/07/2006 184253 PCT/JP/2007/063288 WO/2008/004543

29/06/2007

DIPHOSPHINE LIGANDS SOLVIAS AG CH 01051/06 PCT/EP/2007/056556 WO/2008/000815

124

‫הליך לייצור תרכובת אלכוהול‬

A61L )2009.01(

196177

THIN FILM MULTILOCULAR STRUCTURE MADE OF COLLAGEN, MEMBER FOR TISSUE REGENERATION CONTAINING THE SAME, AND METHOD FOR PRODUCING THE SAME KYOTO UNIVERSITY 2006JP 30/06/2006 180802 PCT/JP/2007/063516 WO/2008/001952

29/06/2007

C07C )2009.01(

196176

‫מבנה שכבה רב תאית דקה עשוייה‬ ,‫ איבר לחידוש רקמה המכילה אותו‬,‫מקולגן‬ ‫ושיטה לייצורו‬

C07F )2009.01(

196178

‫ליגנדים של דיפוספין‬ 30/06/2006

September 22, 2009

–‫ד' בתשרי התש"ע‬

28/06/2007

196179

IDENTIFICATION AND USE OF GPRC VARIANTS IN THE TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE EXONHIT THERAPEUTICS SA US 60/817082 29/06/2006 PCT/EP/2007/056504 WO/2008/000803

25/12/2008

GPRC ‫זיהוי ושימוש של וריאנטים של‬ ‫בטיפול ובדיאגנוזה של מחלת פרקינסון‬

196180

196181

SUBSTITUTED N-PHENYLMETHYL-5OXO-PROLINE-2-AMIDES AS P2X7RECEPTOR ANTAGONISTS AND THEIR METHODS OF USE GLAXO GROUP LIMITED GB 0613473.8 06/07/2006 0622825.8 15/11/2006 GB 0705263.2 19/03/2007 GB 0711439.0 13/06/2007 GB PCT/EP/2007/056675 WO/2008/003697

03/07/2007

September 22, 2009

–‫ד' בתשרי התש"ע‬

C07D )2009.01(

‫–אמידים‬2–‫–אוקסו–פרולינ‬5–‫–פנילמתיל‬N ‫מותמרים כאנטגוניסטים של רצפטור‬ ‫ ושיטות לשימושם‬X2P7

196182

SPUTTER TARGET ASSEMBLIES HAVING A CONTROLLED SOLDER THICKNESS PRAXAIR TECHNOLOGY, INC. US 11/480831 06/07/2006

G08B )2009.01( ‫מכשיר זיהוי מיקום‬

POSITION DETECTING DEVICE WACOM CO., LTD. P2007JP 28/12/2007 340099

03/07/2007

C07K )2009.01(

H01J )2009.01(

‫התקנים למטרת מתיז בעלי עובי הלחמה‬ ‫מבוקר‬

125

PCT/US/2007/015411 WO/2008/005461

22/08/2006

METHODS OF TREATING SURFACES WITH IONIC ORGANOSILICON COMPOSITIONS RANKA, SEEMA, AJAY IN 1069/MUM/2006 07/07/2006 PCT/IN/2006/000304 WO/2008/004242

29/06/2007

C12Q )2009.01(

‫תעתיקים ספציפיים לפרוטאז ושימושם‬ ‫לדיאגנוסטיקה וריפוי של סרטן הערמונית‬

A61K )2009.01(

196185

INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID CYDEX PHARMACEUTICALS, INC. US 11/479979 30/06/2006 PCT/US/2006/062346 WO/2008/005053

126

‫שיטות לטיפול במשטחים עם תרכובות‬ ‫אורגנוסיליקון יוני‬

196184

PROSTATE SPECIFIC TRANSCRIPTS AND THE USE THEREOF FOR PROSTATE CANCER THERAPEUTICS AND DIAGNOSTICS EXONHIT THERAPEUTICS SA US 60/817686 03/07/2006 PCT/EP/2007/056584 WO/2008/003656

19/12/2006

B32B )2009.01(

196183

‫הרכב לשאיפה המכיל סולפואלקיל אתר‬ ‫ציקלודקסטרין וקורטיקוסטרואיד‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

06/07/2007

196186

EXPANDABLE VASCULAR ENDOLUMINAL PROSTHESES PRESCIENT MEDICAL INC. US 60/818508 06/07/2006 60/851755 16/10/2006 US 11/822336 05/07/2007 US PCT/US/2007/015579 WO/2008/005535

18/07/2007

196187

NF-kB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. 2006JP 20/07/2006 198116 2006-285169 19/10/2006 JP PCT/JP/2007/064613 WO/2008/010601

28/06/2007

196188

FIBER OPTIC SENSOR USING A BRAGG FIBER THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY US 60/817514 29/06/2006 60/837891 14/08/2006 US PCT/US/2007/072419 WO/2008/003071 September 22, 2009

–‫ד' בתשרי התש"ע‬

A61F )2009.01( ‫תותבות וסקולריות אנדולומינאליות‬ ‫הניתנות להרחבה‬

A61K )2009.01( kB–NF ‫מעכב‬

G01D )2009.01( ‫חיישן סיב אופטי המשתמש בסיב‬ BRAGG

127

27/06/2007

METHODS AND SYSTEMS FOR MONITORING AND CONTROLLING BODY TEMPERATURE OF A GROUP OF HOMOTHERMIC ORGANISMS THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE AND RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, VOLCANI CENTER US 60/816618 27/06/2006 PCT/IL/2007/000783 WO/2008/001367

20/07/2007

‫שיטות ומערכות לבקרת טמפרטורת גוף‬ ‫של קבוצת בעלי חיים הומותרמיים‬ ‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬ ‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬ ‫וולקני‬

AIRCRAFT BURKHARD WIGGERICH DE 102006029603.6 PCT/DE/2007/000592 WO/2008/000203

128

C07D )2009.01(

196190

NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME PIERRE FABRE MEDICAMENT FR 0606682 21/07/2006 PCT/EP/2007/057511 WO/2008/009741

31/03/2007

A01K )2009.01(

196189

‫תולדות כרומן ותיאוכרומן קרבוקסאמיד‬ ‫ שיטות להכנתן ויישומיהן‬,‫חדשות‬ ‫הטיפוליים‬

B64C )2009.01(

196192

‫כלי טייס‬ 26/06/2006

September 22, 2009

–‫ד' בתשרי התש"ע‬

28/06/2007

196193

A COLD INFUSION PROCESS FOR FORTIFING COFFEE BEANS VOYAVA REPUBLIC LLC. US 60/806082 28/06/2006 60/820454 26/07/2006 US 60/820448 26/07/2006 US PCT/US/2007/072384 WO/2008/003054

14/06/2007

‫תהליך מיזוג קר להעשרת פולי קפה‬

196194

AN-ANTI-VIRAL COMPOSITION FOR THE TOPICAL TREATMENT OF HERPES LABIALIS (COLD SORES) AND METHOD FOR USE THEREOF REDOX PHARMACEUTICAL CORP. US 60/805921 27/06/2006 11/762542 13/06/2007 US PCT/US/2007/071222 WO/2008/002777

05/07/2007

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫תכשיר אנטי–ויראלי לטיפול מקומי‬ ‫בהרפס לביאליס (פצעי קור) ושיטה‬ ‫לשימוש בו‬

196195

WIRELESS COMMUNICATION METHOD OF SELECTING AN ENHANCED UPLINK TRANSPORT FORMAT COMBINATION BY SETTING A SCHEDULING GRANT PAYLOAD TO THE HIGHEST PAYLOAD THAT CAN BE TRANSMITTED INTERDIGITAL TECHNOLOGY CORPORATION US 60/818848 06/07/2006

A23L )2009.01(

H04B )2009.01(

‫שיטת תקשורת אלחוטית לבחירת שילוב‬ ‫מערך להעברה מוגברת ללווין באמצעות‬ ‫קביעת תיזמון למתן מטען ייעודי למטען‬ ‫הייעודי הגבוה ביותר שניתן לשדר‬

129

PCT/US/2007/015496 WO/2008/005503

03/07/2007

TDMA CHANNEL ACCESS SCHEDULING WITH NEIGHBOR INDIRECT ACKNOWLEDGMENT ALGORITHM (NBIA) FOR AD-HOC NETWORKS HARRIS CORPORATION US 11/428862 06/07/2006 PCT/US/2007/072765 WO/2008/005994

28/06/2007

‫ עם אלגוריתם‬TDMA ‫תזמון גישה לערוץ‬ HOC– ‫אישור עקיף של שכן עבור רשתות‬ AD

130

‫אבטחה מיקרו–אופטית ומערכת להצגת‬ ‫דמות‬

C12Q )2009.01(

196198

A METHOD OF MODIFYING A MACROMOLECULE WITHOUT PRIOR EXTRACTION FROM A SAMPLE VERIDEX, LLC US 60/817876 29/06/2006 60/828790 10/10/2006 US PCT/US/2007/015329 WO/2008/002680

03/07/2007

G02B )2009.01(

196197

MICRO-OPTIC SECURITY AND IMAGE PRESENTATION SYSTEM VISUAL PHYSICS, LLC US 60/817297 28/06/2006 11/770592 28/06/2007 US PCT/US/2007/072406 WO/2008/008635

29/06/2007

H04L )2009.01(

196196

‫שיטה לשינוי מולקולת ענק ללא מיצוי‬ ‫קודם מדוגמה‬

H04L )2009.01(

196199 September 22, 2009

–‫ד' בתשרי התש"ע‬

SYSTEM AND METHOD FOR VARIABLE FORWARD ERROR CORRECTION (FEC) PROTECTION HARRIS CORPORATION US 11/428689 05/07/2006 PCT/US/2007/072742 WO/2008/005981

05/07/2007

‫מערכת ושיטה עבור הגנת משתנה‬ ‫לשליחת תיקון טעות‬

196200

POLYMORPHIC FORM OF FLUORO-7(2,2,2TRIFLUOROETHOXY)PHENOXATHIN10,10-DIOXIDE CeNeRx BIoPHARMA, INC. US 60/819078 07/07/2006 PCT/US/2007/015533 WO/2008/008273

18/06/2007

196202

INDAZOLE DERIVATIVES FOR THE TREATMENT OF HSP90-INDUCED DISEASES MERCK PATENT GMBH DE 102006030479.9 01/07/2006 PCT/EP/2007/005338 WO/2008/003396

25/12/2008

September 22, 2009

196203

–‫ד' בתשרי התש"ע‬

A61P )2009.01( –7–‫צורה פולימורפית של פלואורו‬ –‫–טריפלואורואתוקסי)פנוקסטין‬2,2,2( ‫–דיאוקסיד‬10,10

C07D )2009.01( ‫תולדות אינדזול לטיפול במחלות‬ HSP90 ‫מושרות‬

B41J )2009.01(

131

‫מערכת ושיטה לפרק חשמל סטטי‬ ‫במדפסת‬ ‫מתן דיגיטל פרינטינג בע"מ‬

SYSTEM AND METHOD FOR DISCHARGING STATIC IN A PRINTER MATAN DIGITAL PRINTING LTD.

29/06/2007

INSULATING WINDOW INCORPORATING PHOTOVOLTAIC CELLS AND A PRESSURE EQUALIZATION SYSTEM VISIONWALL CORPORATION CA 2551356 30/06/2006 PCT/CA/2007/001163 WO/2008/000084

26/06/2007

‫חלון מבודד המכיל תאים פוטו–ואלטאיים‬ ‫ומערכת להשוואת לחצים‬

132

‫שימור של מוצרים שהם פירות או ירקות‬

C07D )2009.01(

196206

ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS ASTRAZENECA AB US 60/830243 12/07/2006 60/913367 23/04/2007 US PCT/SE/2007/000683 WO/2008/008022

05/07/2007

A01N )2009.01(

196205

PRESERVING PRODUCTS FOR HARVEST FRUITS AND VEGETABLES INVERSIONES NAPOLEON LIMITADA CL 1651/2006 27/06/2006 PCT/EP/2007/056372 WO/2008/000741

12/07/2007

E06B )2009.01(

196204

‫נגזרות איזואינדולין לטיפול בהפרעות קצב‬ ‫לב‬

C07D )2009.01(

196207 September 22, 2009

–‫ד' בתשרי התש"ע‬

‫תרכובות פירימידו מאוחות‬

FUSED PYRIMIDO COMPOUNDS ASTRAZENECA AB US 60/818878 06/07/2006 PCT/GB/2007/002490 WO/2008/003958

10/07/2007

196208

METHODS FOR CANCER TREATMENT USING TAK1 INHIBITORS ASTRAZENECA AB US 60/806845 10/07/2006 PCT/GB/2007/002568 WO/2008/007072

02/08/2007

27/06/2007

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

ALPHA––‫גורמים נקשרים מכווני–מטרה ל‬ ‫ ושימושים שלהם‬PDGFR

196210

USE OF STILBENE DERIVATIVES FOR TREATMENT AND PREVENTION OF AQUATIC MOLD INFECTIONS THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE AND RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, VOLCANI CENTER US 60/816619 27/06/2006 PCT/IL/2007/000784 WO/2008/001368

September 22, 2009

‫שיטות לטיפול בסרטן המשתמשות‬ TAK1 ‫במעכבי‬

196209

TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF ASTRAZENECA AB US 60/835647 03/08/2006 PCT/US/2007/075117 WO/2008/112003

C12Q )2009.01(

A61K )2009.01( ‫שימוש בתולדות סטילבן לטיפול ומניעה‬ ‫של זיהומים פטרייתיים ביצורים מימיים‬ ‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬ ‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬ ‫וולקני‬

133

03/07/2007

PRESERVATION AND CONTROLLED DELIVERY/RELEASE OF SPERMATOZOA SPERMVITAL AS GB 0613288.0 04/07/2006 60/807716 19/07/2006 US PCT/NO/2007/000256 WO/2008/004890

29/05/2007

I.B.R ISRAELI BIOTECHNOLOGY RESEARCH LTD IL 176668 02/07/2006 PCT/IL/2007/000648 WO/2008/004206

‫תכשירי קרטנואידים המועילים להלבנת‬ ‫העור‬ '‫ ישראלי ביוטכנולוגי ריסרץ‬.‫אר‬.‫בי‬.‫איי‬ ‫בע"מ‬

B32B )2009.01( ‫בידוד תרמי של חבילות‬ ‫פוטרמן יזום ניהול ושיווק‬

B42D )2009.01(

196214

BOOK AND METHOD FOR MANUFACTURE THEREOF JONGBLOED B.V. NL 1032073 28/06/2006 PCT/NL/2007/000163

134

A61K )2009.01(

196213

THERMAL INSULATION OF PACKAGES PUTERMAN DISTRIBUTORS

28/06/2007

‫ העברה מבוקרת‬/‫שימור ושחרור מבוקר‬ ‫של תאי זרע‬

196212

CAROTENOID COMPOSITIONS USEFUL FOR WHITENING SKIN

25/12/2008

A01N )2009.01(

196211

‫ספר ושיטה לייצורו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

WO/2008/002130

29/06/2007

196215

CONTAINER FOR THE STORGE OF PRODUCTS JANNY SARL FR 0605910 30/06/2006 PCT/FR/2007/001109 WO/2008/000971

24/04/2007

196217

CONCEPT FOR COMBINING MULTIPLE PARAMETRICALLY CODED AUDIO SOURCES FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. US 60/819419 07/07/2006 11/739544 24/04/2007 US PCT/EP/2007/003598 WO/2008/003362

06/07/2007

196218

A BOUNCING CRADLE HAVING A BASE FRAME BABY BJORN AB SE 0601502-8 07/07/2006 PCT/SE/2007/000675 WO/2008/004958

06/07/2007

196219

A BOUNCING CRADLE September 22, 2009

–‫ד' בתשרי התש"ע‬

B65D )2009.01( ‫מיכל לאחסון מוצרים‬

H04N )2009.01( ‫מושג לשילוב מקורות שמע מרובים‬ ‫המקודדים פרמטרית‬

A47D )2009.01( ‫עריסה מקפצת עם מסגרת תחתית‬

A47D )2009.01( ‫עריסה מקפצת‬

135

BABY BJORN AB SE 0601501-0 PCT/SE/2007/000676 WO/2008/004959

07/07/2006

12/07/2007

RATE-ENHANCED CMP COMPOSITIONS FOR DIELECTRIC FILMS CABOT MICROELECTRONICS CORPORATION US 11/491612 24/07/2006 PCT/US/2007/015872 WO/2008/013678

10/07/2007

CMP METHOD FOR METALCONTAINING SUBSTRATES

136

‫הרכבים מוגברי–קצב לליטוש כימי–מכאני‬ ‫עבור שכבות די–אלקטריות‬

C09K )2009.01(

196221

GALLIUM AND CHROMIUM IONS FOR OXIDE REMOVAL RATE ENHANCEMENT CABOT MICROELECTRONICS CORPORATION US 11/491055 21/07/2006 PCT/US/2007/015714 WO/2008/013668

06/07/2007

C09K )2009.01(

196220

‫יוני כרום וגליום עבור הגברת קצב הסרת‬ ‫תחמוצת‬

C09K )2009.01(

196222

‫שיטת ליטוש כימי–מכאני עבור מצעים‬ ‫המכילים מתכת‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

CABOT MICROELECTRONICS CORPORATION US 60/830233 12/07/2006 PCT/US/2007/015555 WO/2008/008282

08/07/2007

196223

RAPID DIAGNOSTIC DEVICES BASED ON MOLECULAR IMPRINTED POLYMERS INFIGO DIAGNOSTICS LTD. US 60/806783 09/07/2006 PCT/IL/2007/000851 WO/2008/007359 28/06/2007

‫התקנים לאבחון מהיר המבוססים על‬ ‫הטבעה מולקולרית בפולימרים‬ ‫אינפיגו דיאגנוסטיקה בע"מ‬

196224

SYSTEM AND METHOD FOR TRACELESS BIOMETRIC IDENTIFICATION INNOVYA RESEARCH & DEVELOPMENT LTD US 11/478404 29/06/2006 PCT/IL/2007/000790 WO/2008/001373

03/07/2007

PHOSPHONATE AND PHOSPHINATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME BRISTOL-MYERS SQUIBB COMPANY US 60/818912 06/07/2006 11/769964 28/06/2007 US PCT/US/2007/072708 WO/2008/005964

September 22, 2009

196227

–‫ד' בתשרי התש"ע‬

G07C )2009.01(

‫מערכת ושיטה לזיהוי ביומטרי ללא עקבות‬

196226

28/06/2007

G01N )2009.01(

‫אינווייה מחקר ופיתוח בע"מ‬

C07F )2009.01( ‫תרכובות פוספונט ופוספינט ותכשירי‬ ‫רוקחות המכילים אותן‬

C12N )2009.01(

137

METHODS FOR DIFFERENTIATING UMBILICAL CORD MATRIX CELLS INTO HEPATOCYTE-LIKE CELLS THE UNIVERSITY OF KANSAS US 60/817251 28/06/2006 PCT/US/2007/015219 WO/2008/002662

18/07/2007

REAR VIEW MIRROR FOR A VEHICLE YOSEF BREGMAN

138

‫–הידרוקסיתיובנזאמיד של‬4 ‫תולדות‬ ‫תרופות‬

C07D )2009.01(

196229

HYDROGEN SULFIDE DERIVATIVES OF NON-STEROIDAL ANTIINFLAMMATORY DRUGS ANTIBE THERAPEUTICS INC. US 60/807639 18/07/2006 60/887188 30/01/2007 US PCT/CA/2007/001289 WO/2008/009127

28/12/2008

C07D )2009.01(

196228

4-HYDROXYTHIOBENZAMIDE DERIVATIVES OF DRUGS ANTIBE THERAPEUTICS INC. US 60/807639 18/07/2006 60/887188 30/01/2007 US PCT/CA/2007/001273 WO/2008/009118

18/07/2007

‫שיטות להתמיינות של תאי מטריצה של‬ ‫חבל הטבור לתאי דימוי–הפטוציט‬

–‫תולדות מימן גופריתי של תרופות אנטי‬ ‫דלקתיות סטרואידיות‬

B60R )2009.01(

196230

‫ראי לצפיה אחורית לכלי רכב‬ ‫יוסף ברגמן‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

02/08/2007

196233

CHEMICAL PROCESS FOR PREPARATION OF AROMATIC CYCLOPROPANE ESTERS AND AMIDES ASTRAZENECA AB GB 0615619.4 05/08/2006 PCT/SE/2007/000706 WO/2008/018822

02/08/2007

‫תהליך כימי להכנת אסטרים ואמידים של‬ ‫ציקלופרופאן ארומטי‬

196234

A PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOPROPYLAMINES ASTRAZENECA AB GB 0615620.2 05/08/2006 PCT/SE/2007/000707 WO/2008/018823

28/12/2008

ORAL CAVITY INSERTION INSTRUMENT AND PHARYNGOSCOPE APPARATUS TSUNODA KOICHI 2007JP 27/12/2007 338336

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61B )2009.01( ‫מכשיר להחדרה לחלל הפה ומכשיר‬ ‫להסתכלות בלוע‬

196236

METHOD AND SYSTEM FOR AUTOMATICALLY PERFORMING A STUDY OF A MULTIDIMENSIONAL SPACE SAM STATHIS US 60/805983 28/06/2006

C07C )2009.01( ‫תהליך להכנת ציקלופרופילאמינים‬ ‫פעילים אופטית‬

196235

26/06/2007

C07C )2009.01(

G06F )2009.01(

‫שיטה ומערכת לביצוע אוטומטי של לימוד‬ ‫מרחב רב מימדי‬

139

11/766672 US PCT/US/2007/072134 WO/2008/002918

21/06/2007

11/06/2007

ARRANGEMENT FOR DETERMINING THE OPERATIONAL CHARACTERISTICS OF A HIGH-FREQUENCY POWER AMPLIFIER ROHDE & SCHWARZ GMBH & CO. KG DE 102006031053.5 05/07/2006 PCT/EP/2007/005133 WO/2008/003385

01/06/2007

G01R )2009.01(

‫התקן לקביעת מאפיינים תפעוליים של‬ ‫מגבר כוח לתדירות גבוהה‬

G11C )2009.01(

196239

METHOD OF ERROR CORRECTION IN A MULTI-BIT-PER-CELL FLASH MEMORY

140

‫התקן לקביעת מאפיינים תפעוליים של‬ ‫מגבר כוח לתדירות גבוהה‬

196238

ARRANGEMENT FOR DETERMINING THE OPERATIONAL CHARACTERISTICS OF A HIGH-FREQUENCY POWER AMPLIFIER ROHDE & SCHWARZ GMBH & CO. KG DE 102006031046.2 05/07/2006 PCT/EP/2007/004887 WO/2008/003376

04/07/2007

G01R )2009.01(

196237

‫שיטה לתיקון טעות בזיכרון פלאש רב‬ ‫ביטים לתא‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

RAMOT AT TEL AVIV UNIVERSITY LTD. US 60/806534 04/07/2006 11/607945 04/12/2006 US PCT/IL/2007/000830 WO/2008/004226

19/07/2006

196240

FLUID FLOW LABYRINTH NETAFIM LTD. WO PCT/IB2006/052473 PCT/IB/2006/052473 WO/2008/010026

‫מעבר זרימה טורבולנטי‬ ‫נטפים בע"מ‬ 19/07/2006

29/06/2007

196241

A METHOD FOR DETECTING NUCLEIC ACIDS ROSETTA GENOMICS LTD. US 60/806404 30/06/2006 60/822371 14/08/2006 US 60/850455 10/10/2006 US 60/871095 20/12/2006 US PCT/IB/2007/003732 WO/2008/029295

28/06/2007

196242

INTRADERMAL NEEDLE-LESS INJECTION DEVICE PERF-ACTION TECHNOLOGIES LTD. US 60/816866 28/06/2006 60/907564 09/04/2007 US September 22, 2009

A01G )2009.01(

–‫ד' בתשרי התש"ע‬

C12Q )2009.01( ‫שיטה לקביעת חומצות גרעין‬ ‫רוזטה ג'נומיקס בע"מ‬

A61M )2009.01( ‫התקן הזרקה תת–עורי ללא מחט‬

141

PCT/IL/2007/000796 WO/2008/001378

13/07/2007

FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE AMGEN INC. US 60/830882 14/07/2006 PCT/US/2007/016068 WO/2008/008539 14/12/2001

142

H04L )2009.01(

‫הפקה ויישום פרוטוקול וממשך תקשורת‬ ‫להעברת אות בקצב נתונים גבוה‬

H04L )2009.01(

196245

GENERATING AND IMPLEMENTING A COMMUNICATION PROTOCOL AND INTERFACE FOR HIGH DATA RATE SIGNALTRANSFER QUALCOMM INCORPORATED US 60/255833 15/12/2000 PCT/US/2001/047807 WO/2002/049314

14/12/2001

‫נגזרות הטרוציקליות מאוחות ושיטות‬ ‫שימוש‬

196244

GENERATING AND IMPLEMENTING A COMMUNICATION PROTOCOL AND INTERFACE FOR HIGH DATA RATE SIGNALTRANSFER QUALCOMM INCORPORATED US 60/255833 15/12/2000 PCT/US/2001/047807 WO/2002/049314

14/12/2001

C07D )2009.01(

196243

‫הפקה ויישום פרוטוקול וממשך תקשורת‬ ‫להעברת אות בקצב נתונים גבוה‬

H04L )2009.01(

196246

September 22, 2009

–‫ד' בתשרי התש"ע‬

GENERATING AND IMPLEMENTING A COMMUNICATION PROTOCOL AND INTERFACE FOR HIGH DATA RATE SIGNALTRANSFER QUALCOMM INCORPORATED US 60/255833 15/12/2000 PCT/US/2001/047807 WO/2002/049314

14/12/2001

‫הפקה ויישום פרוטוקול וממשך תקשורת‬ ‫להעברת אות בקצב נתונים גבוה‬

196247

GENERATING AND IMPLEMENTING A COMMUNICATION PROTOCOL AND INTERFACE FOR HIGH DATA RATE SIGNALTRANSFER QUALCOMM INCORPORATED US 60/255833 15/12/2000 PCT/US/2001/047807 WO/2002/049314

09/07/2007

‫הפקה ויישום פרוטוקול וממשך תקשורת‬ ‫להעברת אות בקצב נתונים גבוה‬

196248

SECURE HEAD-UP DISPLAY THALES FR 0606308 11/07/2006 PCT/EP/2007/056951 WO/2008/006798

25/06/2007

196249

SHUT-OFF DEVICE FRIATEC AKTIENGESELLSCHAFT Country Number Date International application number September 22, 2009

–‫ד' בתשרי התש"ע‬

H04L )2009.01(

G01C )2009.01( ‫תצוגת התראות בטיחות‬

F16K )2009.01( ‫התקן סגירה‬

143

International publication number

23/07/2007

C10M )2009.01(

196250

‫תכשיר לסיכה‬

LUBRICANT COMPOSITION CIBA HOLDING INC. US 60/834383 31/07/2006 PCT/EP/2007/057552 WO/2008/015116

30/07/2007

SOLUBLE EPOXIDE HYDROLASE INHIBITORS ARETE THERAPEUTICS, INC. US 60/834902 01/08/2006 PCT/US/2007/074763 WO/2008/016884

11/07/2007

C12N )2009.01( ‫תהליך ייצור גליקופרוטאינים‬

G06K )2009.01(

196253

SPECTRAL BIOMETRICS SENSOR TODD DOUCET US 11/458607 19/07/2006 11/458619 19/07/2006 US PCT/US/2007/073886 WO/2008/111994

144

‫מעכבי אפוקסיד הידרוקסילאז מסיסים‬

196252

PRODUCTION OF GLYCOPROTEINS WYETH US 60/830658 13/07/2006 PCT/US/2007/015767 WO/2008/008360

19/07/2007

A61K )2009.01(

196251

‫חיישן ביומטריה ספקטראלי‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

19/07/2007

196254

MULTIBIOMETRIC MULTISPECTRAL IMAGER LUMIDIGM, INC. US 60/832233 19/07/2006 PCT/US/2007/073894 WO/2008/100329

30/07/2007

196255

SPATIAL-SPECTRAL FINGERPRINT SPOOF DETECTION LUMIDIGM, INC. US 11/461244 31/07/2006 11/461253 31/07/2006 US PCT/US/2007/074747 WO/2008/108871

13/07/2007

196256

4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. US 60/830488 13/07/2006 60/945786 22/06/2007 US PCT/US/2007/016018 WO/2008/008502

17/07/2007

196257

CALCANEAL PLATE ORTHO-HELIX SURGICAL DESIGNS, INC. September 22, 2009

–‫ד' בתשרי התש"ע‬

G06K )2009.01( ‫סורק מולטי ביומטרי מולטי ספקטראלי‬

G06K )2009.01( ‫חשיפת תרמית טביעת אצבע‬ ‫ספקטראלית–מרחבית‬

C07K )2009.01( ‫–אוקסובוטאנואילים‬4–‫–אמינו‬4 ‫פפטידים‬ ‫כמעכבי שכפול ויראלי‬

A61B )2009.01( ‫פלטת עצם העקב‬

145

US 60/831647 60/880910 US 11/879118 US PCT/US/2007/016185 WO/2008/011018

29/06/2007

18/07/2006 17/01/2007 16/07/2007

‫תוית ניתנת לזיהוי של חומצה נוקלאית‬

DETECTABLE NUCLEIC ACID TAG AMBIT BIOSCIENCES CORPORATION US 60/806422 30/06/2006 PCT/US/2007/015089 WO/2008/005310

06/07/2007

‫עמידות בפני קימחון אבקי והיעדר‬ SATIVUS CUCUMIS–‫נמק ב‬

H01Q )2009.01(

196261

MULTI-ANTENNA SYSTEM FOR DIFFERENTIAL WIRELESS COMMUNICATION DEVICES IN4TEL LTD. US 60/817380 30/06/2006 PCT/IL/2007/000807 WO/2008/001384

146

C12N )2009.01(

196260

RESISTANCE TO POWDERY MILDEW AND ABSENCE OF NECROSIS IN CUCUMIS SATIVUS ENZA ZADEN BEHEER B.V. EP PCT/EP2006/064033 07/07/2006 PCT/EP/2007/056911 WO/2008/003783

28/06/2007

C12Q )2009.01(

196258

‫מערכת מרובת אנטנות למכשירי תקשורת‬ ‫אלחוטית משתנים‬ ‫ טל בע"מ‬4 ‫אין‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

30/06/2006

196262

SURVEILLANCE METHOD AND SYSTEM USING OBJECT BASED RULE CHECKING ULTRAWAVES DESIGN HOLDING B.V.

G08B )2009.01( ‫שיטה ומערכת למעקב על בסיס בקרת‬ ‫תנאי מבוסס אובייקטים‬

PCT/NL/2006/050160 WO/2008/002128

28/06/2007

196263

SYSTEM AND METHOD FOR MANAGEMENT OF PROPERTY DATA AND PROCESSES ZAID ORNIR LTD US 60/817559 29/06/2006 PCT/IL/2007/000789 WO/2008/001372

29/12/2008

196264

A ZIPPER SYSTEM WITH 3 SETS OF TEETH CHAGIM NEHALIM LTD.

September 22, 2009

–‫ד' בתשרי התש"ע‬

B65D )2009.01(

A61B )2009.01( ‫ מערכות שיניים‬3 ‫רוכסן בעל‬ ‫חגים נחלים בע"מ‬

196266

A FOLDED CUSHION FOR BACK SUPPORT

‫אורניב בע"מ‬-‫זייד‬

‫ ייצור מוצרי אריזה‬-1990 ‫ימ"א‬

196265

30/12/2008

‫שיטה ומערכת לניהול מידע ותהליכים‬ ‫לנכסים‬

‫קופסה בעלת פינות מחוזקות‬

BOX WITH REINFORCED CORNERS IMA 1990-PACKAGING PRODUCTS MANUFACTURE

30/12/2008

G06Q )2009.01(

A61B )2009.01( ‫כרית תמיכה מתקפלת לגב‬

147

‫מיכל טייכמן‬

MICHAL TAICHMAN

27/07/2007

INDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME MITSUBISHI TANABE PHARMA CORPORATION US 60/820604 27/07/2006 60/886178 23/01/2007 US PCT/JP/2007/065213 WO/2008/013322

11/07/2007

C07H )2009.01(

196267

‫תולדות אינדול ותכשירי רוקחות המכילים‬ ‫אותן‬

C12N )2009.01(

196268

‫שיטות בדיקה‬

ASSAY METHODS TRELLIS BIOSCIENCES, INC. US 60/830507 12/07/2006 60/839174 21/08/2006 US 60/848112 29/09/2006 US 60/911483 12/04/2007 US PCT/US/2007/073293 WO/2008/008858

03/08/2007 PROCESS FOR PREPARING CLOPIDOGREL BISULPHATE TEVA PHARMACEUTICAL INDUSTRIES LTD.

148

C07D )2009.01(

196270

‫תהליך להכנת קלופידוגרל ביסולפאט‬ ‫טבע תעשיות פרמצבטיות בע"מ‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

US 60/835551 60/858127 US 60/877987 US PCT/US/2007/017324 WO/2008/019053

03/08/2006 09/11/2006 28/12/2006

09/11/2006

196272

SOLID COMPOSITIONS COMPRISING TADALAFIL AND AT LEAST ONE CARRIER TEVA PHARMACEUTICAL INDUSTRIES LTD. US 60/819215 07/07/2006 PCT/US/2006/043664 WO/2008/005039

10/07/2006

196273

STABLE FORMULATION COMPRISING A COMBINATION OF A MOISTURE SENSITIVE DRUG AND A SECOND DRUG AND MANUFACTURING PROCEDURE THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD.

A61K )2009.01( ‫תרכובות מוצקות המכילות טדלפיל‬ ‫ולפחות נשא אחד‬ ‫טבע תעשיות פרמצבטיות בע"מ‬

A61K )2009.01( ‫פורמולציה יציבה המכילה שילוב של‬ ‫תרופה רגישה ללחות ותרופה נוספת‬ ‫ותהליך הכנתה‬ ‫טבע תעשיות פרמצבטיות בע"מ‬

PCT/US/2006/026899 WO/2008/008057

07/08/2007

September 22, 2009

196274

–‫ד' בתשרי התש"ע‬

C07C )2009.01(

149

AMINO ALCOHOL DERIVATIVE AND IMMUNOSUPPRESSIVE AGENT HAVING SAME AS AN ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. 2006JP 08/08/2006 215281 PCT/JP/2007/065426 WO/2008/018447

07/08/2007

S1P ‫תולדות אמינו פוספאט וקולטן מאפנן‬ ‫בעל מרכיב פעיל זהה‬

150

A61B )2009.01(

196277

METHODS, COMPOSITIONS,, UNIT DOSAGE FORMS, AND KITS FOR PHARMACOLOGIC STRESS TESTING WITH REDUCED SIDE EFFECTS ADENOBIO N.V. US 60/818928 05/07/2006 11/772684 02/07/2007 US PCT/EP/2007/005923 WO/2008/003479

12/06/2007

C07F )2009.01(

196275

AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. 2006JP 08/08/2006 215280 PCT/JP/2007/065397 WO/2008/018427

04/07/2007

‫תולדות אמינו אלכוהולית וגורם‬ ‫אימיונוסופרסיבי בעל מרכיב פעיל זהה‬

‫ צורות ליחידת מנה‬,‫ תכשירים‬,‫שיטות‬ ‫וערכות בעלי תופעות לוואי מופחתות‬ ‫לבדיקת לחץ פרמקולוגי‬

A61K )2009.01(

196280 September 22, 2009

–‫ד' בתשרי התש"ע‬

USE OF AMPK-ACTIVATING IMIDAZOLE DERIVATIVES, PREPARATION PROCESS THEREFOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM MERCK PATENT GMBH FR 06/06415 13/07/2006 PCT/EP/2007/005164 WO/2008/006432

04/07/2007

,AMPK ‫שימוש בנגזרות אימידזול מפעילות‬ ‫תהליך להכנתן ותכשירים המכילים אותן‬

196282

COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES MERCK PATENT GMBH US 60/818741 06/07/2006 60/856139 02/11/2006 US PCT/EP/2007/005904 WO/2008/003473

29/06/2007

196283

SYSTEM AND METHOD FOR COLLECTING NETWORK PERFORMANCE INFORMATION EMBARQ HOLDINGS COMPANY LLC US 11/479751 30/06/2006 60/839333 22/08/2006 US 11/583288 19/10/2006 US 11/583765 19/10/2006 US 60/897543 26/01/2007 US 60/905624 07/03/2007 US 60/922246 05/04/2007 US 11/809536 31/05/2007 US PCT/US/2007/015311 WO/2008/097254

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫תכשירים ושיטות להגברת היעילות של‬ IL2 ‫תגובות חיסוניות מתווכות על ידי‬

H04L )2009.01( ‫מערכת ושיטה לאיסוף מידע על ביצועי‬ ‫רשת‬

151

29/06/2007

SYSTEM AND METHOD FOR ADJUSTING CODEC SPEED IN A TRANSMISSION PATH DURING CALL SET-UP DUE TO REDUCED TRANSMISSION PERFORMANCE EMBARQ HOLDINGS COMPANY LLC US 11/479751 30/06/2006 60/839333 22/08/2006 US 11/583288 19/10/2006 US 11/583765 19/10/2006 US 60/897543 26/01/2007 US 60/905624 07/03/2007 US 60/922246 05/04/2007 US 11/809882 31/05/2007 US PCT/US/2007/015299 WO/2008/030292

29/06/2007

‫מערכת ושיטה להתאמת מהירות‬ ‫מפענח בערוץ שידור במהלך ביסוס‬/‫מקודד‬ ‫תקשורת עקב ביצועי שידור פחותים‬

H04J )2009.01(

196285

SYSTEM AND METHOD FOR MANAGING SUBSCRIBER USAGE OF A COMMUNICATIONS NETWORK EMBARQ HOLDINGS COMPANY LLC US 11/479751 30/06/2006 60/839333 22/08/2006 US 11/583288 19/10/2006 US 11/583765 19/10/2006 US

152

H04L )2009.01(

196284

‫שיטה ומערכת לניהול שימוש מנוי ברשת‬ ‫תקשורות‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

60/897543 US 60/905624 US 60/922246 US 11/809405 US PCT/US/2007/015252 WO/2008/005393

26/01/2007 07/03/2007 05/04/2007 31/05/2007

04/07/2006

196288

METHOD AND DEVICE FOR RETRIEVING INFORMATION FROM AN OPTICAL RECORD CARRIER AT VARIOUS READING SPEEDS KONINKLIJKE PHILIPS ELECTRONICS N.V.

G11B )2009.01(

‫שיטה והתקן לאחזור מידע מנשא רשומה‬ ‫אופטית במהירויות קריאה מגוונות‬

PCT/IB/2006/052246 WO/2008/004032

02/07/2007

196289

BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP JANSSEN PHARMACEUTICA NV EP 06116564.3 04/07/2006 PCT/EP/2007/056619 WO/2008/003665

31/12/2008

196290

INLINE FLUID CONTROL DEVICE MEDIMOP MEDICAL PROJECTS LTD. September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫בנזימידאזולים אגוניסטים לקנאבינואיד‬ ‫בעלי קבוצה הטרוציקלית מותמרת‬

A61B )2009.01( ‫התקן לבקרת נוזלים בקו ישר‬ ‫מדימופ פרויקטים רפואיים בע"מ‬

153

31/12/2008 MEASUREMENT EQUIPMENT FOR MEASURING ACCOMMODATING INTRAOCULAR LENSES NULENS LTD.

05/07/2007

‫ציוד מדידה למדידת עדשות תוך עיניות‬ ‫מסתגלות‬ ‫ניולנס בע"מ‬

C07K )2009.01(

196292

CSF3R POLYPEPTIDES, THEIR PREPARATION AND USES THEREOF LABORATOIRES SERONO SA EP 06116704.5 06/07/2006 60/832177 19/07/2006 US PCT/EP/2007/056846 WO/2008/003763

31/12/2008

H01B )2009.01(

196291

‫ הכנתם והשימוש‬CRF3R ‫פוליפפטידים‬ ‫בהם‬

B65D )2009.01(

196293

‫נשא בקבוקים‬ ‫אלעד יעקב אגבר‬

BOTTLE HOLDER ELAD J. EGBER

05/07/2007

AUTOMATIC GENERATION OF VIDEO FROM STRUCTURED CONTENT SUNDAYSKY LTD. US 60/806626 06/07/2006 PCT/IL/2007/000843 WO/2008/004237

154

G11B )2009.01(

196294

‫יצירה אוטומטית של מידע חוזי מתוכן‬ ) CONTENT STRUCTURED( ‫מובנה‬ ‫סנדייסקי בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

05/07/2007

H04N )2009.01(

196295

‫יצירה אוטומטית של מידע חוזי מתוכן‬ ‫מובנה‬ )CONTENT STRUCTURED (

AUTOMATIC GENERATION OF VIDEO FROM STRUCTURED CONTENT SUNDAYSKY LTD. US 60/806626 PCT/IL/2007/000842 WO/2008/004236

‫סנדייסקי בע"מ‬ 06/07/2006

03/07/2007

196296

MANUFACTURE, METHOD, AND USE OF ACTIVE SUBSTANCE-RELEASING MEDICAL PRODUCTS FOR PERMANENTLY KEEPING BLOOD VESSELS OPEN HEMOTEQ AG DE 102006030586.8 03/07/2006 PCT/DE/2007/001173 WO/2008/003298

05/07/2007

196297

AIRCRAFT BRAKING CONTROL MEGGITT AEROSPACE LIMITED GB 0613286.4 05/07/2006 PCT/GB/2007/002513 WO/2008/003971

07/07/2006

196298

AN ENANTIOSELECTIVE SYSTHESIS OF PYRROLIDINE-SUBSTITUTED FLAVONES. AND INTERMEDIATES THEREOF PIRAMAL LIFE SCIENCES LIMITED

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61L )2009.01( ‫ שיטה ושימוש של מתקנים‬, ‫ייצור‬ ‫רפואיים המוציאים חומרים לשם קיום‬ ‫כלי–דם פתוחים באופן קבוע‬

B64C )2009.01( ‫בקר בלימת כלי טייס‬

C07D )2009.01( ‫סינתזה אננטיו–סלקטיבית של פלבונים‬ ‫ ותיווכיהם‬,‫מותמרים בפירולידין‬

155

PCT/IB/2006/052294 WO/2008/007169

23/05/2001

MEDICAMENT FOR THE TREATMENT OF HAPATITIS C UNIVERSITA DEGLI STUDI DI CAGLIARI US 60/206585 23/05/2000 PCT/US/2001/016671 WO/2001/090121

02/07/2007

07/08/2007

C07D )2009.01(

‫תיאופנים מותמרים בפיראזולאלקנאמיד‬ ‫כריאגנטים המגבירים תגובה מתווכת על‬ AMPA ‫ידי קולטני‬

04/07/2006

C07D )2009.01(

196303

PURIFICATION PROCESS OF MONTELUKAST AND ITS AMINE SALTS ESTEVE QUIMICA, S.A. EP 06118690.4 09/08/2006 60/836856 09/08/2006 US PCT/EP/2007/058180

156

C ‫תכשיר רפואי לטיפול בצהבת מסוג‬

196302

PYRAZOLEALKANAMIDE SUBSTITUTED THIOPHENES AS AMPA POTENTIATORS N.V. ORGANON EP 06116592.4 PCT/EP/2007/005851 WO/2008/003452

C12N )2009.01(

196301

‫תהליך לטיהור מונטלוקסט ומלחיו‬ ‫האמינים‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

WO/2008/017669

03/08/2007

196304

‫תקשורת אל–חוטית המבוססת על‬ ‫פורמאט רשת‬

WEB FORMAT-BASED WIRELESS COMMUNICATIONS MICROSOFT CORPORATION US 11/465328 17/08/2006 PCT/US/2007/017417 WO/2008/021032

11/07/2007

196305

A METHOD AND APPARATUS FOR MANUFACTURING A TRANSVERSELY ORIENTED FILM OF THERMOPLASTIC POLYMER MATERIAL AND PRODUCTS OBTAINABLE BY THE SAME MTHOD OLE-BENDT RASMUSSEN GB 0613969.5 13/07/2006 PCT/EP/2007/057119 WO/2008/006858

31/07/2007

September 22, 2009

–‫ד' בתשרי התש"ע‬

B29C )2009.01(

‫שיטה ומערכת לייצור פילם מונחה רוחבית‬ ‫של חומר פולימרי תרמופלסטי ומוצרים‬ ‫המתקבלים ע"י השיטה‬

196306

AQUEOUS SOLUTIONS OF OPTICAL BRIGHTENERS CLARIANT FINANCE (BVI) LIMITED EP 06118570.8 08/08/2006 PCT/EP/2007/057909 WO/2008/017623

H04L )2009.01(

C08L )2009.01( ‫תמיסות מימיות של מבהירים אופטיים‬

157

02/07/2007

INHIBITION OF ALPHA-SYNUCLEIN AGGREGATION ZAPALOID LIMITED US 60/806511 03/07/2006 PCT/GB/2007/002469 WO/2008/003943

31/12/2008

158

B65D )2009.01( ‫שיטה ומערכת לאריזה הכוללת חריצים‬ ‫שנעשו באמצעות לייזר‬

H01B )2009.01(

196311

PLAYHOUSE HAVING PHOTOVOLTAIC CELL FOR POWERING ELECTRICAL COMPONENTS THEREOF TOYMONSTER INTELLECTUAL PROPERTY LIMITED

31/12/2008

‫עיכוב הצטברות אלפא–סינוקלין‬

196309

METHOD AND APPARATUS FOR LASER SCORED PACKAGING KRAFT FOODS GLOBAL BRANDS LLC US 11/969680 04/01/2008

31/12/2008

C07K )2009.01(

196307

‫בית משחק בעל תא פוטוולטאי עבור‬ ‫הספקת כוח לרכיבים חשמליים בו‬

G02B )2009.01(

196312

September 22, 2009

–‫ד' בתשרי התש"ע‬

LUMINESCENT SOLAR CONCENTRATORS GREEN-SUN ENERGY LTD.

05/07/2007

‫מרכז קרני שמש זוהר‬ ‫גירין סאן אנרגי בע"מ‬

196313

PHENYL SUBSTITUTED HETEROARYL-DERIVATIVES AND USE THEREOF AS ANTI-TUMOR AGENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG EP 06116826.6 07/07/2006 PCT/EP/2007/056860 WO/2008/003770

05/07/2007

196314

PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY TORREY PINES INSTITUTE FOR MOLECULAR STUDIES US 60/818804 05/07/2006 60/818910 05/07/2006 US PCT/US/2007/015571 WO/2008/045148

03/07/2007

196315

MEDICAMENT FOR THE ENHANCEMENT OF COGNITIVE FUNCTION AND NEUROPROTECTION EGIS GYOGYSZERGYAR Nyilvanosan Mukodo Reszvenytarsasag September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01( ‫תולדות הטרואריליות מותמרות בפניל‬ ‫ושימושן כגורמים אנטי–גידולים‬

C12N )2009.01( ‫שיטות לסריקת פרוטיאז ופרוטיאזות‬ ‫המזוהות באמצעות השיטות הללו‬

A61K )2009.01( ‫תרופה להגברת התפקוד הקוגניטיבי‬ ‫והגנה נוירונית‬

159

HU P0600555 PCT/HU/2007/000059 WO/2008/004013

01/01/2009

03/07/2006

A METHOD FOR AVOIDING COLLISIONS AND A COLLISION AVOIDANCE SYSTEM ISRAEL AEROSPACE INDUSTRIES LTD. US 11/968405 02/01/2008

27/06/2007

‫התעשייה האוירית לישראל בע"מ‬

B64D )2009.01( ‫מכלול עוגן עבור תדלוק בזמן טיסה‬

C07D )2009.01(

196318

(S)-(-)-AMLODIPINE CAMSYLATE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING HANMI PHARM. CO., LTD. 10-2006KR 21/07/2006 0068401 PCT/KR/2007/003444 WO/2008/010659

160

‫שיטה והתקן למניעת התנגשויות‬

196317

DROGUE ASSEMBLY FOR IN-FLIGHT REFUELLING FLIGHT REFUELLING LIMITED GB 0613386.2 05/07/2006 PCT/GB/2007/002410 WO/2008/003933

16/07/2007

G08B )2009.01(

196316

‫)–(–)–אמלודיפין קמסילט‬S( ‫תולדות‬ ‫ותכשירי רוקחות המכילים אותן‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

13/07/2007

196319

METHODS FOR DETERMINING A HUMAN SUBJECT'S PROPENSITY TO DEVELOP A VASCULAR DISORDER UNIVERSITY OF IOWA RESEARCH FOUNDATION US 60/831018 13/07/2006 60/840073 23/08/2006 US PCT/US/2007/073514 WO/2008/008986

18/07/2007

16/07/2007

–‫ד' בתשרי התש"ע‬

C07D )2009.01(

‫–אתילקווינולונים‬N ‫תולדות ואנאלוגים של‬ ‫–אתילאזאקווינולונים‬N–‫ו‬

196321

PYRAZOLES AS GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG US 60/832907 24/07/2006 60/930819 18/05/2007 US PCT/EP/2007/057315 WO/2008/012227 September 22, 2009

‫שיטות לקביעת נטיה מוקדמת של אדם‬ ‫לפיתוח הפרעה וסקולרית‬

196320

DERIVATIVES AND ANALOGS OF NETHYLQUINOLONES AND NETHYLAZAQUINOLONES GLAXO GROUP LIMITED US 60/807850 20/07/2006 60/913057 20/04/2007 US 07381041.8 18/05/2007 EP PCT/EP/2007/057422 WO/2008/009700

C07K )2009.01(

C07D )2009.01( ‫פיראזולים כמשפעלי גלוקוקינאז‬

161

04/07/2007

IMPROVED PROCESS FOR THE CULTURING OF CELLS DSM IP ASSETS B.V. EP 06014671.9 14/07/2006 07002571.3 06/02/2007 EP PCT/EP/2007/005915 WO/2008/006494

17/07/2007

C07D )2009.01( ‫תרכובות ספירופיפרידין טריציקליות‬ ‫ ייצורן ושימושן כמאפננים של‬,‫חדשות‬ ‫פעילות רצפטור לכימוקין‬

C07D )2009.01(

196324

PROCESS FOR MANUFACTURING 3(R)-(2-HYDROXY-2,2-DITHIEN-2YLACETOXY)-1-(3PHENOXYPROPYL)-1AZONIABICYCLO[2.2.2]OCTANE BROMIDE LABORATORIOS ALMIRALL, S.A. ES P200601951 21/07/2006 PCT/EP/2007/006278 WO/2008/009397

162

‫תהליך משופר לגידול תאים בתרבית‬

196323

NOVEL TRICYCLIC SPIROPIPERIDINE COMPOUNDS, THEIR SYNTHESIS AND THEIR USES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB US 60/831776 19/07/2006 PCT/SE/2007/000694 WO/2008/010765

16/07/2007

C12M )2009.01(

196322

–2,2–‫–הידרוקסי‬R)–(2(3 ‫תהליך לייצור‬ –3(–1–)‫–ילאצטוקסי‬2–‫דיתיאנ‬ –1–)‫פנוקסיפרופיל‬ ‫]אוקטן ברומיד‬2.2.2[‫אזוניאביציקלו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

16/04/2007

B01D )2009.01(

196325

OIL SHALE DERIVED POLLUTANT CONTROL MATERIALS AND METHODS AND APPARATUSES FOR PRODUCING AND UTILIZING THE SAME BATTELLE ENERGY ALLIANCE, LLC US 11/460547 27/07/2006 PCT/US/2007/066709 WO/2008/014027

06/07/2007

‫שמן צפחה המופק מחומרי פיקוח זיהום‬ ‫ושיטות ומכשירים להפקתו ושימוש בו‬

196326

LUNG CANCER DIAGNOSTIC ASSAY UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION US 60/806778 08/07/2006 US PCT/US2006/060796 10/11/2006 PCT/US/2007/072943 WO/2008/008708

17/07/2007

196327

ASYMMETRIC HYDROGENATION OF 1,1,1-TRIFLUOROACETONE F. HOFFMANN-LA ROCHE AG EP 06117928.9 27/07/2006 PCT/EP/2007/057372 WO/2008/012240

01/01/2009 September 22, 2009

196328

–‫ד' בתשרי התש"ע‬

G01N )2009.01( ‫בדיקה לאבחון סרטן ריאות‬

C07C )2009.01( –1,1,1 ‫הידרוגנציה אסימטרית של‬ ‫טריפלואורואצטון‬

E02B )2009.01(

163

LOCK WITH EMERGENCY UNLOCKING MECHANISM HOMEGATE LTD

13/07/2007

‫מנעול עם מנגנון פתיחת חרום‬ ‫הומגייט בע"מ‬

A NOVEL POPULATION OF MULTIPOTENT CARDIAC PRECURSOR CELLS DERIVED FROM HUMAN BLASTOCYSTS DERIVED STEM CELLS CELLARTIS AB DK PA200600970 60/830334 US PCT/EP/2007/006239 WO/2008/006605

11/07/2007

164

C07D )2009.01(

196330

A2A ‫תולדות פורין כאגוניסטים של‬

A61K )2009.01(

196331

METHOD OF IMMUNIZATION AGAINST THE FOUR SEROTYPES OF DENGUE SANOFI PASTEUR FR 0606324 12/07/2006 60/829361 13/10/2006 US PCT/FR/2007/051641 WO/2008/007021

01/01/2009

‫אוכלוסיית תאים מולטיפוטנטיים‬ ‫פרקורסורים של הלב שמופקים‬ ‫מבלסטוציטים אנושיים שהופקו מתאי‬ ‫גזע‬

13/07/2006 13/07/2006

PURINE DERIVATIVES AS A2A AGONISTS NOVARTIS AG EP 06117168.2 13/07/2006 PCT/EP/2007/006156 WO/2008/006563

11/07/2007

C12N )2009.01(

196329

‫שיטה לחיסון כנגד ארבע סרוטיפים של‬ ‫דנגה‬

B32B )2009.01(

196332 September 22, 2009

–‫ד' בתשרי התש"ע‬

COMPOSITION FOR CONSTRUCTION ELEMENTS MOSHE YANAI

06/07/2007

‫תרכובות ליסודות בניה‬ ‫משה ינאי‬

196333

METHOD AND SYSTEMS FOR LOCATING A SOURCE OF PARTICLE, MOLECULE, OR FRAGMENT OF MOLECULE MASSIMO VERGASSOLA US 11/481944 07/07/2006 06291133.4 07/07/2006 EP PCT/IB/2007/003059 WO/2008/007225

01/01/2009

‫שיטה ומערכות עבור איתור מקור של‬ ‫ מולקולה או פרגמנט של מולקולה‬,‫חלקיק‬

196334

SELECTIVE REJECTION OF TOUCH CONTACTS IN AN EDGE REGION OF A TOUCH SURFACE APPLE INC. US 61/019220 04/01/2008 12/242772 30/09/2008 US

05/07/2007

01/01/2009

September 22, 2009

C07D )2009.01(

‫–דיאונים מותמרים בעמדות‬2 ,1–‫ציקלובוטן‬ ‫–כמוקין‬CXC ‫ כליגנדים של קולטן‬4–‫ ו‬3

196336

–‫ד' בתשרי התש"ע‬

A61B )2009.01( ‫פסילה סלקטיבית של מגעים באזורי‬ ‫השוליים של משטח מגע‬

196335

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXCCHEMOKINE RECEPTOR LIGANDS SCHERING CORPORATION US 60/819541 07/07/2006 PCT/US/2007/015671 WO/2008/005570

G05D )2009.01(

A62B )2009.01(

165

THREE-DIMENSIONAL IMAGE RECONSTRUCTION USING DOPPLER ULTRASOUND BIOSENSE WEBSTER, INC. US 11/969504 04/06/2008 06/07/2007

‫בניה מחדש של תמונה תלת מימדית‬ ‫בעזרת אולטרה–סאונד דופלר‬

‫מעכבי טירוזין קינאז‬

TYROSINE KINASE INHIBITORS MERCK & CO., INC. US 60/819764 10/07/2006 PCT/US/2007/015675 WO/2008/008310

04/01/2009

"‫"ממזער קרינה סלולרית" "עצלן אלחוטי‬

COLLECTING SHEATH AND METHOD OF USE THEREOF

166

G08B )2009.01( ‫מערכת אזעקה נגד פריצה וחיישן‬ ‫רועי פרטס‬

A22C )2009.01(

196343

BONE FRACTURE DETECTION SOREQ NUCLEAR RESEARCH CENTER ISRAEL ATOMIC ENERGY COMMISSION US 61/006259 03/01/2008

05/07/2007

‫אמנון רוזן‬

196342

A BURGLARY ALARM SYSTEM AND SENSOR ROEI PORTAS

04/01/2009

H04B )2009.01(

196339

CELLULAR RADIATION REDACTOR WIRELESS INDOLENT AMNON ROZEN

04/01/2009

C07D )2009.01(

196337

‫זיהוי שבר בעצם‬ ‫המרכז למחקר גרעיני נחל שורק הועדה‬ ‫לאנרגיה אטומית‬

A61M )2009.01(

196344

‫נרתיק איסוף ושיטה לשימוש בו‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

ANGIOSLIDE LTD US 60/818528 PCT/IL/2007/000844 WO/2008/004238

‫אנג'יוסלייד בע"מ‬ 06/07/2006

05/07/2007

A61M )2009.01(

196345

COLLECTING SHEATH AND METHOD OF USE THEREOF ANGIOSLIDE LTD US 60/818529 06/07/2006 PCT/IL/2007/000845 WO/2008/004239

19/06/2007

‫נרתיק איסוף ושיטה לשימוש בו‬ ‫אנג'יוסלייד בע"מ‬

196347

PLATE-SHAPED STRUCTURAL COMPONENT DUCOSTONE GMBH (GERMANY) DE 202006010610/3 07/07/2006 202007005496/3 13/04/2007 DE PCT/DE/2007/000955 WO/2008/003276

05/01/2009

‫רכיב בעל מבנה שטוח‬

196348

HIGH-TORQUE ROTARY RADIAL INTERNAL COMBUSTION PISTON ENGINE LEONID YAKHNIS

05/01/2009

September 22, 2009

–‫ד' בתשרי התש"ע‬

F02B )2009.01( ‫מנוע שריפה פנימית רוטורי בעל מומנט‬ ‫גבוה‬ ‫יאכניס לאוניד‬

196349

A METHOD OF OBTAINING ELECTRIC ENERGY BY USING DALIY ROTATION OF EARTH AND THE DEVICE FOR ITS IMPLEMENTATION VLADIMIR SAKHAROV

E04C )2009.01(

G01V )2009.01(

‫שיטה להפקת אנרגיה חשמלית באמצעות‬ ‫סיבוב יומי של כדור הארץ והמתקן ליישום‬ ‫שיטה זו‬ ‫ולדימיר סחרוב‬

167

05/01/2009

A METHOD TO ENABLE OPTIMIZING TOWARDS GOALS CLICKSOFTWARE TECHNOLOGIES LTD US 12/344886 29/12/2008

26/07/2007

‫שיטה לייעול תהליכים‬ ‫קליקסופטוור טכנולוגיות בע"מ‬

‫פרודראג של תרכובת סינאמיד‬

‫שיטה ומערכת לניבוי זמן העברת מים‬ ‫חמים במערכת חימום מים‬ ‫גל חיזוי מים בע"מ‬

G01J )2009.01(

196353

MEANS AND METHODS FOR RAPID DROPLET AND AEROSOLS INFECTION ANALYSIS OPTICUL DIAGNOSTICS LTD

168

F24D )2009.01(

196352

METHOD AND SYSTEM FOR PREDICTING HOT WATER FLOW DURATION IN A WATER HEATING SYSTEM GAL WATER PREDICTIONS LTD.

05/01/2009

C07D )2009.01(

196351

PRODRUG OF CINNAMIDE COMPOUND EISAI R&D MANAGEMENT CO., LTD. 2006JP 28/07/2006 206007 60/820761 28/07/2006 US 2006-331274 08/12/2006 JP 60/869259 08/12/2006 US PCT/JP/2007/064637 WO/2008/013213

05/01/2009

G06F )2009.01(

196350

‫התקן ושיטה לאנליזה מהירה של זיהומים‬ ‫אירוסולים‬ ‫אופטיקאל דיאגנוסטיקה בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

05/01/2009

196354

METHOD FOR SECURING A GOLDEN ARTICLE TO ROUGH STONE ABRAHAM YESHAYAHU TABISAL

16/07/2007

‫שיטה לקבע חפץ זהוב לאבן ירושלמית‬ ‫אברהם ישעיהו טביסל‬

196355

EP2 AGONISTS PFIZER PRODUCTS, INC. US 60/833907 60/941923 US PCT/IB/2007/002044 WO/2008/015517

A44C )2009.01(

C07D )2009.01( EP2 ‫אגוניסטים של‬

28/07/2006 04/06/2007

05/07/2007

196358

AN ORAL PHARMACEUTICAL COMPOSITION OF AN ANILINOPYRIMIDINE, ITS PREPARATION AND USE THEREOF ARES TRADING S.A. US 60/818831 06/07/2006 06116903.3 10/07/2006 EP PCT/EP/2007/056859 WO/2008/003769

10/04/2007

‫תכשיר רוקחי למתן דרך הפה של‬ ‫ הכנתו ושימושו ברפואה‬,‫אנילינופירימידין‬

196359

CONE-BEAM CT ARINETA LTD.

A61K )2009.01(

A61B )2009.01( ‫ עם קרן בצורת כונוס‬CT ‫מערכת‬ ‫ארינטה בע"מ‬

PCT/IL/2007/000462 WO/2008/122971

September 22, 2009

–‫ד' בתשרי התש"ע‬

169

05/07/2007

METHOD FOR PRODUCING INSULIN ANALOGS HAVING A DIBASIC B CHAIN TERMINUS SANOFI-AVENTIS DEUTSCHLAND GMBH DE 102006031955.9 11/07/2006 PCT/EP/2007/005933 WO/2008/006497

10/07/2007

DICARBOXYLIC ACID FOAMABLE VEHICLE AND PHARMACEUTCAL COMPOSITIONS THERE OF FOAMIX LTD

170

A61K )2009.01( ‫שיטות משולבות לטיפול בסרטן‬ ‫רמות ליד אוניברסיטת תל אביב בע"מ‬

H01S )2009.01(

196362

OPTICAL APPARATUS SOREQ NUCLEAR RESEARCH CENTER US 60/818303 05/07/2006 PCT/IL/2007/000818 WO/2008/004218

05/07/2007

‫שיטה להפקת אנלוגים של אינסולין‬ ‫ עם קצה ובו שתי‬B ‫בעלי שרשרת‬ ‫קבוצות חד–ערכיות להתמרה‬

196361

COMBINATION METHODS OF TREATING CANCER SEPAL PHARMA LTD. US 60/819375 10/07/2006 PCT/IL/2007/000863 WO/2008/007367

02/07/2007

C07K )2009.01(

196360

‫מתקן אופטי‬ ‫המרכז למחקר גרעיני‬

A61K )2009.01(

196363

‫קצפים כנשאים של חומצות‬ ‫דיקרבוקסיליות וישומן כחומרים‬ ‫פרמצבטיים‬ ‫פואמיקס בע"מ‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

US 60/818634 PCT/IB/2007/003759 WO/2008/038147

05/07/2006

18/06/2007

196364

AMINOINDAZOLYLUREA DERIVATIVES MERCK PATENT GMBH DE 102006033140.0 PCT/EP/2007/005339 WO/2008/009335

‫נגזרות של אמינו אינדזול אוראה‬ 18/07/2006

06/01/2009

196365

APPARATUS AND METHOD FOR TRANSFERRING POWER FROM A STATIONARY UNIT TO A MOBIL UNIT EINAM YIZHAK AMOTZ US 61/019301 07/01/2008

08/07/2007

18/08/2006

‫עינם יצחק אמוץ‬

–‫ד' בתשרי התש"ע‬

A61B )2009.01(

‫התקן משולב לדגימת ובדיקת דם ושיטה‬ ‫לשימוש בו‬ ‫רפידאקס בע"מ‬

196367

USE OF HPPD INHIBITORS IN THE TREATMENT OF DEPRESSION AND/OR WITHDRAWAL SYMPTOMS ASSOCIATED WITH ADDICTIVE DRUGS SYNGENTA LIMITED

H01R )2009.01( ‫מתקן ושיטה להעברת כח מיחידה נייחת‬ ‫ליחידה ניידת‬

196366

INTERGRATED BLOOD SAMPLING AND TESTING DEVICE AND METHOD OF USE THEREOF RAPIDX LTD. US 60/818541 06/07/2006 PCT/IL/2007/000856 WO/2008/149333

September 22, 2009

A61K )2009.01(

A61K )2009.01(

‫או‬/‫ לטיפול בדיכאון ו‬HPPD ‫שימוש במעכבי‬ ‫נסיגת סימפטומים הקשורים לסמים‬ ‫ממכרים‬

171

PCT/GB/2006/003099 WO/2008/020150 06/07/2007

‫אנליזה של דוגמאות מח באמצעות מדידות‬ ‫זמניות‬

ANALYSIS OF BRAIN PATTERNS USING TEMPORAL MEASURES THE REGENTS OF THE UNIVERSITY OF MINNESOTA US 60/818931 06/07/2006 60/851599 13/10/2006 US PCT/US/2007/015545 WO/2008/005513

06/07/2007

A61B )2009.01(

196369

C12N )2009.01(

196370

TEMPERATURE-RESPONSIVE MICROCARRIER ORGANOGENESIS INC. US 60/806679 06/07/2006 PCT/US/2007/015554 WO/2008/005520

06/07/2007

‫מיקרו נשא המגיב לטמפרטורה‬

EFFICIENT PROCESS FOR PURIFICATION OF HIGH MOLECULAR WEIGHT HYALURONIC ACID RELIANCE LIFE SCIENCES PVT. LTD. IN 1065/MUM/2006 06/07/2006 IN MUM/2006/1874 13/11/2006 PCT/IN/2007/000289 WO/2008/035372

07/01/2009

172

C12P )2009.01(

196371

‫תהליך יעיל לטיהור חומצה היאלורונית‬ ‫בעלת משקל מולקולרי גבוה‬

A63B )2009.01(

196374

September 22, 2009

–‫ד' בתשרי התש"ע‬

PASSIVE TRAINER FOR REHABILITATING AND TREATING INCONTINENCE AND METHODS THEREOF ELIAHU ELIACHAR

07/01/2009

‫מכשיר אימון פסיבי ושיטה לשיקום חוסר‬ ‫איפוק שלאחר ניתוח‬ ‫דן שדה הוכשטטר‬

196376

‫אטם משופר לחבקי צינורות‬

IMPROVED PIPE COUPLING SEAL KRAUSZ INDUSTRIES DEVELOPMENT LTD.

12/07/2007

‫קראוס תעשיות פיתוח בע"מ‬

196377

‫מוסד הטכניון למחקר ופתוח בע"מ‬

196378

HYDROELECTRIC POWER STATION AND APPARATUSES AND METHODS IMPLEMENTED THEREIN DSME LTD.

31/07/2007

September 22, 2009

–‫ד' בתשרי התש"ע‬

F03B )2009.01( ‫תחנת כוח הידרואלקטרית ומתקנים‬ ‫ושיטות המיושמים בה‬ ‫אי בע"מ‬.‫ אמ‬.‫ אס‬.‫די‬

196379

RECOMBINANT OR TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS LFB BIOTECHNOLOGIES SOCIETE PAR ACTIONS SIMPLIFIEE UNIPERSONNELLE FR 0607016 01/08/2006

G06F )2009.01( ‫קטגוריזציה של טקסט תוך שימוש בידע‬ ‫חיצוני‬

TEXT CATEGORIZATION USING EXTERNAL KNOWLEDGE TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. US 11/457341 13/07/2006 PCT/IL/2007/000881 WO/2008/007379

07/01/2009

F16L )2009.01(

A61K )2009.01(

‫ רקומביננטית או‬VII ‫תרכובת פקטור‬ ,‫טרנסגנית עם רוב צורות גליקאן‬ ‫ ביסיאלטיות ואל–פוקוסילטיות‬,‫ביאנטנריות‬

173

PCT/FR/2007/001324 WO/2008/015339

25/07/2007

METHOD OF GRINDING AN INDEXABLE INSERT AND GRINDING WHEEL FOR CARRYING OUT THE GRINDING METHOD ERWIN JUNKER MASCHINENFABRIK GMBH DE 102006035845.7 01/08/2006 PCT/EP/2007/057687 WO/2008/015144

04/07/2007

‫שיטה להשחזת אינסרט הניתן למדידה‬ ‫וגלגל השחזה לביצוע שיטת ההשחזה‬

,H2–‫טיפול אנטי–סרטני הכולל חוסם‬ ‫לפחות גורם אחד אנטי דלקתי וגורם‬ ‫ציטוטוקסי‬ ‫תילתן פרמה בע"מ‬

G06F )2009.01(

196382

ELECTRONIC CIRCUITRY AND METHOD FOR DETERMINATION OF AMPLITUDES OF RECEIVED SIGNALS ELTA SYSTEMS LTD. IL 176788 11/07/2006 PCT/IL/2007/000835 WO/2008/007358

174

A61K )2009.01(

196381

ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT TILTAN PHARMA LTD. US 60/819164 07/07/2006 60/880107 12/01/2007 US PCT/IL/2007/000836 WO/2008/004231

04/07/2007

B24B )2009.01(

196380

‫מעגלים חשמליים ושיטה לקביעת עוצמות‬ ‫של אותות מתקבלים‬ ‫אלתא מערכות בע"מ‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

08/01/2009

196385

PREVENTION AND TREATMENT OF AGE AND/OR CHRONIC EXCESSIVE OXIDATIVE STRESS-INDUCED DISEASES DR. AHARON HOFFMAN

12/07/2007

‫ עבור מחלות שנגרמו על‬REDOX ‫תרפית‬ OXIDATION ‫ידי‬ ‫ד"ר אהרון הופמן‬

196386

SYSTEM AND METHOD FOR VISUALIZING MUSIC AND OTHER SOUNDS MASTER KEY, LLC US 60/830386 12/07/2006 11/827264 11/07/2007 US PCT/US/2007/015822 WO/2008/008395

25/08/2006

METHOD AND DEVICE FOR REDUCING EXPOSURE TO UNDESIRABLE ELECTROMAGNETIC RADIATION THERAPY PRODUCTS, INC. DBA ERCHONIA MEDICAL US 11/487045 14/07/2006 PCT/US/2006/033625 WO/2008/008078

196388

A CATHETER ASH ACCESS TECHNOLOGY, INC. September 22, 2009

–‫ד' בתשרי התש"ע‬

G09B )2009.01(

‫מערכת ושיטה להמחשת מוסיקה וקולות‬ ‫אחרים‬

196387

09/07/2007

A61K )2009.01(

H01Q )2009.01( ‫שיטה והתקן להפחתת חשיפה לקרינה‬ ‫אלקטרומגנטית לא רצויה‬

A61M )2009.01( ‫צנתר‬

175

US 60/819927 11/528733 US PCT/US/2007/015283 WO/2008/008221 13/07/2007

11/07/2006 27/09/2006

COMPOSITIONS CONTAINING AN ANTIFUNGAL COMPOUND AND AN IRON CHELATING COMPOUND AND USES THEREOF LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR UCLA MEDICAL CENTER US 60/831099 13/07/2006 60/897620 26/01/2007 US 60/904075 27/02/2007 US PCT/US/2007/016065 WO/2008/008537

12/07/2007

H04L )2009.01( ‫שיטה למיתוג מופעים בהעברה ללוויין‬ ‫במערכת תקשורת אל–חוטית‬

C07D )2009.01(

196391

PYRROLOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DEVELOGEN AKTIENGESELLSCHAFT EP 06014297.3 10/07/2006 PCT/EP/2007/006109 WO/2008/006547

176

‫תכשירים המכילים תרכובת נגד פטריות‬ ‫וקלאטור ברזל וניצולם‬

196390

METHOD OF SWITCHING MODES OF UPLINK TRANSMISSION IN A WIRELESS COMMUNICATION SYSTEM LUCENT TECHNOLOGIES INC. US 11/485761 13/07/2006 PCT/US/2007/015918 WO/2008/008449

10/07/2007

A61K )2009.01(

196389

‫פירולופירימידינים עבור תכשירי רוקחות‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

06/08/2007

196392

USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR TREATMENT OF INFECTIOUS CONDITIONS N.V. ORGANON EP 06118587.2 08/08/2006 PCT/EP/2007/058134 WO/2008/017658

17/07/2007

‫שימוש באנטגוניסטים לקולטן‬ ‫גלוקוקורטיקואיד לטיפול בתנאים זיהומיים‬

196393

AMBIENT TEMPERATURE THERMAL ENERGY AND CONSTANT PRESSURE CRYOGENIC ENGINE MDI MOTOR DEVELOPMENT INTERNATIONAL S.A. FR 0606647 21/07/2006 PCT/EP/2007/057380 WO/2008/009681

10/07/2007

196394

IMPLANTABLE SUSTAINED DRUG DELIVERY DEVICE FOR RELEASING ACTIVE AGENTS TO THE OSTEOMEATAL COMPLEX YU-FEN CHI US 60/819825 10/07/2006 11/775157 09/07/2007 US PCT/US/2007/015813 WO/2008/008389

September 22, 2009

–‫ד' בתשרי התש"ע‬

A61K )2009.01(

F01B )2009.01( ‫אנרגיה תרמית של טמפרטורת החדר‬ ‫ומנוע מקפיא בלחץ קבוע‬

A61K )2009.01( ‫התקן למתן מושהה של תרופה הניתן‬ ‫להשתלה עבור שחרור חומרים פעילים‬ ‫לקומפלקס האוסטיאומיתלי‬

177

09/07/2007

METHOD FOR PRODUCING A BONE PROSTHESIS OR A PRE-IMPLANT SIMULATION, AND EQUIPMENT USED 2INGIS S.A. EP 06116963.7 11/07/2006 PCT/EP/2007/056957 WO/2008/006802

11/07/2007

–‫שיטה לייצור תותבת עצם או חיקוי טרום‬ ‫שתל והציוד שמשתמשים בו‬

‫הרכבים עם שחרור מבוקר‬

C07K )2009.01(

196397

PRLR-SPECIFIC ANTIBODY AND USES THEREOF XOMA TECHNOLOGY LTD. US 60/838648 18/08/2006 60/946360 26/06/2007 US PCT/US/2007/076160 WO/2008/022295

178

A61K )2009.01(

196396

CONTROLLED-RELEASE FORMULATIONS MUTUAL PHARMACEUTICAL COMPANY INC US 60/819914 11/07/2006 60/859772 17/11/2006 US PCT/US/2007/015897 WO/2008/008434

17/08/2007

A61C )2009.01(

196395

‫ ושימושים בו‬PRLR–‫נוגדן ספציפי ל‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

26/07/2007

196399

ONLINE ARABIC HANDWRITING RECOGNITION BGN TECHNOLOGIES LTD. US 60/833900 27/07/2006 PCT/IL/2007/000940 WO/2008/012824

15/07/2007

11/06/2007

‫אן טכנולוגיות בע"מ‬.‫ג'י‬.‫בי‬

–‫ד' בתשרי התש"ע‬

A01N )2009.01(

–‫ג'לים הידרוקולואידיים מיובשים‬ ‫מחושמלים בעלי מבנה ונקבוביות ייחודיים‬

196401

CONNECTIVITY FAULT MANAGEMENT (CFM) IN NETWORKS WITH LINK AGGREGATION GROUP CONNECTIONS CORRIGENT SYSTEMS LTD. US 11/483650 11/07/2006 PCT/IL/2007/000702 WO/2008/007353

September 22, 2009

‫זיהוי מקוון של כתב יד בערבית‬

196400

DRIED ELECTRIFIED HYDROCOLLOID GELS HAVING UNIQUE STRUCTURE AND POROSITY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/830608 14/07/2006 PCT/IL/2007/000888 WO/2007/007383

G06K )2009.01(

‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים‬

G06F )2009.01( ‫) ברשתות‬CFM( ‫ניהול תקלות חיבוריות‬ ‫עם קישורי קבוצת מצבור קווי תקשורת‬ ‫קוריג'נט מערכות בע"מ‬

179

10/07/2007

XINAFOATE SALT OF A SUBSTITUTED 5-OXAZOL-2-YLQUINOLINE COMPOUND SCHERING CORPORATION US 60/830057 11/07/2006 PCT/US/2007/015715 WO/2008/008327

07/09/2007

‫בקרה על זכויות יפויי כח‬

G06F )2009.01( ‫שאילתות באישור בטיחות‬

C07K )2009.01(

196410

VACCINES FOR MALARIA THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY GB 0614254.1 18/07/2006 0614473.7 20/07/2006 GB 0614476.0 20/07/2006 GB 0615115.3 28/07/2006 GB PCT/EP/2007/057296 WO/2008/009650

180

H04L )2009.01(

196408

SECURITY AUTHORIZATION QUERIES MICROSOFT CORPORATION US 11/530438 08/09/2006 PCT/US/2007/077641 WO/2008/030876

16/07/2007

–5 ‫מלח קסינפואטי של תרכובת‬ ‫–איל–קווינולין‬2–‫אוקסאזול‬

196407

CONTROLLING THE DELEGATION OF RIGHTS MICROSOFT CORPORATION US 11/530446 08/09/2006 PCT/US/2007/077898 WO/2008/031043

05/09/2007

C07D )2009.01(

196402

‫חיסונים עבור מלריה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

10/07/2007

196411

ANTI-COCAINE COMPOSITIONS AND TREATMENT COLUMBIA UNIVERSITY US 60/819569 10/07/2006 PCT/US/2007/015762 WO/2008/008358

28/06/2007

11/07/2007

06/07/2007

A61F )2009.01(

‫תותב טרשתי לטיפול בהזדקנות ראיה ואי‬ ‫ התקנים הקשורים‬,‫סדרים עיניים נוספים‬ ‫לכך ושיטות‬

196414

–‫ד' בתשרי התש"ע‬

H02K )2009.01(

,‫אלמנט פעיל עבור מכונה אלקטרומגנטית‬ ‫שיטה לייצורו ומכונה אלקטרומגנטית‬ ‫הכוללת אלמנט פעיל כזה‬

196413

SCLERAL PROSTHESIS FOR TREATING PRESBYOPIA AND OTHER EYE DISORDERS AND RELATED DEVICES AND METHODS REFOCUS GROUP, INC. US 60/819995 11/07/2006 PCT/US/2007/015774 WO/2008/008366

September 22, 2009

‫תכשירים נגד קוקאין וטיפול‬

196412

ACTIVE ELEMENT FOR AN ELECTROMAGNETIC MACHINE PRODUCTION METHOD THEREOF AND ELECTROMAGNETIC MACHINE INCLUDING ONE SUCH ACTIVE ELEMENT MESSIER-DOWTY SA FR 0606335 12/07/2006 PCT/FR/2007/001088 WO/2008/006953

A61K )2009.01(

C12M )2009.01(

181

PHOTOBIOREACTOR SYSTEMS AND METHODS FOR TREATING CO2ENRICHED GAS AND PRODUCING BIOMASS

‫מערכות ושיטות של פוטוביוראקטורים‬ ‫ ולייצור‬CO2–‫לטיפול בגאז מועשר ב‬ ‫ביומאסה‬

GREENFUEL TECHNOLOGIES CORP. US 60/819976 10/07/2006 PCT/US/2007/015513 WO/2008/008262

12/07/2007

H04B )2009.01(

196415

‫מערכת ניטור‬

MONITORING SYSTEM IMPRENDITORE PTY LIMITED AU 2006903740 12/07/2006 2007902358 04/05/2007 AU PCT/AU/2007/000958 WO/2008/006155

28/07/2006

C09C )2009.01(

196416

COATING OF INORGANIC PIGMENTS WITH ALDEHYDE OR KETONE RESINS INXEL TRADEMARK & PATENTS SAGL

‫ציפוי פיגמנטים אנאורגנים עם שרפי‬ ‫אלדהיד או קטון‬

PCT/IT/2006/000588 WO/2008/012848

09/07/2007

182

C07D )2009.01(

196417 September 22, 2009

–‫ד' בתשרי התש"ע‬

TARTRATE SALT OF (7S)-7-[(5FLUORO-2-METHYL-BENZYL)OXY]2-[(2R)-2-METHYLPIPERAZIN-1-YL]6,7-DIHYDRO-5HCYCLOPENTA[b]PYRIDINE PFIZER PRODUCTS INC. US 60/830890 14/07/2006 PCT/IB/2007/002025 WO/2008/010073

27/07/2007

–2–‫–פלואורו‬S)–7–[(57( ‫מלח טרטרט של‬ –R)–22([–2–]‫מתיל–בנזיל)אוקסי‬ –H5–‫–דיהידרו‬6,7–]‫–יל‬1–‫מתילפיפראזינ‬ ‫] פירידין‬b[‫ציקלופנטא‬

196418

THIENO[3,2-C]PYRIDINE-7CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG US 60/836360 08/08/2006 PCT/EP/2007/057748 WO/2008/017594

19/07/2007

196419

ANALYSIS UNIT INTENDED TO BE USED IN ANALYSIS APPARATUS BIOCODE HYCEL FRANCE SA FR 06/06685 21/07/2006 PCT/FR/2007/001241 WO/2008/009821

04/06/2007

September 22, 2009

196420

–‫ד' בתשרי התש"ע‬

C07D )2009.01( –7–‫]פירידינ‬C–2,3[‫תולדות חומצה תיאנו‬ ‫קרבוקסילית‬

B01L )2009.01( ‫יחידת אנאליזה המיועדת לשימוש‬ ‫באנאליזה‬

A01K )2009.01(

183

METHOD AND INSTALLATION FOR TREATING AN AQUEOUS EFFLUENT, IN ORDER TO EXTRACT AT LEAST ONE DISSOLVED GASEOUS COMPOUND; APPLICATION TO AQUACULTURE IN RECIRCULATED AQUEOUS MEDIUM INSTITUT NATIONAL DES SCIENCES APPLIQUEES US 60/830343 13/07/2006 0702308 29/03/2007 FR PCT/FR/2007/000920 WO/2008/006950

11/01/2009

‫מכלול מתנייד ויישום למכשירים מתניידים‬ ‫אפרים דרורי‬

184

A61F )2009.01(

196422

ANNULOPLASTY SYSTEM AND SURGICAL METHOD TIGRAN KHALAPYAN US 60/807119 12/07/2006 PCT/US/2007/073356 WO/2008/008889

30/07/2007

F16H )2009.01(

196421

MOVABLE ASSEMBLY AND APPLICATION TO MOVABLE DEVICES EFFRAYIM DRORI

12/07/2007

‫שיטה והתקן לטיפול בנביעה מימית לשם‬ ‫מיצוי של לפחות תרכובת גזית מומסת‬ ‫אחת ממנה; יישום לטיפוח מקור מים‬ ‫בסביבה מימית ממוחזרת‬

‫מערכת ושיטה לתיקון כירורגי של שסתום‬ ‫לב‬

A61K )2009.01(

196426 September 22, 2009

–‫ד' בתשרי התש"ע‬

MICROPARTICULATES BASED ON AN AMPHIPHILIC COPOLYMER, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME FLAMEL TECHNOLOGIES FR 0653191 28/08/2006 PCT/EP/2007/006722 WO/2008/025425

26/07/2007

196427

MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS THEREOF AND PROCESSES TO PRODUCE THE SAME BRISTOL-MYERS SQUIBB COMPANY US 60/834235 28/07/2006 60/896026 21/03/2007 US 11/782742 25/07/2007 US PCT/US/2007/074377 WO/2008/014360

11/01/2009

196428

METHOD AND SYSTEM FOR PERSONALITY ANALYSIS IN ACCORDANCE WITH THE PALMISTRY TAMAR ZOHAR SHIR

06/07/2007

September 22, 2009

C07D )2009.01( ‫ גבישים‬,‫מאפנני פעילות קולטן הכימוקין‬ ‫שלהם ותהליכים לייצורם‬

G09B )2009.01( ‫שיטה ומערכת לאבחון אישיות על–פי‬ ‫תורת הכירולוגיה‬ ‫תמר זוהר שיר‬

196430

–‫ד' בתשרי התש"ע‬

‫חלקיקי–מיקרו המבוססים על קופולימר‬ ‫ תהליכים להכנתם ותכשירי‬,‫אמפיפילי‬ ‫רוקחות המכילים אותם‬

C10L )2009.01(

185

USE OF COMPOUNDS REVEALING THE EFFICIENCY OF FILTERABILITY ADDITIVES IN HYDROCARBON DISTILLATES, AND SYNERGIC COMPOSITION CONTAINING SAME TOTAL RAFFINAGE MARKETING FR 06/06254 10/07/2006 PCT/FR/2007/001153 WO/2008/006965

30/06/2007

‫סינתזה קטליטית רג'יו–סלקטיבית של‬ ‫בנזימידאזולים ואזאבנזימידאזולים‬ ‫באמצעות פלדיום‬

A61K )2009.01(

196432

NANOPARTICULATE FORMULATIONS OF MODAFINIL ELAN PHARMA INTERNATIONAL LIMITED US 60/807126 12/07/2006 60/882740 29/12/2006 US 60/908067 26/03/2007 US PCT/US/2007/073336 WO/2008/008879

186

C07D )2009.01(

196431

A REGIOSELECTIVE PALLADIUM CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES SANOFI AVENTIS EP 06014789.9 15/07/2006 PCT/EP/2007/005816 WO/2008/009348

12/07/2007

‫שימוש בתרכובות המגלות את היעילות‬ ‫בכושר הסינון של תוספים בחומרים‬ ‫ ותכשיר סינרגי‬,‫פחמימניים מזוקקים‬ ‫המכיל אותן‬

‫פורמולציות ננו–חלקיקיות של מודפיניל‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

12/07/2007

196433

METHODS AND SYSTEMS FOR COMPLIANCE CONFIRMATION AND INCENTIVES ARBITRON INC. US 60/831744 12/07/2006 PCT/US/2007/073390 WO/2008/008911

12/07/2007

196434

MONITORING USAGE OF A PORTABLE USER APPLIANCE ARBITRON INC. US 60/831744 12/07/2006 PCT/US/2007/073393 WO/2008/008913

12/07/2007

196435

METHODS AND SYSTEMS FOR COMPLIANCE CONFIRMATION AND INCENTIVES ARBITRON INC. US 60/831744 12/07/2006 PCT/US/2007/073376 WO/2008/008899

03/07/2007

196436

TWO COMPONENT PHOTODIODE DETECTOR AEROFLEX COLORADO SPRINGS, INC. US 11/456662 11/07/2006 PCT/US/2007/072780 WO/2008/082689

11/01/2009 September 22, 2009

196437

–‫ד' בתשרי התש"ע‬

G06F )2009.01( ‫מערכות ושיטות לתמרוץ ואישור של‬ ‫תאימות‬

G06F )2009.01( ‫פיקוח על שימוש מכשיר מטלטל‬

G06F )2009.01( ‫מערכות ושיטות לתמרוץ ואישור של‬ ‫תאימות‬

G01T )2009.01( ‫גלאי פוטודיאוד בעל שני רכיבים‬

B05B )2009.01(

187

A LIQUID DISPENSER LUICELOOP (PTY) LTD. ZA 2008/07174

‫מחלק נוזלי‬ 20/08/2008

18/03/2007

FLOW DEFLECTION DEVICES AND METHOD FOR ENERGY CAPTURE MACHINES DANIEL FARB US 60/807828 20/07/2006 60/826927 26/09/2006 US 60/864792 08/11/2006 US PCT/IL/2007/000348 WO/2008/010200

11/01/2009 METHOD OF GROOVING SUPERALLOYS AND CUTTING INSERT THEREFOR ISCAR LTD.

11/01/2009

G01T )2009.01(

196438

‫מתקני הטיית זרימה ושיטה למכונות‬ ‫תפיסת אנרגיה‬

B23C )2009.01(

196439

‫שיטה לחירוץ סגסוגות–על ושימת חיתוך‬ ‫עבורה‬ ‫ישקר בע"מ‬

B23G )2009.01(

196440

‫מנגנון כוונון‬

ADJUSTMENT MECHANISM

‫ישקר בע"מ‬

ISCAR LTD.

12/06/2007

188

G06Q )2009.01(

196441 September 22, 2009

–‫ד' בתשרי התש"ע‬

PRINCIPAL GUARANTEED SAVINGS AND INVESTMENT SYSTEM AND METHOD RICHARD J. SIEGEL US 11/456793 11/07/2006 PCT/US/2007/070953 WO/2008/014057

25/05/2001

‫חסכונות הון מובטחים ומערכת להשקעה‬ ‫ושיטה‬

196444

PURIFICATION OF RNA BY A TRIPLE HELIX FORMATION WITH AN IMMOBILIZED OLIGONUCLEOTIDE CENTELION US 09/580923 26/05/2000 PCT/US/2001/017122 WO/2001/092511

09/07/2006

‫טיהור רנ"א על–ידי היווצרות סליל משולש‬ ‫עם אוליגונוקלאוטיד מקובע‬

196445

WAVE ENERGY CONVERTER AUSTRALIAN SUSTAINABLE ENERGY CORPORATION PTY LTD. AU 2006903707 11/07/2006 PCT/AU/2007/000940 WO/2008/006145

02/07/2007

196446

TRANS-DOUGLAS ENDOSCOPICAL SURGICAL DEVICE (TED) STARK MICHAEL US 60/830356 13/07/2006 PCT/IL/2007/000821 WO/2008/007355

11/07/2007

September 22, 2009

196447

–‫ד' בתשרי התש"ע‬

C12N )2009.01(

E02D )2009.01( ‫התקן לשימוש באנרגיית גלים‬

A61B )2009.01( ‫התקן אנדוסקופי העובר דרך החלל על‬ ‫שם דאגלאס‬ ‫פרופ' מיכאל סטארק‬

A61K )2009.01(

189

ENHANCED STABILITY PHENYLEPHRINE LIQUID COMPOSITIONS WYETH US 11/487120 14/07/2006 PCT/US/2007/015771 WO/2008/008364

09/07/2007

‫הרכבים נוזליים של פנילאפרין עם יציבות‬ ‫מוגברת‬

GEOGRAPHICAL INFORMATION DISPLAY SYSTEM AND METHOD RAYTHEON COMPANY US 60/831093 14/07/2006 11/773260 03/07/2007 US PCT/US/2007/073041 WO/2008/008724

17/07/2007

190

‫מערכת ושיטה להצגת מידע גיאוגרפי‬

H04J )2009.01(

196451

MULTIPLEXING OF DS1 TRAFFIC ACROSS WIRED AND WIRELESS ETHERNET DEVICES MEMORYLINK CORP. US 60/807664 18/07/2006 PCT/US/2007/073678 WO/2008/011405

11/07/2007

A61N )2009.01(

196450

‫ על פני התקן‬DS1 ‫שידו מרובב של תנועת‬ ‫אתרנט חוטי ואלחוטי‬

G06F )2009.01(

196452 September 22, 2009

–‫ד' בתשרי התש"ע‬

SYSTEM AND METHOD FOR PROVIDING REMOTE ACCESS TO EVENTS FROM A DATABASE ACCESS SYSTEM RAYTHEON COMPANY US 60/831036 14/07/2006 11/672460 07/02/2007 US PCT/US/2007/073207 WO/2008/011309

11/07/2007

196453

METHOD AND ASSAY FOR GLYCOSYLATION PATTERN DETECTION RELATED TO CELL STATE PROCOGNIA (ISRAEL) LTD US 60/830296 11/07/2006 PCT/IL/2007/000871 WO/2008/007373

12/01/2009

196454

COLLECTING DATA FROM CELLULAR PHONES AND REPORTING RELATED INFORMATION YOSSI KAPLAN

12/01/2009

196457

–‫ד' בתשרי התש"ע‬

‫שיטה להבחנת מצב תאי ע"י איתור‬ ‫תצורות גליקוליזציה‬ ‫פרוקוגניה (ישראל) בע"מ‬

G06F )2009.01(

‫עופר אבני‬

CORKSCREW AND METHOD OF USE SHLOMO BEN-AVI

September 22, 2009

G01N )2009.01(

‫שיטה לאיסוף נתונים מטלפונים‬ ‫סלולאריים ודיווח אינפורמציה קשורה‬

196455

13/07/2007

‫שיטה ומערכת לאספקת גישה מרחוק‬ ‫לאירועים ממערכת גישה למאגר מידע‬

B65D )2009.01( ‫מתקן ושיטה לחילוץ פקקים‬ ‫אבי‬-‫שלמה בן‬

H01G )2009.01(

191

IMPROVEMENTS IN THE PRODUCTION OF ELECTROLYTIC CAPACITOR METALYSIS LIMITED GB 0613984.4 13/07/2006 PCT/GB/2007/002660 WO/2008/007126

12/01/2009

H01S )2009.01( ‫מערכת לייזר שואבת המשתמשת בהיזון‬ ‫חוזר לאמצעי שאיבה‬

B01D )2009.01(

196461

AIRCRAFT ENGINE INLET PIVOTABLE BARRIER FILTER AEROSPACE FILTRATION SYSTEMS, INC. US 60/807389 14/07/2006 PCT/US/2007/073125 WO/2008/076471

192

‫מערכת ושיטה למדידת מומס בדגימה‬

196460

PUMPED LASER SYSTEM USING FEEDBACK TO PUMP MEANS DANMARKS TEKNISKE UNIVERSITET EP 06388051.2 12/07/2006 60/830718 12/07/2006 US PCT/DK/2007/000350 WO/2008/006371

10/07/2007

G01N )2009.01(

196458

SYSTEM AND METHOD FOR MEASURING AN ANALYTE IN A SAMPLE LIFESCAN, INC. US 61/021713 18/01/2008 12/349017 06/01/2009 US

10/07/2007

‫שיפורים ביצור קבל אלקטרוליטי‬

‫מסנן חוסם פתח הניתן לסיבוב על ציר‬ ‫עבור מנוע של כלי טיס‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

11/07/2007

196464

PREPARATION OF FATTY ACID ESTERS OF GLYCEROL FORMAL AND ITS USE AS BIOFUEL INSTITUT NUIVERSITARI DE CIENCIA TECNOLOGIA ES P200601918 12/07/2006 PCT/EP/2007/057123 WO/2008/006860

13/06/2007

‫תכשיר חומצה אסטר שומנית של גליצרול‬ ‫שומני ושימושו כביופיול‬

196466

HYDROGELS CONTAINING LOW MOLECULAR WEIGHT ALGINATES AND BIOSTRUCTURES MADE THEREFROM FMC BIOPOLYMER AS US 60/830959 14/07/2006 PCT/EP/2007/055856 WO/2008/006658

13/07/2007

196470

ANTAGONIST ANTIBODY AGAINST EPHA2 FOR THE TREATMENT OF CANCER SANOFI-AVENTIS EP 06291160.7 18/07/2006 PCT/IB/2007/003074 WO/2008/010101

16/07/2007

196471

VACCINES FOR MALARIA September 22, 2009

–‫ד' בתשרי התש"ע‬

C10L )2009.01(

A61K )2009.01( ‫הידרוג'לים המכילים אלג'ינטים בעלי‬ ‫משקל מולקולרי נמוך ומבנים ביולוגיים‬ ‫העשויים מהם‬

C07K )2009.01( ‫ לטיפול‬EPHA2 ‫נוגדן אנטגוניסטי כנגד‬ ‫בסרטן‬

A61K )2009.01( ‫חיסונים למלריה‬

193

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY GB 0614254.1 18/07/2006 0614473.7 20/07/2006 GB 0614476.0 20/07/2006 GB 0615115.3 28/07/2006 GB PCT/EP/2007/057301 WO/2008/009652

12/07/2007

SEMICONDUCTOR DEVICE NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY 2006JP 13/07/2006 192440 PCT/JP/2007/063926 WO/2008/007748

12/07/2007

194

‫התקן מוליך למחצה‬

H01L )2009.01(

196473

TRANSISTOR AND SEMICONDUCTOR DEVICE NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY 2006JP 13/07/2006 192815 PCT/JP/2007/063927 WO/2008/007749

12/07/2007

H01L )2009.01(

196472

‫התקן טרנזיסטור ומוליך למחצה‬

G06F )2009.01(

196475 September 22, 2009

–‫ד' בתשרי התש"ע‬

INJECTION DEVICE AND CASE WITH REPORTING ABILITY HENRY SCHEIN, INC. US 11/485820 13/07/2006 11/485828 13/07/2006 US 11/485829 13/07/2006 US PCT/US/2007/015922 WO/2008/008451

30/07/2007

196476

METHOD AND APPARATUS FOR PROTECTING RFID TAGS FROM POWER ANALYSIS YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/821515 04/08/2006 PCT/US/2007/074716 WO/2008/019246

19/07/2007

196477

METHOD OF FABRICATING SEMICONDUCTOR DEVICES ON A GROUP IV SUBSTRATE WITH CONTROLLED INTERFACE PROPERTIES AND DIFFUSION TAILS CYRIUM TECHNOLOGIES INCORPORATED US 60/822138 11/08/2006 PCT/CA/2007/001278 WO/2008/017143

13/07/2007

196478

HUMANIZED ANTIBODY AGAINST AMYLOID BETA September 22, 2009

–‫ד' בתשרי התש"ע‬

‫התקן הזרקה ואריזה עם יכולת דיווח‬

H04K )2009.01( RFID ‫שיטה ומערכת להגנת תויות‬ ‫מאנליזת כח‬ ‫ידע חברה למחקר ופיתוח בע"מ‬

H01L )2009.01( ‫שיטה ליצור התקן מוליך למחצה על גבי‬ ‫ בעל תכונות ממשק‬IV ‫מצע מקבוצת‬ ‫מבוקרות ועקבות דיפוזיה‬

C07K )2009.01( ‫נוגדן אנושי נגד אמילואיד בתא‬

195

GENENTECH, INC. EP 06014730.3 06020765.1 EP 60/943289 US 60/943499 US PCT/US/2007/073504 WO/2008/011348

20/07/2007

14/07/2006 02/10/2006 11/06/2007 12/06/2007

PROCESS FOR THE PREPARATION OF LEVETIRACETAM ZACH SYSTEM S.P.A. EP 06015439.0 25/07/2006 PCT/EP/2007/057503 WO/2008/012268

13/09/2001

196

‫תהליך להכנת לוויטיראסטם‬

C07K )2009.01(

196482

HUMAN COAGULATION FACTOR VII VARIANTS, METHOD FOR PRODUCING THEM, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM NOVO NORDISK HEALTH CARE AG DK PA200001361 13/09/2000 60/236455 29/09/2000 US PCT/DK/2001/000596 WO/2002/022776

13/01/2009

C07D )2009.01(

196481

‫גרסאות משתנות של גורם קרישה‬ ‫ שיטה להכנתן ותכשירי‬,‫ממקור אנושי‬ ‫רוקחות המכילים אותן‬

H01H )2009.01(

196484

September 22, 2009

–‫ד' בתשרי התש"ע‬

CIRCUIT-BREAKER AND COMMUNITATION METHOD FOR MEDIUM-AND HIGH VOLTAGE A.C. POWER NETWORK IURII ONUFRIENKO

13/01/2009

196485

TACTILE TRANSPARENT KEYBOARD IGAL SHUSTERI

13/01/2009

196487

MEANS AND METHODS FOR PROVIDING HIGH RESOLUTION MRI ASPECT MAGNET TECHNOLOGIES LTD.

September 22, 2009

196488

–‫ד' בתשרי התש"ע‬

B41J )2009.01(

‫יגאל שושטרי‬

AN OIL BLEND OF SYNERGISTICALLY LOWERED OXIDATION VALUE SHEMEN INDUSTRIES LTD. US 61/083435 24/07/2008

12/07/2007

‫ורי אונופריאנקו‬

‫מקלדת מגע שקופה למסכי מגע‬

196486

13/01/2009

‫מפסק מתח ושיטת מיתוג ברשתות‬ ‫חשמל למתח גבוה ובינוני לזרם חילופין‬

C11C )2009.01( ‫תערובת שמנים עם הנמכה סינרגיסטית‬ ‫של דרגת ההתחמצנות‬ ‫שמן תעשיות בע"מ‬

G01V )2009.01( MRI ‫אמצעים ושיטות להקנייה של‬ ‫ברזולוציה חדה‬ ‫אספקט טכנולוגיות מגנטים בע"מ‬

C23C )2009.01(

197

METHOD FOR DEPOSITING ELECTRICALLY INSULATING LAYERS OERLIKON TRADING AG, TRUBBACH CH 01166/06 19/07/2006 PCT/EP/2007/057179 WO/2008/009619

11/12/2007

‫שיטה להנחת שכבות מבודדות חשמל‬

‫טבעת ושיטת ענידה‬ ‫קציר‬-‫שלי אבנרי‬

RING AND METHOD FOR WEARING YIFAT UNGIEROWICZ BLOCH 18/01/2009 PCT/US/2001/001537

13/07/2007

‫מחלק גז לביוראקטור של חלקיקים‬ ‫מוערמים‬

198

C07D )2009.01(

196494

HETEROCYCLIC SUBSTITUTED PIPERAZINE COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY SCHERING CORPORATION US 60/831053 14/07/2006 PCT/US/2007/015924 WO/2008/008453

29/08/2007

C12M )2009.01(

196492

GAS DISTRIBUTOR FOR A STACKED PARTICLE BIOREACTOR GEOSYNFUELS LLC ZA 2006/05807 14/07/2006 2007/01408 30/01/2007 ZA PCT/IB/2007/052815 WO/2008/010176

12/07/2007

A44C )2009.01(

196489

‫תרכובות פיפרזין מותמרות בהטרוציקלים‬ CXCR3–‫עם פעילות אנטגוניסטית ל‬

C07D )2009.01(

196497 September 22, 2009

–‫ד' בתשרי התש"ע‬

NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION

‫נגזרות אמינופירידין חדשות בעלות עיכוב‬ A ‫סלקטיבי לאורורה‬

BANYU PHARMACEUTICAL CO. LTD 2006JP 31/08/2006 236472 60/926086 25/04/2007 US PCT/JP/2007/067250 WO/2008/026768

12/07/2007

196498

WIMAX ACCESS POINT NETWORK WITH BACKHAUL TECHNOLOGY DESIGNART NETWORKS LTD US 60/830727 13/07/2006 60/843183 08/09/2006 US 60/843079 08/09/2006 US PCT/IL/2007/000875 WO/2008/007375

14/01/2009

‫רשת ווימקס לעמדות גישה עם טכנולוגיית‬ ‫העברה חוזרת‬ ‫דזיינארט נטוורקס בע"מ‬

196499

THREAD RESTORER FOR SMALL INTERNAL TREADS SHILO TECHNOLOGIES LTD.

24/08/2004

‫שילה טכנולוגיות בע"מ‬

A DECK AND SYSTEM FOR DRIVING FLUIDS THROUGH AN EXTRACORPOREAL BLOOD CIRCUIT KIT THERAKOS, INC. US 10/654670 03/09/2003

September 22, 2009

196501

–‫ד' בתשרי התש"ע‬

B23G )2009.01(

‫משחזר תבריגים להברגות פנימיות קטנות‬

196500

24/08/2004

H04B )2009.01(

G01N )2009.01( ‫משטח ומערכת להעברת נוזלים דרך‬ ‫ערכה של מערכת דם חוץ–גופית‬

G01N )2009.01(

199

AN APPARATUS COMPRISING A CASSETTE FOR CONTROLLING MOVEMENT OF BLOOD AND SEPARATED COMPONENTS, AND METHD OF MAKING SUCH CASSETTE THERAKOS, INC. US 10/654670 03/09/2003

24/08/2004

200

G01N )2009.01( ‫מנגנון סינון לשימוש בזרימה חוץ–גופית‬

C07K )2009.01(

196509

ANTIBODIES DIRECTED AGANIST POLYPEPTIDES CAPABLE OF BINDING TO LDCAM, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME IMMUNEX CORPORATION US 60/095663 07/08/1998 PCT/US/1999/017906 WO/2000/008057

14/01/2009

‫משאבה פריסטלטית‬

196503

A FILTER ASSEMBLY FOR USE IN EXTRACORPOREAL BODY FLUID FLOW THERAKOS, INC. US 10/654670 03/09/2003

05/08/1999

G01N )2009.01(

196502

A PERISTALTIC PUMP APPARATUS THERAKOS, INC. US 10/654670 03/09/2003

24/08/2004

‫מכשיר הכולל דסקה לבקרה של זרימת‬ ‫דם ומרכיבי דם נפרדים ושיטה לייצור‬ ‫הדסקה‬

–‫נוגדנים כנגד פוליפפטידים הנקשרים ל‬ ‫ ותכשירים רוקחיים המכילים‬LDCAM ‫אותם‬

F16L )2009.01(

196511 September 22, 2009

–‫ד' בתשרי התש"ע‬

‫אטם למחבר פעמון לצינורות‬

BELL JOINT PIPE SEAL KRAUSZ INDUSTRIES DEVELOPMENT LTD.

14/01/2009

‫קראוס תעשיות פיתוח בע"מ‬

196515

METHOD AND DEVICE FOR IMPROVING USER'S HEALTH CONDITION NETOGREEN LTD

15/01/2009

‫שיטה והתקן לשיפור מצבו הבריאותי של‬ ‫המשתמש‬ ‫נטוגרין בע"מ‬

196530

ANALYTE TESTING METHOD AND SYSTEM LIFESCAN SCOTLAND LTD. US 61/021995 18/01/2008 61/022042 18/01/2008 US 61/059473 06/06/2008 US

07/04/2003

196532

IMMUNOLOGICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO. US 60/373,914 19/04/2002 PCT/CA/2003/000502 WO/2003/089460

18/01/2009

196566

DETECTION OF CURRENT LEAKAGE THROUGH OPTO-SWITCHES September 22, 2009

–‫ד' בתשרי התש"ע‬

A61B )2009.01(

G01N )2009.01( ‫שיטה ומערכת לבדיקת חומר מומס‬

C07K )2009.01( ‫תכשירים אימונולוגים לטיפול במחלת‬ ‫אלצהיימר‬ ‫מועצת המנהלים של אוניברסיטת‬ ,‫טורונטו‬

H01H )2009.01( ‫זיהוי של דליפת זרם חשמלי דרך מתגים‬ ‫אופטיים‬

201

BIOSENSE WEBSTER, INC. US 12/017137 21/01/2008

18/01/2009

G09B )2009.01(

196568

‫מתקן פרסום‬ ‫פרפרית בע"מ‬

ADVERTISEMENT DEVICE PARPARIT LTD.

18/01/2009

WORKPIECE CLAMPING FIXTURE EROWA AG CH 00151/08 04/02/2008

18/01/2009

‫מתקן הידוק חפץ בתהליך ייצור במלחצת‬

‫מגב רצפה ושיטה עבורו‬ ‫תומר דהאן‬

202

B60G )2009.01(

196574

SUSPENSION SYSTEM FOR VEHICLE ASFIR LTD

19/01/2009

A47K )2009.01(

196573

A FLOOR WIPER AND METHOD THEREFOR TOMER DAHAN

19/01/2009

B23Q )2009.01(

196572

‫מערכת מתלים לכלי רכב‬ ‫חברת מאיר אספיר בע"מ‬

A61B )2009.01(

196576

September 22, 2009

–‫ד' בתשרי התש"ע‬

A METHOD AND DEVICE TO ADMINISTER MEDICINE VIA A PACIFIER UZI EZRA HAVOSHA US 61/011204 16/01/2008

19/01/2009

196598

DOSING PUMP TEFEN MANUFACTURE &MARKETING PLASTIC PRODUCTS 1990 LTD

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שיטה ומתקן להעברת תרופה דרך מוצץ‬ ‫עידן חג'בי‬

F01L )2009.01( ‫משאבת מינון‬ 1990 ‫תפן ייצור ושיווק מוצרי פלסטיק‬ ‫בע"מ‬

203

NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967 The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968 Particulars of the applications, where applicable, are given in the following order: [11] [21] Number of application [54] Title of invention [22] Application date [31] [32] [33] Number and date of foreign application – convention country. *[51] Int.Cl. [61] Application for patent of addition [62] Divisional application [71] Applicant [72] Inventor [87] International Publication Number [74] Address for service [57] Abridgement of invention (in the language in which the specification is drawn up) *Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006)

204

- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬ 1976 ‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬ ‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬ ‫להתנגד למתן פטנט על פי בקשה מהבקשות‬ ‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬ ‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬ ‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬ ‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬ .1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬ ‫פרטי הבקשות במידה ויישימים מובאים לפי‬ :‫סדר זה‬ ‫מספר הבקשה‬ ‫שם האמצאה‬ ‫תאריך הבקשה‬ ‫מספר ותאריך של בקשות החוץ – מדינת‬ ‫האגוד‬ ‫*סיווג בינלאומי – מהדורה שביעית‬ ‫בקשה לפטנט מוסף‬ ‫בקשת חלוקה‬ ‫המבקש‬ ‫הממציא‬ ‫מס' פרסום של בקשה הבינלאומית‬ ‫מען למסירת מסמכים‬ )‫תקציר האמצאה (בשפה בה ערוך הפירוט‬

'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬ ‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬1/06 ‫המהדורה השמינית של הסיווג הבינלאומי‬ )2006 ‫של פטנטים (משנה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

TISSUE CHARACTERIZATION BASED ON IMPEDANCE IMAGES AND ON IMPEDANCE MEASUREMENTS

]22[ ]51[ ]71[

05.10.1995 Int. Cl.(2008.04) G01N 27/02 MIRABEL MEDICAL SYSTEMS LTD. G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521

]74[

[57] Apparatus for aiding in identification of tissue type for an anomalous tissue in an impedance image comprising: means (14) for providing a polychromic immitance map of a portion of the body; means (62)

115525 ‫אפיון רקמות על בסיס דמויות עכבה ועל‬ ‫בסיס מדידות עכבה‬

‫ מגדל העמק‬,‫מירבל מדיקל סיסטמס בע"מ‬ ,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬ ,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬ ‫רמת גן‬ for determining a plurality of polychromic measures of an anomalous region of the immitance image; and a display (16) which displays an indication based on said plurality of polychromic measures.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

205

]11[]21[ ]54[

SMALL CART FOR CAR FOR EQUIPMENT AND PRODUCTS

]22[ ]51[ ]71[ ]74[

23.01.1997 Int. Cl.(2008.04) B62B 3/02 AVRAHAM COHEN AVRAHAM COHEN, 2/2 ALMOGIM ST. ASHDOD

120066 ‫עגלת מוצרים וציוד לרכב‬

‫ אשדוד‬,‫אברהם כהן‬ ,‫אברהם כהן‬ ‫ אשדוד‬,2/2 ‫האלמוגים‬

[57] A vehicle storage compartment comprising: a body (82) defining a volume for placing objects therein; a plurality of support legs (90) underneath said body, said set of support legs being provided with wheels (92) to enable rolling transportation of said body along a horizontal surface; at least one ancillary leg (94) underneath said body and provided with a wheel (96), said at least one ancillary leg being located closer towards an end of said body and protruding from an underside to said body

a smaller distance than at least two of said support legs, said at least one ancillary leg and said at least two of said support legs defining a plane angled with respect to said horizontal surface along which said wheels may be rolled; an openable and closeable enclosure (102) located in a portion of a vehicle; and a mounting structure assembled in said enclosure and comprising at least one support member (105, 106) for supporting and fixing said body.

__________

206

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

126376 ‫הכנתם‬,‫תחליפי תא דם אדום שאינו תאי‬ ‫והשימוש בהם‬

]54[

ACELLULAR RED BLOOD PRODUCT CELL SUBSTITUTES, THEIR PREPARATION AND USES THEREOF

]22[ ]31[ ]51[ ]71[

27.09.1998 60/014389 ]32[ 28.03.1996 ]33[ US Int. Cl.(2008.04) A61K 38/42, A61P 7/00, C07K 148/05 NORTHFIELD LABORATORIES, INC., U.S.A. WO/1997/035883 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] An aqueous solution of pyridoxylated, glutaraldehyde-polymerized hemoglobin, having a tetramer content of not more than 0.8% by weight based on the weight of total hemoglobin in the solution and having, based on the weight of total hemoglobin in the solution, a molecular weight distribution of 10 to 24%

hemoglobin polymer with a molecular weight of about 128 kd, 18 to 30% hemoglobin polymer with a molecular weight of about 192 kd, and 45 to 70% hemoglobin polymer with a molecular weight of about 256 kd, determined by size exclusion HPLC.

__________ ]11[]21[ ]54[

ARTIFICIAL VENTILATION SYSTEM AND METHODS OF CONTROLLING CARBON DIOXIDE REBREATHING

]22[ ]31[ ]51[ ]71[ ]74[

30.10.1997 08/751316 ]32[ 18.11.1996 Int. Cl.(2008.04) A61M 16/00 MEDLIS CORP., U.S.A. SOROKER-AGMON, 14 SHENKAR ST., HERZLIYA PITUAH 46725

[57] A unilimb respiratory conduit for use in an assisted ventilation system having an inspiratory gas input and exhaust outlet, comprising: an outer flexible tube (120), an inner flexible tube (110), said outer flexible tube and inner flexible tube each September 22, 2009 –‫ד' בתשרי התש"ע‬

129586 ‫מערכת אוורור מלאכותית ושיטות בקרת‬ ‫שאיפת פחמן דו–חמצני חוזרת‬

]33[

US

,‫אגמון‬-‫סורוקר‬ ‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬ having a proximal end and a distal end (122); the outer diameter of said inner flexible tube being smaller than the inner diameter of said outer flexible tube, said inner flexible tube being at least partially disposed within said outer flexible tube,

207

said distal end of said inner flexible tube being disposed within and in direct fluid communication with said outer flexible tube, and a proximal fitting (130), said unilimb respiratory conduit having a distal end and a proximal end, said proximal fitting located at said proximal end of said unilimb repiratory conduit, and comprising an inner pipe (134) and an outer pipe (136) maintained in fixed coaxial spaced relationship by spacing means, said outer pipe and inner pipe each having a proximal end and a distal end, wherein said distal end of said inner pipe is operably connected to said proximal end of said inner flexible tube and said distal end of said outer pipe is operably connected to said proximal end of said outer flexible

tube, said proximal end of said pipes capable of being operably connected to an inspiratory gas input of the assisted ventilation system while said proximal end of the other one of said pipes is simultaneously operably connectable to an exhaust outlet, and wherein said distal end of said unilimb respiratory conduit can be operably connected to an airway device connected to a mammal, and wherein a user may connect said proximal fitting to an assisted ventilation system in order to use said unilimb respiratory conduit to provide inspiratory gases and exhaust expiratory gases from a mammal, and may disconnect said proximal fitting from the assisted ventilation system after use.

__________ ]11[]21[ ]54[

PHARMACEUTICAL COMPOSITIONS CONTAINING CARBOXYLIC ACIDS AND DERIVATIVES THEREOF

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

23.06.1998 121165 ]32[ 26.06.1997 Int. Cl.(2008.04) A61K 31/20 SYNDROME X LTD. WO/1999/000116 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

208

133540 ‫תכשירים רוקחיים המכילים חומצות‬ ‫קרבוכסיליות ותולדות שלהן‬

]33[

IL ‫ ירושלים‬,‫סינדרום אקס בע"מ‬ ,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] Pharmaceutical composition for treating an HNF-4 mediated disease state comprising a therapeutically effective amount of a compound which inhibits

HNF-4 controlled transcription independently of PPARα activation.

__________ ]11[]21[

134127 ‫מאניפולד לאספקת נוזלים לקטטר‬

]54[

MANIFOLD FOR CATHETERIZATION

]22[ ]51[ ]71[

20.01.2000 Int. Cl.(2008.04) A61B 1/00, A61M 25/18, 39/22 NACHUM BORIVKER BORIS VARSHITSKY

]74[

NACHUM BORIVKER, 5/15 KARPAS ST., JERUSALEM

[57] Manifold for catheterization having some fixed working positions and comprising: a housing (2), when on the external side of the housing are six ports and on the internal side of the housing there is a hollow chamber (21); a valve stem (5) positioned within the said chamber of the housing and being

‫נחום בוריבקר‬ ‫ גילה‬,‫בוריס ורשיצקי‬ ,‫נחום בוריבקר‬ ‫ גילה‬5\15 ‫רח' כרפס‬

constructed from a body with an upper handle in order to move in the axis direction into one of two working levels and for rotating around its axis, all that for establishing one of the said fixed working positions; the body of the said valve stem having fluid flow pathways for connecting with the said ports.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

209

]11[]21[

136137 ‫ מבודדים ושיטות‬hedgehog ‫חלבוני‬ ‫להכנתם‬

]54[

HEDGEHOG ISOLATED PROTEINS AND METHODS OF GENERATING THEM

]22[ ]31[

03.12.1998 60/067423 ]32[ 03.12.1997 ]33[ US 60/078935 20.03.1998 US 60/089685 17.06.1998 US 60/099800 10.09.1998 US Int. Cl.(2008.04) A61K 38/18, A61P 25/00, C07K 144/35 BIOGEN IDEC MA INC., U.S.A. CURIS, INC., U.S.A.

]51[ ]71[ ]87[ ]74[

WO/1999/028343 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An isolated protein comprising an Nterminal amino acid and a C-terminal amino acid, which protein is modified at the N-terminus with at least one hydrophobic moiety, wherein the protein is a hedgehog protein selected from: (a) a portion with an N-terminal cysteine that is appended with at least one hydrophobic moiety; (b) a protein with an N-terminal amino acid that is not a cysteine appended with at least one hydrophobic moiety; and

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

(c) a protein with at least one hydrophobic moiety substituted for the N-terminal amino acid; wherein the hedgehog protein is not modified with a sterol, and wherein the hydrophobic moiety is selected from (i) a peptide comprising at least one hydrophobic amino acid, (ii) a hydrophobic amino acid or (iii) a lipid moiety.

__________

210

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

136216 ‫פוליפפטידים וחומצות גרעין המקודדות‬ ‫אותם‬

]54[

POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME

]22[ ]31[

01.12.1998 60/067411 ]32[ 03.12.1997 ]33[ US 60/069334 11.12.1997 US 60/069335 11.12.1997 US 60/069278 11.12.1997 US 60/069425 12.12.1997 US 60/069696 16.12.1997 US 60/069694 16.12.1997 US 60/069702 16.12.1997 US 60/069870 17.12.1997 US 60/069873 17.12.1997 US 60/068017 18.12.1997 US 60/070440 05.01.1998 US 60/074086 09.02.1998 US 60/074092 09.02.1998 US 60/075945 25.02.1998 US Int. Cl.(2008.04) C07K 14/47, C12N 15/12, 15/13, 15/62 GENENTECH, INC., U.S.A. WO/1999/028462 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] Isolated nucleic acid encoding an amino acid sequence having at least 80% sequence identity to the amino acid sequence shown in Figure 2 (SEQ ID NO:2) as shown in the specification, or the The applications for division from this application have not yet been published

complement thereof, wherein said sequence identity is determined over the full length of the sequences being compared.

,197835,197834,197826,178210

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

137424

211

‫מולקולות חומצות גרעין התואמות פנוטיפ‬ ‫ חלש‬D ‫רזוס‬

]54[

NUCLEIC ACID MOLECULES CORRELATED WITH THE RHESUS WEAK D PHENOTYPE

]22[ ]31[ ]51[ ]71[

18.12.1998 98101203.2 ]32[ 23.01.1998 ]33[ DE Int. Cl.(2008.04) C07K 14/47, 16/18, C12N 15/12, C12Q 1/68, G01N 335/66 DRK BLUTSPENDEDIENST BADEN-WURTTEMBERG-HESSEN GEMEINNUTZIGE GMBH, GERMANY WO/1999/037763 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]87[ ]74[

[57] A nucleic acid molecule encoding a Rhesus D antigen contributing to or indicative of the weak D phenotype, said nucleic acid molecule carrying at least one

missense mutation, as compared to the wild type Rhesus D antigen, in its transmembrane and/or intracellular regions.

__________ ]11[]21[ ]54[

SCALE READING APPARATUS

]22[ ]31[ ]51[ ]71[

12.10.2000 9924331.3 ]32[ 15.10.1999 Int. Cl.(2008.04) G01B 7/28 RENISHAW PLC, UNITED KINGDOM REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]74[

[57] A rotary ring for use in scale reading apparatus, the ring being provided on a surface thereof with scale marks defining a periodic pattern, said scale marks being readable by a reading of the scale reading apparatus, wherein an inner circumferential surface of the ring is provided by a tapered surface at an angle

212

138995 ‫התקן לקריאת סקלה‬

]33[

GB

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

relative to the axis of the ring, and wherein the ring is mountable on a shaft having a central longitudinal axis and an axis of rotation separate from said longitudinal axis, said ring being mounted such that it is concentric with said axis of rotation, thereby providing compensation for eccentricity of the shaft.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

139452 ‫נוגדן מבודד בעל זיקה לאפיטופ של‬ ‫ ושימוש‬,‫ תצמיד הכולל אותו‬,‫פיברונקטין‬ ‫שלו בהכנת תרופה לטיפול במחלות‬ ‫הקשורות אנגיוגנסיס‬

]54[

ISOLATED ANTIBODY WITH AFFINITY TO EPITOPE OF FIBRONECTIN, CONJUGATE COMPRISING IT AND USE THEREOF IN THE PREPARATION OF A MEDICAMENT FOR TREATING DISEASES ASSOCIATED WITH ANGIOGENESIS

]22[ ]31[

11.05.1999 09/075338 ]32[ 11.05.1998 ]33[ US 09/300425 28.04.1999 US Int. Cl.(2008.04) A61K 47/48, 49/16, C07K 16/18 EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH, SWITZERLAND WO/1999/058570 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]51[ ]71[ ]87[ ]74[

[57] An isolated antibody with specific affinity for a characteristic epitope of the Extra Domain B (ED-B) domain of fibronectin, wherein the antibody has an

affinity to said ED-B epitope in the subnanomolar range and recognizes EDB(+) fibronectin.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

213

]11[]21[ ]54[

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

139571

HUMANIZED ANTIBODY THAT ‫נוגדן אנושי המתקשר לורוטוקסין תהליכים‬ BINDS TO VEROTOXIN, ‫להכנתו ותכשירי רוקחות המכילים אותו‬ METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT 19.05.1999 60/086570 ]32[ 20.05.1998 ]33[ US Int. Cl.(2008.04) A61K 39/40, A61P 39/02, C07K 16/12, C12N 5/10, C12P 21/08 TEIJIN LIMITED, JAPAN PDL BIOPHARMA, INC., U.S.A. WO/1999/059629 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

[57] A humanized antibody that specifically binds to VT2 and/or VT2 variant.

__________ ]11[]21[ ]54[

MECHANICAL STRESS INDUCED GENES, EXPRESSION PRODUCTS THEREFROM AND USES THEREOF

]22[ ]31[ ]51[ ]71[

14.05.1999 60/085673 ]32[ 15.05.1998 Int. Cl.(2008.04) C12Q 1/68 QUARK PHARMACEUTICALS, INC., U.S.A. WO/1999/060164 JUDITH ABRAHAMS, P.O.B. 4071, NES ZIONA 70400

]87[ ]74[

[57] An isolated nucleic acid molecule comprising SEQ ID NO:32 encoding protein 608 or a functional portion thereof, or a nucleic acid molecule which is at least

139637 ‫ מוצרי‬,‫גנים הנוצרים ממתח מכני‬ ‫ביטוימהם ושימושים שלהם‬

]33[

US

,‫ מפעלים בע"מ‬.‫אי‬.‫בי‬.‫ קיו‬,‫יהודית אברהמס‬ ‫ נס ציונה‬,4071 .‫ד‬.‫ ת‬, substantially homologous or identical thereto encoding a polypeptide having the same function.

__________ 214

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

139927 ‫מערכת רשת הנוצרת בצורה אוטומטית‬ ‫בעלת בינה מלאכותית מבוזרת להספקת‬ ‫ מדידה‬,‫ חישה מרחוק‬,‫שירותי מולטימדיה‬ ,‫ נוכחות מרחוק‬,‫ תנועה מרחוק‬,‫מרחוק‬ ‫ניהול מרחוק תיקשורת ועיבוד נתונים‬ ‫בנפח ומהירות גבוהים‬

]54[

AUTOPOIETIC NETWORK SYSTEM ENDOWED WITH DISTRIBUTED ARTIFICIAL INTELLIGENCE FOR THE SUPPLY OF HIGH VOLUME HIGH-SPEED MULTIMEDIA, TELESTHESIA, TELEMETRY, TELEKINESIS, TELEPRESENCE, TELEMANAGEMENT, TELECOMMUNICATIONS AND DATA PROCESSING SERVICES

]22[ ]31[ ]51[ ]71[

21.05.1999 330544 ]32[ 29.05.1998 ]33[ NZ Int. Cl.(2008.04) G06N 3/00, 5/00, H04L 12/00, 12/28, 29/06 INDRANET TECHNOLOGIES LIMITED, NEW ZEALAND WO/1999/063450 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

]87[ ]74[

[57] An autopoietic networked communication, control and network and/or environmental management system, comprising: a plurality of cybernetic devices, each device adapted to communicate with other cybernetic devices in a networked system; processing means located on selected devices for controlling said devices, the operation of the processing means in governed by a library of algorithms which includes a plurality of algorithms defining predetermined functions which mediate local and remote activities of the networked system wherein the library of algorithms is stored in media readable by the processing means included within selected devices in the networked system

September 22, 2009

–‫ד' בתשרי התש"ע‬

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

and distributed according to the functional requirements of at least part of the networked system; a plurality of sensing means adapted to sense parameters related to an environment in which the activities occur and output environmental data representative of the environment to corresponding devices, wherein the processing means is programmed to control the activities of the networked system through selection and execution of said algorithms and wherein the selection process occurs in a hermeneutic fashion according to iterative heuristic sequences which are dependent on said environmental data and wherein the result of the selection is dependent on satisfaction of set criteria.

215

,171558

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ ]11[]21[

140017 ‫פוליאנהדרים‬

]54[

POLYANHYDRIDES

]22[ ]51[ ]71[ ]72[ ]74[

30.11.2000 Int. Cl.(2008.04) A61K 47/34, 9/22, A61P 19/00, 35/00, C08G 63/00, 67/04 EFRAT BIOPOLYMERS LTD. ‫ אפרת‬,‫אפרת ביופולימריים בע"מ‬ ABRAHAM J. DOMB ‫אברהם דומב‬ WOLFF, BREGMAN AND GOLLER, ,‫ ברגמן וגולר‬,‫וולף‬ P.O.B. 1352, ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, JERUSALEM 91013

[57] A biodegradable aliphatic polyanhydride multiblock copolymer comprising random ester or amide bonds along the polymer chain, synthesized by the polymerization of a polyanhydride formed of an aliphatic dicarboxylic acid

with a degree of polymerization (n) of 20 to 10,000, reacted with a polyfunctional organic molecule that contains at least two functional groups selected from the group consisting of hydroxyl, amino, carboxylic acid, and combinations thereof.

__________ 216

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

140217 HCV ‫חלקיקים של מעטפת חלבוני‬ ‫ושימושם לחיסון‬

]54[

PARTICLES OF HCV ENVELOPE PROTEINS AND THEIR USE FOR VACCINES

]22[ ]31[

23.06.1999 98870142.1 ]32[ 24.06.1998 ]33[ EP 99870033.0 22.02.1999 EP Int. Cl.(2008.04) A61K 39/29, 393/95, 48/00, A61P 31/12, C07K 14/18, 16/10, C12N 15/51, 15/63, 7/00, G01N 335/76 INNOGENETICS N.V., BELGIUM WO/1999/067285 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] An oligomeric particle consisting of purified HCV envelope proteins and having a diameter of 5 to 100 nanometer.

__________ ]11[]21[ ]54[

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

141516

PHARMACEUTICAL ‫תכשיר רוקחות המכיל ציקלופפטיד‬ PREPARATION CONTAINING A ‫ותכשיר כמוטרפויטי או מעכב אנגיוגנזיס‬ CYCLOPEPTIDE AND A CHEMOTHERAPEUTIC AGENT OR AN ANGIOGENESIS INHIBITOR 09.09.1999 19842415.9 ]32[ 16.09.1998 ]33[ DE Int. Cl.(2008.04) A61K 317/068, 38/12, A61P 19/00, 27/00, 31/00, 35/00, 7/00, 9/00, C07K 7/50, 7/64 MERCK PATENT GMBH, GERMANY WO/2000/015244 EITAN MEHULAL LAW GROUP, ‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ 10 ABBA EBEN BLVD., ,‫פטנטים‬ P.O. B. 2081, ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬ HERZLIYA 46120

[57] Pharmaceutical preparation comprising cyclo (Arg-Gly-Asp-D-PheNMe-Val) and one or more additional compounds, wherein at least one of the additional compounds is selected from the September 22, 2009

–‫ד' בתשרי התש"ע‬

gorup consisting of chemotherapeutic agents and angiogenesis inhibitors other than cyclo (Arg-Gly-Asp-D-Phe-NMeVal); and the physiologically acceptable salts thereof, wherein the

217

chemotherapeutics are selected from the group consisting of: (a) alkylating agents, (b) antibiotics, (c) antimetabolites, (d) biologicals and immunomodulators, (e) hormones and antagonists thereof,

(f) mustard gas derivatives, (g) alkaloids, (h) protein kinase inhibitors, (i) others, selected from the group consisting of Altretamine, Cladribine, Gemcitabine, Leucovorine, Levamisole, Pentostatine and lrinotecane.

__________ ]11[]21[ ]54[

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

CYTOKINE RECEPTOR ‫ פולינוקליוטיד‬,ZALPHA11 ‫קולטן ציטוקין‬ ZALPHA11, POLYNUCLEOTIDE ‫המקודד לקולטן הנ"ל ושיטות המשתמשות‬ ENCODING SAID RECEPTOR ‫בקולטן הנ"ל‬ AND METHODS USING SAID RECEPTOR 23.09.1999 09/159254 ]32[ 23.09.1998 ]33[ US 09/265117 09.03.1999 US 09/347930 06.07.1999 US Int. Cl.(2008.04) C07K 147/15, 16/28, C12N 15/12, 15/19 ZYMOGENETICS INC., U.S.A. WO/2000/017235 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] An isolated polynucleotide that encodes a zalpha 11 (cytokine receptor) polypeptide comprising a sequence of amino acid residues that is at least 90% identical to an amino acid sequence selected from the group consisting of: (a) the amino acid sequence as shown in SEQ ID NO:2 from amino acid number 20 (Cys), to amino acid number 237 (His); (b) the amino acid sequence as shown in SEQ ID NO:2 from amino acid number 20 (Cys), to amino acid number 255 (Leu); (c) the amino acid sequence as shown in SEQ ID NO:2 from amino acid number The applications for division from this application have not yet been published

218

142164

256 (Lys), to amino acid number 538 (Ser); (d) the amino acid sequence as shown in SEQ ID NO:2 from amino acid number 20 (Cys), to amino acid number 538 (Ser); and (e) the amino acid sequence as shown in SEQ ID NO:2 from amino acid number 1 (Met) to amino acid number 538 (Ser), wherein the amino acid percent identity is determined using a FASTA program with ktup=1, gap opening penalty=10, gap extension penalty=1, and substation matrix=BLOSUM62, with other parameters set as default. ,185764 ‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

_________ ]11[]21[

142225 ‫תכשירים רפואיים המכילים אנלוגית גאבא‬ ‫לטיפול במניה ובהפרעות ביפולאריות‬

]54[

PHARMACEUTICAL COMPOSITIONS COMPRISING GABA ANALOGS FOR THE TREATMENT OF MANIA AND BIPOLAR DISORDER

]22[ ]31[ ]51[ ]71[

18.08.1999 60/104535 ]32[ 16.10.1998 ]33[ US Int. Cl.(2008.04) A61K 311/97, A61P 25/18, C07C 229/08, 229/28 WARNER-LAMBERT COMPANY LLC, U.S.A. WO/2000/023067 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]87[ ]74[

[57] Pharmaceutical composition for the treatment of the symptorns of mania in a mammal comprising a therapeutically

effective amount of a compound of the formula

or a pharmaceutically acceptable salt thereof wherein R1 is a straight or branched alkyl of from 1 to 6 carbons,

phenyl, or cycloalkyl of from 3 to 6 carbons; R2 is hydrogen or methyl; and R3 is hydrogen, methyl, or carboxyl.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

142566

219

‫אנטגוניסט לאסטרוגן‬/‫שימוש באגוניסט‬ ‫בהכנת תרופות לטיפול בהפרעה בגירוי‬ ‫מיני אצל נשים‬

]54[

USE OF AN ESTROGEN AGONIST/ANTAGONIST IN THE PREPARATION OF MEDICAMENTS FOR TREATING SEXUAL AROUSAL DISORDER IN A FEMALE SUBJECT

]22[ ]31[ ]51[ ]71[ ]74[

12.04.2001 60/266387 ]32[ 18.04.2000 ]33[ US Int. Cl.(2008.04) A61K 31/40, 31/55, 314/45, 314/985, A61P 15/12 PFIZER PRODUCTS, INC., U.S.A. LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

[57] The use of an effective amount of an estrogen agonist/antagonist wherein the

estrogen agonist/antagonist is a compound of the formula

wherein: A is selected from CH2 and NR; B, D and E are independently selected from CH and N; Y is (a) phenyl, optionally substituted with 1-3 substituents independently selected from R4; (b) naphthyl, optionally substituted with 13 substituents independently selected from R4; (c) C3-C6 cycloalkyl, optionally substituted with 1-2 substituents independently selected from R4; (d) C3-C8 cycloalkenyl, optionally substituted with 1-2 substituents independently selected from R4; (e) a five membered heterocycle containing up to two heteroatoms selected

from the group consisting of –O-, -NR2and –S(O)n-, optionally substituted with 1 3 substituents independently selected from R4; (f) a six membered heterocycle containing up to two heteroatoms selected from the group consisting of –O-, -NR2- and – S(O)n- optionally substituted with 1-3 substituents independently selected from R4; or (g) a bicyclic ring system consisting of a five or six membered heterocyclic ring fused to a phenyl ring, said heterocyclic ring containing up to two heteroatoms selected from the group consisting of –O-,NR2- and –S(O)n-, optionally substituted with 1-3 substituents independently selected from R4; Z1 is

220

September 22, 2009

–‫ד' בתשרי התש"ע‬

(a) –(CH2)p W(CH2)q-; (b) –O(CH2)p CR5R8-; (c) –O(CH2)pW(CH2)q-; (d) –OCHR2CHR3-; or

(e) –SCHR2CHR3-; G is (a) –NR7R8;

(b) wherein n is 0, 1 or 2; m is 1, 2 or 3; Z2 is –NH-, -O-, -S-, or –CH2-; optionally fused on adjacent carbon atoms with one or two phenyl rings and, optionally independently substituted on carbon with one to three substituents and, optionally, independently on nitrogen with a chemically suitable substituent selected from R4; or

(c) a bicyclic amine containing five to twelve carbon atoms, either bridged or fused and optionally substituted with 1-3 substituents independently selected from R4; or Z1 and G in combination may be

W is (a) –CH2-; (b) –CH=CH-; (f)

(c) –O-; (d) –NR2-; (e) –S(O)n-;

(g) –CR2(OH)-; (h) –CONR2-; (i) –NR2CO-; (j)

(k) -C≡C-; R is hydrogen or C1-C6 alkyl; R2 and R3 are independently (a) hydrogen; or (b) C1-C4 alkyl; R4 is September 22, 2009

–‫ד' בתשרי התש"ע‬

(a) hydrogen; (b) halogen; (c) C1-C6 alkyl; (d) C1-C4 alkoxy; (e) C1-C4 acyloxy; (f) C1-C4 alkylthio;

221

(g) C1-C4 alkylsulfinyl; (h) C1-C4 alkylsulfonyl; (i) hydroxy (C1-C4) alkyl; (j) aryl (C1-C4) alkyl; (k) –CO2H; (l) –CN; (m) –CONHOR; (n) –SO2NHR; (o) –NH2; (p) C1-C4 alkylamino; (q) C1-C4 dialkylamino; (r) –NHSO2R; (s) –NO2; (t) –aryl; or (u) –OH; R5 and R6 are independently C1-C8 alkyl or together form a C3-C10 carbocyclic ring; R7 and R8 are independently (a) phenyl; (b) a C3-C10 carbocyclic ring, saturated or unsaturated; (c) a C3-C10 heterocyclic ring containing up to two heteroatoms, selected from –O-, -N- and –S-; (d) H; (e) C1-C6 alkyl; or

(f) form a 3 to 8 membered nitrogen containing ring with R5 or R6; R7 and R8 in either linear or ring form may optionally be substituted with up to three substituents independently selected from C1-C6 alkyl, halogen, alkoxy, hydroxy and carboxy; a ring formed by R7 and R8 may be optionally fused to a phenyl ring; e is 0, 1 or 2; m is 1, 2 or 3; n is 0, 1 or 2; p is 0, 1, 2 or 3; q is 0, 1, 2 or 3; or an optical or geometric isomer thereof; or a pharmaceutically acceptable salt, Noxide, ester, quaternary ammonium salt or prodrug thereof, and a cyclic guanosine 3',5-monophosphate elevator, which is the PDEv phosphodiesterase inhbitor 1-[[3(6,7-dihydro-1-methyl-7-oxo-3-propyl-1Hpyrazolo [4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sufonyl]-4-methylpiperazine citrate salt in preparing a medicament for treating sexual arousal disorder in a female subject in need of treatment thereof.

__________

]11[]21[

222

144739

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫תכשירים רוקחיים המכילים מלחים קשי‬ ‫תמס של פפטידים בטיוניים ונשאים‬ ‫ ושיטות‬,‫מקרומולקולריים יוניים נגדיים‬ ‫להכנתם‬

]54[

PHARMACEUTICAL COMPOSITION COMPRISING A WATER-INSOLUBLE SALT OF A CATIONIC PEPTIDIC COMPOUND AND A COUNTERIONIC CARRIER MACROMOLECULE AND METHODS FOR THE PREPARATION THEREOF

]22[ ]31[ ]51[ ]71[

29.01.2000 60/119076 ]32[ 08.02.1999 ]33[ US Int. Cl.(2008.04) A61K 38/00, 38/09, 47/48, 9/10, 9/14, 9/19 AETERNA ZENTARIS GMBH, GERMANY WO/2000/047234 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method for preparing a pharmaceutical formulation, comprising a peptidic compound and a carrier macromolecule; characterized by the steps of forming the free ions of both compounds by removing the counter ions; combining the ionic peptidic compound

and the ionic carrier macromolecule under conditions such that a water-insoluble salt of the peptidic compound and the carrier macromolecule forms; and preparing a pharmaceutical formulation comprising the water insoluble salt.

__________

]11[]21[ ]54[

HEMOCOMPATIBLE SURFACES AND METHOD FOR PRODUCING SAME

September 22, 2009

–‫ד' בתשרי התש"ע‬

144912 ‫משטחים המוקומפטיבילים ושיטה לייצרם‬

223

]22[ ]31[ ]51[ ]71[

24.02.2000 19908318.5 ]32[ 26.02.1999 Int. Cl.(2008.04) A61L 33/00, 33/18 ROLAND HORRES, GERMANY MICHAEL HOFFMANN, GERMANY

]87[ ]74[

WO/2000/050106 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] Hemocompatible surfaces, characterized in that they contain as materials artificial and/or natural organic and/or inorganic compounds and/or mixtures thereof and/or materials having contact with blood and/or other body fluids in invasive operations and/or animal organs and/or organ parts, and constituents

]33[

DE

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ of the outer layers of blood cells and/or mesothelial cells comprising oligosaccharide, polysaccharide and/or lipid portions of the glycoproteins, glycolipids and/or proteoglycans are applied and/or incorporated onto and/or into the surfaces of said materials.

__________ ]11[]21[ ]54[

PROCESS FOR PARTITIONING OF PROTEINS OR CELLS

145337 ‫תהליך לחציית חלבונים או תאים‬

]22[ ]31[

24.03.2000 990667 ]32[ 25.03.1999 ]33[ FI 19991782 20.08.1999 FI ]51[ Int. Cl.(2008.04) C07K 1/14, 14/37, 7/06, 7/08, C12N 1/15, 15/62, 15/63 ]71[ VALTION TEKNILLINEN TUTKIMUSKESKUS, FINLAND ]72[ MERJA PENTTILA, TIINA NAKARI-SETALA, RICHARD FAGERSTROM, KLAUS SELBER, MARIA-REGINA KULA, MARKUS LINDER, FOLKE TJERNELD ]87[ WO/2000/058342 ]74[ EITAN, PEARL, LATZER AND ,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬ COHEN ZEDEK, ‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬ P.O.B. 12688, HERZLIYA 46733 [57] A process for partitioning of proteins (a) in order to obtain a fusion protein or or cells in aqueous two-phase systems cell, combining a protein or a cell of (ATPS), comprising the steps of interest to a targeting protein selected from the group consisting of hydrophobins and

224

September 22, 2009

–‫ד' בתשרי התש"ע‬

hydrophobin-like proteins and parts thereof, and

(b) subjecting said fusion protein or cell carrying the targeting protein to an ATPS separation.

__________ ]11[]21[

145673 ‫שרפי פלואורופולימר המכילים קבוצות‬ ‫יוניות או קבוצות העוברות יוניזציה‬ ‫ותוצרים המכילים אותם‬

]54[

FLUOROPOLYMER RESINS CONTAINING IONIC OR IONIZABLE GROUPS AND PRODUCTS CONTAINING THE SAME

]22[ ]31[

15.02.2001 60/182732 ]32[ 15.02.2000 ]33[ US 774266 30.01.2001 US Int. Cl.(2008.04) C08F 8/00, C08G 63/48, H01M 2/00 ATOFINA CHEMICALS, INC., U.S.A. WO/2001/060872 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A composition comprising the polymer product of blending: (a) at least one polymer comprising acrylic units, vinyl units or both, and at least one ionic or ionizable group, wherein said ionic or ionizable group is a sulfonated

group or a phosphonated group or both; and (b) at least one thermoplastic fluoropolymer, wherein (a) and (b) are different.

__________

]11[]21[ ]54[

MANAGING OBJECT RELATIONSHIPS USING AN OBJECT REPOSITORY

September 22, 2009

–‫ד' בתשרי התש"ע‬

146161 ‫ניהול יחסי יעדים תוך שימוש במאגר יעדים‬

225

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

28.04.2000 60/131970 ]32[ 30.04.1999 Int. Cl.(2008.04) G06F 17/30 INTERGRAPH HARDWARE TECHNOLOGIES COMPANY, U.S.A. WO/2000/067156 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A method for updating information in a database, comprising a first relation between a first entity and a second entity and a second relation between a second entity and a third entity, the method comprising: changing a first object of the first entity; identifying the first relation as being associated with the first object; using the first relation and repository metadata,

]33[

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, identifying the second entity as an active entity; identifying a semantic object associated with the active entity, wherein the semantic object comprises an action to be performed in response to a change in the first entity; using arguments of the semantic object, identifying the third entity; and evaluating the action to change the third entity.

__________

]11[]21[ ]54[

226

TIMED DUAL RELEASE DOSAGE FORMS COMPRISING A SHORT ACTING HYPNOTIC OR A SALT

146928 ‫תצורת מינון בעלת שחרור כפיל מתוזמן‬ ‫המכילות חומר היפנוטי קצר טווח או מלח‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שלו‬

THEREOF ]22[ ]31[ ]51[ ]71[ ]87[ ]74[

27.06.2000 99401605.3 ]32[ 28.06.1999 Int. Cl.(2008.04) A61K 9/00, 9/50 SANOFI AVENTIS, FRANCE WO/2001/000181 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]33[

EP

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ hydrochloric acid buffer at 37oC, comprising two release pulses, the first release pulse being immediate, having a maximum duration of 30 minutes, and the second release pulse being delayed by a fixed time of between 50 and 200 minutes after the administration, the delayed second release pulse lasting between 30 and 200 minutes.

[57] A pharmaceutical composition comprising a short acting hypnotic or a salt thereof characterised in that it consists of a timed dual release dosage form adapted to release the short acting hypnotic over a predetermined time period, according to an in vitro profile of dissolution when measured in a rotating paddle apparatus of the European pharmacopeia in 0.01 M

__________ ]11[]21[

146954 ‫ מתאים לבני–אדם‬ERB 2 ‫נוגדנים נגד‬ ErB2 ‫וטיפול בנוגדנים נגד‬

]54[

HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

23.06.2000 60/141316 ]32[ 25.06.1999 ]33[ US Int. Cl.(2008.04) A61K 393/95, A61P 35/00, C07K 16/32, C12N 15/13 GENENTECH, INC., U.S.A. WO/2001/000245 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] A humanized antibody which binds ErbB2 and blocks ligand activation of an ErbB receptor, the humanized antibody comprising a variable heavy (VH) domain which comprises nonhuman hypervariable The applications for division from this application have not yet been published

region residues incorporated into a human VH domain and further comprises framework region (FR) substitutions at positions 69H, 71H and 73H. ,197359

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ September 22, 2009

–‫ד' בתשרי התש"ע‬

227

]11[]21[ ]54[

COMPOSITION COMPRISING IL 11 AND A CRYOPROTECTANT HAVING REDUCED IL-11 AGGREGATION

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

14.07.2000 354390 ]32[ 15.07.1999 Int. Cl.(2008.04) A61K 38/20, 47/00 GENETICS INSTITUTE, LLC, U.S.A. WO/2001/005355 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

[57] A composition comprising about 1 μg/ml to about 20 mg/ml IL-11, 100 to about 400 mM glycine and 0.5 to about 2.0% wt/wt cryoprotectant, wherein said

147599 ‫ וחומר מגן בפני נזק‬IL – 11 ‫הרחב המכיל‬ IL – 11 ‫בהקפאה עם אגרציה מופחתת של‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ IL-11 in said composition shows reduced aggregation as compared to IL-11 stored in a composition with glycine and without said cryoprotectant.

__________ ]11[]21[

147639 ‫תהליך להכנת ניטרוקסי אלקיל–אסטרים‬ ‫של נפרוקסן וניטרוקסי אלקיל–אסטרים‬ ‫ואסטרים חדשים שמתקבלים בתהליך זה‬

]54[

PROCESS FOR THE PREPARATION OF NAPROXENE NITROXYALKYLESTERS AND NOVEL CORRESPONDING ESTERS PREPARED THEREBY

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

27.07.2000 MI99A001753 ]32[ 04.08.1999 ]33[ IT Int. Cl.(2008.04) C07B 41/12, 53/00, C07C 201/02, 203/04 NICOX S.A., FRANCE WO/2001/010814 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] A process for obtaining nitroxyalkylesters of the 2-(S)-(6-methoxy2-naphthyl)-propanoic acid having an enantiomeric excess higher than or equal to 97%, preferably higher than or equal to

228

98%, characterized in that a halide of the 2-(S)-(6-methoxy-2-naphthyl)-propanoic acid of formula A-Hal, wherein A is the acyl residue of acid, is reacted in an inert organic solvent with an aliphatic September 22, 2009

–‫ד' בתשרי התש"ע‬

nitroxyalkanol HO-Y-ONO2, wherein Y is as defined in the specification in the

presence of an inorganic base.

__________ ]11[]21[ ]54[

UNIT DOSE CAPSULES AND DRY POWDER INHALER

]22[ ]31[

21.07.2000 60/145464 ]32[ 23.07.1999 60/206123 22.05.2000 Int. Cl.(2008.04) A61M 15/00 MANNKIND CORPORATION, U.S.A. WO/2001/007107 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A dry powder inhaler comprising: an intake section (10), mechanically connected to a mixing section (30), the mixing section mechanically connected to a mouthpiece; wherein the intake section and mouthpiece each have a longitudinal

147724 ‫קופסיות יחידת מינון ומשאף אבקה יבשה‬

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ axis, and, in use, air flows through a passage extending from the intake section through the mixing section and through the mouthpiece; the dry powder inhaler further comprising means for regulating the flow rate of the air.

,188519

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ ]11[]21[ ]54[

MICROELECTROMECHANICAL OPTICAL SWITCH AND METHOD OF MANUFACTURE THEREOF

]22[

01.08.2000

September 22, 2009

–‫ד' בתשרי התש"ע‬

148039 ‫מתג אופטי מיקרואלקטרומכני ושיטה‬ ‫ליצורו‬

229

]31[ ]51[ ]71[ ]87[ ]74[

09/372265 ]32[ 11.08.1999 Int. Cl.(2008.04) B81B 7/00 ADC TELECOMMUNICATIONS, INC., U.S.A. WO/2001/011411 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

[57] A method of forming a mirror on a substrate, comprising: forming, over the substrate, a patterned masking layer covering a first region of the substrate and two side regions of the substrate each adjacent a side of the first region; removing uncovered portions of the substrate using the patterned masking layer to leave a first raised structure in the first

]33[

US

,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

substrate region and two sacrificial raised structures on each side substrate region adjacent the first raised structure; selectively removing the sacrificial raised structures while leaving the first raised structure intact; and forming a reflective surface on a sidewall of the first raised structure.

__________

]11[]21[ ]54[

230

THERAPEUTIC COMPOSITION COMPRISING A BINDING AGENT THAT BINDS MUC-1 ANTIGEN AND USE OF SAID BINDING AGENT

148165 ‫תכשיר תרפיוטי הכולל גורם קושר אנטיגן‬ ‫ ושימוש של גורם הקושר הנ''ל‬MUC– 1

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

18.08.2000 60/149492 ]32[ 18.08.1999 ]33[ US Int. Cl.(2008.04) A61K 39/00, 393/95, C07K 16/30 ALTAREX MEDICAL CORP., CANADA WO/2001/012217 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] A non-radiolabelled therapeutic composition comprising a binding agent that specifically binds to an epitope of tumor-associated MUC-1 and to both circulating and tumor-bound tumorassociated MUC-1 wherein the epitope

comprises an immunological determinant that includes carbohydrate and peptide, and wherein said binding agent is therapeutically effective in treating a mammal having a tumor that expresses a tumor-associated MUC-1.

__________ ]11[]21[

149173 ‫מוטנטים רקומבינטים מוחלשים של נגיף‬ ‫הכלבת ותרכיבי חיסון שהוכנו מהם‬

]54[

ATTENUATED RECOMBINANT RABIES VIRUS MUTANTS AND LIVE VACCINES THEREOF

]22[ ]31[

16.04.2002 01201464.3 ]32[ 23.04.2001 ]33[ NL 01203773.5 05.10.2001 NL Int. Cl.(2008.04) A61K 392/05, C12N 15/47, 7/01, 7/04 INTERVET INTERNATIONAL B.V., THE NETHERLANDS REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]74[

[57] Recombinant rabies virus mutant comprising a mutation in the G protein as well as a mutation in the P protein, wherein the mutation in the G protein is an amino acid substitution of the arginine at

position 333 for another amino acid and wherein the mutation in the P protein is a deletion of amino acids 143 to 149 or 139 to 149.

__________ ]11[]21[ ]54[

GENE MINING SYSTEM AND METHOD

September 22, 2009

–‫ד' בתשרי התש"ע‬

149294 ‫מערכת ושיטה להכוונת גנים למטרה‬

231

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

25.10.2000 60/161495 ]32[ 26.10.1999 ]33[ US Int. Cl.(2008.04) C12N 15/09, G06F 17/50, 19/00 BIOLOGICAL TARGETS, INC., U.S.A. WO/2001/031011 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] A method to design primers which identify and target a first nucleotide sequence wherein the expression of said first nucleotide sequence results in at least one phenotypic characteristic, the method comprising the steps of: providing a second nucleotide sequence that is known to result in the phenotypic characteristics wherein the first nucleotide sequence and second nucleotide sequence are derived from different species; comparing the second nucleotide sequence to nucleotide sequences catalogued in one or more databases that annotate nucleotide sequences with phenotypic characteristics; extracting any catalogued nucleotide sequences that contain a portion of the

second nucleotide sequence and which are annotated with said phenotypic characteristic; aligning the second nucleotide sequence to each extracted nucleotide sequence; prioritizing according to statistical analysis the extracted nucleotide sequences based on at least percent similarity with sequences having the highest percent similarity being highest in priority to ensure alignment to the second nucleotide sequence as determined by said statistical analysis; and designing one or more primers based on matching portions of the aligned prioritized sequences, which primers identify and target said first nucleotide sequence.

__________

]11[]21[ ]54[

BALLISTIC ARMOR

]22[ ]51[ ]71[ ]72[

12.05.2002 Int. Cl.(2008.04) F41H 5/04 PLASAN SASA MOSHE RAVID, YOAV

232

149591 ‫שריון בליסטי‬

‫ מרום הגליל‬.‫נ‬.‫ ד‬,‫פלסן סאסא‬ ‫ יואב הירשברג‬,‫משה רביד‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

]74[

HIRSCHBERG REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] A composite armor unit for providing ballistic protection from an impacting projectile threat, the unit comprising a ceramic body (32) having a cylindrical body portion (34) with two end faces, one of which is adapted to face said threat, and a non-ceramic belt member (36) preformed to have inner and outer

surfaces, and a hollow region defined by the inner surface and adapted to receive therein said ceramic body; said belt member being mounted on said ceramic body so that said member contiguously surrounds said cylindrical body portion without covering said one end face.

__________

]11[]21[ ]54[

N-[5-[[[5-ALKYL-2 OXAZOLYL] METHYL]THIO]-2-THIAZOLYL] CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]22[

07.12.2000

September 22, 2009

–‫ד' בתשרי התש"ע‬

149755 –2–‫–אלקיל‬N–]5–]]]–5 ‫תולדות‬ [‫–תיאזוליל‬2–[‫אוקסאזוליל[מתיל[תיו‬ ‫קרבוקסאמיד ותכשירי רוקחות המכילים‬ ‫אותן‬

233

]31[ ]51[ ]71[ ]87[ ]74[

[57]

09/464511 ]32[ 15.12.1999 ]33[ US 09/616627 26.07.2000 US Int. Cl.(2008.04) A61K 314/27, 314/54, A61P 35/00, C07D 417/00, 417/10, 417/14 BRISTOL-MYERS SQUIBB COMPANY, U.S.A. WO/2001/044242 WOLFF, BREGMAN AND GOLLER, ,‫ ברגמן וגולר‬,‫וולף‬ P.O.B. 1352, ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, JERUSALEM 91013 A compound of the formula

and enantiomers, diastereomers and pharmaceutically acceptable salts thereof wherein R is t-butyl; R1 is hydrogen or alkyl;

X is NR2 or CHNR2R3; R2 and R3 are each independently hydrogen, alkyl, substituted alkyl, cycloalkyl or substituted cycloalkyl; and n is 0, 1, 2 or 3.

__________ ]11[]21[ ]54[

LOCK

]22[ ]51[ ]71[

27.05.2002 Int. Cl.(2008.04) E05B 47/06 MUL-T-LOCK TECHNOLOGIES LTD. DEKEL PATENT LTD., 18 MENUHA VENAHALA ST., REHOVOT 76209

]74[

[57] A lock comprising: a body (10); a locking assembly (12) arranged for selectable locking engagement with respect to said body; a magnetic coupling assembly (54, 56) for retaining said locking assembly in a locked orientation notwithstanding at least one of vibration thereof and application of mechanical shocks thereto; wherein said locking assembly comprises a plug (18), defining a keyway (20), which is rotatably mounted within a bore (22) formed in said

234

149876 ‫מנעול‬

‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬ ,‫דקל פטנט בע"מ‬ ‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬ body, wherein said keyway communicates with locking pins in the plug, which in turn cooperate with locking pins in said body, to provide conventional key-operated locking of the plug relative to said body; a lockable assembly (34) disposed in a portion (24) of said plug, which is operative for selectable looking of said plug within said body, wherein said locking assembly comprises a housing (36) fixed within said plug and an actuator (38) disposed within said housing, said locking September 22, 2009

–‫ד' בתשרי התש"ע‬

assembly being operated by an electrical circuit (26), and wherein said actuator selectably rotatably positions a partially cut away cylindrical locking element (40); and a selectably positionable locking element (42) mounted on said housing which is normally urged into engagement

with a corresponding socket (46), and wherein said selectably positionable locking element is lockingly retained in engagement with said socket by suitable positioning of said cylindrical locking element by said actuator.

__________ ]11[]21[

150065 ‫תאי גזע או עובריים המיוצרים באמצעות‬ ‫השתלה גרעינית של מינים מוצלבים‬

]54[

EMBRYONIC OR STEM-LIKE CELLS PRODUCED BY CROSS SPECIES NUCLEAR TRANSPLANTATION

]22[ ]31[ ]51[ ]71[

10.05.2000 467076 ]32[ 20.12.1999 ]33[ US Int. Cl.(2008.04) C12N 15/08, 15/09, 15/87, 5/02, 5/10 UNIVERSITY OF MASSACHUSETTS, U.S.A. WO/2001/046401 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method of producing embryonic or stem-like cells comprising the following steps: (i) inserting a donor differentiated human or mammalian cell or cell nucleus into a recipient animal oocyte, wherein such oocyte is derived from a different animal species than the human or mammalian cell under conditions suitable for the formation of a nuclear transfer (NT) unit, wherein the endogenous oocyte nucleus is removed or September 22, 2009

–‫ד' בתשרי התש"ע‬

inactivated before, concurrent, or after introduction of donor cell or nucleus; (ii) activating the resultant nuclear transfer unit; (iii) additionally inserting into said oocyte cytoplasm derived from an oocyte or blastomere of the same species as the donor cell or nucleus ("compatible cytoplasm"); (iv) culturing said activated nuclear transfer unit until greater than the 2 cell developmental stage; and

235

(v) culturing cells obtained from said cultured NT units to obtain embryonic or

stem-like cells.

__________ ]11[]21[

150222 ‫תכשירי רוקחות המכילים מטבולית של‬ ‫גיפירון‬

]54[

PHARMACEUTICAL COMPOSITIONS CONTAINING A GEPIRONE METABOLITE

]22[ ]31[

18.12.2000 60/172684 ]32[ 20.12.1999 ]33[ US 09/709741 13.11.2000 US Int. Cl.(2008.04) A61K 314/96, A61P 25/00, C07D 401/00 FABRE-KRAMER PHARMACEUTICALS, INC., U.S.A. EDWARD H. RUEDIGER, CANADA JOSEPH P. YEVICH, U.S.A. WO/2001/045687 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

]51[ ]71[

]87[ ]74[

[57] The use of a gepirone metabolite, or pharmaceutically acceptable salt or hydrate thereof for the manufacture of a medicament for administration to a

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

mammal, wherein the gepirone metabolite is selected from the group consisting of 3OH gepirone and 3,5-dihydroxy gepirone.

__________

]11[]21[ ]54[

236

AGRICULTURAL OR HORTICULTURAL FUNGICIDAL COMPOSITIONS CONTAINING CYANOMETHYLENE COMPOUNDS, SOME SUCH NOVEL COMPOUNDS AND PROCESS FOR PREPARING THEM

150293 ‫תכשירים קוטלי פטריות לחקלאות או‬ ,‫לגננות המכילים תרכובות ציאנומתילן‬ ‫מספר תרכובות ציאנומתילן כאלו ותהליך‬ ‫להכנתן‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

05.09.2000 11/367615 ]32[ 24.12.1999 ]33[ JP Int. Cl.(2008.04) A01N 43/72, C07D 277/10, 277/22, 279/06, 281/02, 281/18, 291/08, 417/04, 417/12, 417/14, 419/04, 419/12, 419/14 OTSUKA CHEMICAL CO., LTD., JAPAN WO/2001/047902 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] A fungicidal composition, for use in agriculture and horticulture, comprising a cyanomethylene compound of the formula

wherein: A, R1, and R are as defined in the specification. Claimed as novel are the compounds of formula (1) wherein: R is phenyl, optionally substituted with at least one substituent selected from the group consisting of a halogen atom, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkylcarbonyl, C1-4 alkylthio and cyano; R1 is phenyl or pyridyl, the phenyl and the pyridyl

optionally substituted with at least one substituent selected from the group consisting of a halogen atom, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkoxycarbonyl, C1-4 alkylamino, di-C1-4 alkylamino, C2-4 alkenyl, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsufonyl, phenyl, phenoxy, nitro and cyano; A is C1-6 straight-chain or branched-chain alkylene; and Y is a sulfur atom.

__________ ]11[]21[

150481 ‫–אמינו– ניקוטינאמיד ושימושן‬2 ‫נגזרות של‬ ‫ של טירוזין‬VEGF– ‫כמעכבים של רצפטור‬ ‫קינאז‬

]54[

2-AMINO-NICOTINAMIDE DERIVATIVES AND THEIR USE AS VEGF-RECEPTOR TYROSINE KINASE INHIBITORS

]22[ ]31[ ]51[

25.01.2001 0001930.7 ]32[ 27.01.2000 ]33[ GB Int. Cl.(2008.04) A61K 314/35, A61P 35/00, C07D 213/78, 213/89, 401/12, 401/14, 417/12 NOVARTIS AG, SWITZERLAND

]71[

September 22, 2009

–‫ד' בתשרי התש"ע‬

237

]87[ ]74[

WO/2001/055114 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

[57] Use of a compound of the formula

wherein n is from 1 up to and including 6; W is O or S; R1 and R3 represent independently of each other hydrogen, lower alkyl or lower acyl; R2 represents cyclohexyl, phenyl, indazolyl, thiazolyl, benzo[d]thiazolyl, benzo[d] pyrazolyl or isoquinolinyl, which in each case is unsubstituted or mono-or disubstituted by C1-C7 alkyl, C1-C7 alkenyl or C1-C7 alkynyl, wherein each radical R2 can be unsubstituted or mono-or polysubstituted with halogen; R and R1 are

independently of each other hydrogen or lower alkyl; X represents phenyl, pyridyl, primidyl or quinolyl, which in each case is unsubstituted or mono-or polysubstituted by oxo, hydroxy, N-C1-C7 alkylcarbamoyl, C1-C7 alkyl or C1-C7 alkoxy; or of a N-oxide or a possible tautomer thereof; or of a pharmaceutically acceptable salt of such a compound for the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity.

__________

]11[]21[

150851 ‫אבקה מתכתית המכילה חנקן ותהליך‬ ‫להכנתה‬

]54[

NITROGEN CONTAINING METALLIC POWDER AND METHODS FOR THE PRODUCTION THEREOF

]22[ ]31[ ]51[ ]71[

22.07.2002 2000-31029 ]32[ 08.02.2000 ]33[ JP Int. Cl.(2008.04) B22F 9/24, C22C 1/04, H01G 90/52 CABOT SUPER METALS K.K.,

238

September 22, 2009

–‫ד' בתשרי התש"ע‬

]74[

JAPAN WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A nitrogen-containing metallic powder consisting essentially of tantalum containing 50-20,000 ppm nitrogen in a form of solid solution, and optionally containing phosphorus, boron, oxygen, or combinations thereof, and wherein

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, substantially all of any nitrogen present in said nitrogen-containing metallic powder is in the form of solid solution, and said nitrogen-containing metallic powder has a mean particle size of 80 to 360 nm.

__________ ]11[]21[ ]54[

METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR PROVIDING SECURITY OF JAVA OBJECTS

]22[ ]51[ ]71[ ]74[

28.07.2002 Int. Cl.(2008.04) G06F 21/22 YURY BENDERSKY YURY BENDERSKY, 4 MATA ST., OFRA 90627

[57] A method for a secure authentication of a Java object (as a client) via a Java virtual machine and a web browser and a web server or a local computer (as a server), the method comprising the steps of: loading a Java class file for the client from the server (from the web site or from the local file system) to a byte array; defining the Java class from the loaded byte array; starting the Java client object; calculation of the secure authentication ID (digest) of the said Java object, comprising in its turn the calculation of: the digest of

September 22, 2009

–‫ד' בתשרי התש"ע‬

150933 ‫ ומוצר תוכנת מחשב‬,‫ מכשיר‬,‫שיטה‬ ‫לאספקת אבטחה של עצמים של ג'ווא‬

‫ עופרה‬,‫יורי בנדרסקי‬ ,‫יורי בנדרסקי‬ ‫ עופרה‬,4‫מטע‬ the said Java object itself via reflection of the said Java object as well as the serialization of the said Java object (parsing and analysis of the Java class file); the digests of the external objects, including the system ClassLoader, the JVM parameters, and the digests of the calling Java objects (if any); and, finally, the calculation of the general digest of the aforementioned entities; creating the secure connection between the Java client and the server; and approving the secure authentication ID by the server.

239

__________ ]11[]21[

151695 ‫בטא–קרבולינים מותמרים בעלי פעילות‬ ‫–קינאז‬IKB ‫מעכבת‬

]54[

SUBSTITUTED BETACARBOLINES WITH IKB-KINASE INHIBITING ACTIVITY

]22[ ]31[

28.02.2001 00105514.4 ]32[ 15.03.2000 ]33[ EP 00125169.3 18.11.2000 EP Int. Cl.(2008.04) A61K 31/44, A61P 29/00, C07D 471/04, 498/12 SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2001/068648 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]51[ ]71[ ]87[ ]74[

[57] A compound of the formula

240

September 22, 2009

–‫ד' בתשרי התש"ע‬

or a stereoisomeric form of a compound of the formula I or a physiologically tolerable salt of a compound of the formula I, where B6, B7, B8 and B9 are ring atoms independently chosen from carbon atoms and nitrogen atoms, where B6, B7, B8 and B9 together comprise not more than two nitrogen atoms; wherein in case (a) the substituents R1, R2 and R3 may be independently chosen from: (1.1) hydrogen atom, (1.2) halogen, (1.3) –CN, (1.4) –COOH, (1.5) –NO2, (1.6) –NH2, (1.7) –O-(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono- to pentasubstituted by substituents independently chosen from: 1.7.1 phenyl, which is unsubstituted or mono-to penta-substituted by substituents indepdenently chosen from halogen or –O(C1-C4)-alkyl, 1.7.2 halogen, 1.7.3 –NH2, 1.7.4 –OH, 1.7.5 –COOR16, wherein R16 is hydrogen atom or –(C1-C10)-alkyl, 1.7.6 –NO2, 1.7.7 –S(O)y –R14, wherein y is zero, 1 or 2, R14 is –(C1-C10)-alkyl, phenyl, which phenyl is unsubstituted or mono- to pentasubstituted by substituents independently chosen from those defined under 1.7.1 to 1.7.11, amino or –N(R13)2, wherein R13 is independently of one another chosen from hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, -C(O)NH-phenyl, -C(O)-O-(C1-C7)-alkyl, -S(O)y –R14, wherein R14 and y are as defined in 1.7.7, and wherein the R13 alkyl or phenyl groups in each case are unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11, or R13 together with the nitrogen atom to which it is bonded may be independently chosen to September 22, 2009

–‫ד' בתשרי התש"ע‬

form a heterocycle having 5 to 7 ring atoms, 1.7.8 –O-phenyl, wherein phenyl is unsubstituted or mono- to pentasubstituted independently of one another as defined under 1.7.1 to 1.7.11, 1.7.9 a radical selected from pyrrolidine, tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan, morpholine, pyridine, pyridazine, pyrazine, oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine, 1.7.10 –(C3-C7) – cycloalkyl or 1.7.11=O, (1.8) –N(R13)2, wherein R13 is as defined in 1.7.7 above, (1.9) –NH-C(O)-R, wherein R15 is 1.9.1 a radical selected from pyrrolidine, tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan, morpholine, pyridine, pyridazine, pyrazine, oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine, wherein said radical is unsubstituted or mono-to penta-substituted by substituents independently chosen from as defined under 1.7.1 to 1.7.11 above, by –CF3, by benzyl or by –(C1-C10)-alkyl, wherein the – (C1-C10) – alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 1.9.2 –(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono-to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above or by –O-(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 1.9.3-(C3-C7)-cycloalkyl, 1.9.4-N(R13)2, wherein R13 is as defined in 1.7.7 above, or 1.9.5 phenyl, wherein phenyl is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, by –O-(C1-C10)-alkyl, by –CN, by –

241

CF3, by –(C1-C10)-alkyl, wherein alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, or by two substituents of said phenyl which form a dioxolan ring, (1.10) –S(O)y-R14, wherein R14 and y are as defined in 1.7.7 above, (1.11) –O(O)-R12, wherein R12 is phenyl or –(C1-C7)-alkyl, wherein alkyl or phenyl are unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, (1.12) –O(O)-O-R12, wherein R12 is as defined in 1.11 above, (1.13) –(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono- to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, (1.14) –O-(C1-C6)-alkyl-O- (C1-C6)-alkyl, (1.15)-O-(C0-C4)-alkyl-(C3-C7)-cycloalkyl, (1.16)-(C1-C4)-alkyl-N(R13)2, wherein R13 is as defined in 1.7.7 above (1.17)-CF3 or (1.18) –CF2-CF3, R4 is (1) –(C1-C10)-alkyl, wherein alkyl is monoto penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.10 above, (2)-CF3, (3)-CF2-CF3, (4)-CN, (5)-S(O)y-R14, wherein R14 and y are as defined in 1.7.7 above, (6)-NH2, (7) –O-(C1-C10)-alkyl, wherein alkyl is mono-to penta-substituted by substituents independently chosen from 7.1 phenyl, which is unsubstituted or mono-to pentasubstituted by substituents independently chosen from halogen or –O-(C1-C4)-alkyl, 7.2 halogen, 7.3 –NH2, 7.4-OH,

242

7.5-COOR16, wherein R16 is hydrogen atom or –(C1-C10)-alkyl, 7.6 –NO2, 7.7-S(O)y-R14, wherein y is zero, 1 or 2, R14 is –(C1-C10)-alkyl, phenyl, which phenyl is unsubstituted or mono- to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11, amino or wherein R13 is independently of one another chosen from hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, - C(O)NH-(C1-C7)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl,-C(O)-O-(C1-C7)-alkyl, -S(O)yR14, wherein R14 and y are defined as in 7.7 above, and wherein the R13 alkyl or phenyl groups in each case are unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, or R13 together with the nitrogen atom to which it is bonded form a heterocycle having 5 to 7 ring atoms 7.8O-phenyol, wherein phenyl is unsubsituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 7.9 a radical selected from pyrrolidine, tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan, morpholine, pyridine, pyridazine, pyrazine, oxolan, isoxazolidine, thiophene, 2isoxazoline, isothiazolidine, 2isothiazoline, or thiomorpholine, 7.10-(C3C7)-cycloalkyl or 7.11=O, (8) –N(R17)2, wherein R17 is independently of one another chosen from hydrogen atom, phenyl, -(C1-C10)-alkyl, -C(O)phenyl, -C(O)-NH-(C1-C7)-alkyl, -C(O)(C1-C10)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl, -C(O)-O-(C1-C7)-alkyl, S(O)y-R14, wherein R14 and y are as defined as in 7.7 above, and wherein alkyl or phenyl in each case are unsubstituted or mono-to penta-substituted independently of one another as defined under 1.7.1 to September 22, 2009

–‫ד' בתשרי התש"ע‬

1.7.11 above, or R17 together with the nitrogen atom to which it is bonded form a heterocycle having 5 to 7 ring atoms, (9)-NH-C(O)-R15, wherein R15 is 9.1 a radical selected from pyrrolidine, tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan, morpholine, pyridine, pyridazine, pyrazine, oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine, wherein said radical is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, -CF3, benzyl or by –(C1-C10)-alkyl, wherein alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 9.2 –(C1-C10)-alkyl, wherein alkyl is mono- to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above or by – O-(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 9.3-(C3-C7)-cycloalkyl, 9.4-N(R13)2, wherein R13 is as defined in 1.7.7 above provided that – N(R13)2 is not –NH2, or 9.5 phenyl, wherein phenyl is unsubstituted or mono- to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, by –O-(C1-C10)-alkyl, by – CN, by –CF3, by –(C1-C10)-alkyl, wherein alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, or by two substituents of the phenyl radical which form a dioxolan ring, (10) –O(O)-R12, wherein R12 is phenyl or – (C1-C7)-alkyl, wherein phenyl or alkyl are mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, September 22, 2009

–‫ד' בתשרי התש"ע‬

(11)-O(O)-O-R12, wherein R12 is phenyl or –(C1-C7)-alkyl, wherein phenyl or alkyl are mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, (12) –O-(C1-C6)-alkyl-O-(C1-C6)-alkyl, (13) –O-(C0-C4)-alkyl-(C3-C7)-cycloalkyl or (14) –(C1-C4)-alkyl-N(R13)2, wherein R13 is as defined in 1.7.7 above, R5 is (1) a hydrogen atom, (2) –(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.4 above, (3) –C(O)-R9, wherein R9 is -NH2, -(C1-C10)-alkyl, wherein alkyl is unsubsituted or mono-to penta-substituted by substituents independently chosen from those as defined under 7.1 to 7.4, or – N(R13)2, wherein R13 is as defined in 1.7.7 above, or (4) –S(O)2-R9, wherein R9 is as defined in 3 above, or R4 and R5 together with the atom to which they are bonded form a heterocycle, or R3 and R5 together with the atom to which they are bonded form a heterocycle containing an additional oxygen atom in the ring and R6, R7 and R8 independently of one another are chosen from hydrogen atom or methyl, or in case (b) the substituents R1, R2 and R4 may be independently chosen as defined under 1.1 to 1.18 in case (a) above, R3 is (1)-CF3, (2)-CF2-CF3, (3)-CN, (4)-COOH, (5)-NO2, (6)-NH2, (7)-O-(C1-C10)-alkyl, wherein alkyl is mono-to penta substituted by substituents independently chosen from 7.1 phenyl, which is unsubstituted or mono-to penta-substituted by substituents

243

independently chosen from halogen or –O(C1-C4)-alkyl, 7.2 halogen, 7.3 –NH2, 7.4 – OH, 7.5 – COOR16, wherein R16 is hydrogen atom or –(C1-C10)-alkyl, 7.6 – NO2, 7.7 – S(O)y – R14, wherein y is zero, 1 or 2, R14 is –(C1-C10)-alkyl, phenyl, which phenyl is unsubstituted or mono-to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11, amino or wherein R13 is independently of one another chosen from hydrogen atom, phenyl, -(C1-C10)-alkyl, C(O)-(C1-C7)-alkyl, -C(O)-phenyl, - C(O)NH-(C1-C7)-alkyl, -C(O)-O-phenyl, -C(O)NH-phenyl, - C(O)-O-(C1-C7)-alkyl, S(O)y –R14, wherein R14 and y are defined as in 7.7 above, and wherein the R13 alkyl or phenyl groups in each case are unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, or R13 together with the nitrogen atom to which it is bonded form a heterocycle having 5 to 7 ring atoms, 7.8 – O-phenyl, wherein phenyl is unsubsituted or mono-to penta-by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 7.9 a radical selected from tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan, morpholine, pyridine, pyridazine, pyrazine, oxolan, isoxazolidine, 2-isoxazoline, isothiazolidine, 2-isothiazoline, thiophene or thiomorpholine, 7.10 – (C3-C7)-cycloalkyl or 7.11=O, (8)-N(R13)2, wherein R13 is as defined in 1.7.7 above, (9)-NH-C(O)-R15, wherein R15 is 9.1 a radical selected from pyrrolidine, tetrahydropyridine, piperidine, piperazine, imidazoline, pyrazolidine, furan,

244

morpholine, pyridine, pyridazine, pyrazine, oxolan, imidazoline, isoxazolidine, 2isoxazoline, isothiazolidine, 2isothiazoline, thiophene or thiomorpholine, wherein said radical is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, -CF3, benzyl or by –(C1-C10)-alkyl, wherein alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 9.2 –(C1-C10)-alkyl, wherein alkyl is unsubsituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above or by –O-(C1-C10)-alkyl, wherein alkyl is unsubstituted or mono-to pentasubstituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, 9.3-(C3-C7)-cycloalkyl, 9.4-N(R13)2, wherein R13 is as defined in 1.7.7 above, or 9.5 phenyl, wherein phenyl is unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, by –O-(C1-C10)-alkyl, by –CN, by CF3, by –(C1-C10)-alkyl, wherein alkyl is mono to tri-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, or by two substituents of the phenyl radical which form a dioxolan ring, (10)-S(O)y-R14, wherein R14 and y are as defined in 1.7.7 above, (11)-C(O)-R12, wherein R12 is phenyl or – (C1-C7)-alkyl, wherein phenyl or alkyl are unsubstituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, (12) –O(O)-O-R12, wherein R12 is phenyl or –(C1-C7)-alkyl, wherein phenyl or alkyl are unsubstituted or mono-to pentasubstituted by substituents independently September 22, 2009

–‫ד' בתשרי התש"ע‬

chosen from those as defined under 1.7.1 to 1.7.11 above, (13)-(C1-C10)-alkyl, wherein alkyl is unsubsituted or mono-to penta-substituted by substituents independently chosen from those as defined under 1.7.1 to 1.7.11 above, (14)-O-(C1-C6)-alkyl-O-(C1-C6)-alkyl, (15)-O-(C0-C4)-alkyl-(C3-C4)-cycloalkyl or (16)-(C1-C4)-alkyl-N(R13)2, wherein R13 is as defined in 1.7.7 above, R5 is as defined as R5 in a case (a) above,

R6, R7 and R8 independently of one another are chosen from hydrogen atom or methyl, with the following provisos for case (b): when R6 is methyl, R3 is not an O-(C1C10)-alkyl monosubstituted by either an unsubstituted phenyl or a –COO-(C1-C10)alkyl; and when R3 is an O-(C1-C10)-alkyl monosubstituted by a –(C3-C7)-cycloalkyl, R6 is hydrogen.

__________ ]11[]21[ ]54[

POLISHING AGENT AND METHOD FOR PRODUCING PLANAR LAYERS

]22[ ]31[

19.03.2001 10016020.4 ]32[ 31.03.2000 10063870.8 21.12.2000 Int. Cl.(2008.04) C09G 1/00 BAYER AKTIENGESELLSCHAFT, GERMANY WO/2001/074958 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

151794 ‫גורם להברקה ושיטה ליצור שכבות‬ ‫מישוריות‬

]33[

DE DE

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] A polishing abrasive containing (b) 95 to 5% by weight silica particles of a spherical, discrete silica particles which size from 50 to 200 nm, are not linked to one another via bonds, with the proviso that the total set of characterized in that the polishing abrasive particles has a bimodal particle size contains: (a) 5 to 95% by weight silica distribution. particles of a size from 5 to 50 nm, and __________ ]11[]21[ 152200 ]54[

METHOD FOR IDENTIFYING A PERSON AMONG A POPULATION BY SENSING HIS FINGERPRINTS

]22[ ]31[ ]51[

13.06.2001 00/07707 ]32[ 16.06.2000 Int. Cl.(2008.04) A61B 51/17

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שיטה לזיהוי בן–אדם בקהל באמצעות‬ ‫חישה של טביעת האצבעות שלו‬

]33[

FR

245

]71[ ]87[ ]74[

SAGEM SECURITE, FRANCE WO/2001/095804 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A method for identifying a person among a population, by sensing the fingerprints of at least one finger of the hand of said person and comparing said sensed fingerprints with information of fingerprints of said person previously stored in a file, in which process: by a previous registration step, the shape of the least one hand and fingerprints of at least one finger of the hand of all the persons of the population are sensed, the hand shape information is stored in said file in correlation with at least the respective fingerprint information, and in said file a secondary file is created which includes

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

groups of substantially identical hand shapes; then, by a later step of identification of one person belonging to the population; the shape of the hand of the person is sensed at the same time as the fingerprints of at least one of his/her fingers are sensed; a group consisting of the hand shapes substantially identical to the sensed hand shape of the person to be identified is selected from said secondary file; and finally, the sensed fingerprints of the finger of the person to be identified are compared with the fingerprint information stored in said secondary file of only the persons of said selected group.

__________

]11[]21[

152269 ‫מבנה טקסטיל לא ארוג הכולל מכלולי‬ ‫סיבים מיוצבים‬

]54[

NON WOVEN TEXTILE STRUCTURE INCORPORATING STABILIZED FILAMENT ASSEMBLIES

]22[ ]51[

18.04.2000 Int. Cl.(2008.04) B32B 5/26, D02G 1/00, 3/00, D04H 13/00, 3/04, 3/07, 3/10, 3/14

246

September 22, 2009

–‫ד' בתשרי התש"ע‬

]71[ ]72[ ]87[ ]74[

VLIESSTOFF-TECHNOLOGIE IN 3. DIMENSION KG, GERMANY GEORG MARTIN BARTH, EDMUND HUGH CARUS WO/2000/063479 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

[57] A method of producing a non-woven textile structure comprising the steps of: initial consolidation of a plurality of substantially parallel continuous filaments to provide a partially stabilized filament assembly (10); further constraining said

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ filament assembly by a folding, bundling, twisting or intertwining operation; and bonding a spaced array of such resulting constrained filament assemblies to a carrier layer (12, 14).

__________

]11[]21[

152287 ,‫תולדות של חומצת גרעין פוליאמידית‬ ‫תכשירים ושיטות להכנתם‬

]54[

POLYAMIDE NUCLEIC ACID DERIVATIVES AND AGENTS AND METHODS FOR PRODUCING THE SAME

]22[ ]31[ ]51[

07.04.2001 10019136.3 ]32[ 18.04.2000 ]33[ DE Int. Cl.(2008.04) A61K 38/04, 48/00, A61P 31/04, 31/10, 35/00, 9/00, C07F 9/09, 9/24, 9/40, 95/47, C07H 21/00, C07K 14/00, C12Q 1/68, G01N 33/53

September 22, 2009

–‫ד' בתשרי התש"ע‬

247

]71[ ]87[ ]74[

SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2001/079249 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬

[57] Polyamide nucleic acid (PNA) derivative of the formula

where V is oxygen, sulfur, NR1, a group U(CR3R4)u'-CH2-C(O)-NH or a group U(CH2CH2O)u'-C(O)NH, U is, independently of each other, oxygen, sulfur or NH, u' is, independently of each other, from 1 to 10, preferably from 1 to 4, particularly preferably 1, W is, independently of each other, oxygen, sulfur or NR1, Y is, independently of each other, hydroxyl, mercapto, oxyanion, thioate or NR1R2, R1 and R2 are, independently of each other, a radical consisting of hydrogen or C1-C6alkyl, preferably hydrogen, R3 and R4 are, independently of each other, a radical consisting of hydrogen or C1-C6alkyl, or the radical of an amino acid side chain, preferably hydrogen, X is, independently of each other, a group U-(C2-C22-alkanediyl)-U or a group U(CH2CH2-O)u', or X is a bifunctional labeling group, preferably selected from the group consisting of fluorescein, rhodamine, TAMRA, biotin, pyrene, dinitrophenyl,

248

acridine, cyanine dye, Dabcyl, digoxygenin or Edans derivative, particularly preferably a biotin dertivative, or X is a bifunctional group for crosslinking with complementary nucleic acids, preferably a psoralen derivative, or X is a bifunctional group which promotes intracellular uptake, preferably selected from the group consisting of cholesteryl, adamantyl and vitamin E derivatives, or X is a bifunctional group which increases the binding affinity of the PNA derivative for a target nucleic acid, preferably acridine and lexitropsin derivatives, Z is hydroxyl, mercapto, oxyanion, thioate, or NR1R2, C1-C22-alkyl, C1-C8-arylalkyl, C1-C22-alkyl-U, C1-C8-arylalkyl-U, hydroxy-C1-C18-U, aminoalkyl-U, arylalkyl-U or mercaptoalkyl-U, or a group of the formula R9(CH2CH2-O)m, where R9 is hydroxyl, amino or C1-C22-alkoxy, and m is from 1 to 100, preferably from 2 to 10, or Z is a monofunctional or bifunctional labeling group, preferably selected from the group consisting of fluorescein, rhodamine, TAMRA, biotin, pyrene, dinitrophenyl, acridine, cyanine dye, Dabcyl, digoxygenin or Edans September 22, 2009

–‫ד' בתשרי התש"ע‬

derivatives, particularly preferably a biotin derivative, or Z is a monofunctional or bifunctional crosslinking group, preferably a psoralen derivative, or Z is a monofunctional or bifunctional group which promotes intracellular uptake, preferably selected from the group consisting of cholesteryl, adamantyl and vitamin E derivatives, or Z is a monofunctional or bifunctional group

which promotes the binding affinity of the PNA derivative for a target nucleic acid, preferably a lexitropsin derivative, n is from 0 to 10, preferably from 0 to 3, Q is hydroxyl, amino, NHR7, NR7R8, an amino acid derivative or a peptide radical, R7 and R8 are, independently of each other, C1C18-alkyl or hydroxyl-C1-C18-alkyl, and where {POLY} is described by the formula

where {BLOCK} is, independently of each other, either described by the formula

or the formula

or the formulae

September 22, 2009

–‫ד' בתשרי התש"ע‬

249

where each building block {BLOCK} can be different, and where it furthermore applies that z' is from 0 to 100, preferably 1-20, particularly preferably 4-15, A is, independently of each other, a group (CR1R2)s, where s is from 1 to 3, preferably 1, B is, independently of each other, either an aromatic radical, which can also possess heteroaromatic character, or hydrogen, or hydroxyl or C1-C18-alkyl, or a nucleobase which occurs naturally, and is customary in nucleotide chemistry, or which does not occur naturally, where at least one B radical is a nucleobase, D is, independently of each other, a group (CR3R4)t, where t is

from 2 to 10, preferably from 2 to 4, particularly preferably 2, where two adjacent R3 and R4 radicals can also form a C5-C8-cycloalkyl ring, E is, independently of each other, a group (CR5R6)u', where two adjacent R5 and R6 radicals can also form a C5-C8-cycloalkyl ring or a spiro compound, R5 and R6 are, independently of each other, a radical consisting of hydrogen or C1-C6alkyl, preferably hydrogen, or an amino acid side chain, and also physiologically tolerated salts of the PNA derivative of the formula l, with the proviso that at least one Y or Z radical is hydroxyl, mercapto, oxyanion or thioate.

__________

]11[]21[

152352 ‫–אמינים ביציקלים‬3–‫מלחים של אימידזו‬ ‫–אמינים ביציקלים שעברו‬5–‫ואימידזו‬ ‫אצילציה בחנקן‬

]54[

SALTS OF BICYCLIC, NACYLATED IMIDAZO-3-AMINES AND IMIDAZO-5-AMINES

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

03.04.2001 10019714.0 ]32[ 20.04.2000 ]33[ DE Int. Cl.(2008.04) A61K 314/16, 314/353, 314/95, C07D 471/04, 487/04, 513/04 GRUNENTHAL GMBH, GERMANY WO/2001/081344 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬

250

September 22, 2009

–‫ד' בתשרי התש"ע‬

26A HABARZEL ST., RAMAT HACHAYAL 69710

‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] A salt of a bicyclic, N-acylated imidazo-3-amine or an imidazo-5-amine of the formula

wherein R1 is tert-butyl; 1,1,3,3-tetramethylbutyl; (CH.2)nCN where n=4, 5 or 6; optionally substituted phenyl; C4-C8 cycloalkyl; CH2CH2R where R=4-morpholino; or CH2Ra, wherein Ra represents hydrogen; straight or branched C1-C8 alkyl; optionally substituted phenyl; CO(OR') where R'=straight or branched C1-C8 alkyl; PO(OR")2 where R"=straight or branched C1-C4 alkyl; or Si(RxRyRz) where Rx, Ry, and Rz each independently is straight or branched C1-C4 alkyl, C4-C8 cycloalkyl or phenyl, R2 is hydrogen; CORb, wherein Rb is straight or branched C1-C8 alkyl; straight or branched C1-C8 alkoxy; C3-C8 cycloalkyl; CH2CH2CO(OR') where R'=straight or branched C1-C4 alkyl; adamantyl; optionally substituted phenyl; benzyloxy; optionally substituted 1naphthyl or 2-naphthyl or respectively

September 22, 2009

–‫ד' בתשרי התש"ע‬

optionally substituted 2-pyridyl, 3-pyridyl, 4-pyridyl, thiazolyl or furyl; CH2Rc, wherein Rc is hydrogen, straight or branched C1-C8 alkyl or optionally substituted phenyl; CH2CH2Rd, wherein Rd is optionally substituted phenyl; or CONHRe, wherein Re is branched or straight C1-C8 alkyl; aryl; heteroaryl; C3-C8 cycloalkyl or an aryl bound via a C1-C3 alkylene group, heteroaryl or C3-C8 cycloalkyl radical, R3 is straight or branched C1-C8 alkyl; C3-C8 cycloalkyl; optionally substituted phenyl; optionally substituted 1-naphthyl; 2-naphthyl; quinoline; anthracene; phenanthrene; benzothiophene; benzofurfuryl; optionally substituted pyrrole; 2-, 3- or 4-pyridyl; optionally substituted furfuryl; or optionally substituted thiophene, A is a four-membered ring fragment of the formula:

251

wherein R4, R5, R6 and R7 each independently is hydrogen; straight or branched C1-C8 alkyl; fluorine; chlorine; bromine; CF3; CN; NO2; NHRf, wherein Rf represents hydrogen; straight or branched C1-C8 alkyl; or COR'" wherein R'"=straight or branched C1-C4 alkyl or optionally substituted phenyl; SRg, wherein Rg represents hydrogen, straight or branched C1-C4 alkyl, optionally substituted phenyl, optionally substituted pyridine, optionally substituted benzyl, or optionally substituted fluorenyl; ORh, wherein Rh represnts hydrogen; straight or branched C1-C8 alkyl; COR'" where R'"=straight or branched C1-C4 alkyl or optionally substituted phenyl; or

CO(OR') wherein R'=straight or branched C1-C8 alkyl; CO(ORi) or CH2CO(ORi), wherein Ri is branched or straight C1-C8 alkyl, or optionally substituted phenyl; or R6 and R7 together represent a ring fragment –CRi=CRj-CH=CH-, wherein Ri and Rj each represents hydrogen, or one of Ri and R1 is not hydrogen and represents F, Cl, Br, I or straight or branched C1-C8 alkyl, whereas R4 and R5 independently thereof have the meaning given above, R8 is branched or straight C1-C8 alkyl; aryl, heteroaryl; C3-C8 cycloalkyl; or an aryl bound by a C1-C3 alkylene group, heteroaryl or C3-C8 cycloalkyl radical, and X represents an anion of an inorganic or organic acid.

__________ ]11[]21[

152574

]54[

TRANSDERMAL DELIVERY SYSTEM FOR DRIED PARTICULATE OR LYOPHILIZED MEDICATIONS

]22[ ]51[ ]71[ ]74[

31.10.2002 Int. Cl.(2008.04) A61M 37/00, A61N 1/30 TRANSPHARMA MEDICAL LTD. WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121

[57] A system for transdermal delivery of a dried pharmaceutical composition, comprising: an apparatus for facilitating transdermal delivery of a drug through skin of a subject, said apparatus capable of

‫מערכת להולכה דרך העור של פריטים‬ ‫יבשים או תרופות מיובשות‬

‫ לוד‬,‫טראנספארמה מדיקל בע"מ‬ ,'‫ד"ר וב ושות‬ ‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬ generating at least one micro-channel in an area on the skin of the subject, and a patch comprising a therapeutically effective amount of the dried pharmaceutical composition.

__________ ]11[]21[ ]54[

252

MEDIUM CRACKING PRESSURE VALVE ARRANGEMENT

152694 ‫סידור ווסת בעל לחץ פתיחה בינוני‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

07.06.2001 00113777.7 ]32[ 29.06.2000 Int. Cl.(2008.04) A61M 39/24 SOCIETE DES PRODUITS NESTLE S.A., SWITZERLAND WO/2002/000291 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063

[57] A valve arrangement which is suitable for use with a peristaltic pump and which is capable of allowing flow of fluid in a first direction and capable of preventing flow of fluid in a second direction, wherein the valve arrangement comprises a valve having a cracking pressure of about 0.10 to about 0.20 bar,

]33[

EP

,‫ד"ר יצחק הס ושותפיו‬ ‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬

characterized in that the valve comprises a flexible membrane which is deformable under pressure in a desired flow direction, the flexible membrane including normally closed perforations therethrough which are configured to open at a selected extent of deformation of the flexible membrane to permit flow through said membrane.

__________

]11[]21[ ]54[

]22[ ]31[ ]51[ ]71[

152795 ‫–קומארונים‬2 ‫–קומארון ו‬2 ‫שיטה ליצור‬ ‫מותמרים‬

METHOD FOR THE PRODUCTION OF 2COUMARONE AND SUBSTITUTED 2-COUMARONES

09.05.2001 A983/2000 ]32[ 06.06.2000 Int. Cl.(2008.04) C07D 307/00, 307/83 DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG, AUSTRIA ]87[ WO/2001/094329 ]74[ REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., September 22, 2009 –‫ד' בתשרי התש"ע‬

]33[

AT

,‫ריינהולד כהן ושותפיו‬

253

‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

RAMAT HACHAYAL 69710 [57] A process for preparing 2coumarone or substituted 2-coumarones,

characterized in that cyclohexanone or substituted cyclohexanones of the formula

where R is H or a C1-C3-alkyl or alkoxy radical, are reacted with a carboxylic acylating agent of the formula

where R1 and R2 are each independently hydrogen or a C1-C3-alkyl radical and R3 is a C1-C3-alkyl radical, (a) to give alkyl 2-(2-oxocyclohexyl)-2hydroxyacetate or substituted alkyl 2-(2oxocyclohexyl)-2-hydroxyacetates which (a1) are either converted directly to 2coumarone or substituted 2-coumarones by catalytic gas phase dehydrogenation, or (a2) dehydrated by azeotropic distillation using an acid or an acidic ion exchanger to give a mixture of alkyl 2oxocyclohexylideneacetate and the enol lactone of 2-oxocyclohexylideneacetic acid or a mixture of substituted alkyl 2oxocyclohexylideneacetate and the enol

lactone of the substituted 2oxocyclohexylideeacetic acid which is then in turn converted by catalytic gas phase dehydrogenation into 2-coumarone or substituted 2-coumarones, or (b) reacted directly under acidic conditions to give a mixture of alkyl 2oxocyclohexylideneacetate and the enol lactone of 2-oxocyclohexylideneacetic acid or a mixture of substituted alkyl 2oxocyclohexylideneacetate and the enol lactone of the substituted 2oxocyclohexylideneacetic acid which is then in turn converted by catalytic gas phase dehydrogenation to 2-coumarone or substituted 2-coumarones.

__________ ]11[]21[ ]54[

METHOD AND APPARATUS FOR TREATING THE TEATS OF AN ANIMAL

]22[

17.05.2001

254

152960 ‫שיטה והתקן לטיפול בפטמות של בעלי‬ ‫חיים‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]31[ ]51[ ]71[ ]87[ ]74[

00305277.6 ]32[ 22.06.2000 Int. Cl.(2008.04) A01J 7/04 DELAVAL HOLDING AB, SWEDEN WO/2001/097603 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An apparatus for applying topical composition to at least a part of an udder, in particular a teat, of an animal, comprising a robot arm and at least one composition applying member positionable by the robot arm for applying the topical composition to the teat, characterised in that different topical composition are applicable by the at least one composition

]33[

EP

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

applying member, and a control device is arranged to control the robot arm and the at least one composition applying member for one of the topical compositions selected in accordance with information relating the skin health condition of an animal teat and/or climatic conditions of the animal environment to be applied to the teat.

__________ ]11[]21[

153172 ‫ התקן ונהלים לעיצוב לבקרה‬,‫שיטה‬ ‫ מערכות מרובות‬LTI ‫באמצעות משוב‬ ‫קלט מרובות פלט התלויות במשתנים‬

]54[

METHOD, APPARATUS AND DESIGN PROCEDURE FOR CONTROLLING MULTI-INPUT, MULTI-OUTPUT (MIMO) PARAMETER DEPENDENT SYSTEMS USING FEEDBACK LTI`ZATION

]22[ ]31[ ]51[

30.05.2001 09/580587 ]32[ 30.05.2000 ]33[ US Int. Cl.(2008.04) B64C 13/00, 13/18, G05B 11/32, 13/02, 13/04, G05D 1/08, G06F 17/50 ATHENA TECHNOLOGIES, INC.,

]71[

September 22, 2009

–‫ד' בתשרי התש"ע‬

255

]87[ ]74[

U.S.A. WO/2001/092972 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A method of designing vehicle control laws using multi-input, multioutput feedback LTIzation, said method comprising the following steps: determining co-ordinates for vehicle equations of motion; transforming the coordinates for the vehicle equations of motion into a multi-input linear time

The applications for division from this application have not yet been published

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

invariant system; establishing vehicle control laws yielding the transformed equations of motion linear time invariant; adjusting the vehicle control laws to obtain a desired closed loop behaviour for the controlled system; and converting the transformed co-ordinates vehicle control laws to physical co-ordinates.

,190441

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_______ ]11[]21[

153420 ‫שיטה והתקן להערכת הספק שידור‬ ‫ליחידות קצה במערכת סלולארית‬

]54[

METHOD AND APPARATUS FOR ESTIMATING TRANSMISSION POWER TO SUBSCRIBER UNITS IN A CELLULAR SYSTEM

]22[ ]51[ ]71[

12.12.2002 Int. Cl.(2008.04) H04B 17/07, H04Q 7/20, 7/28 FAZAN COMMUNICATIONS LLC, U.S.A. AHARON SHAPIRA ‫אהרון שפירא‬ EITAN MEHULAL LAW GROUP, ‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ 10 ABBA EBEN BLVD., ,‫פטנטים‬ P.O. B. 2081, ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬ September 22, 2009 –‫ד' בתשרי התש"ע‬

]72[ ]74[

256

HERZLIYA 46120 [57] In a cellular radio system that transmits data from an IP-based network, through a base station controller (BSC) and any Base Station Transceiver (BTS) controlled by the BSC, to a plurality of active subscriber units, which are in radio communication with the BTS and in a data connection state, the data transmission from the BTS to any active subscriber unit at any time being at one of a plurality of given transmission rates and at a defined power level, relative to a maximum total power transmittable by the corresponding BTS; the power level is associated with said transmission rate and is a product of a specific power and a multiplier, the specific power being the power level of transmission to the subscriber unit at a given fundamental data rate and said

multiplier having a fixed direct relation to the associated transmission rate: a method for estimating the specific power of transmission from the BTS to each of the active subscriber units at any given time, the method comprising: (i) defining in time a succession of observation windows; (ii) observing the data flowing into the BSC and addressed to each of the active subscribers and, for each subscriber, measuring the amount of such data flowing during each of a plurality of said observation windows, obtaining measured amounts; and (iii) calculating from said measured amounts an estimated specific power for each of the subscribers.

__________ ]11[]21[ ]54[

METHOD OF REDUCING OR ELIMINATING NEOPLASTIC CELLS IN AN EX VIVO SUSPENSION WITH NORMAL HAEMATOPOIETIC CELLS BY CONTACTING IT WITH VESICULAR STOMATITIS VIRUS (VSV), AND USE OF THIS VIRUS IN THE MANUFACTURE OF A

September 22, 2009

–‫ד' בתשרי התש"ע‬

153570 ‫שיטה להפחתתת או להסרת תאים‬ ‫ניופלסטים בתרחיף חוץ –גופי עם תאים‬ ‫הימאטופויאטים נורמלים באמצעות מגע‬ ) VSV( ‫עם וירוס סטומאטיטיס משולחף‬ ‫ושימוש בוירוס זה לייצור של תרופה‬ ‫לטיפול בסרטן‬

257

MEDICAMENT FOR TREATING CANCER ]22[ ]31[ ]51[

26.06.2001 60/214014 ]32[ 26.06.2000 ]33[ US Int. Cl.(2008.04) A61K 35/12, 35/76, 39/42, 392/05, A61P 35/00, 37/00, C12N 15/06, 5/06, 5/08 ]71[ WELLSTAT BIOLOGICS CORPORATION, U.S.A. UNIVERSITY OF OTTAWA, CANADA ]72[ HAROLD L. ATKINS, JOHN C. BELL, CONRAD J. HEILMAN JR., BRIAN D. LICHTY, ROBERT M. LORENCE, MICHAEL S. ROBERTS, DAVID F. STOJDL ]87[ WO/2002/000233 ]74[ JMB, FACTOR & CO. LTD., ,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬ HAR HOTZVIM HI-TECH PARK, ,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬ P.O.B. 45087, ‫ירושלים‬ JERUSALEM 91450 [57] Method of reducing or eliminating cells by contacting said mixture with neoplastic cells in an ex vivo mixture of vesicular stomatitis virus, wherein the normal haematopoietic cells and neoplastic mixture is a suspension.

__________ ]11[]21[ ]54[

WATERPROOFED CEMENTITIOUS COMPOSITIONS AND METHOD OF MAKING THE SAME

]22[ ]31[ ]51[ ]71[

03.05.2002 0111145.9 ]32[ 08.05.2001 Int. Cl.(2008.04) C04B 24/42, 28/00 CONSTRUCTION RESEARCH & TECHNOLOGY GMBH, GERMANY WO/2002/090287 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method of conferring water impermeability on a hardened cementitious composition which is formed from a fluid

258

153588 ‫הרכבי מלט חסיני מים ושיטה לייצרם‬

]33[

GB

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

cementitious mix, by the addition to the mix of an aqueous emulsion of organosilicon material, which material September 22, 2009

–‫ד' בתשרי התש"ע‬

comprises from 0.25-4.5% by weight of the emulsion of an alkoxysilane and from

0.1-2.0% of an alkoxysiloxane.

__________ ]11[]21[ ]54[

METHOD OF SIMULTANEOUSLY GENOTYPING MULTIPLE SAMPLES IN A SINGLE ROUND OF HYBRIDIZATION

]22[ ]31[ ]51[ ]71[

03.07.2001 09/613006 ]32[ 10.07.2000 Int. Cl.(2008.04) C12Q 1/68 TELECHEM INTERNATIONAL, INC., U.S.A. WO/2002/003849 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method of simultaneously genotyping multiple samples in a single round of hybridization, the method comprising: (a) providing a microarray having on its surface a plurality of amplified genomic segments from a plurality of samples, wherein said plurality of amplified genomic segments are obtainable by amplifying a plurality of genomic segments from a plurality of samples using a plurality of polymerase chain reaction primers, each genomic segment comprising a distinct genetic locus, wherein each location on the surface contains amplified material derived from a single sample and consisting of essentially a single genomic segment; (b) incubating the microarray with a probe mixture of synthetic oligonucleotides, wherein the mixture comprises oligonucleotides having sequences specifically complementary to the genomic

153848 ‫שיטה לאבחון בו זמנית של המבנה הגנטי‬ ‫של מספר דוגמאות במעגל הכלאה יחיד‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ segments for each sample for which a genotype is to be determined, wherein the incubating forms hybrids of polynucleotides of the microarray and directly or indirectly labeled complementary oligonucleotides of the probe mixture, and allows discrimination at single nucleotide resolution; and (c) deriving genotyping information simultaneously for the plurality of the detecting signals from the hybridized microarray wherein either the probe mixture comprises oligonucleotides specifically complementary to wild type and mutant alleles and said oligonucleotides are directly or indirectly labeled with fluorescent tags that fluoresce at different wavelengths or different color tags and the detected signals are indicative of a genotype of an individual or the strength of the signal is detected and is indicative of a genotype of an individual.

__________ ]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

153990

259

‫מטען פורק מחסנית‬

]54[

MAGAZINE LOADER AND UNLOADER ACCESSORY

]22[ ]31[ ]51[ ]71[

22.07.2001 60/221393 ]32[ 23.07.2000 Int. Cl.(2008.04) F41A 9/83 RAN TAL GUY TAL

]87[ ]74[

WO/2002/008681 GUY TAL, 86/2 SHILO ST., ROSH HA'AIN

[57] A firearm magazine loader and unloader accessory for magazines (70) having an open side and containing topmost and second-to-topmost rounds which are exposed at and urged towards said open side, comprising: thrusting means for alternately (a) thrusting said topmost round farther into said magazine for creating space adjacent said open side for enabling a new round to be loaded into said space, and (b) thrusting said secondto-topmost round farther into said magazine for releasing force on said

]33[

US ‫ תל אביב‬,‫רן טל‬ ‫העין‬-‫ ראש‬,‫גיא טל‬ ,‫גיא טל‬ ‫העין‬-‫ ראש‬,86/2 ‫שילה‬

topmost round to enable said topmost round to fall out of said magazine, and mounting means (12) for operatively positioning said thrusting means at said open side of said magazine, whereby by sequentially thrusting topmost rounds farther into said magazine, said magazine may be easily loaded with new rounds, and alternatively, when sequentially thrusting second-to-topmost rounds farther into said magazine, topmost rounds may be easily unloaded.

__________ ]11[]21[

260

154170

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫תכשירים רפואים המכילים אריתרופואיטין‬ ‫רקומביננטי בעל פעילות גבוהה ותופעות‬ ‫לוואי מצומצמות‬

]54[

THERAPEUTIC COMPOSITIONS COMPRISING A RECOMBINANT ERYTHROPOIETIN HAVING HIGH ACTIVITY AND REDUCED SIDE EFFECTS

]22[ ]31[ ]51[ ]71[

09.08.2001 09/637962 ]32[ 11.08.2000 ]33[ Int. Cl.(2008.04) A61K 38/18, A61P 7/06 BAXTER HEALTHCARE S.A., SWITZERLAND WO/2002/014356 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] Use of a recombinant erythropoietin selected from the group consisting of: Epoetin Omega, an erythropoietin produced in baby hamster kidney cells, erythropoietin expressed from an Apa I restriction fragment of human genomic erythropoietin DNA, an erythropoietin having a glycosylation pattern characterized by the presence of N-linked glycosylated residue on at least three asparagine residues, an erythropoietin having an O-linked oligosaccharide content of less than 1 mole per mole of glycoprotein, an erythropoietin having one or more isoforms at pI 4.3, or 4.5, or 4.6,

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

and a recombinant erythropoietin that retains substantially all of its in vitro biological activity after being subjected to N-deglycosylation for the manufacture of a medicament for treatment of anemia in a subject adversely affected when treated with a therapeutic amount of Epoetin Alpha or Beta, the medicament having a therapeutic amount of the recombinant erythropoietin selected to provide a therapeutic benefit within a treatment period without producing or exacerbating an adverse effect associated with treatment by a therapeutic amount of Epoetin Alpha or Beta. ,197584

The applications for division from this application have not yet been published

US

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ ]11[]21[ ]54[

ARRANGEMENT FOR TYING A PORTABLE OBJECT TO A STATIONARY OBJECT BY A CABLE

]22[ ]51[ ]71[

30.01.2003 Int. Cl.(2008.04) E05B 73/00 MEIR AVGANIM

September 22, 2009

–‫ד' בתשרי התש"ע‬

154194 ‫סידור לקשירת חפץ נייד לחפץ נייח‬ ‫באמצעות כבל‬

651 ‫ מושב גאליה‬,‫מאיר אבגנים‬

261

]74[

651 ‫ מושב גאליה‬,‫לי אבגנים‬-‫גבי‬ ,'‫דניאל פריימן ושות‬ ‫ תל אביב‬,10 ‫ בית כלל קומה‬5‫דרויאנוב‬

GABI-LEE AVGANIM DANIEL FREIMANN & CO., 5 DROYANOV ST., 10TH FLOOR , TEL AVIV 63143

[57] An arrangement for arresting a portable object against a stationary object by looping around the stationary object one end of a cable (40) and releasably coupling the other end thereof to the portable object, the arrangement comprising: a block-shaped body (44) to which said other end of the cable is affixed, the body having a planar side surface; an oblong circular cavity formed in the planar side surface with an undercut portion extending along about 180o of one side thereof; a a circular ribbed attachment member (24) having a circular rib (28)

extending therearound configured to fit into said cavity, said rib being at a width less than said undercut portion so that after fitting into the cavity it can be shifted into engagement with the undercut portion thereby preventing a head – on releasing thereof from the cavity; the said body being further provided with a key operated locking device (50) having a locking pin projectable into the said cavity to restrain the shifting of the attachment member lock from the first shifted position thereof; and means for affixing the attachment member to a side wall of the portable object.

__________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]71[ ]72[ ]87[ ]74[

262

154429

METHOD FOR THE DIAGNOSIS ‫שיטה לאבחון של סכיזופרניה‬ OF SCHIZOPHRENIA 15.08.2001 137865 ]32[ 15.08.2000 ]33[ IL Int. Cl.(2008.04) C12N 15/12, C12Q 1/68 YEDA RESEARCH AND ‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬ DEVELOPMENT CO. LTD. SARA FUCHS, TAL ILANI, ORLY ‫ אורלי פרל‬,‫ טל אילני‬,‫שרה פוקס‬ PERL WO/2002/014547 BEN-AMI & ASSOCIATES, ,'‫בן עמי ושות‬ 8 PLAUT ST., ‫ רחובות‬,94 .‫ד‬.‫ ת‬, 8‫מנחם פלאוט‬ PARK TAMAR, September 22, 2009

–‫ד' בתשרי התש"ע‬

P.O.B. 94, REHOVOT 76100 [57] Method for the diagnosis of schizophrenia in a tested individual, comprising: (i) measuring mRNA of D3 dopamine receptor or of α7 nicotinic acetylcholine receptor (α7 AChR) and of a control gene in peripheral blood lymphocytes (PBLs) of said tested individual and of at least one healthy control individual or a pool of two or more healthy individuals; (ii) calculating the ratio between the D3 dopamine receptor mRNA and the control gene mRNA or the ratio between the α7 AChR mRNA and the control gene mRNA for the tested individual and the at least

one healthy control individual or pool of two or more healthy individuals; and (iii) evaluating the ratios obtained in (ii) for the tested individual and for the at least one healthy control indivudal or pool of two or more healthy individuals, wherein an increase of above 1.6 fold in the ratio of D3 dopamine receptor mRNA/control gene mRNA or a decrease of more than 20% in the ratio of α7 AChR mRNA/control gene mRNA in the tested individual in comparision to that of the at least one healthy control individual or pool of two or more healthy individuals, indicates that said tested individual has a high likelihood of having schizophrenia.

__________ ]11[]21[ ]54[

SHIP HULL

]22[ ]51[ ]71[ ]72[ ]87[ ]74[

12.04.2000 Int. Cl.(2008.04) B63B 1/00, 1/40 ALBERTO A. CALDERON, U.S.A. ALBERTO A. CALDERON WO/2001/079054 JMB, FACTOR & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450

[57] A transonic hull portion having a bow, a stern, and a length, a substantially triangular waterplane, side surfaces extending from said bow to outboard edges of said stern with a deep draft forward and a shallow draft to the rear, said hull portion being immersed in a water body in a displacement mode having a remote reference water level and a supercritical transonic three-dimensional hydrofield in direct contact with and translating and supporting by means of buoyant forces, the submerged surfaces of said transonic hull September 22, 2009

–‫ד' בתשרי התש"ע‬

154454 ‫גוף של אוניה‬

,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬ ,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬ ‫ירושלים‬ portion translating at high speed in said water body in said displacement mode, said hydrofield being further characterized in having (a) a substantially triangular planform at water level with substantially rectilinear longitudinal sides with the base of said triangular planform corresponding to the stern of said hull portion and the pointed end forward; (b) lateral hydrodynamic rays of small elevation and narrow width in cross-section extending along said sides of said planform; continuing downstream of said base of said

263

hydrofield as generally straight rearward extensions of said rays; (d) with a generally flat wake extending downstream from said base of said planform, said generally flat wake being contained

between the portion of said rays located to the rear of said base, and having a water level therebetween substantially equal to that of said remote waterplane outboard of said rays.

__________

]11[]21[ ]54[

PROCESS TO PRODUCE HALO-4PHENOXYQUINOLINES

]22[ ]31[ ]51[ ]71[ ]72[

07.09.2001 60/231719 ]32[ 08.09.2000 Int. Cl.(2008.04) C07D 215/20 DOW AGROSCIENCES LLC, U.S.A. KARL LEOPOLD KRUMEL, RUTH CEZAR REED, THOMAS A. OLMSTEAD, GARY ALAN ROTH, IAN ROBERT KING, DONALD NEIL BRATTESANI, KENT DOUGLAS CAMPBELL, JOHN DAVIES WO/2002/020490 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120

]87[ ]74[

154764 ‫–פנוקסיקווינולינים‬4–‫תהליך להכנת הלו‬

]33[

US

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ ,‫פטנטים‬ ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬

[57] Process comprising: (1) reacting a compound of formula (I) with a compound of formula (II) to produce a compound of formula (III)

264

September 22, 2009

–‫ד' בתשרי התש"ע‬

wherein R1 and R3 are indepdnently halo and R2 and R3 are independently halo and R2 and R4 are H; or R3 is halo, R1 is halo or H, and R2 and R4 are H; or R4 is halo and

R1 to R3 are H; R5 is a (C1-C4) alkyl and R6 and R7 are independently a (C1-C4) alkyl; (2) reacting said compound of formula (III) to produce a compound of formula (IV);

wherein R8 is a (C1-C4) alkyl;

(3) reacting said compound of formula four with water to produce a compound of the formula

wherein H2O interacts with the –C(=O)-OR8 group on compound (IV) to produce a compound of formula (VI)

(4) reacting said compound of formula VI with SOCl2 to produce a compound of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

265

wherein SOCl2 interacts with the -OH group on Compound (VI) to produce a compound of formula VIII; wherein X is – F, Cl, Br or I; and

(3) reacting said compound of formula (VIII) with a compound of formula (IX) to produce a compound of the formula

wherein R9 to R13 are independently H, CN, NO2, OH, halo, (C1-C4) alkyl, (C2-C4) alkanoyl, halo (C1-C7) alkyl, hydroxy (C1C7) alkyl, (C1-C7) alkoxy, halo (C1-C7) alkoxy, (C1-C7) alkylthio, halo (C1-C7) alkylthio, phenyl, substituted phenyl, phenoxy, substituted phenoxy, phenylthio, substituted phenylthio, phenyl (C1-C4) alkyl, substituted phenyl (C1-C4) alkyl,

benzoyl, SiR20R21R22, or OSiR20R21R22 where R20, R21, and R22 are H, a (C1-C6) alkyl group, phenyl, or substituted phenyl, provided that at least one of R20, R21, and R22 is other than H, or R11 and R12 or R12 and R13 combine to form a carbocyclic ring, and provided that unless all of R9 to R13 are H or F, then at least two of R9 to R13 are H.

__________ ]11[]21[

154840 ‫נגזרות של טריאזולון‬

]54[

TRIAZOLONE DERIVATIVES

]22[ ]31[ ]51[

09.11.2001 60/247317 ]32[ 10.11.2000 ]33[ US Int. Cl.(2008.04) A61K 314/196, 314/27, A61P 3/10, 9/02, C07C 281/06, C07D 249/12, 401/06, 405/06, 409/06, 413/06 ELI LILLY & CO., U.S.A. WO/2002/038553 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352,

]71[ ]87[ ]74[

266

September 22, 2009

–‫ד' בתשרי התש"ע‬

BEER-SHEVA 84152 [57] A compound of the formula

and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) R1 is selected from the group consisting of hydrogen, substituted or unsubstituted group selected from C1-C8 alkyl, aryl-C0-4-alkyl, heteroaryl-C0-4alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl, and –CH2-C (O)-R17-R18, wherein R17 is O or NH and R18 is benzyl, wherein the R1 optional substituents are each independently selected form the group consisting of C1-C5 haloalkyl, C1-C5 haloalkoxy, nitro, cyano, CHO, hydroxyl, C1-C4 alkanoic acid phenyl, aryloxy, SO2R7, SR7, benzyloxy, alkylcarboxamido and COOH; (b) W is O or S; (c) R2 is H or a substituted or unsubstituted group selected from the group consisting of C1-C6 alkyl, C1-C6 allyl, aryl-C0-4-alkyl, heteroaryl-C0-4-alkyl, sulfonamide, amide, OR10 and C3-C6 cycloalkyl; and wherein the R2 optional substituents are each independently selected from the group consisting of: OH, alkoxy, haloalkyl, amino, COOH, heteroaryl-O-, heteroaryl-C(O)-, alkyl-O-, alkyl-C(O)-, C3-C6 cycloalkyl, aryl-O-, aryl-C(O)-, heteroaryl, aryl, heterocycloalkyl, heterocycloalkyl-O-, and heterocycloalkyl-C(O)wherein

September 22, 2009

–‫ד' בתשרי התש"ע‬

(d) X is an optionally substituted C2-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S and the optional alkylene linker substituents are each independently selected from the group consisting of C1C6 alkyl, oxo, substituted or unsubstituted aryl C0-C3 alkyl, C1-C3 alkoxy, hydroxy, C3-C6 cycloalkyl and halo; (e) Y is C, O, S, NH or a single bond; and (f) E is selected from the group consisting of C(R3) (R4)A, (CH2)n COOR19 wherein the (CH2)n COOR19 moiety is unsubstituted or substituted with from one to three substituents each independently selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5 haloalkyl, C1-C5 haloalkoxy, nitro, cyano, CHO, hydroxyl, C1-C4 alkanoic acid phenyl, aryloxy, SO2R7, SR7, benzyloxy, alkylcarboxamido, and COOH, and the optional (CH2)n COOR19 moiety substituents are each independently selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5 haloalkoxy, nitro, cyano, CHO, hydroxyl, C1-C4 alkanoic acid phenyl, aryloxy, SO2R7, SR7, benzyloxy, alkylcarboxamido or COOH; wherein R7 is alkyl or haloalkyl,

267

(i) n is 0, 1, 2 or 3; (ii) A is a moiety selected from the group consisting of carboxyl; (iii) R3 is H, saturated or unsaturated C1C5 alkyl, C1-C5 alkoxy; (iv) R4 is H, halo, a substituted or unsubstituted group selected from C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, aryl C0-C4 alkyl and phenyl, or R3 and R4 are combined to form a C3-C4 cycloalkyl; (v) R19 is selected from the group consisting of hydrogen, optionally substituted arylmethyl and optionally substituted C1-C4 alkyl; wherein the optional substituents for R4, R5, R9 and R19 are each independently selected from the group consisting of C1C5 alkyl, C1-C5 alkoxy, C1-C5 haloalkyl, C1-C5 haloalkoxy, nitro, cyano, CHO,

hydroxyl, C1-C4 alkanoic acid phenyl, aryloxy, SO2R7, SR7, benzyloxy, alkylcarboxamido and COOH; (vi) R14 is selected from the group consisting of CF3, phenyl, aryl-C0-4-alkyl, and C1-C6 alkyl; (g) R8 is independently selected from the group consisting of hydrogen, C1-C4 alkyl, C1-C4 alkylenyl, and halo; (h) R9 is independently selected from the group consisting of hydrogen, C1-C4 alkyl, C1-C4 alkylenyl, halo, substituted or unsubstituted aryl, substituted or unsubstituted aryl -C1-C4 alkyl, substituted or unsubstituted heteroaryl, C1-C6 allyl, and OR10; and (i) R10 is independently selected from the group consisting of hydrogen and C1-C4 alkyl.

__________ ]11[]21[ ]54[

ANGULAR MOTION MEASUREMENT ARRANGEMENT

]22[ ]51[ ]71[

11.03.2003 Int. Cl.(2008.04) G01P 3/04 RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

]72[

TZVI EFRATI, MICKY NARODITSKY, MAKSIM GOLDSHTEIN DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH

]74[

268

154871 ‫סידור למדידת תנועה סיבובית‬

,‫רפאל מערכות לחימה מתקדמות בע"מ‬ ‫חיפה‬ ‫ מקסים‬,‫ מיקי נרודיצקי‬,‫צבי אפרתי‬ ‫גולדשטיין‬ ,‫ד"ר מרק פרידמן בע"מ‬ ,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ גן‬-‫רמת‬

FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [57] An angular motion measurement system disposed on a movable platform having a first section and a second section, comprising; (a) a first measurement arrangement (24) configured to provide a first output indicative of angular motion of the section, said first measurement arrangement having a bandwidth above 50 Hertz and at least one of, a bias above 5 degrees per second and a scale factor above 10%; (b) a second measurement arrangement (26) configured to provide a second output

indicative of angular motion of the second section, said second measurement arrangement having a bandwidth below 50 Hertz, a bias below 5 degrees per second and a scale factor below 10%; and (c) a processor arrangement (30) responsive to a plurality of inputs, which include said first output and said second output, generating a corrected output having a bandwidth above 50 Hertz, a bias below 5 degrees per second and a scale factor below 10%.

__________ ]11[]21[

155029 –‫ – יל‬1 – ‫ – מתילפיפרזין‬4( – 4 –‫שימוש ב‬ – ‫ – פירידין‬4( – 3 – ‫ – מתיל‬N – [4 – )‫מתיל‬ – ]‫ – יל – אמינו) פניל‬2 – ‫ – יל)פירימידין‬3 ‫בנזמיד להכנת תרופה לטיפול בסרטן של‬ ‫משתית של מערכת העיכול‬

]54[

USE OF 4 - ( 4 METHYLPIPERAZIN - 1 - YLMETHYL) - N - [4 - METHYL - 3 - (4 - PYRIMIDIN - 3 - YL) PYRIMIDIN - 2 - YL - AMINO) PHENYL] BENZAMIDE IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMOR

]22[ ]31[ ]51[ ]71[ ]87[

26.10.2001 60/243810 ]32[ 27.10.2000 ]33[ US Int. Cl.(2008.04) A61K 313/95, A61P 35/00, C07D 401/14 NOVARTIS AG, SWITZERLAND WO/2002/034727

September 22, 2009

–‫ד' בתשרי התש"ע‬

269

]74[

,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

[57] The use of 4-(4-methylpiperazin-1ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)

pyrimidin-2-yl-amino) phenyl)-benzamide of the formula

or a pharmaceutically acceptable salt thereof for the manufacture of pharmaceutical compositions for the

treatment of gastrointestinal stromal tumours.

__________ ]11[]21[

155217 ‫שיטה והתקן לעיבוד מידע‬

]54[

METHOD AND APPARATUS FOR DATA PROCESSING

]22[ ]31[ ]51[ ]71[

01.10.2001 507386 ]32[ 09.10.2000 ]33[ Int. Cl.(2008.04) G06F 11/20, 12/00, 17/30 MAXIMUM AVAILABILITY LIMITED, NEW ZEALAND WO/2002/031696 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method of replicating information from a source system at a target system comprising the steps of: (i) receiving information strings from the source system; (ii) assigning the information strings to serialization groups for processing, (iii) arranging interdependent information strings into groups, wherein information

270

NZ

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

strings having members that having a database type relationship with other members are grouped together to ensure that they are updated in the correct sequence, and wherein each group of interdependent information strings is processed in one of a plurality of serialization groups, and September 22, 2009

–‫ד' בתשרי התש"ע‬

(iv) processing the serialization groups in parallel, to replicate the information from

the source system.

,192136

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ ]11[]21[ ]54[

PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND

]22[ ]31[

15.10.2001 2000-316345 ]32[ 17.10.2000 2001-034216 09.02.2001 Int. Cl.(2008.04) C07D 239/26, 239/74 IHARA CHEMICAL INDUSTRY CO., LTD., JAPAN WO/2002/032882 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013

]51[ ]71[ ]87[ ]74[

155486 ‫תהליך לייצור תרכובת אנילין מותמר‬

]33[

JP JP

,'‫זליגסון גבריאלי ושות‬ ‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬

[57] A process for producing a substituted aniline compound of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

271

wherein R1, R2 and R3 are each independently an alkyl group, an alkoxy group, an alkoxyalkyl group, a haloalkyl group, a carboxyl group, a nitro group, an aryl group, an arylalkyl group, an aryloxy group, a halogen atom or a hydrogen atom; and X and Y are each independently a

hydrogen atom, an alkyl group, an alkoxy group, an alkoxyalkyl group, a haloalkyl group, a carboxyl group, or a halogen atom, the process comprising: oxidizing a substituted indole compound of the formula

wherein, R1, R2, R3, X and Y have the same definitions as given above to give

ring opening of the indole ring to produce an acetanilide compound of the formula

wherein, R1, R2, R3, X and Y have the same definitions as given above, and Ac is an acetyl group; and subjecting compound

(4) to reduction and deacetylation to give compound (6).

The applications for division from this application have not yet been published

,192827

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ 272

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

155812 GLP–1 ‫חלבוני התכה‬

]54[

GLP-1 FUSION PROTEINS

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

29.11.2001 60/251954 ]32[ 07.12.2000 Int. Cl.(2008.04) C07K 19/00 ELI LILLY & CO., U.S.A. WO/2002/046227 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

]33[

US

,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

[57] A heterologous fusion protein comprising a first polypeptide with a Nterminus and a C-terminus fused to a second polypeptide with a N-terminus and a C-terminus wherein the first polypeptide is a Glucagon-Like Peptide 1 (GLP-1) compound and the second polypeptide is selected from

(a) the Fc portion of an immunoglobulin; (b) an analog of the Fc portion of an immunoglobulin; and (c) fragments of the Fc portion of an immunoglobulin, and wherein the C-terminus of the first polypeptide is fused to the N-terminus of the second polypeptide. ,184429

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ ]11[]21[

155990 ‫נגזרות של קרבפנם‬

]54[

CARBAPENEM DERIVATIVES

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

22.11.2001 2000-356997 ]32[ 24.11.2000 ]33[ JP Int. Cl.(2008.04) A61K 314/439, A61P 31/04, C07D 477/00, 477/14, 513/00, 519/00 MEIJI SEIKA KAISHA, LTD., JAPAN WO/2002/042312 REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A compound of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

273

or a pharmaceutically acceptable salt thereof wherein R1 represents methyl, R2 and R3, which may be the same or different, each represent a hydrogen atom; a halogen atom; lower alkyl optionally substituted by a halogen atom, cyano, hydroxyl, carbamoyl, amino, formylamino, lower alkylcarbonylamino, aminosulfonylamino, lower alkylthio, lower alkoxy, lower cycloalkyl, N,N-dilower alkylamino, or N-carbamoyl lower alkyl-N,N-di-lower alkylamino; lower cycloalkyl; lower alkylcarbonyl; carbamoyl; aryl; lower alkylthio is optionally substituted by amino, hydroxyl, azide, a halogen atom, cyano, carbamoyl, formylamino, lower alkylcarbonylamino, aminosulfonylamino, or lower alkylthio; morpholinyl; lower alkylsulfonyl; or formyl; n is 0 and Hy represents pyridine3-yl, pyridinium-3-yl or (2S)-pyrrolidin-2yl the heterocyclic group represented by Hy is optionally substituted by a halogen atom; cyano; lower alkyl wherein one or more hydrogen atoms on the lower alkyl group are optionally substituted by groups selected from the group consisting of a halogen atom; hydroxyl; carboxylamethylsubstituted carbamoyl; amino; N,N-dilower alkylamino; aryl optionally substituted by amino; a monocyclic or bicyclic heterocyclic group containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur atoms, optionally substituted by aminosulfonyl or carboxyl; carboxyl;

imino; lower alkoxycarbonyl; lower alkylcarbonyl; aminosulfonylamino; amino lower alkylsulfonyl; (N,N-di-lower alkylamino) sulfonylamino; N'-(N,N-dilower alkylamino) sulfonyl-N'-lower alkylamino; halogenated lower Naminosulfonyl piperidinyl; and cyano; lower alkylthio wherein one or more hydrogen atoms on the alkyl group are optionally substituted by a group selected from the group consisting of a halogen atom, hydroxyl, carbamoyl, amino, and aryl; lower alkylsulfonyl wherein one or more hydrogen atoms on the alkyl group are optionally substituted by a group selected from the group consisting of a halogen atom, hydroxyl, carbamoyl, amino,1-iminoethylamino, and aryl; hydroxyl; lower alkoxy; halogenated lower alkoxy; aminophenyl-substituted lower alkoxy; formyl; lower alkylcarbonyl; arylcarbonyl; carboxyl; lower alkoxycarbonyl; carbamoyl; N-lower alkylcarbamoyl; N,N-di-lower alkylaminocarbonyl; amino; N-lower alkylamino; N,N-di-lower alkylamino; formylamino; lower alkylcarbonylamino; aminosulfonylamino; (N-lower alkylamino) sulfonylamino; (N,N-di-lower alkylamino) sulfonylamino; aryl; or a monocyclic or bicyclic heterocyclic group containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur atoms, optionally substituted by aminosulfonyl or carboxyl.

__________ 274

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

SEMICONDUCTOR DEVICE FABRICATED ON SURFACE OF SILICON HAVING DIRECTION OF CRYSTAL PLANE AND ITS PRODUCTION METHOD

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

02.10.2002 2001-307899 ]32[ 03.10.2001 Int. Cl.(2008.04) H01L 29/78 TADAHIRO OHMI, JAPAN WO/2003/032399 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A semiconductor device comprising: a plurality of field effect transistors formed on an unstrained silicon surface having substantially a ‹110› orientation, the plurality of field effect transistors each having a gate insulator film containing krypton atoms with a surface density of up to 5x1011 cm-2, wherein the field effect transistors are disposed on the silicon surface such that a direction connecting a

156116 ‫התקן מוליך למחצה המיוצר על שטח‬ ‫< של מישור גביש‬011> ‫סיליקון בעל כיוון‬ ‫ושיטת הייצור‬

]33[

JP

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, source region and a drain region of said field effect transistor is coincident to a substantially ‹110› direction, and wherein the field effect transistors have an electron mobility at least about 1.4 times greater than an electron mobility of a field effect transistor formed in the same manner on a silicon surface having substantially a ‹100› orientation.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

275

]11[]21[ ]54[

METHOD FOR IN-SITU FOCUSFUSION MULTI-LAYER SPECTRAL IMAGING AND ANALYSIS OF PARTICULATE SAMPLES

]22[ ]31[ ]51[ ]71[ ]72[

02.12.2001 09/727753 ]32[ 04.12.2000 Int. Cl.(2008.04) G06K 9/00 GREEN VISION SYSTEMS LTD. DANNY S. MOSHE, MICHAEL KHAZANSKI WO/2002/047017 APPELFELD ZER FISHER, B.S.R TOWER 1, FLOOR 16 2 BEN GURION ST. RAMAT GAN 52573

]87[ ]74[

[57] A method for in-situ focus-fusion multi-layer spectral imaging and analysis of a particulate sample, particles of the particulate sample exhibiting layer or depth dependent features and characteristics, the method comprising the steps of: (a) preparing the sample for the in-situ focus-fusion multi-layer spectral imaging and analysis; (b) providing a spectroscopic imaging system, including a light illumination source and a sample holder moveable by a three dimensional translation stage, for insitu spectral imaging of the sample; (c) selecting and defining imaging scenario parameters for acquiring and analyzing insitu spectral images of the sample, said imaging scenario parameters are particle physicochemical information and parameters relating to particle chemical composition and particle morphology, and, particle spectral information and parameters relating to pixel energy level or intensity, signal-to-noise ratio, image sharpness, and, spectral fingerprints associated with distinct spectral emission

276

156325 ‫שיטה לאיחוי–פוקוס בהדמיה ספקטרלית‬ ‫רב–ממדית באתר ובחינה של דגימות‬ ‫חלקיקיות‬

]33[

US ‫ תל אביב‬,‫גרין ויז'ן מערכות בע"מ‬ ‫ מיכאל חזנסקי‬,‫דני משה‬

,‫ עו"ד עורכי פטנטים‬,‫אפלפלד זר פישר‬ ‫ גן‬- ‫ רמת‬,16 ‫ קומה‬.‫ר‬.‫ס‬.‫ מגדל ב‬2 ‫בן גוריון‬

patterns of the particles of the sample, each said spectral emission pattern featuring emission intensity as a function of wavelength of light emitted by the sample; (d) adjusting and setting said spectroscopic imaging system for said in-situ spectral imaging of the sample at a selected i-th field of view, having central (x, y) position coordinates relative to said translation stage; (e) acquiring a spectral plane image of the sample in said selected i-th field of view, at a selected j-th differential imaging/focusing distance, in a selected range of imaging distance defined along zdirection between the sample and said light illumination source of said spectroscopic imaging system, by focusing said imaging system in said z-direction until receiving a sharp gray level image of the sample; (f) constructing and analyzing a focused spectral plane imageij of the sample for said selected i-th field of view, at said selected j-th differential imaging/focusing distance, from said acquired spectral plane image of the sample, whereby said constructing and analyzing features September 22, 2009

–‫ד' בתשרי התש"ע‬

identifying target in said sharp gray level image of the sample by using said selected and said defined particle physicohemical imaging scenario parameters and said selected and said defined particle spectral imaging scenario parameters; (g) repeating step (e) and step (f) in said selected i-th field of view, for a plurality of said selected j-th differential imaging/focusing distances, in said selected range of imaging distance, for forming a plurality of said focused spectral plane imagesij of the sample for said selected i-th field of view; (h) constructing a fused focused spectral image, for said selected i-th field of view, using a plurality of said identified targets having high content selected from said plurality of said focused spectral plane imagesij, and, using spectral background parameters, empirically determined from

said plurality of said focused spectral plane imagesij; (i) acquiring and constructing a plurality of said fused focused spectral imagesi of the sample in other said selected i-th fields of view, having corresponding said central (x, y) position coordinates relative to said translation stage, for a plurality of said selected j-th differential imaging/focusing distances, by repeating step (d) through step (h), until selected sample viewing/imaging range is imaged and analyzed; and (j) applying at least one image analysis algorithm to data of said plurality of said fused focused spectral imagesi for correlating said particle spectral information and parameters to said particle physicochemical information and parameters, thereby characterizing the particulate sample.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

277

]11[]21[

156341 ,‫ תהליכים ליצורם‬,‫נגזרות בנזותיאזפין‬ ‫תכשירי רוקחות המכילים אותם והשימוש‬ ‫בהם ליצור תרופות וכתרופות ליצירת‬ ‫ בבעל חיים בעל דם‬IBAT ‫אפקט מעכב‬ ‫חם‬

]54[

BENZOTHIAZEPINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICAMENTS AND AS MEDICAMENTS FOR THE PRODUCTION OF AN IBAT INHIBITORY EFFECT IN A WARM-BLOODED ANIMAL

]22[ ]31[

17.12.2001 0004811-6 ]32[ 21.12.2000 ]33[ SE 0112592.1 24.05.2001 GB Int. Cl.(2008.04) A61K 315/54, 316/75, 38/05, 38/06, A61P 3/06, C07D 281/10, 417/12, C07F 96/536, C07K 50/65, 50/87 ALBIREO AB, SWEDEN INGEMAR STARKE, MIKAEL ULF JOHAN DAHLSTROM, DAVID BLOMBERG WO/2002/050051 S. HOROWITZ & CO., ,'‫ הורוביץ ושות‬.‫ש‬ ZION HOUSE, ‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬ 41-45 ROTHSCHILD BLVD., ‫אביב‬ TEL AVIV 65784

]51[ ]71[ ]72[ ]87[ ]74[

[57] A compound of the formula

wherein: Rv and Rw are independently selected from hydrogen or C1-6 alkyl;

278

R1 and R2 are independently selected from C1-6 alkyl; September 22, 2009

–‫ד' בתשרי התש"ע‬

Rx and Ry are independently selected from hydrogen or C1-6 alkyl, or one of Rx and Ry is hydrogen or C1-6 alkyl and the other is hydroxy or C1-6 alkoxy; Rz is selected from halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6 alkyl, C2-6alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 alkanoyl, C1-6 alkanoyloxy, N(C1-6 alkyl) amino, N,N-(C1-6 alkyl)2 amino, C1-6 alkanoylamino, N-( C1-6 alkyl)

carbamoyl, N,N-( C1-6 alkyl)2 carbamoyl, C1-6 alkylS(O)a wherein a is 0 to 2, C1-6 alkoxycarbonyl, C1-6 alkoxycarbonylamino, ureido, N', N'-(C1-6 alkyl)2 ureido, N'-(C1-6 alkyl)-N-(C1-6 alkyl) ureido, N-(C1-6 alkyl) sulphamoyl and N,N-(C1-6 alkyl)2 sulphamoyl; v is 0-5; R3, R4, R5 and R6 are as defined in the specification or a pharmaceutically acceptable salt or an in vivo hydrolysable ester or amide thereof.

__________ ]11[]21[

156435 IGF–1 ‫גיבוש של‬

]54[

CRYSTALLIZATION OF IGF-1

]22[ ]31[

01.02.2002 60/267977 ]32[ 09.02.2001 ]33[ US 60/287072 27.04.2001 US Int. Cl.(2008.04) C07K 14/65, C30B 29/58, G01N 23/20 GENENTECH, INC., U.S.A. WO/2002/064627 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A crystal of IGF-1 having approximately the following cell constants a=31.831Å, b=71.055Å, c=65.995Å, and a space group of C2221 to allow the

determination of the three-dimensional structure of IGF-1 by X-ray diffraction studies.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

279

]11[]21[

156440 ‫מערכת נקודה לרב נקודות ותהליך‬ ‫להעברת נתונים דיגיטליים דרך רשת‬ ‫החשמל‬

]54[

POINT TO MULTIPOINT SYSTEM AND PROCESS FOR THE TRANSMISSION OF DIGITAL DATA OVER THE ELECTRICITY NETWORK

]22[ ]31[ ]51[ ]71[

18.12.2001 P200003024 ]32[ 18.12.2000 ]33[ ES Int. Cl.(2008.04) H04B 3/54, H04J 11/00, H04L 27/26, 5/02 DISENO DE SISTEMAS EN SILICIO, S.A., SPAIN WO/2002/051024 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] System for the digital transmission of data, point to multipoint over the electricity network, that comprises a communication in the downstream channel, determined by a link from the head-end to various different users, and a communication in the upstream channel, determined by a link from each of the users to the head-end, where the communication medium is the electricity network (5) and communication is achieved by means of an OFDM modulation (orthogonal frequency division multiplexing) to obtain OFDM symbols, where both the head-end and the users contain a transmitter/receiver that includes a medium access control module (MAC) to provide a master-slave communication, as well as means to add/extract a cyclic prefix in the OFDM symbols and means of converting the OFDM symbols from frequency to time and from time to frequency, and digital-to-analog and analog-to-digital converters; characterized in that the transmitter (1) / receiver (2) of the head-end and the users comprises: means to adapt the digital signal to the electricity network that provide: an OFDM modulation with a carrier width reduced to

280

at least 1,5 KHz and with the number of carriers increased to at least 500 carriers for each 10MHz to strengthen against selective frequency fadings arising from the varying cable lengths in the electricity network between each user and the headend and to strengthen against interferences in the electricity network; a cyclic prefix of long duration, at least 7 microseconds, to recover the signal; where the transmitter (1) includes means of sharing the medium in time TDMA (Time Division Multiple Access), in frequency FDMA (Frequency Division Multiple Access), and/or in Orthogonal Frequency Division Multiple Access (OFDMA), of the data transmitted in both the upstream and downstream channels for multiple users; where the receivers (2) include means to process the information corresponding to the data transmitted in the communication in the time and frequency domains, to reach maximum throughput; means to calculate without interruption the SNR (signal to noise ratio) for each of the carriers in the OFDM modulation in both the upstream and downstream, so that different users located at differing distances from the head-end use dynamically different September 22, 2009

–‫ד' בתשרי התש"ע‬

carriers in the same OFDM symbol, with a variable number of bits per carrier, maximizing the throughput of the channel in time; where the transmitter includes means to assign without interruption the carriers and a particular number of bits per carrier to each of the carriers in the OFDM modulation from the result of the SNR calculation, and means to associate the number of the bits to be transmitted to each designated carrier to achieve the transmission taking into consideration the

changes suffered by the electricity line (5) response at different distances between the users and the head-end in each frequency, and to adapt transmission speed in function of the SNR calculation and the quality of transmission required for each user; means to translate the frequency to user bandwidths higher than base band, so as to be adapted to the electricity network and to allow the use of spectral zones superior to base band.

__________ ]11[]21[ ]54[

DEVICE FOR ELLIPSOMETRIC TWO-DIMENSIONAL DISPLAY OF SAMPLE, DISPLAY METHOD AND ELLIPSOMETRIC MEASUREMENT METHOD WITH SPATIAL RESOLUTION

]22[ ]31[ ]51[ ]71[

18.12.2001 00/16529 ]32[ 18.12.2000 Int. Cl.(2008.04) G01N 21/21 CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S), FRANCE UNIVERSITE PIERRE ET MARIE CURIE, FRANCE WO/2002/050513 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

September 22, 2009

–‫ד' בתשרי התש"ע‬

156480 ‫התקן לתצוגה אליפסומטרית דו–מימדית‬ ‫ שיטת תצוגה ומדידה‬,‫של דגימה‬ ‫אליפסומטרית עם הפרדה מרחבית‬

]33[

FR

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

281

[57] A device for ellipsometric twodimensional display of a sample (1), comprising an object (4), placed in an incident medium (32), observed between a convergent light cross-reflected analyzer and polarizer, wherein the ellipsometric parameters of the set composed of the object and a substrate (8) whereon it is placed, are processed, characterised in that:

the substrate comprises a base (7) and a stack (5) of layers and that its ellipsometric properties are known, the ellipsometric properties of the substrate being such that the variations of the ellipsometric parameters of the sample due to the object are displayed with a contrast greater than the contrast produced in the absence of such substrate.

,193361

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ ]11[]21[

156505 ‫נגזרות של דהידרו–נפתלן ותרופות‬ ‫המכילות תרכובות אלו כמרכיב הפעיל‬

]54[

DIHYDRONAPHTHALENE DERIVATIVES AND AGENTS COMPRISING THE DERIVATIVES AS ACTIVE INGREDIENT

]22[ ]31[ ]51[

21.12.2001 2000-392723 ]32[ 25.12.2000 ]33[ JP Int. Cl.(2008.04) A61K 314/21, 314/26, A61P 3/00, 43/00, 9/00, C07D 263/32, 413/04, 413/10, 413/12, 413/14, 417/04 ONO PHARMACEUTICAL CO., LTD., JAPAN WO/2002/051820 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]71[ ]87[ ]74[

[57] Dihydronaphthalene derivatives of the formula

282

September 22, 2009

–‫ד' בתשרי התש"ע‬

(wherein X represents a bond, or C1-4 alkylene, Y represents –O-, or –S-, Z represents C1-4 alkylene, A represents –O-, or –S-, R1 represents COOR5, CONH2, CONHOH, CH2OH, CHO, 1H-tetrazol-5-yl, or 3,5dioxoisooxazolin-4-yl, R5 represents

hydrogen, or C1-8 alkyl, R2 and R3 each independently represents hydrogen, C1-8 alkyl, C1-8 alkoxy, or C1-8 alkoxy substituted by a phenyl, R4 represents hydrogen, or C1-8 alkyl, D represents D1, D2, or D3, D1 represents

ring l represents benzene D2 represents

ring2 represents pyridine, dioxaindan, morpholine, piperidine, thiomorpholine, pyrazole, pyrazine, dihydropiperidine, piperazine, D3 represents C1-8 alkyl, R6 represents hydrogen, C1 -8 alkyl, nitro, NR7R8, halogen, C1-8 alkoxy, C1-8 The applications for division from this application have not yet been published

alkylthio, CF3, CF3O, cyclohexane, morpholine or piperidine, R7 and R8 each independently represents hydrogen atom, or C1-alkyl, m represents 1-3), or nontoxic salts thereof. ,197407

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_______

September 22, 2009

–‫ד' בתשרי התש"ע‬

283

]11[]21[

156646 ‫ תכשירים‬,‫תרכובות איזואינדול–אמיד‬ ‫רפואיים המכילים אותן והשימוש בהן‬ ‫להכנת תרופות‬

]54[

ISOINDOLE-IMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES THEREOF FOR PREPARING MEDICAMENTS

]22[ ]31[

21.12.2001 60/258372 ]32[ 27.12.2000 ]33[ US 09/972487 05.10.2001 US Int. Cl.(2008.04) A61K 314/45, A61P 29/00, 35/00, 43/00, C07D 401/04, 401/14, 405/14, 409/14 CELGENE CORPORATION, U.S.A. WO/2002/059106 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A compound of the formula

or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, enantiomer, diastereomer, racemate, or mixture thereof, wherein: one of X and Y is C=O and the other is CH2 or C=O; R1 is H, (C1-C8) alkyl, (C3C7) cycloalkyl, (C2-C8) alkynyl, benzyl, aryl, (C0-C4) alkyl-(C1-C6) heterocycloalkyl, (C0-C4) alkyl-(C2-C5) heteroaryl, C(O)R3, C(S)R3, C(O)OR4, (C1-C8) alkyl-N(R6)2, (C1-C8) alkyl-OR5, (C1-C8) alkyl-C(O)OR5, C(O)NHR3, C(S)NHR3, C(O)NR3R3', C(S)NR3R3', or (C1-C8) alkyl-O(CO)R5; R2 is H, or (C1-C8) alkyl; R3 and R3' are independently (C1-C8) alkyl, (C3-C7) cycloalkyl, (C2-C8) alkenyl, (C2-C8) alkynyl, benzyl, aryl, (C0-C4)

alkyl-(C1-C6) heterocycloalkyl, (C0-C4) alkyl-(C2-C5) heteroaryl, (C0-C8) alkylN(R6)2, (C1-C8) alkyl-OR5, (C1-C8) alkylC(O)OR5, (C1-C8) alkyl-O(CO)5, or C(O)OR5; R4 is (C1-C8) alkyl, (C2-C8) alkenyl, (C2-C8) alkynyl, (C1-C4) alkylOR5, benzyl, aryl, (C0-C4) alkyl-(C1-C6) heterocycloalkyl, or (C0-C4) alkyl- (C2-C5) heteroaryl; R5 is (C1-C8) alkyl, (C2-C8) alkenyl, (C2-C8) alkynyl, benzyl, aryl, or (C2-C5) heteroaryl; each occurrence of R6 is independently H, (C1-C8) alkyl, (C2-C8) alkenyl, (C2-C8) alknyl, benzyl, aryl, (C2C5) heteroaryl, or (C0-C8) alkyl-C(O)OR5, or the R6 group can join to form a heterocycloalkyl group; and the* represents a chiral-carbon center.

__________ 284

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

156801 ‫מעקב זמן בסביבת רווח רבת–נתיבים‬ ‫שאינה זניחה‬

]54[

TIME TRACKING IN A NONNEGLIGIBLE MULTIPATHSPACING ENVIRONMENT

]22[ ]31[

11.01.2002 60/261402 ]32[ 11.01.2001 ]33[ US 09/964589 25.09.2001 US Int. Cl.(2008.04) H04B 17/07, 7/06, 7/08 QUALCOMM INCORPORATED, U.S.A. WO/2002/061963 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A method for offset time tracking in a non-negligible multipath spacing environment encompassing an antenna diversity system, the antenna diversity system comprising a plurality of antennas each transmitting a modulated signal, the method comprising: demodulating each of the plurality of modulated signals based on a time offset, a plurality of data despreading sequences, and a plurality of pilot estimates, each signal having a different data despreading sequence of the plurality of data despreading sequences

and a different pilot estimate of the plurality of pilot estimates; generating a plurality of time tracking error signals, one for each of the plurality of demodulated signals, in response to a pilot despreading sequence for each of the plurality of demodulated signals; generating an average time tracking error signal in response to the plurality of time tracking error signals; and generating an updated offset in response to the average time tracking error signal.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

156862

285

‫אריג שאינו ארוג בלול באמצעות מים‬ ‫ושיטות והתקנים להכנתו‬

]54[

NONWOVEN HYDROENTANGLED FABRIC AND METHODS AND APPARATUS FOR PRODUCING THE SAME

]22[ ]51[ ]71[ ]87[ ]74[

12.01.2001 Int. Cl.(2008.04) D04H 1/46, 1/56, 3/10, 3/16, 5/02 POLYMER GROUP, INC., U.S.A. WO/2002/055778 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A nonwoven fabric formed on a three-dimensional image transfer device, said fabric consisting of a continuous web (8) of substantially endless thermoplastic melt extruded filaments (2) comprised of polyolefins, or polyesters, said filaments having a denier of about 0.5 to 3, wherein said filaments are collected and thereafter hydroentangled in the form of interengaged packed loops, with the

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

substantially endless filaments being substantially free of breaking, wrapping and knotting, said fabric exhibiting crossdirection elongation of at least about 90%, and machine direction elongation of at least about 75%, while exhibiting tensile strength generally proportional to crossdirection and machine-direction elongation values.

__________

]11[]21[ ]54[

286

SYSTEM FOR DETECTION AND

156868 ‫מערכת לזיהוי והערכה של מבנים מחזוריים‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

‫באות רועש‬

ESTIMATION OF PERIODIC PATTERNS IN A NOISY SIGNAL ]22[ ]51[ ]71[

10.07.2003 Int. Cl.(2008.04) A61B 5/05 RAFAEL ADVANCED DEFENSE SYSTEMS LTD.

]72[

LIDROR TROYANSKY, ARNON BREUER YORAM TSIVION, 2 HATOCHEN ST. P.O.B. 3148, CAESAREA 38900

]74[

[57] A method for discerning periodicities in signals, comprising the succession of steps of: sampling and preprocessing of the raw-signal in discrete succession of equally spaced slices of time; generating short-term characteristics vectors for each such slice of time;

,‫רפאל מערכות לחימה מתקדמות בע"מ‬ ‫חיפה‬ ‫ ארנון ברויאר‬,‫לידרור טרוינסקי‬ ,‫יורם צביון‬ ,3148 .‫ד‬.‫ ת‬, ‫ פארק התעשיה‬,2 ‫רח' הטוחן‬ ‫קיסריה‬ grouping said short-term characteristics vectors into sets; obtaining at least one representative vector for each of said sets of short-term characteristics vectors, and estimation of periodic structures using said representative vectors.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

287

]11[]21[ ]54[

FREQUENCY SEARCHER AND FREQUENCY-LOCKED DATA DEMODULATOR USING A PROGRAMMABLE ROTATOR

156947 ‫מחפש תדר ודימודולטור מידע נעול תדר‬ ‫המשתמש ברוטטור הנתון לתיכנות‬

]22[ ]31[

18.01.2002 60/262691 ]32[ 19.01.2001 ]33[ US 10/017073 07.12.2001 US ]51[ Int. Cl.(2008.04) H04B 17/07, H04L 27/22, 272/27 ]71[ QUALCOMM INCORPORATED, U.S.A. ]87[ WO/2002/069594 ]74[ SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122 [57] A searcher method for finding a increments to generate a total phase signal having a frequency deviation from increment; and when the total phase an expected frequency, the method increment has reached a predetermined comprising the steps of: initializing the total phase increment threshold, searcher on predetermined frequency bins; performing a phase rotation function that is determining a phase error in the signal; substantially equivalent to the total phase generating a phase increment in response increment. to the phase error; accumulating the phase

__________ ]11[]21[ ]54[

288

157030 ‫חומר סופג חבטה‬

IMPACT ABSORBING MATERIAL

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

23.01.2002 60/263644 ]32[ 24.01.2001 ]33[ Int. Cl.(2008.04) B32B 3/02, D04H 1/46 AUBURN UNIVERSITY, U.S.A. WO/2002/059412 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] An impact resistant material (10) comprising: a plurality of in-plane fibers defining a fabric plane, and a plurality of upright fibers, wherein at least a portion of each upright fiber is oriented generally

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

perpendicular to the fabric plane, said upright fibers comprising a ballistic fiber material (34), wherein said upright fibers comprise at least about 25% of said material.

__________ ]11[]21[

157208 ‫–אילבנזאמיד‬2–‫–אינדן‬N– ‫–פלואורו‬4 ‫והשימוש בו לייצור תרופות‬

]54[

USE OF 4-FLUORO-N-INDAN-2-YL BENZAMIDE FOR THE MANUFACTURE OF MEDICAMENTS

]22[ ]31[ ]51[ ]71[

12.02.2002 01102852.9 ]32[ 13.02.2001 ]33[ EP Int. Cl.(2008.04) A61K 311/66, A61P 9/00, C07C 233/65 SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2002/064146 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]87[ ]74[

[57] The use of 4-fluoro-N-indan-2-yl benzamide of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

289

for the manufacture of a medicament for the treatment of stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, thrombosis, peripheral artery occlusive disease, atherosclerosis, restenosis, endothelial damage after PTCA, hypertension, essential hypertension, pulmonary hypertension,

secondary hypertension, renovascular hypertension, chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, diabetes, nephropathy, retinopathy, angiogenesis, asthma bronchiale, chronic renal failure, cirrhosis of the liver or osteoporosis or for the lowering of cardiovascular risk of postmenopausal women or after intake of contraceptiva.

__________ ]11[]21[ ]54[

PROCESS FOR THE PREPARATION OF (E)-5-(2 BROMOVINYL)- 2'DEOXYURIDINE

]22[ ]31[ ]51[ ]71[

21.02.2002 10109657.7 ]32[ 28.02.2001 Int. Cl.(2008.04) C07H 190/73 MENARINI RICERCHE S.P.A., ITALY BERLIN-CHEMIE AG, GERMANY WO/2002/068443 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

157573 – )‫ – ברומוויניל‬E) – 5 – (2( ‫תהליך להכנת‬ ‫' – דאוקסיורידין‬2

]33[

DE

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] Process for the preparation of (E)-5(2-bromovinyl)-2'-deoxyuridine of the formula

290

September 22, 2009

–‫ד' בתשרי התש"ע‬

comprising: (a) reaction of a compound of the formula

in which R is an alkanoyl C1-C8 group, a benzyol group or a benzoyl group substituted at the para position with a C1C4 alkyl group or with a halogen atom, with a brominating agent in the presence of

a radical initiator, in a halogen-free solvent selected from an alkyl ester or a cyclic ether; (b) dehydrobromination of the resulting compound of the formula

wherein R has the above defined meaning, with or without bases, in a halogen-free

solvent to give an intermediate of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

291

wherein R has the above defined meaning; (c) deprotection of the intermediate of formula (IV).

__________ ]11[]21[

157589 ‫תרכובות קרבמט לשימוש במניעה ובטיפול‬ ‫בהפרעת ביפולאר‬

]54[

CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING BIPOLAR DISORDER

]22[ ]31[

21.02.2002 60/271680 ]32[ 27.02.2001 ]33[ US 10/081606 21.02.2002 US Int. Cl.(2008.04) A61K 31/27, A61P 25/18, 25/24, C07C 271/10 ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A. WO/2002/067924 DR. SHLOMO COHEN & CO., ,'‫ד"ר שלמה כהן ושות‬ 124 IBN GABIROL ST., ‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬ P.O.B. 11490, TEL AVIV 62038

]51[ ]71[ ]87[ ]74[

[57] A medicament comprising a therapeutically effective amount of an enantiomer of the formula

or enantiomeric mixture, wherein one enantiomer predominates, for use in preventing or treating bipolar disorder in a subject in need thereof,

wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl;

wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).

__________

292

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

157610 ‫שיטות לייצור תחמוצת מתכתית של‬ ‫ניוביום‬

]54[

METHODS OF MAKING A NIOBIUM METAL OXIDE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

27.02.2002 60/271983 ]32[ 28.02.2001 Int. Cl.(2008.04) C01G 33/00 CABOT CORPORATION, U.S.A. WO/2002/068333 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013

]33[

US

,'‫זליגסון גבריאלי ושות‬ ‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬

[57] A method of milling material comprising milling said material with a first milling media having a first size and then milling said material with a second milling media having a size smaller than

said first size, wherein said material comprises a getter material, a starting metal oxide, an oxygen reduced metal oxide, or combinations thereof.

__________

]11[]21[ ]54[

SKIN SUBSTITUTES AND USES THEREOF

]22[ ]31[

01.03.2002 60/273034 ]32[ 02.03.2001 60/287898 01.05.2001 Int. Cl.(2008.04) C12N 5/00, 5/02 STRATATECH CORPORATION, U.S.A. WO/2002/070729 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

]51[ ]71[ ]87[ ]74[

[57] A composition comprising a pregraft human skin equivalent, said pre-graft skin equivalent having a surface electrical capacitance of from about 40 to about 240 The applications for division September 22, 2009

–‫ד' בתשרי התש"ע‬

157667 ‫תחליפי עור ושימושיהם‬

]33[

US US

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ pF measured as the difference in reading over a 10 second interval, wherein said pre-graft skin equivalent comprises Near Diploid Immortalized Keratinocyte cells. ,195076

‫בקשות חלוקה מבקשה זו‬

293

.‫שטרם פורסמו‬

from this application have not yet been published

________ ]11[]21[

157695 ‫פולימרים אניונים המורכבים מחומצות‬ ‫דיקרבוקסיליות ומוצרי דשן המכילים אותם‬

]54[

ANIONIC POLYMERS COMPOSED OF DICARBOXYLIC ACIDS AND FERTILIZER PRODUCTS CONTAINING THEM

]22[ ]31[ ]51[ ]71[

27.02.2002 09/799210 ]32[ 05.03.2001 ]33[ Int. Cl.(2008.04) C05G 3/10, C08F 222/04 SPECIALTY FERTILIZER PRODUCTS, LLC, U.S.A. JOHN LARRY SANDERS, U.S.A. WO/2002/071086 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]87[ ]74[

[57] A polymer consisting of recurring polymeric subunits each made up of at least two different moieties individually and respectively taken from the group

US

,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬ ‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬

consisting of B and C moieties, or recurring C moieties, where moiety B is of the formula

and moiety C is of the formula

294

September 22, 2009

–‫ד' בתשרי התש"ע‬

wherein each R7 is individually and respectively selected from the group consisting of H, OH, C1-C30 straight, branched chain and cyclic alkyl or aryl groups, C1-C30 straight, branched chain and cyclic alkyl or aryl based ester groups, R'CO2 groups, OR' groups and COOX groups, wherein R' is selected from the group consisting of C1-C30 straight, branched chain and cyclic alkyl or aryl groups and X is selected from the group consisting of H, the alkali metals, NH4 and the C1-C4 alkyl ammonium groups, R3 and R4 are individually and respectively selected from the group consisting of H,

C1-C30 straight, branched chain and cyclic alkyl or aryl groups, R5, R6, R10 and R11 are indivudally and respectively selected from the group consisting of H, the alkali metals, NH4 and the C1-C4 alkyl ammonium groups, Y is selected from the group consisting of Fe, Mn, Mg, Zn, Cu, Ni, Co, Mo, V and Ca, and R8 and R9 are individually and respectively selected from the group consisting of nothing (i.e., the groups are non-existent), CH2, C2H4, and C3H6, each of said moieties having or being modified to have a total of two COO groups therein.

__________ ]11[]21[ ]54[

INJECTION NEEDLE ASSEMBLY

]22[

15.03.2002

September 22, 2009

–‫ד' בתשרי התש"ע‬

157945 ‫התקן מחט להזרקה‬

295

]31[ ]51[ ]71[

PA200100483 ]32[ 23.03.2001 Int. Cl.(2008.04) A61B 532/ NOVO NORDISK A/S, DENMARK NIPRO CORPORATION, JAPAN

]87[ ]74[

WO/2002/076540 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An injection needle assembly comprising: a needle cannula with a lumen extending through said needle cannula from a skin piercing distal end (4) to an opposite proximal end along a longitudinal axis of the needle cannula, which longitudinal lumen is cylindrical and has approximately the same uniform inside diameter through the needle cannula from the skin piercing distal end to the opposite proximal end, wherein a first elongated portion (6) of the needle cannula has a conical tapered outside over at least a part of the length which conical taper terminates at the skin piercing distal end, and a second elongated portion (7) of the

]33[

DK

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

needle cannula has an outside diameter equal to or larger than the largest diameter of the first elongated portion, characterized by a needle hub (14) comprising a base and an annular sleeve (16) extending from the base, the annular sleeve having means for removably mounting the hub onto a syringe, wherein the needle cannula is fastened in the base such that the first elongated portion extends from the base in a direction away from the sleeve and the second elongated portion extends in the opposite direction, the second portion being at least partly surrounded by the sleeve.

__________ ]11[]21[ ]54[

296

DEVELOPMENT AND TESTING SYSTEM AND METHOD

158007 ‫מערכת לפיתוח ובדיקה ושיטה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

22.03.2002 60/278212 ]32[ 23.03.2001 60/299555 19.06.2001 60/363436 11.03.2002 Int. Cl.(2008.04) G06F 11/28, 9/46 S2 TECHNOLOGIES, INC., U.S.A. WO/2002/077813 DR. SHLOMO COHEN & CO., 124 IBN GABIROL ST., P.O.B. 11490, TEL AVIV 62038

[57] A system for providing communication between a host computer and an embedded computer comprising: an embedded computer executing a plurality of threads that provide a communication interface, each communication interface having a plurality of data fields; a script engine for executing script instructions; a communication database identifying each of the communication interfaces, wherein the communication database is automatically generated, at least in part, from information comprising: an interface description file that defines the communications interfaces; machine characteristics of the embedded device; and machine characteristics of a platform that is executing the script engine; a

]33[

US US US

,'‫ד"ר שלמה כהן ושות‬ ‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬

communication module for providing an application programming interface for the script instructions to access the communication interface, wherein the communication module is automatically generated based upon information from information from the communication database; and wherein the script instructions identify at least one of the communication interfaces in the communication database and invoke a function with respect to at least one field in the identified communication interface via the application programming interface, wherein the function is selected from the group comprising: storing data in one of the data fields, reading data from one of the data fields, and testing a data field.

__________ ]11[]21[

September 22, 2009

–‫ד' בתשרי התש"ע‬

158102

297

]54[

SCALABLE AUDIO/CODING METHOD AND APPARATUS

]22[ ]31[

24.09.2003 97-12232 ]32[ 02.04.1997 97-61298 19.11.1997 Int. Cl.(2008.04) G10L 21/00 SAMSUNG ELECTRONICS CO., LTD., REPUBLIC OF KOREA SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]74[

[57] A computer usable medium having computer readable program code means embodied therein for coding audio signals into a layered datastream having a base layer and enhancement layers of a predetermined number, the computer readable program code means in said computer usable medium comprising: (a) computer readable program code means for causing a computer to effect signalprocessing input audio signals and quantizing the same for each predetermined coding band; (b) computer readable program code means for causing a computer to effect coding the quantized data corresponding to the base layer within a predetermined layer size; (c) computer readable program code means for causing a computer to effect coding the quantized data corresponding to the next

‫פענוח של צננים‬/‫מתקן ושיטה להצפנה‬ ‫שמעיים שניתן לייצגו‬

]33[

KR KR

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ enhancement layer of the coded base layer and the remaining quantized data uncoded and belonging to the enhancement layer, within a predetermined layer size; and (d) computer readable program code means for causing a computer to effect sequentially performing the layer coding steps for all layers, wherein the computer readable program code means (b), (c) and (d) each comprise; (e) computer readable program code means for causing a computer to effect representing the quantized data corresponding to a layer to be coded by digits of a predetermined number; and (f) computer readable program code means for causing a computer to effect coding the most significant digit sequences of most significant digits of the magnitude data of said quantized signal-processing input audio signals.

__________ 298

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

METHOD FOR PREPARING (E) -7[2 - CYCLOPROPYL - 4 - (4 FLUOROPHENYL)- QUINOLIN- 3 YL] - 3, 5 - DIHYDROXYHEPT-6ENOATES

]22[ ]31[ ]51[ ]71[

22.03.2002 2001-106820 ]32[ 05.04.2001 Int. Cl.(2008.04) C07D 215/14 NISSAN CHEMICAL INDUSTRIES LTD., JAPAN KENICHI TOKUNAGA, MASAMI KOZAWA, KENJI SUZUKI WO/2002/081451 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120

]72[ ]87[ ]74[

158151 ‫ – ציקלופרופיל‬E) – 7 – [2( ‫שיטות להכנת‬ ]‫ – יל‬3 – ‫ – פלואורופניל) – קווינולין‬4( – 4 – ‫ אנואטים‬6 – ‫ – דיהידרוקסיהפט‬5 ,3 –

]33[

JP

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ ,‫פטנטים‬ ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬

[57] Method for preparing a 7-quinolinyl3,5-dihydroxyhept-6-enoate of the formula

(wherein R represents an alkyl group or a an aryl group), characterized in that a compound of the formula

(wherein R is as defined above), or a compound of the formula September 22, 2009

–‫ד' בתשרי התש"ע‬

299

(wherein R is as defined above), is reduced by sodium borohydride in a reaction solvent in the presence of a boron compound of the formula R'OBR" 2 (wherein R' and R" represent independently an alkyl group), the reaction

solvent is removed, and then the resultant reaction mixture is treated with an aqueous solution of hydrogen peroxide in the presence of an inorganic base in a two phase system with an organic solvent which separates from water.

__________

]11[]21[ ]54[

USE OF FATTY ALCOHOL ETHOXYLATES AS PENETRATION PROMOTERS

]22[ ]31[ ]51[ ]71[

02.04.2002 10118076.4 ]32[ 11.04.2001 Int. Cl.(2008.04) A01N 43/40, 47/40 BAYER CROPSCIENCE AG, GERMANY WO/2002/098230 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

158180 ‫שימוש בכהלים אתוקסילטוטים שומניים‬ ‫כמסייעים להחדרה‬

]33[

DE

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] Use of fatty alcohol ethoxylates of the formula

in which

300

September 22, 2009

–‫ד' בתשרי התש"ע‬

m represents average values from 8.0 to 13.0 and n represents average values from 6.0 to 17.0 for the preparation of penetrating plant treatment compositions containing insecticidally active compounds from the group of the neonicotinyls, where said fatty alcohol ethoxylates are employed in

such amounts that, in commercial formulations, they are present in concentrations from 0.1 to 30% by weight, and the weight ratio of insecticidally active compound from the group of the neonicotinyls to said fatty alcohol ethoxylate is from 1:0∙1 to 1:2.0.

__________

]11[]21[

158185 –‫–הלו–בתא‬2' ‫תהליך להכנת נוקליאוצידים‬ ‫–אראבינופואנוציל‬L

]54[

PROCESS FOR THE PREPARATION OF 2'-HALOBETA-L-ARABINOFURANOSYL NUCLEOSIDES

]22[ ]31[ ]51[ ]71[

29.03.2002 60/280307 ]32[ 30.03.2001 ]33[ Int. Cl.(2008.04) C07H 15/04, 19/04, 190/73 BUKWANG PHARMACEUTICAL CO., LTD., REPUBLIC OF KOREA WO/2002/079213 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] A process for the preparation of a 2'deoxy-2'-halo-β-L-arabinofuranosyl nucleoside of the formula

September 22, 2009

–‫ד' בתשרי התש"ע‬

301

wherein X is a halogen (F, Cl, Br or I); and B is a pyrimidine, purine, heterocylic or heteroaromatic base; by preparing a 2-

deoxy-2-halo-L-arabinofuranose comprising the steps of: (a) obtaining a 2-dexoy-2-halo-Larabinopyranose of the formula

wherein each of R1 and R2 is independently hydrogen, alkyl, acyl or silyl; and

(b) converting the 2-deoxy-2-halo-Larabinopyranose to the 2-deoxy-2-halo-Larabinofuranose. __________

]11[]21[ ]54[

CYLINDRICAL WING TIP WITH HELICAL SLOT

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

09.04.2002 01/04998 ]32[ 11.04.2001 Int. Cl.(2008.04) B64C 23/06 CHRISTIAN HUGUES, FRANCE WO/2002/083497 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] Wingtip device integrated with or articulated on said wingtip, the object of which is to increase lift, reduce induced drag and marginal swirl (vortex) to increase lift/drag ratio, characterized by the fact that it resembles a goose feather or

302

158327 ‫קצה כנף צילינדרית עם חריץ סלילי‬

]33[

FR

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

small tongue (18) with an ovoid bevel cut (15) on the opposite side to the device attachment (24) and towards leading edge (1), the body of which represents a cylindrical or approximately cylindrical cavity, approximately spiral in form and/or September 22, 2009

–‫ד' בתשרי התש"ע‬

approximately spiral with a helical or approximately helical slot, with the tip of said small tongue always or approximately always having the same diameter, said device commencing at leading edge on upper surface (10), then broadening to form an approximately semi-cylindrical shape up to the approximately cylindrical inlet approximately at the point of maximum wing thickness, where starts a rolled up envelope surface part in seemingly helical form (29) between approximately 180o and 360o; showing, on an approximately helical slot round axis (9) arranged approximately along and parallel to wingtip airfoil chord (6) this approximately helical slot at helix angle and with thickness that can be approximately adapted to the airfoil and wing aspect-ratio, wing taper, wing sweep, speed and angle of attack in the medium considered, whether gaseous or liquid, in which the wing moves, and on the flow path along this approximately helical slot, the trailing edge of the wingtip runs approximately the mid-point of thickness of said approximately helical slot always

in continuity, so that the depth of said device extends beyong trailing edge of the wingtip to about one third of the depth of the chord and terminating in a approximately annular form, said device making it possible to thus increase lift/drag ratio by decreasing resistance to the vortex effect induced by relative wind (16) penetrating frontally, and lateral induced flow (26) from overpressure (13) on undersurface (11), to direct and merge the flows in a cylindrical duct to the point of ejection; said device being applicable to airplanes, gliders, all types of blade, tractor and pusher propellers, wind-powered generator blades, also underwater devices for surface vessels or submarines using standard or symmetrical profiles to move in one, two or three axes, thus providing for the use of lower power drive systems, longer distance travel at higher speeds and with reduced energy consumption, or increased energy production in the case of wind-powered generators, and even transport of heavier loads and increased safety for transit, incoming and outgoing airport traffic.

__________ ]11[]21[ ]54[

THERAPEUTIC COMPOSITIONS FOR TARGETING LYSOSOMES

]22[

30.04.2002

September 22, 2009

–‫ד' בתשרי התש"ע‬

158623 ‫תכשירים רפואיים להכוונה לליזוזומים‬

303

]31[

]51[ ]71[ ]87[ ]74[

60/287531 ]32[ 30.04.2001 ]33[ US 60/304609 10.07.2001 US 60/329461 15.10.2001 US 60/351276 23.01.2002 US Int. Cl.(2008.04) A61K 45/00, 47/00, 47/48, A61P 3/00, C07K 19/00 ZYSTOR THERAPEUTICS, INC., U.S.A. WO/2002/087510 BOROCHOV, KORAKH & CO., ,'‫בורוכוב קורח ושות‬ 15TH FLOOR, ATIDIM TOWER, ‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬ KIRYAT ATIDIM, P.O.B. 58100, TEL AVIV 61580

[57] A targeted therapeutic comprising a lysosomal enzyme and a peptide that binds an extracellular domain of human cationindependent mannose-6-phosphate receptor in a mannose-6-phosphateindependent manner, wherein the peptide: (a) has sufficient amino acid sequence identity to human IGF-II such that the peptide binds the human cationindependent mannose-6-phosphate receptor; or The applications for division from this application have not yet been published

(b) comprises IGF-II or an antibody variable domain that recognizes the receptor; or (c) comprises the amino acid sequence of IGF-I or of a mutein of IGF-I which: (i) amino acids 55 and 56 are changed; or (ii) amino acids 1-4 are deleted or changed; or (iii) amino acids 55 and 56 are changed and amino acids 1-4 are deleted or changed. ,197348

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ ]11[]21[

158728 ‫תולדות פיפראזין אוקסים בעלות פעילות‬ NK–1 ‫מעכבת לקולטן‬

]54[

PIPERAZINE OXIME DERIVATIVES HAVING NK-1 RECEPTOR ANTAGONISTIC ACITIVITY

]22[ ]31[ ]51[ ]71[

03.07.2002 01202631.6 ]32[ 09.07.2001 ]33[ EP Int. Cl.(2008.04) A61K 314/95, A61P 25/00, C07D 403/06, 403/14, 405/06, 413/12 SOLVAY PHARMACEUTICALS B.V., THE NETHERLANDS WO/2003/006459 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

304

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] Compounds of the formula:

wherein: X represents phenyl or pyridyl substituted with 1 to 2 substituents from the group CH3, CF3, OCH3, halogen, cyano and 5CF3-tetrazol-1-yl; Y represents 2- or 3-indolyl, phenyl, 7-azaindol-3-yl or 3-indazolyl, 2-naphthyl, 3benzo[b] thiophenyl or 2-benzofuranyl, which groups may be substituted with one or more halogen or alkyl (1-3C); n has the value 0-3; m has the value 0-2; R1 represents NH2, NH-alkyl (1-3C), dialkyl (1-3C)N, morpholino or morpholino

substituted with one or two methyl and/or methoxymethyl groups, thiomorpholino, 1,1-dioxothiomorpholino, 2-, 3- or 4pyridyl or 4-CH3-piperazinyl; R2 is hydrogen, alkyl (1-4C) or phenyl, or R2 together with (CH2)m wherein m is 1, and the intermediate carbon, nitrogen and oxygen atoms forms an isoxazolyl or a 4,5dihydroisoxazolyl group; R3 and R4 independently represent hydrogen or methyl, or R3 and R4 together are oxygen; and physiologically acceptable salts thereof.

__________ ]11[]21[

158884 ‫פרוצדורה עבור מדידת איכות דינמית של‬ ‫ערוץ עבור אפנון מוסגל ושיטות הצפנה‬

]54[

DYNAMIC CHANNEL QUALITY MEASUREMENT PROCEDURE FOR ADAPTIVE MODULATION AND CODING TECHNIQUES

]22[ ]31[

15.04.2002 60/290877 ]32[ 14.05.2001 ]33[ US 029569 21.12.2001 US Int. Cl.(2008.04) H04B 17/00, 7/26, H04J 13/00, H04L 1/00, 12/56, H04Q 7/38 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2002/093951 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A user equipment mobile terminal (UE) comprising: a receiver configured to receive a request to begin channel quality (CQ) measurements; a transmitter September 22, 2009

–‫ד' בתשרי התש"ע‬

configured to transmit CQ measurement results in response to the request; and the receiver being further configured to receive an allocation of radio resources,

305

the allocation of radio resources being based on the CQ measurement results, and

to receive downlink data in accordance with the allocation of radio resources.

__________

]11[]21[

158915 ‫חומצת שומן גראם חיובית לפירוק ושיטה‬ ‫לפרק חומצת שומן או שומן‬

]54[

GRAM-POSITIVE FATTY ACID DEGRADER AND A METHOD FOR DEGRADING FATTY ACID OR GREASE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

26.04.2002 09/861142 ]32[ 18.05.2001 ]33[ US Int. Cl.(2008.04) C02F 3/34, C12N 1/20, 1/38, C12R 1/11 NOVOZYMES A/S, DENMARK WO/2002/094181 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

[57] A composition comprising Bacillus megaterium having all of the characteristics of strain SB-3112, ATCC PTA-3142, and a component selected from the group consisting of a non-toxic nutrient

formulation, surfactant, activator, preservative, filler, stabilizer, fragrance, viscosifier, enzymes, and a combination thereof.

__________ 306

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

METHOD AND SYSTEM FOR DETERMINING THE RANGE AND VELOCITY OF A MOVING OBJECT

]22[ ]51[ ]71[

18.11.2003 Int. Cl.(2008.04) G01S 13/58, 72/92 EL-OP ELECTRO-OPTICS INDUSTRIES LTD.

]72[ ]74[

YAIR SHIMONI BOROCHOV, KORAKH & CO., 15TH FLOOR, ATIDIM TOWER, KIRYAT ATIDIM, P.O.B. 58100, TEL AVIV 61580

[57] Device for determining a range of a moving object, when a received signal respective of a sequence of pulses, transmitted toward said moving object, is of the order of ambient noise, the device comprising: at least one sampler for producing a plurality of sampled signals, by sampling said received signal; a multiprocess array running a plurality of processes, said multi-process array being coupled with said at least one sampler, wherein each of said processes is associated with one of said at least one sampler, each of said processes being

158937 ‫שיטה ומערכת לקביעת טווח ומהירות של‬ ‫גוף בתנועה‬

,‫אופטיקה בע"מ‬-‫אופ תעשיות אלקטרו‬-‫אל‬ ‫רחובות‬ ‫יאיר שמעוני‬ ,'‫בורוכוב קורח ושות‬ ‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬

associated with a respective time shift which is determined according to a respective radial velocity assumption of said moving object with respect to said device, and with the pulse rate of said sequence of pulses, each of said processes producing a signal summation by sequentially shifting said sampled signals by said respective time shift, and adding together said sampled signals; and a selector coupled with said multi-process array, said selector determining said range according to at least one signal summation which includes a summed pulse event.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

307

]11[]21[

158986 ‫אמצעי תקשורת עם אנטנה חכמה‬ ‫המשתמשת באות כיוון איכותי‬

]54[

COMMUNICATION DEVICE WITH SMART ANTENNA USING A QUALITY-INDICATION SIGNAL

]22[ ]31[ ]51[ ]71[

09.05.2002 60/294290 ]32[ 31.05.2001 ]33[ US Int. Cl.(2008.04) H04B 17/07, 7/06, 7/10, 7/26, 70/05 MAGNOLIA BROADBAND, INC., U.S.A. WO/2002/099999 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]87[ ]74[

[57] A method for a first communication device to communicate with a second communication device over a communication link, the first communication device having a plurality of antenna elements, the method comprising: receiving a quality-indication signal from the second communication device, the communication link configured according to at least one Code-DivisionMultiple-Access (CDMA) protocol from the group of CDMA-IS-95 A/B, CDMA 2000 IX/RTT, CDMA 2000 3X, CDMA EV-DO, WCDMA, 3G Universal Mobile Telecommunications System (UMTS) and 4G UMTS, the quality-indication signal being a power-control bit according to the CDMA protocol, the power-control bit having a value of one or zero for each time period from a plurality of time periods, the power-control bit being generated by the second communication device and indicating an adjustment to a power of a transmitted signal at the first communication device so that a predetermined threshold requirement for the second communication device can be satisfied; calculating a complex weighting based on the quality-indication signal, the

308

complex weighting being associated with a total power of the transmitted signal and at least one from a phase rotation and a power ratio associated with each antenna element from the plurality of antenna elements, the complex weighting associated with the total power of the transmitted signal and the phase rotation associated with each antenna element from the plurality of antenna elements, the calculating of the complex weighting being performed for each antenna element from the plurality of antenna elements and wherein said calculating includes: adjusting the total power of the transmitted signal while maintaining the phase rotation associated with an antenna element from the plurality of antenna elements until a steady state is obtained at a first time; adjusting the phase rotation associated with each antenna element from the plurality of antenna elements while maintaining the total power of the transmitted signal to produce an optimal phase rotation for each antenna element; and adjusting the total power of the transmitted signal while maintaining the optimal phase rotation for each antenna element until a second steady state is September 22, 2009

–‫ד' בתשרי התש"ע‬

obtained at a second time subsequent to the first time; modifying a pre-transmission signal based on the complex weighting to produce a plurality of modified pretransmission signals, each modified pretransmission signal from the plurality of modified pre-transmission signals being

uniquely associated with an antenna element from a plurality of antenna elements; and sending the plurality of modified pre-transmission signals from the plurality of antenna elements to produce the effective combined transmitted signal.

__________ ]11[]21[

159151 ‫ תהליך‬,‫פולימורף יציב של פליבאנסרין‬ ‫טכני להכנתו והשימוש בו להכנת תרופות‬

]54[

STABLE POLYMORPH OF FLIBANSERIN, TECHNICAL PROCESS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

]22[ ]31[

30.07.2002 01118593.1 ]32[ 02.08.2001 ]33[ EP 01130180.1 19.12.2001 EP Int. Cl.(2008.04) A61K 314/95, A61P 25/00, C07D 403/06 BIDACHEM S.P.A., ITALY WO/2003/014079 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] Crystalline polymorph A (form A) of flibanserin

September 22, 2009

–‫ד' בתשרי התש"ע‬

309

having an endothermic maximum at 161oC which occurs during thermal analysis using DSC and process for its preparation,

characterized in that in a first reaction step a benzimidazolone derivatire:

wherein R denotes a suitable aminoprotecting group, is reacted with a piperazine derivative:

wherein X is a leaving group selected from chlorine, bromine, iodine, methanesulphonate, trifluoromethanesulphonate and paratoluenesulphonate in a suitable solvent selected from water, alcohols, mixtures of

water with alcohols, polar aprotic solvents and mixtures thereof with water in presence of a suitable base and that in a second reaction step the amino protecting group R is cleaved under suitable cleaving conditions.

__________ ]11[]21[

159260 ‫ ערכות ומחסניות‬,‫ תרכובות‬,‫תהליכים‬ ‫ של‬18 ‫להכנת סמנים המסומנים באיזוטופ‬ ‫פלואור ושימושם בטופוגרפיה של פליטת‬ ‫פוזיטרונים‬

]54[

PROCESSES, COMPOUNDS, KITS AND CARTRIDGES FOR THE PRODUCTION OF TRACERS LABELED WITH F18 AND USES THEREOF IN POSITRON EMMISION TOMOGRAPHY

]22[ ]31[ ]51[

18.06.2002 0115927.6 ]32[ 29.06.2001 ]33[ GB Int. Cl.(2008.04) A61K 101/02, 51/04, C07B 59/00, C07C 229/36, 309/69, C07D 239/54, C07H 11/00, C07M 5/00 GE HEALTHCARE LIMITED, UNITED KINGDOM

]71[

310

September 22, 2009

–‫ד' בתשרי התש"ע‬

]87[ ]74[

HAMMERSMITH IMANET LIMITED, UNITED KINGDOM WO/2003/002157 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A process for the production of an 18 F-labeled tracer which comprises treatment of a resin-bound precursor of the formula solid support – linker – x- tracer precursor wherein X is a group which

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

promotes nucleophilic substitution at a specific site on the attached tracer precursor; with 18F to produce the labeled tracer of the formula 18F-TRACER.

__________

]11[]21[

159298 ‫התקן ושיטה לסימון מים של תמונה‬ ‫דיגיטלית‬

]54[

APPARATUS AND METHOD FOR WATERMARKING A DIGITAL IMAGE

]22[ ]31[ ]51[ ]71[

13.06.2002 09/881017 ]32[ 13.06.2001 ]33[ US Int. Cl.(2008.04) G06T 1/00, H04N 7/08, 70/81, 71/67 QUALCOMM INCORPORATED, U.S.A. WO/2002/101648 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] An apparatus for adding a watermark to a moving image as it is displayed, the apparatus comprising: a watermark generator in which data representing a watermark is generated containing first information pertaining to the displaying of the moving image and protected by forward error encoding and second information pertaining to the displaying of September 22, 2009

–‫ד' בתשרי התש"ע‬

the moving image and protected by scrambling; and a watermark applicator for applying the watermark data to image data representing substantially all of the moving image depending on a characteristic of the data, wherein the watermark generator is connected to receive at least one of program data identifying the moving image and frame data unique in identifying

311

a predetermined number of frames of the moving image as said second information

pertaining to the displaying of the image.

__________ ]11[]21[

159323 ‫ארכיטקטורה סף מסתגל בעלת שני‬ ‫מצבים עבור מערך מוקדי מישורי של‬ ‫מגלה טווח לייזר תלת מימדי‬

]54[

DUAL MODE ADAPTIVE THRESHOLD ARCHITECTURE FOR 3-D LADAR FOCAL PLANE ARRAY

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

08.01.2003 10/040214 ]32[ 08.01.2002 ]33[ US Int. Cl.(2008.04) G01S 17/00, 17/10, 17/89, 7/48, 74/81, 74/87 RAYTHEON COMPANY, U.S.A. WO/2003/058274 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

[57] An integrated detector and signal processor (31) for ladar focal plane arrays (30) comprising: a first circuit (42) for receiving an input signal, wherein said first circuit is located in an interior of said array; a second circuit (72) for generating an adaptive threshold setting based on a characteristic of said input signal; and a third circuit (74) for

312

detecting when said input signal is above said threshold, characterized in that said second and third circuits are located on a periphery of said array, and said second circuit is comprised in a threshold generation and detection unit (52) which continuously monitors said input signal and estimates the noise level to set said threshold. September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

METHOD AND DEVICES FOR DATA TRANSFER

]22[ ]51[ ]71[

28.06.2001 Int. Cl.(2008.04) G06F 13/00, 13/36 TREK 2000 INTERNATIONAL LTD., SINGAPORE WO/2003/003141 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

September 22, 2009

–‫ד' בתשרי התש"ע‬

159391 ‫שיטה והתקן להעברת מידע‬

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

313

[57] A method of transferring data between a plurality of electronic devices including a computer device, a portable transfer apparatus and one or more secondary devices external to the computer device, each of the computer device and the secondary devices including wireless communication means, and the transfer apparatus comprising a processor, a nonvolatile memory having a capacity of at least 1 GB and wireless transceiver means, the method including the steps of: a first

one of the devices transmitting a wireless signal to the transceiver means including data for transmission to the computer device, the processor storing the data as at least one file in a directory, in the nonvolatile memory of the transfer apparatus, the computer device reading the directory on the transfer apparatus and selecting some or all of the files stored therein; and the processor using the transceiver means to transmit the selected files to the computer device.

__________ ]11[]21[

159412 ‫תצריף רוקוחות סינרגיסטי למניעה או‬ ‫טיפול בסכרת‬

]54[

SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE PREVENTION OR TREATMENT OF DIABETES

]22[ ]31[

10.07.2002 P0102982 ]32[ 17.07.2001 ]33[ HU P0202204 05.07.2002 HU Int. Cl.(2008.04) A61K 314/55, 45/06, A61P 3/10, C07D 401/00 N-GENE RESEARCH LABORATORIES INC., U.S.A. WO/2003/007951 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

314

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] A synergistic pharmaceutical combination for the prevention or treatment of a prediabetic state, metabolic X-syndrome or diabetes mellitus as well as disorders which are associated with the states listed above, namely endogenic metabolic disorders, insulin resistance, dislipidemia, alopecia and/or diffuse effluvium comprising (a) a first pharmaceutical composition containing an antidiabetic active agent selected from the group consisting of insulin, peroxisome proliferator-activated receptor γ-agonists, sulfonylurea

derivatives and biguanidine derivatives or an anti-hyperlipidemic active agent, namely a HMG coenzyme reductase inhibitor or, if desired and chemically possible, a pharmaceutically suitable acid addition salt or a salt formed with a pharmaceutically suitable base thereof and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-lpropyl) nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof, and one or more conventional carrier(s).

__________ ]11[]21[ ]54[

IN VIVO SENSING DEVICE WITH A CIRCUIT BOARD HAVING RIGID SECTIONS AND FLEXIBLE SECTIONS

]22[ ]31[ ]51[ ]71[ ]72[ ]87[ ]74[

18.06.2002 60/298387 ]32[ 18.06.2001 Int. Cl.(2008.04) A61B 5/07 GIVEN IMAGING LTD. DOV AVNI WO/2002/102224 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

[57] A swallowable in vivo sensing capsule (10) comprising: a circuit board that comprises at least two rigid sections (33, 35) and a flexible section (32')

September 22, 2009

–‫ד' בתשרי התש"ע‬

159450 ‫מכשיר לחישה תוך גופית עם לוח מעגלים‬ ‫שיש בו מקטעים קשיחים ומקטעים‬ ‫גמישים‬

]33[

US ‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬ ‫דב אבני‬

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ connecting said two rigid sections, and one or more batteries (25) positioned between the two rigid sections.

315

__________ ]11[]21[

159510 ‫שיטה ומתקן לבקרת רמת ההגברה בערוץ‬ CDMA ‫נוסף במערכת תקשורת‬

]54[

METHOD AND APPARATUS FOR CONTROLLING GAIN LEVEL OF A SUPPLEMENTAL CHANNEL IN A CDMA COMMUNICATION SYSTEM

]22[ ]31[ ]51[ ]71[

17.06.2002 09/895375 ]32[ 29.06.2001 ]33[ US Int. Cl.(2008.04) H04B 17/07, H04Q 7/22 QUALCOMM INCORPORATED, U.S.A. WO/2003/003593 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] In a code division multiple access communication system, a method for controlling gain of a forward supplemental channel comprising: determining gain level of a forward fundamental channel (Gfch), wherein said forward fundamental channel is associated with said forward supplemental channel for being targeted for a common mobile station; determining

316

an adaptive margin (Ma) for said forward supplemental channel; determining a forward supplemental channel gain (Gsch) based on said Gfch and said Ma; successively descreasing said Gsch for subsequent data frames targeted for said common mobile station on said forward supplemental channel.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

BALLNOSE END MILL

]22[ ]51[ ]71[ ]74[

29.12.2003 Int. Cl.(2008.04) B23C 5/00 HANITA METAL WORKS LTD. PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

[57] A ballnose end mill having a diameter and a central rotational axis about which the end mill is to be rotated, said end mill comprising: a shank portion being configured to be held by a tool; a fluted portion connected to said shank portion; said fluted portion comprising a rounded, semispherical tip portion disposed opposite said shank portion; and said fluted portion comprising: a first chip flute and a corresponding first cutting tooth; a second slip flute and a corresponding second cutting tooth; said first cutting tooth comprising a first flank surface; said second cutting tooth comprising a second flank surface; said first chip flute being September 22, 2009

–‫ד' בתשרי התש"ע‬

159639 ‫כרסום קצה–כדורי‬

‫חניתה מפעלי מתכת בע"מ‬ ,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ disposed to intersect with said first flank surface to form a first cutting edge; said second chip flute being disposed to intersect with said second flank surface to form a second cutting edge; said first cutting edge being disposed to extend along the length of said first chip flute and across a portion of said rounded, semispherical tip portion; said second cutting edge being disposed to extend along the length of said first chip flute and across a portion of said rounded, semispherical tip portion; said first flank surface merging with said second flank surface on said rounded, semispherical tip portion to form a continuous flank surface

317

extending continuously along the length of said first cutting tooth, across said rounded, semispherical tip portion, and along the length of said second cutting tooth; said first cutting edge comprises a first cutting edge end section and said second cutting edge comprises a second cutting edge end section; said first cutting edge end section is disposed to run on one side of the central rotational axis and said second cutting edge end section is disposed to run on another side of the central rotational axis; said first cutting edge end section and said second cutting

edge end section are each disposed on said tip portion at a distance from the central rotational axis; said first cutting edge end section is disposed opposite said second cutting edge end section about the central rotational axis and at least substantially parallel to said second cutting edge end section; and said continuous flank surface comprises a smooth uninterruptedly curved, rounded surface portion disposed between said first cutting edge end section and said second cutting edge end section and which said rounded surface portion passes through the central rotational axis.

__________ ]11[]21[

159698 ‫מלחים של נגזרות נוגדות פירכוסים‬

]54[

ANTICONVULSANT DERIVATIVE SALTS

]22[ ]31[ ]51[ ]71[

03.07.2002 60/303962 ]32[ 09.07.2001 ]33[ US Int. Cl.(2008.04) A61K 31/34, A61P 25/08, C07D 493/14 ORTHO-MCNEIL PHARMACEUTICAL, INC., U.S.A. WO/2003/006467 DR. SHLOMO COHEN & CO., ,'‫ד"ר שלמה כהן ושות‬ 124 IBN GABIROL ST., ‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬ P.O.B. 11490, TEL AVIV 62038

]87[ ]74[

[57] A crystalline sodium or potassium salt of a compound of the formula:

318

September 22, 2009

–‫ד' בתשרי התש"ע‬

wherein the salt of said compound is formed at the sulfamate group, and has a

structure selected from the group consisting of

__________ ]11[]21[

159770 ‫תכשירי רוקחות המכילים‬ ‫טריפלורואצטט הסידן עם פעילות‬ ‫ציטוטוקסית‬

]54[

PHARMACEUTICAL COMPOSITIONS CONTAINING CALCIUM TRIFLUOROACETATE HAVING CYTOTOXIC ACTIVITY

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

01.07.2002 MI2001A001495 ]32[ 12.07.2001 ]33[ IT Int. Cl.(2008.04) A61K 33/00, 33/06, 33/16, A61P 35/00 EUREON AG, GERMANY WO/2003/006031 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

September 22, 2009

–‫ד' בתשרי התש"ע‬

319

[57] The use of calcium trifluoroacetate for the preparation of cytotoxic medicaments for the treatment of tumours

substantially as described in the specification.

__________

]11[]21[ ]54[

MULTILAYER COMPOSITE ARMOUR

]22[ ]31[ ]51[ ]71[

12.07.2002 01/09261 ]32[ 12.07.2001 Int. Cl.(2008.04) F41H 5/04 ETAT FRANCAIS REPRESENTE PAR LE DELEGUE GENERAL POUR L'ARMEMENT, FRANCE ARC LEICHTMETALLKOMPETENZZENTRUM RANSHOFEN GMBH, AUSTRIA WO/2003/012363 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] Multilayer armour (1), comprising: a first material comprising a metal or a metal alloy; a second material where the second material is porous; and a cage made of plates having openings, wherein the second material is mounted in the cage and

320

159805 ‫שיריון מורכב משכבות‬

]33[

FR

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

the first material passes through the openings to infiltrate some or all of the pores of the second material and coats the cage, at least partly, with the first material, the melting point of the cage being higher than that of the first material.

September 22, 2009

–‫ד' בתשרי התש"ע‬

________

]11[]21[ ]54[

APPARATUS, METHOD AND SYSTEM OF TRANSFERRING CORRECTION INFORMATION

]22[ ]31[ ]51[ ]71[

19.07.2002 09/910365 ]32[ 20.07.2001 Int. Cl.(2008.04) G01S 1/00, 5/14 QUALCOMM INCORPORATED, U.S.A. WO/2003/008994 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]87[ ]74[

[57] A method comprising: calculating a plurality of correction factors, each correction factor relating to a position of at least a corresponding one among a set of physical objects; and transmitting said plurality of correction factors in a predetermined order, wherein said correspondence of each among said plurality of correction factors with at least one among the set of physical objects is indicated at least in part by said

September 22, 2009

–‫ד' בתשרי התש"ע‬

159806 ‫ שיטה ומערכת להעברת מידע‬,‫התקן‬ ‫תיקוני‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ predetermined order; wherein said calculating a plurality of correction factors comprises: computing a reference position of each among the set of physical objects; and computing a supplemental position of each among the set of physical objects, wherein each among said correction factors is based at least in part on a difference between said corresponding reference and supplemental positions.

321

__________

]11[]21[ ]54[

FUEL CELL WITH PROTON CONDUCTING MEMBRANE AND WITH IMPROVED WATER AND FUEL MANAGEMENT

]22[ ]31[

18.07.2002 60/305865 ]32[ 18.07.2001 60/305866 18.07.2001 Int. Cl.(2008.04) H01M 8/04 TEL-AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P. WO/2003/009410 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A cathode suitable for use in a fuel cell having a proton conducting membrane, the cathode comprising a plurality of layers including a catalyst layer and a hydrophobic porous support layer, wherein at least one of said plurality of layers is a liquid-water leak-proof layer

322

159878 ‫תא דלק בעל ממברנה מוליכת פרוטונים‬ ‫וניהול משופר של משק המים והדלק‬

]33[

US US

‫אביב פיתוח טכנולוגיות‬-‫אוניברסיטת תל‬ ‫ תל אביב‬,‫ שותפות מוגבלת‬,‫עתידיות‬ ,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

capable of allowing passage of gas and preventing passage of liquid water and/or aqueous fuel solution, from the cathode catalyst layer to the airside of the cathode and outside the fuel cell, wherein said fuel cell is a direct oxidation fuel cell fed by water soluble fuels.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________

]11[]21[ ]54[

TAMPON APPLICATOR WITH PETALS

]22[ ]31[ ]51[ ]71[

06.08.2002 923201 ]32[ 06.08.2001 Int. Cl.(2008.04) A61F 13/26 THE PROCTER & GAMBLE COMPANY, U.S.A. WO/2003/013407 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] An applicator (10) capable of receiving a tampon, having a tube (21) with a first end portion and a second end portion, the first end portion having an end portion edge (15), which is connected to or integral with a dome shaped insertion tip (20), said insertion tip extending from said end portion edge and having at least 3 petals (23); each petal having a first edge and a second edge, wherein the first edge and the second edge of each petal extends September 22, 2009

–‫ד' בתשרי התש"ע‬

159924 ‫ממקם טמפון בעל שוליים‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

from said end portion edge; wherein for each petal, at least a portion of the first edge of the petal is positioned on top of at least a portion of one directly neighbouring petal and at least a portion of the second edge of said petal is positioned under another directly neighbouring petal to form, for each petal, a region of overlap; and wherein said tampon is expelled through said petals of said applicator.

323

__________

]11[]21[ ]54[

METHOD AND APPARATUS FOR PRODUCING UNIFORM PROCESS RATES

]22[ ]31[

18.07.2002 60/308469 ]32[ 27.07.2001 10/033807 18.12.2001 Int. Cl.(2008.04) H01J 37/00 LAM RESEARCH CORPORATION, U.S.A. WO/2003/012821 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

]51[ ]71[ ]87[ ]74[

[57] An antenna arrangement for generating an electric field inside a process chamber, said antenna arrangement comprising: a first loop disposed around an antenna axis, comprising: a first turn with a first turn gap wherein a first end of the first turn is on a first side of the first turn gap and a second end of the first turn is on a second side of the first turn gap; a second turn with a second turn gap wherein a first end of the second turn is on a first side of the second turn gap and a second end of

324

159935 ‫שיטה והתקן לייצור שעורי עיבוד אחידים‬

]33[

US US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, the second turn is on a second side of the second turn gap, wherein the second turn is concentric and coplanar with the first and spaced apart from the first turn, and where the antenna axis passes through the centre of the first turn and second turn, and a first current path connector electrically connected to the first turn and the second turn comprising a spanning section between and coplanar with the first turn and the second turn and which spans the first turn gap, wherein the first current path September 22, 2009

–‫ד' בתשרי התש"ע‬

connector is connected between the first turn and the second turn and comprises: a spanning section with a first end and a second end, wherein the spanning section is substantially parallel to a circumference of the first turn; a first turn connector leg connected between the first end of the spanning section and the second end of the

first turn, wherein the first turn connector leg is substantially radial to the first turn, and a second turn connector leg connected between the second end of the spanning section and the first end of the second turn, wherein the second turn connector leg is substantially radial to the second turn.

__________ ]11[]21[ ]54[

METHOD AND DEVICE FOR ACTIVE RADIAL CONTROL OF WHEEL PAIRS OR WHEEL SETS ON VEHICLES

]22[ ]31[

29.07.2002 10137443.7]32[ 27.07.2001 21 Int. Cl.(2008.04) B61F 5/38 BOMBARDIER TRANSPORTATION GMBH, GERMANY WO/2003/010039 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]51[ ]71[ ]87[ ]74[

[57] A method for active radial control of the wheels (11) of at least one wheel unit (8, 9, 10) of a running gear, in particular a running gear of a rail vehicle, wherein September 22, 2009

–‫ד' בתשרי התש"ע‬

160014 ‫מתקן ושיטה לבקרה רדיאלית פעילה של‬ ‫זוגות גלגלים או מערכי גלגלים בכלי רכב‬

]33[

DE

,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬ ‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬

control movements are applied to said wheel unit characterised in that an integrated control with control movements in at least two non-identical frequency

325

ranges is carried out, wherein first control movements in a first frequency range, and second control movements in a second

frequency range, different from said first frequency range, are superimposed and applied to said wheel unit.

__________ ]11[]21[ ]54[

FROZEN CONFECTIONERY

]22[ ]51[ ]71[

17.08.2001 Int. Cl.(2008.04) A23G 9/00 SOCIETE DES PRODUITS NESTLE S.A., SWITZERLAND WO/2003/015530 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063

]87[ ]74[

[57] Frozen confectionery, comprising fat, sweetener, milk solids-not-fat, water and starch, characterized in that the sum of the quantities of starch and milk solids-

160054 ‫ממתק מוקפא‬

,‫ד"ר יצחק הס ושותפיו‬ ‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬

not-fat is between 2.5 and 18% by weight and in that the starch/milk solids-not-fat weight ratio is between 0.03 and 1.5.

__________

326

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

160140 ‫שיטה ומתקן לתקשורת מועברת בשידור‬ ‫המשתמשים בסיגנלים עוברי–פס עבור‬ ‫ביטול הפרעה–עצמית‬

]54[

METHOD AND APPARATUS FOR RELAYED COMMUNICATION USING BAND-PASS SIGNALS FOR SELF-INTERFERENCE CANCELLATION

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

24.09.2001 09/925410 ]32[ 08.08.2001 ]33[ US Int. Cl.(2008.04) H04B 1/50, 1/52, H04L 25/38, 25/52 VIASAT, INC., U.S.A. WO/2003/015295 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

[57] A method for providing selfinterference cancellation in two-way relayed electromagnetic communication between a first device and a second device through a relay station comprising the steps of: generating at said first device a modulated near signal; transmitting said modulated near signal from said first device to said relay station; receiving at said first device a composite signal from said relay station, said composite signal containing a relayed version of said modulated near signal and a relayed version of a modulated far signal transmitted from said second device; providing said composite signal in a representation as a first interface signal to a canceler module of said first device; providing a representation of said modulated near signal as a second interface signal to said canceler module, said second interface signal being of a frequency centered at a or near a second interface frequency not at baseband;

September 22, 2009

–‫ד' בתשרי התש"ע‬

canceling at said canceler module a portion of said relayed version of said modulated near signal from said representation of said composite signal using said second interface signal to a produce a cancellation-processed signal; outputting said cancellation-processed signal as a third interface signal from said canceler module; and wherein said canceling step includes; applying a time delay and phase rotation to a representation of said second interface signal to obtain a time-delayed and phase-rotated local near signal; correlating said time-delayed and phaserotated local near signal with at least a representation of said first interface signal to obtain correction signals for said timedelayed and phase-rotated local near signal; adaptively filtering said timedelayed and phase-rotated local near signal to produce a filtered signal; and applying said filtered signal with said at least said representation of said composite signal to yield said cancellation-processed signal.

327

__________ ]11[]21[

160232 ‫תכשירים למתן דרך הפה לטיפול‬ ‫בהפרעות בקרקפת‬

]54[

ORAL COMPOSITIONS FOR THE TREATMENT OF SCALP DISORDERS

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

14.11.2001 MI2001A001732 ]32[ 07.08.2001 ]33[ IT Int. Cl.(2008.04) A61K 35/00, 36/20, 36/87, A61P 17/14 INDENA S.P.A., ITALY WO/2003/013561 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] The use of (a) extract of Serenoa repens and (b) extract of Vitis vinifera in the free form and/or as phospholipid complexes for the

preparation of oral pharmaceutical compositions for the treatment and the prevention of scalp disorders.

__________

328

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

160235 ‫שיטה לנתינת כתובת ואיתות של יחידות‬ ‫משתמש רבגוניות בחריץ אחד‬

]54[

METHODS OF ADDRESSING AND SIGNALING A PLURALITY OF SUBSCRIBER UNITS IN A SINGLE SLOT

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

07.05.2003 09/910365 ]32[ 11.06.2002 ]33[ US Int. Cl.(2008.04) H04B 72/12, H04L 12/28, H04Q 7/22 MOTOROLA, INC., U.S.A. WO/2003/105378 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] In a system having at least a first slot, a method comprising the steps of: configuring the first slot into at least a first segment and a second segment, wherein the first slot comprises a fixed number of symbols; appropriating a first set of symbols to the first segment; and appropriating a second set of symbols to the second segment, wherein the sum of at

least the first set of symbols and the second set of symbols equals the fixed number of symbols, wherein the first segment is addressed to a first subscriber unit and the second segment is addressed to a second subscriber unit, and wherein the first segment is modulated at a first modulation rate and the second segment is modulated at a second modulation rate.

__________

]11[]21[

September 22, 2009

–‫ד' בתשרי התש"ע‬

160251

329

‫שיטה עבור בקשה לשידור חוזר אוטומטית‬ ‫בשכבה פיסית עבור תחנת בסיס‬

]54[

METHOD FOR PHYSICAL LAYER AUTOMATIC REPEAT REQUEST FOR A BASE STATION

]22[ ]31[

21.08.2002 939410 ]32[ 24.08.2001 ]33[ US 084043 27.02.2002 US Int. Cl.(2008.04) H04B 72/16, H04J 11/00, 13/00, H04L 1/16 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2003/019838 REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A method for adjusting data modulation at a base station comprising: receiving data in data blocks from a higher layer ARQ mechanism at a physical layer transmitter for transmission; formatting the received data blocks into packets for transmission, the packets being smaller in size than the data blocks, and each packet having a forward error correction (FEC) type of encoding/data modulation; appending an error check sequence for each packet; providing a physical layer ARQ mechanism performing steps including: transmitting the packets; storing the packets for retransmission in a buffer memory incorporated into the physical layer transmitter; monitoring a return channel for receipt of an acknowledgment for each packet that the packet has been received; limiting the number of retransmissions to an operator-defined integer value; clearing the buffer memory after the integer value is reached; and retransmitting an original or selectively modified packet at the physical layer transmitter in response to failure to receive

330

a corresponding acknowledgement for a given packet; wherein the physical layer ARQ mechanism and physical layer transmitter operate transparently with respect to the higher layer ARQ mechanism; receiving and demodulating received packets at a physical layer receiver; receiving a corresponding acknowledgement for a given packet at the physical layer receiver, wherein a mechanism configured to receive the corresponding acknowledgment for the given packet operates transparently with respect to the higher layer ARQ mechanism; collecting retransmission statistics and adjusting the particular encoding/data modulation using the collected statistics at an adaptive modulation and coding controller; buffering, decoding, and detecting packet errors at a combiner/decoder; and generating an acknowledgement for each received packet in an acknowledgment generator if that packet has an acceptable error rate.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

160305 ‫תכשירים ושיטות למודולציה של‬ DARPP–32 ‫פוספורילציה של‬

]54[

COMPOSITIONS AND METHODS FOR MODULATION OF DARPP-32 PHOSPHORYLATION

]22[ ]31[ ]51[ ]71[

12.08.2002 60/311641 ]32[ 10.08.2001 ]33[ US Int. Cl.(2008.04) A61K 49/00, G01N 33/15, 33/53, 335/67 THE ROCKEFELLER UNIVERSITY, U.S.A. WO/2003/014321 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method for identifying an agent for use in treating depression in a patient in need thereof, comprising: (a) contacting an agent with phosphatase 2C ("PP2C") and Ser137-phosphorylated Dopamine-and cyclic-AMP-Regulated PhosphoProtein of molecular weight 32,000 Dalton ("DARPP-32"); (b) detecting the amount of dephosphorylation of Ser137-

phosphorylated DARPP-32; and (c) testing the agent in an animal model of depression, wherein the agent is identified as an agent for use in treating depression if a decrease in the dephosphorylation of Ser137-phosphorylated DARPP-32 is detected in the presence of the agent in step (b) and if the agent is effective in the animal model tested in step (c).

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

331

]11[]21[

160331 ‫שיטה לביצוע בקשת שידור חוזר‬ ‫אוטומטית על שכבה פיסית עבור יחידת‬ ‫מנוי‬

]54[

METHOD FOR PHYSICAL LAYER AUTOMATIC REPEAT REQUEST FOR A SUBSCRIBER UNIT

]22[ ]31[

23.08.2002 939410 ]32[ 24.08.2001 ]33[ US 085187 27.02.2002 US Int. Cl.(2008.04) H04B 72/12, H04L 1/16, 1/18, 1/20, H04Q 7/22 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2003/019812 REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A method for adjusting data modulation at a subscriber unit, comprising: receiving data at a transmitter for transmission, wherein the received data is received in data blocks from a higher layer ARQ mechanism; formatting the received data into packets for transmission, wherein the packets are smaller in size than the data blocks, and each packet having a forward error correction (FEC) encoding/data modulation, and wherein the packets are transmitted using an orthogonal frequency division multiple access (OFDMA) air interface; appending an error check sequence for each packet; transmitting the packets; storing the packets for retransmission in a buffer memory incorporated into the transmitter; monitoring a return channel for receipt of an acknowledgment for each packet that that packet has been received; limiting the number of retransmissions to an operatordefined integer value; clearing the buffer memory after the integer value is reached; retransmitting an original or selectively modified packet at the transmitter, if an acknowledgment for that packet has not

332

been received within a predetermined period of time; collecting retransmission statistics; adjusting the particular encoding/data modulation of each packet using the collected retransmission statistics; wherein if the collected retransmission statistics indicate a low number of retransmissions, a higher capacity encoding/data modulation scheme is selected as the particular encoding/data modulation and if the collected retransmission statistics indicate a high number of retransmissions, a lower capacity encoding/data modulation scheme is selected as the particular encoding/data modulation; combining the retransmitted original or selectively modified packet with the transmitted packets; and selectively nulling subchannels from an OFDM frequency set wherein the use of a poor quality subchannel is precluded for a predetermined period and adding a previously nulled subchannel back into the OFDM frequency set where a retransmission rate or retransmission rate

September 22, 2009

–‫ד' בתשרי התש"ע‬

or link quality indicates a high quality for

the previously nulled subchannel.

__________ ]11[]21[

160352 ‫תת–רישום של שרת זכויות ניהול‬/‫רישום‬ DRM ‫דיגיטליות לתוך ארכיטקטורת‬

]54[

ENROLLING/SUB-ENROLLING A DIGITAL RIGHTS MANAGEMENT (DRM) SERVER INTO A DRM ARCHITECTURE

]22[ ]31[ ]51[ ]71[

12.02.2004 373458 ]32[ 25.02.2003 ]33[ US Int. Cl.(2008.04) G06F 21/24, G06Q 30/00, 50/00, H04L 9/32, H04N 71/67 MICROSOFT CORPORATION, U.S.A. REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

]74[

[57] A method in combination with a Digital Rights Management (DRM) system having a plurality of DRM servers performing DRM functionality, the method of an entering DRM-E server to be enrolled into the system by an enrolling DRM-R server such that the entering DRM-E server is to be trusted within the system and comprising: the DRM-E server procuring a public/private key pair (PU-E, PR-E) for identifying such DRM-E server within the DRM system; the DRM-E server procuring a proffering identification September 22, 2009

–‫ד' בתשרי התש"ע‬

thereof; the DRM-E server sending an enrollment request to the DRMR server, the request including the proffering identification and (PU-E); the DRM-R server validating the proffering identification; the DRM-R server, if the request is to be honored, generating a digital enrollment certificate for the DRME server to enroll such DRM-E server into the DRM system; the DRM-R server returning the generated enrollment certificate to the requesting DRM-E server; and the now-enrolled DRM-E server

333

storing the returned enrollment certificate in an appropriate location for future use, the DRM-E server with the enrollment certificate able to employ same to issue

DRM documents within the DRM system, the enrollment certificate employable to issue the DRM documents being based at least in part on (PU-E).

__________ ]11[]21[ ]54[

TRANSDERMAL THERAPEUTIC SYSTEM (TTS) WITH FENTANYL AS ACTIVE INGREDIENT

]22[ ]31[ ]51[ ]71[

10.07.2002 10141651.2 ]32[ 24.08.2001 Int. Cl.(2008.04) A61K 9/70 LTS-LOHMANN THERAPIESYSTEME AG, GERMANY WALTER MULLER WO/2003/018071 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120

]72[ ]87[ ]74[

[57] A transdermal therapeutic system (TTS) containing an active substance having increased security against overdose of the active substance comprising an active substance impermeable backing layer (1); an active substance layer (2), the active substance being fentanyl and/or a fentanyl analog derivative and/or a salt of fentanyl and/or a salt of a fentanyl analog

334

160515 ‫מערכת להעברה תוך עורית של פנטניל‬ ‫כחומר הפעיל‬

]33[

DE

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ ,‫פטנטים‬ ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬ derivative, where said active substance layer comprises a polymer or a polymer mixture with microreservoirs (3) dispersed therein, wherein the active substance is dissolved in the microresrvoirs and a membrane layer (4) following the skin side comprises of an ethylene-vinyl acetate copolymer or a polyethylene or polypropylene microporous film; September 22, 2009

–‫ד' בתשרי התש"ע‬

optionally a subsequent adhesive layer (5) and a protective layer (6), which is

removed before use.

__________ ]11[]21[ ]54[

SYSTEM AND METHOD FOR FAST DYNAMIC LINK ADAPTATION

]22[ ]31[ ]51[ ]71[

18.10.2002 60/344693 ]32[ 19.10.2001 Int. Cl.(2008.04) H04B 7/26, 70/05 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2003/041317 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A method for selecting a transport format combination (TFC) out of a transport format combination set (TFCS) for use in wirelessly transferring a coded composite transport channel (CCTrCh), the method comprising: selecting a TFC out of the TFCS; eliminating the selected TFC

September 22, 2009

–‫ד' בתשרי התש"ע‬

160526 ‫מערכת ושיטה לסיגנל קישור דינמי מהיר‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

for future selection and repeating the step of selecting a TFC, if a determined transmission power level for the selected TFC exceeds a maximum allowed power level; and transmitting the CCTrCh using the selected TFC, if the selected TFC was not eliminated.

335

The applications for division from this application have not yet been published

,194767

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ ]11[]21[

160700 ‫–פירימידון ותרופות‬4–‫–מותמרות‬3 ‫תולדות‬ ‫המכילות אותן לטיפול במחלת עצב ניוונית‬

]54[

3-SUBSTITUTED-4-PYRIMIDONE DERIVATIVES AND MEDICAMENTS COMPRISING THEM FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE

]22[ ]31[

20.09.2002 2001-331677 ]32[ 21.09.2001 ]33[ JP 2001-331678 21.09.2001 JP 2001-331674 21.09.2001 JP 2001-331675 21.09.2001 JP Int. Cl.(2008.04) A61K 315/13, 315/386, A61P 25/28, 3/10, C07D 401/04, 401/14, 405/14, 409/14, 413/14, 417/14, 498/10 SANOFI AVENTIS, FRANCE MITSUBISHI TANABE PHARMA CORPORATION, JAPAN WO/2003/037888 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

336

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] A pyrimidone derivative of the formula

or a salt thereof, or a solvate thereof or a hydrate thereof wherein R1 represents a

C1-C12 alkyl group; R represents any one of groups of the formulas

wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl

group and R4, R5, R6, R7, R8, R9, R10 and X are as defined in the specification.

__________ ]11[]21[ ]54[

FAST DURABLE MAGAZINE LOADER

]22[ ]31[ ]51[ ]71[

09.09.2002 145348 ]32[ 10.09.2001 Int. Cl.(2008.04) F41A 9/83 RAN TAL GUY TAL

]87[ ]74[

WO/2003/023308 GUY TAL, 86/2 SHILOH ST. , ROSH HA'AYIN

[57] A loading device for loading a plurality of ammunition rounds (50) or cartridges into a firearm magazine (60), said magazine comprising a substantially hollow body having a predetermined size and shape with a case end having a rim or September 22, 2009

–‫ד' בתשרי התש"ע‬

160729 ‫מטען מהיר ועמיד של מחסנית‬

]33[

IL ‫ תל אביב‬,‫רן טל‬ ‫ ראש העין‬,‫גיא טל‬ ,‫גיא טל‬ ‫ ראש העין‬,86/2 ‫רח' שילה‬

flange, and an opposite bullet or slug end, said loading device comprising: (a) an elongated body (2) having an upper surface with a magazine recess or compartment at one end of said body

337

which extends into said body from said upper surface, (b) said magazine recess having a predetermined shape and size for receiving and holding said firearm magazine, (c) said body having an elongated rounds recess or slideway at another end of said body extending into said body from said upper surface, (d) said elongated rounds recess communicating with said magazine recess, (e) said elongated rounds recess having a bottom and a pair of opposing sidewalls, (f) each of said sidewalls having at its tip a protruding elongated projection, ledge, or rib so as to provide and partially define an elongated groove or recess on each sidewall under said elongated projection, (g) the groove on one sidewall being a case-holding groove and having a predetermined shape and size so that it can hold and slidingly guide said case ends of said plurality of said rounds when said case ends are stacked in said case-holding groove, (h) the groove on the opposite sidewall being a bullet-holding groove and having a predetermined shape and size so that it can

338

hold and slidingly guide said bullet ends of said plurality of said rounds when said bullet ends are stacked in said bulletholding groove, (i) said case-holding and bullet-holding grooves thus enabling said rounds to slide in and be captured by said elongated rounds recess with said case and bullet ends in said case-holding and bulletholding grooves, respectively, and (j) a slider (40) or pusher having a plunger positioned in and extending between said case-holding and bullet-holding grooves, said plunger being shaped to fit in said case-holding and said bullet-holding grooves, such that said plunger can slide in said rounds recess, whereby when said magazine is placed in said magazine recess, a user can load it with said ammunition rounds quickly, easily, and safely by inserting said rounds in said rounds recess and moving said slider toward said magazine to force said rounds sequentially into said magazine, and said loading device has few parts, lighter weight, requires less handling time, and is more durable.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

160734 ‫תכשיר רוקחות המכיל גמא–בוטירובטאין‬ ‫ושימוש שלו‬

]54[

PHARMACEUTICAL COMPOSITION COMPRISING GAMMA-BUTYROBETAINE AND USE THEREOF

]22[ ]31[ ]51[ ]71[

04.03.2002 P-01-00134 ]32[ 07.09.2001 ]33[ LV Int. Cl.(2008.04) A61K 311/95, 312/05, 45/00, A61P 15/10, C07C 229/10, 243/14 IVARS KALVINSH, LATVIA MARIS VEVERIS, LATVIA ANATOLIJS BIRMANS, LATVIA

]87[ ]74[

WO/2003/022262 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

[57] Use of gamma-butyrobetaine as free base or its pharmaceutically acceptable salt

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ for producing a medicament for treatment of impotence in male mammals.

__________ ]11[]21[ ]54[

CUTTING TOOL AND CUTTING INSERT THEREFOR

]22[ ]51[ ]71[ ]72[ ]74[

18.03.2004 Int. Cl.(2008.04) B23B 27/04 ISCAR LTD. GIL HECHT ISCAR LTD., P.O.B. 11,TEFEN 24959

[57] A cutting tool comprising an insert holder and a cutting insert, the insert holder comprising a body portion and a clamping portion, the clamping portion comprising a base jaw, a clamping jaw and an insert pocket therebetween, the insert pocket extending from a pocket opening at a forward end of the pocket to a rear end

September 22, 2009

–‫ד' בתשרי התש"ע‬

160935 ‫כלי חיתוך ושימת חיתוך עבורו‬

‫ תפן‬,‫ישקר בע"מ‬ ‫גיל הכט‬ ,‫ישקר בע"מ‬ ‫ תפן‬,11 .‫ד‬.‫ ת‬, thereof, the clamping jaw comprising two elongated sub-clamping jaws separated by an elongated forward recess, wherein the cutting insert is resiliently clamped in the insert pocket between the two elongated sub-clamping jaws and the base jaw and wherein the two elongated sub-clamping jaws are independently resilient.

339

__________ ]11[]21[ ]54[

METHOD AND KIT FOR DETECTING EXPLOSIVE SUBSTANCES CONTAINING CERTAIN OXIDANTS

]22[ ]51[ ]71[ ]74[

21.03.2004 Int. Cl.(2008.04) G01N 31/22 MISTRAL DETECTION LTD. JMB, FACTOR & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450

[57] A method for detecting an explosive substance which contains an oxidant selected from chlorate, bromate and organic peroxide, which method comprises the sequential steps of: providing a sample of suspect explosive substance; contacting the sample of said substance with a first reagent, which is a strongly acid solution of at least one primary or secondary aromatic amine, whereby the presence of a chlorate or bromate type explosive affords

160989 ‫שיטה וערכה לגילוי חומרי נפץ המכילים‬ ‫מחמצים מסוימים‬

‫ הרצליה פיתוח‬,‫מיסטרל דטקשון בע"מ‬ ,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬ ,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬ ‫ירושלים‬ a distinct coloration; and in the absence of such coloration, contacting the same sample, which is already in contact with the first reagent, with a second reagent, which is a solution comprising cations of at least one transition metal, whereby the presence of organic peroxides in the sample, which has been hydrolyzed at least partly to hydrogen peroxide by the strong acid of the first reagent, affords a distinct coloration.

__________

340

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

161079 ‫זן של סטרפטומיזיה פלווידווירנס ותהליך‬ ‫להכנת פראבסטאטין המשתמש בו‬

]54[

STRAIN OF STREPTOMYCES FLAVIDOVIRENS AND PROCESS FOR THE MANUFACTURE OF PRAVASTATIN UTILIZING THE SAME

]22[ ]51[ ]71[ ]87[ ]74[

27.09.2001 Int. Cl.(2008.04) C12N 1/20, C12P 7/62, C12R 14/65 BIOCON LIMITED, INDIA WO/2003/027302 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A new strain Streptomyces flaviodovirens DSM 14455 and a

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

microbial process for the preparation of the compound of the formula

from a substrate compound of the formula

wherein R represents an alkali metal or ammonium ion, comprising steps of (i) preparing seed inoculum of a strain of Streptomyces flavidovirens DSM 14455 able to 6β-hydroxylate a compound of formula II, September 22, 2009

–‫ד' בתשרי התש"ע‬

(ii) transferring the said seed inoculum to a production medium, (iii) subjecting the said production medium to fermentation,

341

(iv) feeding the substrate to be transformed in the said production medium at different intervals, (v) controlling the pH during fermentation by feeding carbon sources,

(vi) fermenting the substrate until the end of bioconversion, (vii) extracting the whole cell broth and separating the compound of formula I, and (viii) isolating the compound of formula I.

__________ ]11[]21[ ]54[

RECORD CARRIER AND APPARATUS FOR SCANNING THE RECORD CARRIER

]22[ ]31[ ]51[ ]71[

23.09.2002 01203881.6 ]32[ 15.10.2001 Int. Cl.(2008.04) G11B 7/00 KONINKLIJKE PHILIPS ELECTRONICS N.V., THE NETHERLANDS WO/2003/034434 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] Record carrier comprising a servo track indicating an information track intended for recording information blocks represented by marks, which servo track has a periodic variation of a physical parameter at a predetermined frequency and modulated parts for encoding position information at regular intervals, a first type of modulated parts starting with a bit sync element and being of a data type having a data bit element, and a second type of modulated parts starting with a bit sync element and being of a word sync type having a word sync element, the word sync element and the data bit element being

342

161350 ‫נשא להקלטה והתקן לסריקת נשא‬ ‫ההקלטה‬

]33[

EP

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

modulated according to a same predetermined type of modulation of the periodic variation, characterized in that the word sync element comprises two equal, modulated partial elements separated by an interval of not modulated periodic variations and the effective strength of the partial elements of the word sync element and the effective strength of the data bit element are equal, the effective strength being the number of periodic variations that are substantially different and available for detection of the corresponding element.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

161750 ‫מטרות התזה מסגסוגת אלומניום בעלות‬ ‫מרקם בלתי יציב‬

]54[

TEXTURED-METASTABLE ALUMINUM ALLOY SPUTTER TARGETS

]22[ ]31[ ]51[ ]71[

23.10.2002 09/991851 ]32[ 14.11.2001 ]33[ US Int. Cl.(2008.04) C22C 21/00, C23C 14/34 PRAXAIR S.T. TECHNOLOGY, INC., U.S.A. WO/2003/066929 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]87[ ]74[

[57] An aluminum alloy sputter target, the sputter target having a sputter target face for sputtering the sputter target, the sputter target face having a texturedmetastable grain structure, the texturedmetastable grain structure having a grain orientation ratio of at least about 35

percent (200) orientation, the texturedmetastable grain structure being stable during sputtering of the sputter target, the textured-metastable grain structure having a grain size of less than about 5 μm.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

161769

343

–‫פוליפפטידים נוגדי חיידקים המופקים מ‬ NIGRELLA PSEUDOPLECTANIA

]54[

ANTIMICROBIAL POLYPEPTIDES FROM PSEUDOPLECTANIA NIGRELLA

]22[ ]31[

20.11.2002 PA200101732 ]32[ 20.11.2001 ]33[ DK PA200201243 23.08.2002 DK Int. Cl.(2008.04) A23K 1/16, 1/17, A61K 38/16, C07K 14/37, C12N 15/31 NOVOZYMES A/S, DENMARK WO/2003/044049 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A polypeptide having antimicrobial activity, selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence which has at least 65% identity with amino acids 1 to 40 of SEQ ID NO:2; (b) a polypeptide which is encoded by a nucleotide sequence which hybridizes under medium stringency conditions, using 0.2xSSC at 42oC for washing, with a

polynucleotide probe selected from the group consisting of: (i) the complementary strand of nucleotides 166 to 285 of SEQ ID NO:1, (ii) the complementary strand of nucleotides 70 to 285 of SEQ ID NO:1, and (iii) the complementary strand of nucleotides 1 to 285 of SEQ ID NO:1; and (e) a fragment of (a) or (b) that has antimicrobial activity.

__________

]11[]21[

344

161773

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שיטה לבחירת תאים מותמרים גנטית‬

]54[

METHOD FOR SELECTING GENETICALLY TRANSFORMED CELLS

]22[ ]31[ ]51[ ]71[

06.11.2002 1019308 ]32[ 06.11.2001 ]33[ NL Int. Cl.(2008.04) A01H 5/00, C12N 15/82, 5/04 EXPRESSIVE RESEARCH B.V., THE NETHERLANDS JOSEPHUS CHRISTIANUS MARIA SMEEKENS, HENRIETTE SCHLUPMANN WO/2003/040377 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]72[ ]87[ ]74[

[57] Method for selecting genetically transformed cells from a population of cells, comprising the steps of (a) introducing into a cell at least one desired nucleotide sequence and at least one selection-nucleotide sequence to obtain a genetically transformed cell, wherein the selection-nucleotide sequence comprises a region which codes for a

protein involved in the metabolizing of trehalose; (b) placing a population with transformed and non-transformed cells into contact with trehalose and/or derivative thereof; and (c) selecting the transformed cells from the population on the basis of the capacity of the transformed cells to metabolize the trehalose and/or derivative.

__________ ]11[]21[ ]54[

REVERSE LINK POWER CONTROLLED REPEATER

161882 ‫משחזר בעל בקרת כוח מקושרת במהופך‬

]22[ ]31[ ]51[ ]71[

20.11.2002 60/331943 ]32[ 20.11.2001 ]33[ US Int. Cl.(2008.04) H04B 1/00, 70/05, 71/55 QUALCOMM INCORPORATED, U.S.A. ]87[ WO/2003/044970 ]74[ SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122 [57] A method of controlling output coupling a pre-selected portion of a donor power for a repeater communicating with base station communication signal one or more base stations in a wireless intended for remote stations to an communication system, comprising: embedded wireless communication device September 22, 2009

–‫ד' בתשרי התש"ע‬

345

within said repeater establishing a reverse communication link between said wireless communication device and said donor base station in response to said pre-selected portion using a reverse link signal path in common with remote station communication signals being transferred to

said base station; and receiving power adjustment information for said wireless communication device from said donor base station and generating at least one power control signal for adjusting the return link gain of said repeater.

__________

]11[]21[ ]54[

346

REVERSE PULSE CLEANING OF

162015 ‫ניקוי רכיבי מסנן באמצעות פולס הפיך‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

FILTER ELEMENTS ]22[ ]31[ ]51[ ]71[ ]87[ ]74[

18.12.2002 PR9668 ]32[ 20.12.2001 Int. Cl.(2008.04) B01D 19/00, 46/04 GOYEN CONTROLS CO. PTY. LTD., AUSTRALIA WO/2003/053539 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An air supply system adapted to provide a reverse pulse of air for cleaning a filter element located in a filter housing, said system comprising: a pressure vessel adapted to contain a volume of compressed air to be used for supplying said reverse pulse, said pressure vessel having a wall with at least one outlet aperture therein: valve means (16) mounted to said wall around said aperture to control the flow of air from said pressure vessel, said valve means comprising a valve body having an inlet, an outlet and a flow passage connecting the inlet and outlet, a portion of said valve body located within said vessel, said inlet, said outlet and said flow passage generally extending axially through said valve body defining a relatively straight flow passage, a valve seat surrounding said

September 22, 2009

–‫ד' בתשרי התש"ע‬

]33[

AU

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

flow passage, and a valve closure member movable towards and away from said valve seat into closed and open positions to thereby close or open said flow passage, and operating means for moving said valve closure member between said closed and open positions, said relatively straight flow passage providing minimal pressure drop across said valve when said valve is in an open position to allow substantially all of the air from said pressure vessel to discharge rapidly; and a conduit (18) mounted to said valve body around said outlet and adapted to extend into said filter housing in use so as to direct a pulse of air towards a filter element to be cleaned when said valve closure member is in said open position.

347

__________ ]11[]21[

162047 ‫התקן נשתל להספקת תרופה באמצעות‬ ‫מנגנון פתחים המסוגל להזרים נוזל בקצב‬ ‫נמוך‬

]54[

IMPLANTABLE DEVICE FOR DELIVERING DRUGS USING ORIFICE MECHANISM CAPABLE OF LOW FLUID FLOW RATES

]22[ ]31[ ]51[ ]71[ ]74[

19.05.2004 459969 ]32[ 12.06.2003 ]33[ US Int. Cl.(2008.04) A61F 2611/00, A61M 1/12, 37/00, 51/42 CORDIS CORPORATION, U.S.A. REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An implantable device (100) for delivering a drug comprising: a housing (105); a source of drug (108) contained within the housing; an orifice mechanism (200) at the housing and communicating with the source of drug, the orifice mechanism comprising:

348

(i) an inner member (210) having a proximal end (234) and a distal end (236); (ii) a winding helically wound around the inner member; (iii) the winding and the inner member defining a first channel for carrying the September 22, 2009

–‫ד' בתשרי התש"ע‬

drug therethrough and an inlet at the proximal end of the winding and an outlet at the distal end of the winding; and

the drug being carried by the orifice mechanism and dispensed outside of the housing.

__________ ]11[]21[

162053 ‫ערכות לשימוש בטיפול באי סדרים של‬ ‫עצם‬

]54[

KITS FOR USE IN THE TREATMENT OF BONE DISORDERS

]22[ ]31[ ]51[ ]71[

16.12.2002 60/344875 ]32[ 21.12.2001 ]33[ US Int. Cl.(2008.04) A61K 31/66, 316/63, 316/75, A61P 19/00, 19/10, C07F 9/00, 9/38 THE PROCTER & GAMBLE COMPANY, U.S.A. WO/2003/055496 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

[57] A kit for use in the treatment for increasing bone mass comprising unitary doses of bisphosphonate for a loading period and unitary doses of a

bisphosphonate for a maintenance period wherein the unitary loading period dose is from 2 to 20 times greater that the unitary dose for the maintenance period.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

349

]11[]21[ ]54[

METHOD AND APPARATUS FOR MEASURING STRESS IN SEMICONDUCTOR WAFERS

]22[ ]31[ ]51[ ]71[ ]72[

26.11.2002 09/991709 ]32[ 26.11.2001 Int. Cl.(2008.04) G01B 9/02 NANOMETRICS- ISRAEL LTD. YARON ISH-SHALOM, OFER DUNOUR WO/2003/046474 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521

]87[ ]74[

[57] Apparatus for measuring properties of a wafer (54), the apparatus comprising: at least one monochromatic light source (52), for producing monochromatic light for directing at said wafer, at least a first (62) and a second beam director (64), each optically associated with said monochromatic light source for directing said monochromatic light from said source to provide respective substantially parallel light beams towards said wafer, said beam directors being configured to cause said respective beams to strike at respective places on a planar surface of said wafer, said first beam director (62) being arranged to direct a first of said respective

162102 ‫שיטה ומכשיר למדידת מתח ברכיבים‬ ‫מוליכים למחצה‬

]33[

US ‫ יוקנעם‬,‫ישראל בע"מ‬-‫נאנומטריקס‬ ‫נור‬-‫ עופר די‬,‫שלום‬-‫ירון איש‬

,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬ ,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬ ‫רמת גן‬ beams substantially centrally onto said planar surface and said second beam director (66) being alignable to direct a second of said respective beams substantially outwardly of said center to a point at a selected distance (xh) from said first beam, an optical processor (58) arranged to receive reflections of each beam and further comprising an interferometer unit to process said reflections together, thereby to detect any optical difference between said reflections, said optical difference being indicative of bow (Y) in said wafer, said bow being usable with said selected distance to calculate a stress within said wafer.

__________ 350

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

162277 ‫מחסנית הכוללת מדית הדפסה מצופה‬ ‫בדבק ואספקת דיו‬

]54[

CARTRIDGE INCLUDING ADHESIVE COATED PRINT MEDIA AND AN INK SUPPLY

]22[ ]31[

09.11.1999 PP7019 ]32[ 09.11.1998 ]33[ AU PP7017 09.11.1998 AU PP7026 09.11.1998 AU PP7020 09.11.1998 AU PP7021 09.11.1998 AU PP7027 09.11.1998 AU Int. Cl.(2008.04) A63F 13/00, B41J 2/01, 21/75, G03B 17/02, 19/02, 27/52, 29/00, G06C 11/04, G06F 3/12, 30/33, H04M 1/03, H04N 57/65 DIVISION FROM 142715 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2000/028379 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]51[ ]62[ ]71[ ]87[ ]74[

[57] A cartridge assembly (19) for a printhead assembly (30), said cartridge including: a cartridge assembly casing defining a first container portion for

September 22, 2009

–‫ד' בתשרי התש"ע‬

housing therein a supply of a sticker roll (18) and a second container portion for storing an ink supply (7).

351

________ ]11[]21[

162354 ‫יהלום מסומם בבורון‬

]54[

BORON DOPED DIAMOND

]22[ ]31[ ]51[ ]71[

13.12.2002 0130005.2 ]32[ 14.12.2001 ]33[ GB Int. Cl.(2008.04) C23C 16/26, C30B 25/10, 29/04 ELEMENT SIX LIMITED, UNITED KINGDOM WO/2003/052174 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

352

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] A layer of single crystal boron doped diamond produced by CVD wherein the total boron concentration is uniform, with a variation over the majority volume which is less than 50%, measured with a lateral resolution at each measurement point of less than 50μm, wherein the majority volume represents at least 70% of the total volume of the layer, and wherein the layer

has at least one of the following characteristics: (i) the layer is formed from a single growth sector, (ii) the layer thickness exceeds 100 μm, and (iii) the volume of the layer exceeds 1 mm3.

__________ ]11[]21[

‫חומר קולט אנרגיה‬

]54[

ENERGY ABSORBING MATERIAL

]22[ ]31[ ]51[ ]71[

23.12.2002 0130834.5 ]32[ 22.12.2001 Int. Cl.(2008.04) A41D 13/00 DESIGN BLUE LTD., UNITED KINGDOM WO/2003/055339 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]87[ ]74[

162679

[57] A self-supporting energy absorbing composite comprising: (i) a solid foamed synthetic polymer matrix; (ii) a polymer-based dilatant, different from (i) distributed through the matrix and

]33[

GB

,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬ ‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬

incorporated therein during manufacture of (i); and (iii) a fluid distributed through the matrix, the combination of matrix, dilatant and fluid being such that the composite is resiliently compressible.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

353

]11[]21[

162809 ‫שיטה והתקן לבחירה יעילה ולרכישה‬ ‫יעילה של מערכת תקשורת אלחוטית‬

]54[

METHOD AND APPARATUS FOR EFFICIENT SELECTION AND ACQUISITION OF A WIRELESS COMMUNICATIONS SYSTEM

]22[ ]31[ ]51[ ]71[

10.01.2003 10/043695 ]32[ 10.01.2002 ]33[ US Int. Cl.(2008.04) H04L 12/56, H04Q 7/38 QUALCOMM INCORPORATED, U.S.A. WO/2003/061327 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] In a mobile station including a preferred roaming list, a system acquisition procedure comprising the steps of: maintaining a list of unusable wireless communications systems, each entry in the list of unusable wireless communications systems including a system identifier and corresponding avoidance criterion; selecting a wireless communication system from the preferred roaming list in accordance with a predetermined system

acquisition sequence and repeating the step of selecting until a usable system is selected; and attempting to acquire and register with the selected wireless communications system, wherein the selected wireless communications system is unusable if the list of unusable wireless communications systems includes a corresponding system identifier and the corresponding avoidance criterion is satisfied.

__________

354

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

APPARATUS FOR SEARCHING AND DETECTING DEFECTS IN PARTS BY ENDOSCOPY

]22[ ]31[ ]51[ ]71[

01.07.2004 03/08156 ]32[ 04.07.2003 Int. Cl.(2008.04) A61B 1/00 SNECMA SERVICES, FRANCE SNECMA, FRANCE

]72[

ISABELLE BONNINGUE, JOHN LEQUELLEC, JEAN-CLAUDE LEMOAL, MICHEL BACCELLA EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]74[

[57] Apparatus for searching for and detecting defects on parts by penetration testing and endoscopy, the apparatus comprising: a rigid tubular cylindrical rod (16) of small diameter, pipes received in the rod for feeding air and penetration test substances on a portion of the part (12) under examination, and light guide and image transmission means received in the rod to illuminate and observe said portion of the part under examination, characterized in that the light guide and image transmission means are constituted by a first endoscope (22) that operates with

162830 ‫מכשיר לחיפוש ואבחון פגמים בחלקים על‬ ‫ידי אנדוסקופיה‬

]33[

FR

,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬ ‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬

visible light mounted axially in the rod and surrounded by pipes for air and penetration test substances, said endoscope having a rectilinear tube in which the visible light guide means and the image transmission means are mounted in parallel, and in that the apparatus further comprises a second endoscope that operates with ultraviolet light, independent of the first endoscope and of the above-mentioned rod for observing the portions of the part that has been treated by the penetration test substances.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

162882

355

‫מיכל עם מיכסה בעל קפיץ גמיש‬

]54[

CONTAINER WITH ELASTOMERIC LID SPRING

]22[ ]31[ ]51[ ]71[ ]74[

06.07.2004 633422 ]32[ 01.08.2003 ]33[ Int. Cl.(2008.04) B65D 1/12, 43/16, 43/24 DART INDUSTRIES INC., U.S.A. REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A spring (40) fur use in resiliently biasing a container lid from a closed position to an open position about a pivot axis relative to a container body (12), said spring comprising a block of elastomeric material, characterized by a central

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

foldable area of maximum thickness and tapering to opposed ends of minimal thickness which are adapted to selectively engage with the container body and lid with the area of maximum thickness alignable with the pivot axis.

__________ ]11[]21[

356

163031

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫שיטה לבקרת חיובים של שרות שידור‬ ‫באמצעות יחידות זמן‬

]54[

METHOD FOR CONTROLLING THE BILLING OF A BROADCAST SERVICE BY UNITS OF TIME

]22[ ]31[ ]51[

07.02.2003 0265/02 ]32[ 15.02.2002 ]33[ CH Int. Cl.(2008.04) G06F 21/00, 21/24, G06Q 30/00, 50/00, G09C 1/00, H04N 1/00, 1/16, 71/67 NAGRACARD S.A., SWITZERLAND WO/2003/069910 WOLFF, BREGMAN AND GOLLER, ,‫ ברגמן וגולר‬,‫וולף‬ P.O.B. 1352, ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, JERUSALEM 91013

]71[ ]87[ ]74[

[57] A time accounting method of access to a stream of data encrypted by control words (CW) modified at intervals representing a crypto-period (CP), said stream being received by a user unit (UU) connected to a security module (SC) in charge of verifying the rights of a user and of decrypting messages (ECM) comprising the control words, said accounting being based on accounting units (CT) authorizing the use of the service for an assigned time (AT), said method comprising the following stages: (a) commutation by the user on an encrypted stream constituting an access service per time unit, (b) reception by the security module of encrypted messages containing the control words and data specific to said service allowing to determine the assigned time and its cost of the accounting unit, (c) reading of a time variable (Rdate) representative of the time during which the use of said service is authorized,

(c) determination, on the basis of the timecurrent if it is placed during the authorization time defined by the time variable (Rdate), and if this is the case, to authorize the service by resending the control words to the user unit, (e) if this is not the case, to order the debit of an accounting unit and to determine if the time-current is comprised in an assigned time adjacent to the time interval defined by the time variable, if this is the case to determine the new value of the time variable in order to move the latter from an assigned time, and to authorize the service by resending the control words in plaintext to the user unit, (f) if this is not the case, to load the time variable (Rdate) of an assigned time (AT) starting from the time-current and to authorize the service by resending the control words in plaintext to the user unit.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

357

]11[]21[

163252 ‫העברת נתונים עם פיזור בלתי אחיד של‬ ‫קצבי נתונים ממערכת (מימו) רב–קלטי‬ ‫ורב–פלטי‬

]54[

DATA TRANSMISSION WITH NON-UNIFORM DISTRIBUTION OF DATA RATES FOR MULTIPLE-INPUT MULTIPLEOUTPUT (MIMO) SYSTEM

]22[ ]31[ ]51[ ]71[

27.02.2003 10/087503 ]32[ 01.03.2002 ]33[ US Int. Cl.(2008.04) H04B 7/04, 7/26, H04J 11/00, 15/00, H04L 1/00, 1/06 QUALCOMM INCORPORATED, U.S.A. WO/2003/075479 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] A method for determining data rates for a plurality of data streams to be transmitted via a plurality of transmission channels in a multi-channel communication system, comprising: determining a required signal-to-noiseand-interference ratio (SNR) for each of a plurality of data rates to be used for the plurality of data streams, wherein at least two of the data rates are unequal;

358

determining an effective SNR for each of the plurality of data streams based in part on successive interference cancellation processing at a receiver to recover the plurality of data streams; comparing the required SNR for each data stream against the effective SNR for the data stream; and determining whether or not the plurality of data rates are supported based on results of the comparing.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

163671 ‫שיטה והתקן לטעון אשראי מחדש‬ ‫לכרטיסי שבב‬

]54[

METHOD AND DEVICE FOR RECHARGING A CREDIT TO CHIP CARDS

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

17.03.2003 PV2002-1130 ]32[ 29.03.2002 ]33[ CZ Int. Cl.(2008.04) G07F 7/08, H04M 17/00 SAZKA, A.S., CZECH REPUBLIC WO/2003/083791 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

[57] A method for recharging of chip cards, in which method the recharging is executed from a terminal (1), which terminal is connected with a service center for chip card (5) recharging, and in which method input data are loaded into the terminal, which input data comprise at least the identification number of the recharged chip and the amount to be recharged to the credit of the chip card; and loaded input data are checked (4) with regard to their correctness, and when the terminal is connected with the service September 22, 2009

–‫ד' בתשרי התש"ע‬

center an assessment of meaningfulness of the requirement to recharge the chip card is carried out, and in the case of a positive evaluation of said check, the value corresponding to the amount loaded into the chip card is transferred, and eventually, the account associated with the card by means of an identification number is increased by this amount, wherein the input data are loaded by incremental crossing of frames in the respective part of a fill-in coupon, which part corresponds to the respective input datum; the terminal is

359

connected with the first service center (2), where detection of a requirement for recharging of a chip card is carried out and the requirement is registered, whereupon, the first service center is connected with a second service center (3), in which second service center meaningful assessment of the requirement for recharging of a chip card is carried out, whereby after a positive meaningful assessment of the requirement for recharging, a unique code is allocated to the requirement and a report is sent from the second service center to the first service center, by which report it is confirmed that the requirement is realizable, whereupon, the requirement is queued into a queue (6) of waiting requirements in the first service center for

a preset time period, during which time period the first service center determines whether a cancellation of the requirement has not been sent from the terminal, whereupon, after elapse of said preset time period, if there was not a cancellation sent via the terminal, the second service center issues an instruction to transfer the value into the chip card and sends a text message about recharging to the identification number of the chip card, whereby, the length of the waiting queue is set by characteristics, while in the case of negative meaningful assessment of the requirement for recharging, the second service center issues an instruction to cancel the whole transaction.

This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬ 1968 – ‫ תשכ"ח‬,‫הפטנטים‬

________

]11[]21[

360

163833

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫מעקב לאחר מהירות ביחס לזמן‬

]54[

VELOCITY RESPONSIVE TIME TRACKING

]22[ ]31[ ]51[ ]71[

12.03.2003 10/097043 ]32[ 12.03.2002 ]33[ US Int. Cl.(2008.04) H04B 17/07, H04Q 7/38 QUALCOMM INCORPORATED, U.S.A. WO/2003/079570 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] A system for providing velocity responsive tracking of a timing reference in a signal received by a wireless communications device (WCD), comprising: a velocity estimator that estimates the velocity of the WCD; and a

filter having a tracking speed that corresponds to the estimated velocity, wherein said filter filters a timing error signal to produce a control signal that controls the timing of a synchronization clock.

__________

]11[]21[ ]54[

SECURE METHOD OF STORING ENCRYPTED DATA ON A

September 22, 2009

–‫ד' בתשרי התש"ע‬

163890 ‫שיטה מאובטחת לאיחסון נתונים מקודדים‬ ‫על רשם ספרתי אישי‬

361

PERSONAL DIGITAL RECORDER ]22[ ]31[ ]51[ ]71[ ]87[ ]74[

13.03.2003 0456/02 ]32[ 15.03.2002 ]33[ Int. Cl.(2008.04) H04L 9/14, H04N 59/13 NAGRAVISION S.A., SWITZERLAND WO/2003/079683 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A recording method of a content encrypted by control words in a receiver/decoder unit connected to a security unit, said control words as well as the necessary rights for the access of this content being transmitted in entitlement messages encrypted by system keys that are shared by a plurality of

CH

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

receiver/decoder units, characterized in that it consists in storing the encrypted content as well as the entitlement messages in the storage unit, in locally encrypting the system keys by a predefined local key contained in the security unit, and storing in the storage unit the system keys in encrypted form by a predefined local key.

__________ ]11[]21[ ]54[

BROADBAND DIPOLE ANTENNA TO BE WORN BY A USER AND ASSOCIATED METHODS

]22[ ]31[ ]51[ ]71[ ]74[

06.09.2004 665004 ]32[ 19.09.2003 Int. Cl.(2008.04) H01Q 1/27 HARRIS CORPORATION, U.S.A. REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] An antenna assembly (21) to be worn by a user and comprising: an antenna (25) comprising a dipole feed (40) comprising a broadband matching network, a first dipole element (42) connected to and extending outwardly from said dipole feed in a first direction, a transmission line (44) extending from said dipole feed in a second direction opposite

362

163915 ‫אנטנה לפס רחב שניתנת לנשיאה על ידי‬ ‫משתמש ושיטות הקשורות בכך‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

the first direction, and a flexible electrically conductive sleeve (45) surrounding said transmission line and connected to and extending outwardly from said dipole feed to serve as a second dipole element and as a balun; and at least one fastener (26a, 26b) to removably fasten the antenna to a garment of the user; wherein said broadband matching network September 22, 2009

–‫ד' בתשרי התש"ע‬

comprises: a three Winding transformer (T1) connected across pair of dipole elements, a first capacitor (C1), a first inductor (L1), and a third inductor (L3) connected in series between an inner

conductor of an input and the transformer, and a second capacitor (C2) and second inductor (L2) connected in parallel with each other and across transformer between the first and third inductors.

__________ ]11[]21[ ]54[

PROCESS FOR IMPROVING MEMBRANES

]22[ ]51[ ]71[

19.09.2004 Int. Cl.(2008.04) B01D 67/00, 71/56 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY CHARLES LINDER, SOPHIA BELFER, ROSALIA FAINSTEIN, LUBA KESSELMAN WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

]72[ ]74[

[57] A process for improving the antifouling properties and for increasing the selectivity of composite polyamide nanofiltration (NF) and reverse osmosis (RO) membranes comprising circulating from 0.01% to 5% of water soluble monomers and an initiating redox couple September 22, 2009

–‫ד' בתשרי התש"ע‬

164122 ‫תהליך לשיפור ממברנות‬

‫ הרשות למחקר‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬ ‫ באר שבע‬,‫ופיתוח‬ ,‫ רוזליה פיינשטיין‬,‫ סופיה בלפר‬,‫צ'רלס לינדר‬ ‫לובה קסלמן‬ ,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, in an aqueous solvent without transverse pressure over the surface of the membrane thereby effecting a free-radical graft polymerization on the surface of the membrane, characterised in that the process comprises grafting between 1 and 5 additional layers in sequence, wherein a

363

second graft layer is grafted onto a first grafted layer, and wherein the flow rate at which the monomer and initiator are

circulated over the surface of the membranes is between 0.1 l/min and 2 l/min.

__________ ]11[]21[

164231 ‫אבקות רסס ה מכילות כרומיה–אלומינה‬ ‫ותהליך להכנתן‬

]54[

CHROMIA-ALUMINA SPRAY POWDERS AND A PROCESS FOR MAKING THE SAME

]22[ ]31[

04.04.2003 10/118133 ]32[ 08.04.2002 ]33[ US 10/234422 03.09.2002 US Int. Cl.(2008.04) C01G 370/33, C04B 35/12, C23C 4/10 SAINT-GOBAIN CERAMICS & PLASTICS, INC., U.S.A. WO/2003/086974 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]51[ ]71[ ]87[ ]74[

[57] A thermosprayable powder comprising from 45 to 100% chromia and correspondingly from 0 to 55% of alpha alumina, all proportions being by weight, and less than 50 ppm of each of any alkali metals and alkaline earth metals that

stabilize chromium in the hexavalent state, wherein the thermosprayable powder is essentially single-phase such that alumina in phases other than alpha phase does not exceed 10 wt% of the total alumina content.

__________

]11[]21[ ]54[

364

GEO-INTELLIGENT TRAFFIC

164237 ‫מדווח תנועה גיואוגרראפי חכם‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

REPORTER ]22[ ]31[ ]51[ ]71[ ]72[ ]87[ ]74[

22.09.2004 10/106523 ]32[ 25.03.2002 ]33[ US Int. Cl.(2008.04) H04L 12/24, 12/26, 12/56, 29/08 DIGITAL ENVOY INC., U.S.A. ROBERT FRIEDMAN, SANJAY PAREKH WO/2003/084159 SOROKER-AGMON, ,‫אגמון‬-‫סורוקר‬ 14 SHENKAR ST., ‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬ HERZLIYA PITUAH 46725

[57] A method for routing network traffic based on geographic information in a network (7) having a plurality of traffic managers which route traffic in the network based on information stored in a database reflecting the normal network traffic conditions; the method comprises: (1) obtaining local real-time information on traffic traveling through a network by monitoring local traffic network; (2) maintaining a database of historical data on historical network traffic at an entity named traffic reporter; (3) comparing the historical data on the historical network traffic to the real-time information on the traffic; (4) determining significant changes between the historical data and the realtime information on the traffic; wherein determining if changes are significant

comprises concluding the changes to be significant based on a magnitude of change from the historical data or comprise concluding the changes to be significant if the change exceeds a predetermined percentage; (5) generating traffic reports by the traffic reporter, wherein the reports contain the significant changes in the network traffic derived from the real-time information and which are tailored to the geographical regions in which the traffic managers are located; (6) transmitting each report to the traffic manager to which the report is matched, enabling the traffic manager to derive routing directions through the network in response to changes to the real-time information on network traffic by using the information given in the report.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

365

]11[]21[

164378 MIMO ‫מדידות תדירות פנימית עם מסופי‬

]54[

INTER-FREQUENCY MEASUREMENTS WITH MIMO TERMINALS

]22[ ]31[ ]51[ ]71[

20.03.2003 113690 ]32[ 02.04.2003 ]33[ US Int. Cl.(2008.04) H04B 7/26, H04J 13/00, 15/00, H04Q 7/22, 7/38 NOKIA CORPORATION, FINLAND NOKIA, INC., U.S.A.

]87[ ]74[

WO/2003/084253 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] In a data transmission system including a station which transmits M encoded data streams using M antennas to a terminal and a station controller which controls the station, wherein M is an integer at least equal to 2, the terminal comprising: at least one radio transceiver including P radio receivers and at least one transmitter with P being an integer at least equal to 2, each radio receiver including an antenna which receives the M encoded data streams and a detecting function which decodes the M encoded data streams into decoded data; and a terminal controller which controls the at least one radio transceiver, and wherein in response

366

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

to a transmission from the station that the terminal is to operate at least one of the radio receivers in at least one frequency band not used to receive the M encoded data streams during at least one identified data frame therein to measure a radio indicator of the at least one frequency band not used to receive the M encoded data streams, the terminal controller causes at least one of the radio receivers to be tuned to the at least one frequency band during the at least one identified data frame and to make measurements therein and to transmit the measurements with the at least one transmitter of the at least one radio transceiver to the station.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

164434 ‫תכשירי רוקחות מקומיים המכילים‬ ‫פרואנתוציאנידינים לטיפול בדלקת עור‬

]54[

TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING PROANTHOCYANIDINS FOR THE TREATMENT OF DERMATITIS

]22[ ]31[ ]51[ ]71[

31.03.2003 MI2002A000756 ]32[ 09.04.2002 ]33[ IT Int. Cl.(2008.04) A61K 314/25, 36/00, 9/00, 9/06, 9/10, A61P 17/00 SINCLAIR PHARMACEUTICALS LIMITED, UNITED KINGDOM WO/2003/084553 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

]87[ ]74[

[57] A pharmaceutical composition for topical administration, comprising as active ingredients proanthocyanidins, September 22, 2009

–‫ד' בתשרי התש"ע‬

glycyrrhetinic acid and telmesteine in admixture with a suitable carrier.

367

__________ ]11[]21[ ]54[

RADIO INTERFACE SYNCHRONIZATION

]22[ ]31[

11.04.2003 60/372,296 ]32[ 11.04.2002 60/388,705 13.06.2002 Int. Cl.(2008.04) H04B 17/07, 7/26 QUALCOMM INCORPORATED, U.S.A. WO/2003/088527 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A method in a wireless device of determining a timing offset of a channel relative to reference channel, the method comprising: determining an integer number of full frames offsetting the channel from the reference channel; determining a fractional number, less than one, of full frames offsetting the channel from the reference channel such that the

368

164481 ‫סינכרון ממשק רדיו‬

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ timing offset may be determined from the sum of the integer number of full frames with the fractional number of full frames; re-determining the fractional number of full frames; and updating to a memory the integer number of full frames based, at least in part, on the fractional number of full frames.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

164519 ‫צורת מתן רוקחית של דסמופרסין‬ ‫ תהליך להכנתה‬,‫המתפרקת בפה‬ ‫והשימושים בה‬

]54[

ORODISPERSIBLE PHARMACEUTICAL DOSAGE FORM OF DESMOPRESSIN, A PROCESS FOR ITS PREPARATION AND ITS USE

]22[ ]31[

07.05.2003 0210397.6 ]32[ 07.05.2002 ]33[ PCT/IB02/04036 10.01.2005 Int. Cl.(2008.04) A61K 38/11, 47/42, 9/00, 9/20 FERRING B.V., THE NETHERLANDS WO/2003/094886 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] An orodispersible pharmaceutical dosage form of desmopressin acetate

GB WO

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

which disintegrates in the mouth within 10 seconds.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

369

]11[]21[ ]54[

PACIFIER, SYSTEM AND METHOD FOR MAINTAINING PROPER DENTITIONS

]22[ ]31[

19.09.2003 60/412454 ]32[ 20.09.2002 10/665458 18.09.2003 Int. Cl.(2008.04) A61J 17/00 ORTHO-TAIN, INC., U.S.A. WO/2004/026219 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A pacifier (90) sized to be worn in the mouth of a user, the pacifier comprising: a shield (92) having a substantially planar body; a shelf (94) attached to the shield wherein the shelf has a first end, a second end located opposite to the first end and a midline located in the middle of the first end of the shelf and the second end of the shelf wherein the midline of the shelf is adjacent to the shield wherein the first end of the shelf and the second end of the shelf extend rearward with respect to the mouth of the

164886 ‫ מערכת ושיטה לאחזקת מערכת‬,‫מוצץ‬ ‫שיניים‬

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ user when the shelf is worn in the mouth of the user wherein the shelf is substantially U-shaped and wherein the shelf has a width defined between an upper side of the shelf and a lower side of the shelf wherein the width at the first end of the shelf and the second end of the shelf is thicker than the width at the midline of the shelf; and a depression (97) within the top side of the shelf and the bottom side of the shelf wherein the depression is substantially Ushaped.

__________

370

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

165081 ‫הרכבים יעילים לטיפול באין אונות‬ ‫גברית ונשית‬

]54[

FORMULATIONS USEFUL IN THE TREATMENT OF MALE AND FEMALE IMPOTENCE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

30.04.2003 MI2002A000990 ]32[ 10.05.2002 ]33[ IT Int. Cl.(2008.04) A61K 35/00, 36/16, 36/54, A61P 15/00, 15/10 INDENA S.P.A., ITALY WO/2003/094943 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] Pharmaceutical compositions containing: Tribulus terrestris, Turnera diffusa and Cinnamon cassia extracts in the weight ratio of 1.5-3.5 : 1-2:0.1-0.4 respectively; extract of Ginkgo biloba, and

optionally arginine or a physiologically equivalent ester, salt or precursor thereof in admixture with a suitable carrier or excipient. ,192138

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

________ ]11[]21[

165122 ‫תכשיר המשמש לטיפול באין–אונות‬ ‫אצל גברים ונשים‬

]54[

FORMULATIONS USEFUL IN THE TREATMENT OF MALE AND FEMALE IMPOTENCE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

02.05.2003 MI2002A000994 ]32[ 10.05.2002 ]33[ IT Int. Cl.(2008.04) A61K 35/00, 36/00, 36/54, A61P 15/00, 15/10 INDENA S.P.A., ITALY WO/2003/094944 REINHOLD COHN AND PARTNERS, ,‫ריינהולד כהן ושותפיו‬ 26A HABARZEL ST., ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ RAMAT HACHAYAL 69710

[57] Pharmaceutical compositions comprising: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5 : 1-2; 0.1-0.4, respectively; The applications for division September 22, 2009 –‫ד' בתשרי התש"ע‬

and optionally arginine or a physiologically equivalent ester, salt or precursor thereof and a suitable carrier or excipient. ,192137

‫בקשות חלוקה מבקשה זו‬

371

.‫שטרם פורסמו‬

from this application have not yet been published

________ ]11[]21[

165132 ‫אטם למשאבה‬

]54[

PUMP BOOT SEAL

]22[ ]51[ ]71[ ]74[

10.11.2004 Int. Cl.(2008.04) F04D 29/08, 29/12, F16J 15/34 CARMELI ADAHAN REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A boot seal (28) for a rotary pump (10) comprising a drive unit (14) including an eccentric drive member, and a pump unit (12) including an eccentrically driven member (20) disposed within a pump housing (16) and being engaged to said eccentric drive member so as to impart an orbital motion to the eccentrically driven member, the boot seal being compliant, and configured for being affixed on one of its ends to the eccentrically driven member and on its other end to the pump housing, such that the eccentric drive member can freely drive the eccentrically driven member, by a crank (21) orbiting within the boot seal, transmitting drive torque to

‫ ירושלים‬,‫ רמות‬,‫כרמלי אדהאן‬ ,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

the eccentrically driven member, without any rotary movement between said boot seal and the eccentrically driven member or the pump housing when affixed thereto, wherein said boot seal is prevented from moving inward or collapsing, when outside pressure is applied on it, by means of rigid support members which are placed within it, yet providing for free orbital movement of the eccentric crank within the booth seal and rendering the boot seal equally effective in sealing when pressure is applied inwards or outwards, and wherein said boot is made of compliant material such as rubber.

__________

372

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

DEVICE FOR THE HEATING OF A LIQUID

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

03.07.2003 02015461.3 ]32[ 12.07.2002 Int. Cl.(2008.04) A47J 31/54 NESTEC S.A., SWITZERLAND WO/2004/006742 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063

[57] A device (5) for the heating of a liquid in a beverage machine comprising: a tube or flat base arranged so that liquid can traverse it for being heated, a first individual resistor (R1) placed on a portion of the tube or flat base to heat liquid at a first temperature, a set of at least two resistors (R2, R3) is placed on a portion of the tube or flat base to heat the liquid from said first temperature to a final desired temperature, wherein said set of at least

165297 ‫מתקן עבור החימום של נוזל‬

]33[

EP

,‫ד"ר יצחק הס ושותפיו‬ ‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬

two resistors is electrically linked together so that one resistor can be empowered either individually or in serial mounting with one or more of the resistors (R3) of the same set, and wherein the first individual resistor can be empowered either individually or in parallel mounting with one resistor of said set of resistors or in parallel mounting with a serial mounting of said set of resistors.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

165667

373

]54[

AIRCRAFT DE-ICING SYSTEM

]22[ ]51[ ]62[ ]71[

30.07.1999 Int. Cl.(2008.04) B64D 15/12 DIVISION FROM 146852 NORTHCOAST TECHNOLOGIES, U.S.A. WO/2001/008463 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]87[ ]74[

[57] A heat-conducting tape having a length and comprising at least two layers laminated to each other under heat and pressure, the layers comprising (i) an outer heat-conducting layer (130) that is an electrical insulator, and (ii) a non-metallic electrical and heat-conducting layer (120), the non-metallic electrical and heatconducting layer consisting of a continuous flexible expanded graphite foil

‫מערכת הפשרה למטוס‬

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ sheet and having a first area (122) along the length of the tape comprising a first thickness, and a second area (123, 124) disposed on a side of the first area along the length of the tape comprising a second thickness, wherein the thickness of the flexible expanded graphite foil sheet in the first area is greater than the thickness of the foil sheet in the second area.

__________

]11[]21[

374

165981 September 22, 2009

–‫ד' בתשרי התש"ע‬

‫התקן לבדיקת נגישה ושיטת שימושה‬

]54[

ACCESSIBLE ASSAY DEVICE AND METHOD OF USE

]22[ ]31[

09.06.2003 60/398758 ]32[ 26.07.2002 10/422336 24.08.2003 Int. Cl.(2008.04) G01N 335/58 QUANTUM DESIGN, INC., U.S.A. WO/2004/001194 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬

[57] A lateral flow assay test device for detection of target analytes in a sample, said device comprising: a housing member (30) shaped and configured to have two arms connected by a spanning portion, thereby generally forming an open space between the two arms, the housing also having an interior space exposed on one side of the housing; a cover element (39) shaped and configured to enclose the interior space of the housing member; at least one analytical test strip (10) having first and second ends and being positioned between the two arms, the strip also being at least partially sandwiched between the housing member and the cover element, the strip comprising: a base member (24);

an analytical membrane (18) having a first end and a second end; a conjugate pad (11) at the first end of the analytical membrane; and at least one capture region (15) in the analytical membrane intermediate said first and second ends thereof, said capture region being configured to capture labeled analytes moving from said first end of said analytical membrane toward said second end of said analytical membrane; the open space in the housing member being shaped and configured to provide lateral access to the test strip and to enable the determination of the presence of target analytes in the capture region of the test strip while the test strip remains mounted to the housing.

__________

]11[]21[ ]54[

METHOD FOR THE PREPARATION OF AEROGELS

September 22, 2009

–‫ד' בתשרי התש"ע‬

166212 ‫שיטה להכנת אירוג'לים‬

375

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

24.06.2003 NO2002A000010 ]32[ 12.07.2002 ]33[ Int. Cl.(2008.04) B01J 13/00, C01B 331/58 NOVARA TECHNOLOGY S.R.L., ITALY WO/2004/007368 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A process for the preparation of aerogels comprising, (a) exchanging the liquid phase of an aquagel with xenon liquid to form a xenongel; and

IT

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

(b) extracting xenon from the xenongel of step (a) under hypercritical or supercritical drying conditions of xenon; and (c) optionally, recovering xenon from step (b).

__________ ]11[]21[ ]54[

INDEX TAB SYSTEM

]22[ ]31[ ]51[ ]71[ ]72[

18.01.2005 10/231926 ]32[ 29.08.2002 Int. Cl.(2008.04) B42F 13/00 ESSELTE CORPORATION, U.S.A. MICHAEL SLATTERY, JAMES LYNCH, ROCHELLE NARUP WO/2004/020219 WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121

]87[ ]74[

[57] An index tab system comprising a strip of resilient plastic film providing a plurality of tab-forming structures each of which is capable of providing an index tab member, wherein said strip of plastic film is attachable to an object that is in need of such index tabs wherein each said tab

376

166369 ‫מערכת תוויות לקטלוג‬

]33[

US

,'‫ד"ר וב ושות‬ ‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬ forming tab structure includes first interlocking means for forming the index tab member, and second interlocking means for forming a tab cavity that is capable of receiving an informational insert.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

166739 ‫פורמולציות של פוליתיאופן לשיפור‬ ‫דיודות אורגניות הפולטות אור‬

]54[

POLYTHIOPHENE FORMULATIONS FOR IMPROVING ORGANIC LIGHT-EMITTING DIODES

]22[ ]31[

08.02.2005 102004006583.7 ]32[ 10.02.2004 ]33[ 102004010811.0 05.03.2004 Int. Cl.(2008.04) C08L 65/00, H01L 51/30 H.C. STARCK GMBH, GERMANY REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]74[

DE DE

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

[57] Formulation comprising

(A) at least one polythiophene containing recurring units of the formula

wherein A represents an optionally substituted C1C5-alkylene radical, in particular an optionally substituted ethylene or propylene radical, R represents a linear or branched C1-C18-alkyl radical, a C5-C12cycloalkyl radical, a C6-C14-aryl radical, a C7-C18-aralkyl radical, a C1-C4hydroxyalkyl radical or a hydroxyl radical,

x represents an integer from 0 to 8 and in the case where several radicals R are bonded to A, these can be identical or different, (B) at least one polymer containing SO3M+ or COO-M+ groups, wherein M+ represents H+, Li+, Na+ K+, Rb+, Cs+ or NH4+, in particular H+, Na+ or K+ and

September 22, 2009

–‫ד' בתשרי התש"ע‬

377

(C) at lest one partly fluorinated or perfluorinated polymer containing SO3-M+ groups, wherein M+ represents H+, Li+,

Na+ K+, Rb+, Cs+ or NH4+, in particular H+, Na+ or K+.

__________ ]11[]21[ ]54[

FLUID CONTROL DEVICE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

22.08.2003 2002-256617 ]32[ 02.09.2002 Int. Cl.(2008.04) F16K 311/22 FUJIKIN INCORPORATED, JAPAN WO/2004/023011 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A fluid control device (1) comprising a valve case (2) having a fluid inlet (2a) and outlet (2b) channels, a valve element holder (5) upwardly or downwardly movable for opening or closing the fluid channel, a lower casing (7) provided on an upper portion of the valve case, an upper casing (8) joined to the lower casing, a valve stem (9) disposed in a space defined by the upper and lower casings and having a lower end in bearing contact with the valve element holder and a piston (10) secured to the valve stem, an upper space being formed between and

378

166866 ‫התקן לבקרת ניגרים‬

]33[

JP

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, defined by an upper surface of the piston and a lower surface of a top wall (8a) of the upper casing, a lower space (S2) being formed between and defined by a lower surface of the piston and an upper surface of a bottom wall (7a) of the lower casing, the fluid control device being characterized in that a compression coil spring (11) is provided in one of the upper space and the lower space for biasing the piston, a compressed air admitting passageway being in communication with the other of the upper and lower spaces.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

PROCESS OF SCREENING LIBRARIES OF SMALL ORGANIC COMPOUNDS

]22[ ]31[ ]51[ ]71[

15.02.2005 105372 ]32[ 26.06.1998 Int. Cl.(2008.04) G01N 33/53 SUNESIS PHARMACEUTICALS, INC., U.S.A. WO/2000/000823 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A process comprising: (a) screening a library of small organic compounds, less than about 2000 daltons in size, with a target protein-ligand conjugate formed by the covalent bonding of a target protein comprising a first reactive functionality with a ligand that (1) comprises less than about 20 carbon atoms; (2) has affinity for interacting with a particular site on the target protein, (3) comprises a second reactive functionality September 22, 2009

–‫ד' בתשרי התש"ע‬

166892 ‫תהליך לסריקת ספריות של מולקולות‬ ‫אורגניות קטנות‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

and (4) comprises a free chemically reactive group, wherein the second reactive functionally of the ligand reacts with the first reactive functionality of the target protein to form a first covalent bond such that the ligand in the target proteinligand conjugate contains a free chemically reactive group, in aqueous solution, under conditions wherein at least one member of the library forms a second covalent bond

379

with said free chemically reactive group in the target protein-ligand conjugate, and (b) determining the identity of a small organic compound that binds covalently to

the free chemically reactive group of the target protein-ligand conjugate.

__________ ]11[]21[ ]54[

FLUID CONDITION MONITOR

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

22.09.2003 10/260754 ]32[ 30.09.2002 Int. Cl.(2008.04) G01N 33/28 UNIVERSITY OF DAYTON, U.S.A. WO/2004/031764 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A sensor device (10) for monitoring the condition of a fluid comprising: a member (12); a plurality of liquid sensors (20) provided at various lengths along said member and each comprising at least two wires or wire rods (22, 23, 24, 26) for measuring liquid parameters of the fluid, said at least two wires or wire rods are adapted to be electrically connected to one another by the fluid when said at least two wires or wire rods are immersed in and in contact with the fluid to complete an electrical circuit such that in use current passes between said at least two wires or wire rods through the fluid in order to

380

167479 ‫משגוח מצב ניגרים‬

]33[

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, monitor the condition of the fluid, and a plurality of vapor sensors (30) in contact with vapors of the fluid for measuring vapor parameters of the fluid coupled to said member, at least one of said plurality of vapor sensors comprising conductive surfaces (27) adapted to be electrically connected to one another by vapor of the fluid such that in use current passes between said conductive surfaces through the vapor, wherein said plurality of liquid sensors and plurality of vapor sensors are positioned a distance from one another so that said plurality of vapor sensors do not contact a liquid of the fluid.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

METHOD AND SYSTEM FOR DETERMINING THE RATE OF NON UNIFORMITY OF BOLOMETER BASED SYSTEMS

]22[ ]51[ ]71[

24.03.2005 Int. Cl.(2008.04) G01J 5/20 SEMI-CONDUCTOR DEVICES - AN ELBIT SYSTEMS - RAFAEL PARTNERSHIP UDI MIZRAHI, AVRAHAM FRAENKEL, ZVI KOPOLOVICH, AMNON ADIN, LEONID BIKOV LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

]72[ ]74[

[57] A focal plan array system of the bolometer type having means for determining the rate of non uniformity, which comprises: (a) an array of i x j pixel detectors of the bolometer type for sensing scenery radiation; September 22, 2009

–‫ד' בתשרי התש"ע‬

167637 ‫שיטה ומערכת לקביעת שיעור אי האחידות‬ ‫של מערכות המבוססות על בלומטר‬

‫ שותפות אלביט‬- ‫התקני מצב מוצק‬ ‫ חיפה‬,‫ רפא"ל‬- ‫מערכות‬ ,‫ צבי קופולוביץ‬,‫ אברהם פרנקל‬,‫אודי מזרחי‬ ‫ לאוניד ביקוב‬,‫אמנון עדין‬ ,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

(b) a case which accommodates said array of detectors, said case (13) having a front window (15) that provides exposure to the sensing element of all the i x j pixel detectors to radiation coming from the scenery; (c) at least a portion of column j + 1 of blind detectors (Rr) that are shielded from

381

the scenery by a homogeneous reference surface (14); (d) reading circuitry for reading indication for the scenery radiation as sensed by each of i x j detectors of the array, and for reading indication for the non uniformity as sensed by said detectors in column (j+1);

(e) a register (16) for recording the radiation values as read from all the detectors within column (j+1); and (f) a processing unit for finding the standard deviation б of all the values in said register, and for comparing the same to a predetermined threshold Q, wherein a standard deviation above Q being an indication for a non uniformity above the allowed level.

__________ ]11[]21[ ]54[

COMMUNICATION INTERFACE FOR DIAGNOSTIC CIRCUITS OF AN INTEGRATED CIRCUIT

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

17.09.2003 10/417330 ]32[ 17.04.2003 Int. Cl.(2008.04) G01R 313/185 ARM LIMITED, UNITED KINGDOM WO/2004/095041 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

382

167671 ‫ממשק תקשורת למעגלים דיאגונוסטיים‬ ‫של מעגל משולב‬

]33[

US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] An integrated circuit (2) for processing data, said integrated circuit comprising: a functional circuit (10, 12, 14, 16) operable to perform data processing operations; a diagnostic circuit (8) operable to perform diagnostic operations upon said functional circuit; and an interface circuit (16) operable to provide communication between said diagnostic circuit and an external diagnostic device (4); wherein said

interface circuit is configured to use a bidirectional line carrying a bi-directional serial signal to transfer: (i) control signals from said external diagnostic device to said diagnostic circuit to control said diagnostic operations of said diagnostic circuit; and (ii) diagnostic data between said external diagnostic device and said diagnostic circuit.

__________ ]11[]21[ ]54[

METHOD FOR THE MANUFACTURE OF A BABY FEEDING BOTTLE BEING PROVIDED WITH A ONE-WAY VALVE

]22[ ]51[ ]71[ ]74[

29.03.2005 Int. Cl.(2008.04) A61J 9/04 HISENSE LIMITED DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063

[57] A method for the manufacture of a baby feeding bottle (1) being provided with a one-way valve (hereinafter: "valve") which valve carries at its end a tail (11) said bottle having an opening at the top through which said valve is inserted by any suitable inserting means, which valve is inserted up to the end through a small round opening having a suitable size

September 22, 2009

–‫ד' בתשרי התש"ע‬

167726 ‫שיטה עבור הייצור של בקבוק האכלה‬ ‫לתינוק המצוייד בשסתום חד–כיווני‬

‫לציון‬-‫ ראשון‬,‫היסנס בע"מ‬ ,‫ד"ר יצחק הס ושותפיו‬ ‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬

corresponding to the groove of the valve being located at the bottom of said bottle, through which round opening the valve is pulled by any suitable pulling means inside the bottle until the bottom of the bottle is closed hermetically by the valve, finally the tail of the valve being cut off by any cutting means (13).

383

__________ ]11[]21[

167781 11 ‫נגזרות הידרוקסי–פניל–אלקאן בעל‬ ‫ תהליך לייצורן ותכשירים‬,‫פחמנים‬ ‫רפואיים המכילים אותן‬

]54[

HYDROXYPHENYLUNDECANE DERIVATIVES, A PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

]22[ ]31[ ]51[ ]71[

18.09.2003 02022095.0 ]32[ 02.10.2002 ]33[ EP Int. Cl.(2008.04) A61K 312/35, A61P 25/00, C07C 305/24, 69/00, 69/88 SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2004/031123 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]87[ ]74[

[57] A compound of the formula

wherein R1 and R2 are independently H or SO3H, and/or a physiologically tolerated salt thereof.

__________

384

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

FUEL NOZZLE FOR A FOSSIL FUEL FIRED COMBUSTION ARRANGEMENT

]22[ ]31[ ]51[ ]71[

20.04.2005 829878 ]32[ 22.04.2004 Int. Cl.(2008.04) F23D 1/00 ALSTOM TECHNOLOGY LTD., SWITZERLAND REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]74[

[57] An apparatus (210) for pivotally mounting one side of a coal nozzle tip (212) of a coal nozzle (208) operable in a pulverized solid fuel-fired furnace to a coal nozzle body (214) of the coal nozzle, the one side of the coal nozzle tip having a through hole (216) therethrough and the coal nozzle tip and the coal nozzle body being mounted relative to one another such that the one side of the coal nozzle tip is outward of the coal nozzle body, the apparatus comprising: a latch interconnecting assembly (220) including: a pin (222) for insertion in a traversing movement along an insertion axis (IAX) through both the through hole of the coal nozzle tip and a correspondingly aligned pivot support hole (218) of the coal nozzle body, the pin having a traverse end (226) and an inside end (228) with the traverse end of the pin being inserted during the traversing movement initially through the pivot support hole of the coal nozzle body and thereafter through the through hole of the one side of the coal nozzle tip, whereupon, in the fully inserted position of the pin, the traverse end of the pin is

September 22, 2009

–‫ד' בתשרי התש"ע‬

168162 ‫פי צינור דלק עבור התקן לשריפת דלק‬ ‫מאובנים‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

outward of the one side of the coal nozzle body and the inside end of the pin is inward of the coal nozzle body; and an engagement element (232) for resisting a withdrawal movement of the pin in a direction opposite to its traversing movement, the engagement element being reversibly movable between a deployed position in which the engagement element engages the pin to resist withdrawal movement of the pin in a direction opposite to its traversing movement and a non-deployed position in which resistance of withdrawal movement of the pin by the engagement element is insufficient to prevent withdrawal of the pin from the through hole of the coal nozzle tip, the path of movement of the engagement element between its deployed position and its non-deployed position being such that, throughout such movement of the engagement element, the path of movement of the engagement element can be intersected by a radial plane passing through the pin perpendicular to the insertion axis.

385

__________ ]11[]21[ ]54[

METHOD AND DEVICE FOR MANUFACTURING A DRILL BLANK OR A MILL BLANK

]22[ ]31[ ]51[ ]71[

21.04.2005 0401150-8 ]32[ 04.05.2004 Int. Cl.(2008.04) B21C 23/14 SANDVIK INTELLECTUAL PROPERTY AB, SWEDEN WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

]74[

[57] Method for manufacturing a drill blank or a mill blank by extrusion, said method comprising the forming of a first blank portion (B1) having external, axially extending external flutes and the forming of a further blank portion (B3) in the shape of a shaft, characterized in the following steps: (1) extruding a first blank portion having a free end and external flutes; (2) allowing the extrusion to continue in order to enter the free end and an adjacent portion of the first blank portion into a cavity and sealing said cavity in the area of the free end of the first blank portion; (3) allowing the extrusion to continue to supply further extruding mass to the

386

168169 ‫שיטה והתקן לייצור גולם למקדח וגולם‬ ‫לכרסום‬

]33[

SE

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, cavity, said supply of extruding mass completely filling out the external flutes of the first blank portion to produce a second blank portion integral with the first blank portion; (4) allowing the extrusion to continue and the sealing to terminate in order to allow the second blank portion to be pushed out of the cavity; (5) allowing the extrusion to continue to produce a desired length of the first blank portion; and (6) cutting off the first blank portion at the end facing away from the second blank portion.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

168238 ‫ תהליך לייצורו וחומר‬,‫מוצר ביולוגי משופר‬ ‫ביניים‬

]54[

MODIFLED BIOLOGICAL SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND INTERMEDIATE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

20.11.2003 2002-337113 ]32[ 20.11.2002 ]33[ JP Int. Cl.(2008.04) A61K 38/43, 47/48, C08G 2/00, 65/32 NOF CORPORATION, JAPAN WO/2004/046222 REINHOLD COHN AND ,‫ריינהולד כהן ושותפיו‬ PARTNERS, ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬ 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A compound of the formula

wherein R is a hydrocarbon group having 1 to 24 carbon atoms, the different R groups in the compound being the same or different from each other; OA2 is an oxyalkylene group having 2 to 4 carbon atoms, the different OA2 groups in the

compound being the same or different from each other, m, which is the average number of moles of oxyalkylene groups, is 10 to 1000; and X is a moiety selected from Group (l) or Group (ll): group (I)

September 22, 2009

–‫ד' בתשרי התש"ע‬

387

Group (ll) –Z-NH2(g)-NH2 (j)-Z-COOH (k) wherein Y represents a hydrocarbon group having 1 to 10 carbon atoms which may

contain fluorine atom(s), and Z is selected from the following (zl)-(z6):

,194501

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________ ]11[]21[ ]54[

PLASMA TORCH FOR USE IN A WASTE PROCESSING CHAMBER

]22[ ]51[ ]71[

28.04.2005 Int. Cl.(2008.04) F23G 5/00, 7/00 E.E.R. ENVIRONMENTAL ENERGY RESOURCES (ISRAEL) LTD. VALERI G. GNEDENKO, DAVID PEGAZ, ALEXANDER L. SURIS LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

]72[ ]74[

388

168286 ‫לפיד פלזמה לשימוש במערכת לעיבוד‬ ‫פסולת‬

‫אר החברה למשאבי סביבה ואנרגיה‬.‫אי‬.‫אי‬ ‫ גן‬- ‫ רמת‬,‫(ישראל) בע"מ‬ ‫ סוריס‬.‫ אלקסנדר ל‬,‫ דוד פגץ‬,‫ גנדנקו‬.‫ולרי ג‬ ,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

[57] A plasma torch (140) for insertion through an opening (11) in a wall of a waste processing chamber (10), said processing chamber having at least one liquid outlet (20) at a lower part thereof, for removing molten material, said plasma torch comprising a body having a front end (143), a rear end (145), a longitudinal outer surface (141), an outlet through which the high temperature plasma jet (39) exits and a heat protecting ring (21), both located at said front end; said plasma torch characterized by comprising a coaxial sleeve (52), said sleeve surrounding at

least a portion (56) of said outer surface of said torch that is located in said opening in said wall, thereby forming an insulating chamber (54) between said outer surface of said torch and the inner surface of said sleeve; wherein at least a part of said portion of said coaxial sleeve that surrounds at least said portion of said outer surface of said torch that is located in said opening in said wall is porous or permeable to a heat exchanging fluid, said torch comprising an inlet for introducing said heat exchanging fluid into said insulating chamber.

__________ ]11[]21[

168345 ‫שימוש בבנזופיראנים בהכנת תרופה‬ ‫להמרצת גידול שיער‬

]54[

USE OF BONZOPYRANS IN THE MANUFACTURE OF MEDICAMENTS FOR STIMULATING HAIR GROWTH

]22[ ]31[ ]51[ ]71[

03.11.2003 60/425686 ]32[ 12.11.2002 ]33[ US Int. Cl.(2008.04) A61K 313/53, 315/01, A61P 17/14, C07D 311/00, 405/12 WARNER-LAMBERT COMPANY LLC, U.S.A. WO/2004/043424 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]87[ ]74[

[57] Use of (3S, 4R)-3,4-dihydro-4-(2,3dihydro-2-methyl -3-oxopyridazin-6-yl) September 22, 2009

–‫ד' בתשרי התש"ע‬

oxy-3-hydroxy-6-(3-hydroxyphenyl) sulphonyl 1-2,2,3-trimethyl-2H-benzo[b]

389

pyran, or pharmaceutically acceptable salt thereof, in the manufacture of a medicament for an alopecia selected from the group consisting of alopecia areata,

hair loss secondary to chemotherapy or radiation treatment, stress-related hair loss, self-induced hair loss, and scarring alopecia.

__________ ]11[]21[ ]54[

COMPOSITE SACRIFICIAL ANODES

]22[ ]31[

14.11.2003 0226706.0 ]32[ 15.11.2002 0310021.1 01.05.2003 Int. Cl.(2008.04) C23F 13/10 MAGNESIUM ELEKTRON LIMITED, UNITED KINGDOM WO/2004/046422 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A composite sacrificial anode (10) for immersion in a corrosive environment comprising a plurality of castings of a sacrificial material each disposed around a corresponding electrical connector for attachment to a structure to be protected, a part of the surface of each casting being protected from corrosion by the

168557 ‫אנודות של הקרבה מחומר מורכב‬

]33[

GB GB

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ environment by being adjacent to at least one other casting, wherein the castings are connected electrically together only via their respective electrical connectors, wherein the composite anode has a weight greater than 10 kg and wherein the castings are joined together by a waterproof mastic or resin.

__________ 390

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

THERMAL INK JET PRINTHEAD WITH SYMMETRIC BUBBLE FORMATION

]22[ ]31[ ]51[ ]71[

17.11.2003 10/303433 ]32[ 23.11.2003 Int. Cl.(2008.04) B41J 2/05 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2004/048109 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152

]87[ ]74[

[57] An ink jet printhead comprising: a plurality of nozzles (3); and at least one respective heater element (10) corresponding to each nozzle, wherein each heater element is arranged for being in thermal contact with a bubble forming liquid, each heater element is configured to heat at least part of the bubble forming liquid to a temperature above its boiling

168609 ‫ראש מדפסת הזרקת דיו תרמי עם תבנית‬ ‫בועה סימטרית‬

]33[

US

,‫לוצאטו את לוצאטו‬ ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬

point to form a gas bubble therein thereby to cause the ejection of a drop of an ejectable liquid through the nozzle corresponding to that heater element, and each heater element has two opposite sides and is configured such that a gas bubble formed by that heater element is formed at both of said sides.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

168657

391

]54[

SENSOR SYSTEM AND METHOD FOR SENSING IN AN ELEVATEDTEMPERATURE ENVIRONMENT, WITH PROTECTION AGAINST EXTERNAL HEATING

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

30.04.2004 10/427408 ]32[ 30.04.2003 Int. Cl.(2008.04) G01J 5/04, G01K 1/08 RAYTHEON COMPANY, U.S.A. WO/2004/099743 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A sensor system (22) comprising a structure affixed to an aircraft (20) in a forward facing orientation, wherein the structure affixed to the aircraft includes: a sensor housing (30) having an exterior wall (32) with a window-support region (34) having an outwardly facing external face (36), wherein the window-support region of the exterior wall comprises a segment of a mounting flange (42) adapted to attach the remainder of the sensor unit (44) to the aircraft, and a window (40) through the window-support region of the exterior wall and affixed to the exterior

392

‫מערכת חיישן ושיטות חישה של סביבה‬ ‫עם טמפרטורות גבוהות והגנה כנגד חימום‬ ‫חיצוני‬

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

wall; a sensor unit contained within the sensor housing and receiving an input signal (26) through the window, wherein the sensor unit comprises an infrared sensor (46), and a cryocooler (48) that cools the sensor; and a thermal-insulation layer (50) affixed to the external face of the window-support region of the exterior wall at a location immediately adjacent to the window, wherein the thermalinsulation layer is a stand-alone piece of an insulating material affixed to the external face of the window-support region with an adhesive layer.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

‫וורה‬-‫כפפה שטופלה עם קמומיל או אלו‬

]54[

CAMOMILE/ALOE VERA TREATED GLOVE

]22[ ]31[ ]51[ ]71[

08.12.2003 10/321897 ]32[ 17.11.2002 Int. Cl.(2008.04) A01N 25/34 ANSELL HEALTHCARE PRODUCTS LLC, U.S.A. WO/2004/060064 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

168841

[57] A treated glove comprising cured material and a moist film on the interior surface of the cured material, the film comprising water, glycerol, and a botanical

]33[

US

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

extract; wherein the water is present in an amount ranging from about 30 mg to about 90 mg per glove.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

393

]11[]21[ ]54[

AREAL METAL ELEMENT AND PROFILE ELEMENT

]22[ ]31[ ]51[ ]71[

25.11.2003 10259307.8 ]32[ 18.12.2002 Int. Cl.(2008.04) E04C 2/08, 2/42, 3/08 PROTEKTORWERK FLORENZ MAISCH GMBH & CO. KG, GERMANY WO/2004/055289 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

]87[ ]74[

[57] An areal metal element having a surface (13) which extends from a first outside edge (8) to a second outside edge (9) lying opposite the first outside edge, with the region of the metal element adjoining the first outside edge forming a first side region (26) and the region of the metal element adjoining the second outer edge forming a second side region (27), both said side regions being connected to one another by a central region (28) lying between them, and with at least one completely bordered aperture (22, 23) being formed in at least one of the side regions with its border being formed in one part by said side region and in the other part by the central region, with the central region including at least two sections (29, 30) which each consist of two outwardly disposed part sections (31, 33, 34, 36) and a central part section (32, 35) lying between them, with the outwardly

394

168923 ‫אלמנט מתכת איזורי ופרופיל אלמנט‬

]33[

DE

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ disposed part sections being folded over with respect to the central part section for the production of the aperture, with the sections forming part of the border of the aperture, and with the central region, including the sections, being made in one piece with the two side regions of the metal element, characterized in that, in the central region, at least one further section is formed for each section and is associated with and of the same type as this section, with the sections associated with one another being arranged sequentially in a direction from the first side region to the second side region and with each of the two outwardly disposed part sections of one of these sections being directly connected to the respective corresponding outwardly disposed part section of the other section by an areal region (24, 25) of the metal element.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

HIP PROSTHESIS COMPRISING A SHAFT TO BE FIXED IN THE MEDULLARY CANAL OF THE FEMUR

]22[ ]31[

14.01.2004 03001040.9 ]32[ 17.01.2003 03016156.6 16.07.2003 Int. Cl.(2008.04) A61F 2/36 WALDEMAR LINK GMBH & CO. KG, GERMANY WO/2004/064688 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]51[ ]71[ ]87[ ]74[

[57] A hip prosthesis with a shaft (1) to be anchored in the medullary canal of the femur, of which the distal portion (7) configured to be anchored in a diaphysis has a core cross-section which tapers toward a distal end (11) and which has longitudinal ribs (16) at least on a lateral side and a medial side whose height increases from a proximal portion of the shaft to a distal end portion of the shaft, characterized in that the shaft core cross-

September 22, 2009

–‫ד' בתשרי התש"ע‬

169353 ‫ירך תותבת המכילה מוט לקיבוע בתעלה‬ ‫לשדית של עצם הירך‬

]33[

EP EP

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

section at a distance of 1 cm from the distal end portion has substantially rectangular boundary with an axis ratio of at least 1.5 to 1 and, at least near a distal end thereof has a rib on each of its two lateral edges, the height of which is on average under 2 mm, the boundary of the shaft core cross-section between the two ribs located on the lateral edges not protruding further laterally than the ribs.

395

__________ ]11[]21[ ]54[

SLANTED KEY COMBINATION ELEMENT IN KEY BLANK AND KEY

]22[ ]51[ ]71[

23.06.2005 Int. Cl.(2008.04) E05B 19/08, 35/00 MUL-T-LOCK TECHNOLOGIES LTD. SHLOMO AVITAL DEKEL PATENT LTD., 18 MENUHA VENAHALA ST., REHOVOT 76209

]72[ ]74[

[57] A key blank (10) comprising: a generally elongate shaft portion (12) defining first and second generally flat oppositely directed side surfaces (14, 16) joined by edge surfaces (18), at least one of said first and second side surfaces cuttable to form key cuts (20) that define a key combination surface, said shaft portion having a longitudinal axis (13) that extends along a length thereof and a transverse axis

396

169371 ‫אלמנט צירוף מפתח באלכסון בגלם מפתח‬ ‫ובמפתח‬

‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬ ‫שלמה אביטל‬ ,‫דקל פטנט בע"מ‬ ‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬ (15) that extends along a width thereof; and at least one key combination element (26) movably disposed in the elongate shaft portion and adapted for touching a lock combination element (54) disposed in a cylinder lock plug (46), characterized by said at least one key combination element comprising a resilient arm (28) disposed in a recess (30) formed in said elongate shaft portion, said resilient arm and recess being September 22, 2009

–‫ד' בתשרי התש"ע‬

slanted at a non-zero angle with respect to both longitudinal and transverse axes of

said shaft portion.

__________ ]11[]21[ ]54[

TOOL GUIDING DEVICE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

05.01.2004 10300722.9 ]32[ 11.01.2003 Int. Cl.(2008.04) B30B 15/06 JOHANN ANDERL, GERMANY WO/2004/062901 HENRY SINAI, P.O.B. 669, RAANANA

[57] A tool guiding device with a base frame (1) and guide rails (2) which are parallel relative to each other arranged on the base frame and at least one carriage (3, 4) having a processing tool (13, 14) displaceably linearly guided via a carriage connector (10, 11) by a drive mechanism, the tool guiding device comprising: the carriage coupled to the carriage connectors via at least one compensating device having at least one angle compensation element and at least one lateral compensation element; the angle compensation element comprising a ball element or a ball section element rigidly September 22, 2009

–‫ד' בתשרי התש"ע‬

169432 ‫מכשיר לכיוונון כלי עבודה‬

]33[

DE

,‫הנרי סיני עו"פ‬ ‫ רעננה‬,669 .‫ד‬.‫ת‬ connected with the carriage connector; the at least one lateral compensation element including an intermediate piece forming a ball socket, wherein the angle compensation element is seated in the ball socket of the intermediate piece; the intermediate piece either forming a further ball socket on a side facing away from the ball socket in which one of a further ball element and a further ball section element connected with the carriage is seated in an articulated manner, or on the side facing away from the ball socket the intermediate piece is seated on a bearing that is

397

moveable transversely to a displacement

direction of the carriage.

__________ ]11[]21[ ]54[

CONVERSION OF SPECTRAL COMPONENTS FOR ENCODING AND LOW-COMPLEXITY TRANSCODING

]22[ ]31[

30.01.2004 60/445931 ]32[ 06.02.2003 10/458798 09.06.2003 Int. Cl.(2008.04) G10L 19/14 DOLBY LABORATORIES LICENSING CORPORATION, U.S.A. WO/2004/072957 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]71[ ]87[ ]74[

[57] A method of processing an audio signal comprising: receiving a signal conveying initial scaled values and initial scale factors representing spectral components of the audio signal, wherein each initial scale factor is associated with

398

169442 ‫המרה של מרכיבים ספקטרליים מסונתזים‬ ‫לקידוד וקידוד–טרנס ברמת סיבוך נמוכה‬

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ one or more initial scaled values, each initial scaled value is scaled according to its associated initial scale factor, and each initial scaled value and associated initial scale factor represent the value of a respective spectral component; generating September 22, 2009

–‫ד' בתשרי התש"ע‬

coded spectral information by performing a coding process that is responsive to initial spectral information that comprises at least some of the initial scale factors; deriving one or more first control parameters in response to the initial scale factors and a first bit-rate requirement; allocating bits according to a first bit allocation process in response to the one or more first control parameters; obtaining quantized scaled values by quantizing at least some of the initial scaled values using quantizing resolutions based on numbers of bits allocated by the first bit allocation process; deriving one or more second control parameters in response to at least some of the initial scale factors, one or more modified scale factors and a second bit-rate requirement, wherein the one or more modified scale factors are obtained by: analyzing the initial spectral information with respect to a synthesis process to be applied to the coded spectral information in a decoding method that generates synthesized spectral components represented by synthesized scaled values

and associated synthesized scale factors to identify one or more potentially unnormalized synthesized scaled values, wherein the synthesis process is quasiinverse to the coding process, and generating the one or more modified scale factors to represent modified values of initial scale factors in the initial spectral information corresponding to synthesized scale factors that are associated with at least some of the one or more potentially unnormalized synthesized scaled values to compensate for loss of normalization of the identified potentially unnormalized synthesized scaled values to compensate for loss of normalization of the identified potentially unnormalized synthesized scaled values; and assembling encoded information into an encoded signal, wherein the encoded information represents the quantized scaled values, at least some of the initial scale factors, the coded spectral information, the one or more first control parameters and the one or more second control parameters.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

399

]11[]21[

169611 ‫שסתום עבור מערכת ריקון בריק‬

]54[

VALVE FOR VACUUM DISCHARGE SYSTEM

]22[ ]31[ ]51[ ]71[

09.02.2004 2003-034762 ]32[ 13.02.2003 ]33[ Int. Cl.(2008.04) F16K 27/00, 51/02, 7/12 TADAHIRO OHMI, JAPAN FUJIKIN INCORPORATED, JAPAN

]87[ ]74[

WO/2004/072519 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A valve (1) in a vacuum exhaustion system which comprises a body (2) having a valve seat (8) formed on the bottom face of a valve chamber (7) being in communication with a flow-in passage (3) and a flow-out passage (6), a valve body permitted to rest on or move away from the afore-mentioned valve seat, and a driving means (4) operating to allow the

JP

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, afore-mentioned valve body to rest on or move away from the valve seat such that the fluid passage is closed or opened for controlling the fluid by allowing the valve body to rest on and move away from the valve seat wherein aluminum passivation is applied at least on the surfaces of the body which come in contact with fluids.

__________

400

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

REWINDING MACHINE TO PRODUCE LOGS OF WEB MATERIAL AND RELATIVE WINDING METHOD

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

09.02.2004 FI2003A000036 ]32[ 12.02.2003 Int. Cl.(2008.04) B65H 19/22, 35/08 FABIO PERINI S.P.A., ITALY WO/2004/071914 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

[57] Rewinding machine (1) to produce logs of web material comprising: a winding cradle (7), an insertion member (29) to insert a winding core (A) into said winding cradle; an ejector to eject a log formed in said winding cradle by causing the log to roll on an unloading chute (41), a severing device (53) to sever the web material after the log is ejected from said winding cradle; wherein disposed along the unloading chute is an aperture (43) elongated in a direction transverse to a direction in which the log is unloaded

169898 ‫מכונת גלילה ליצור גליל חומר ארוג‬ ‫ושיטת גלילה בהתאם‬

]33[

IT

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ along said unloading chute; said severing device comprises a movable element (55) that is inserted into said aperture to cause severing of the web material between the winding cradle and the log of wound web material, and a first glue container (45) is disposed underneath said unloading chute and wherein a first movable dispensing member that collects glue from said first glue container to apply the glue to the log of wound web material is associated with said first glue container.

__________

September 22, 2009

–‫ד' בתשרי התש"ע‬

401

]11[]21[ ]54[

DISPENSER

]22[ ]31[ ]51[ ]71[

20.02.2004 0304000.3 ]32[ 21.02.2003 Int. Cl.(2008.04) A61M 15/00 CLINICAL DESIGNS LIMITED, UNITED KINGDOM WO/2004/073776 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] A dispenser for dose dispensing of a gaseous, gas borne or droplet substance from a source (c) thereof, the dispenser comprising: a body (1) with a mouthpiece; a junction member in the body and having: a socket for receiving a spout of the substance source; a breath actuatable valve (48) incorporated with the junction member, for controlling the release of the gas and/or liquid containing or comprising the substance, the valve comprising: a flexible tube for receiving a dose of the said substance gas or liquid, the tube extending from a valve inlet connected to the junction member spout and having; a portion which is kinkable for closure of the valve and movable to a release position in which the tube is un-kinked for opening of the valve and an outlet end movable for kinking/unkinking of the tube; and an outlet member carrying the outlet end of the flexible tube and pivotally connected to the junction member for control of kinking/un-kinking movement of the flexible tube; the tube being kinked to an

402

169921 ‫מכשיר לחלוקה‬

]33[

GB

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

obturating extent when the pivoted outlet member is in a ready position and unkinked when the pivoted outlet member is moved to its release position; and a sear on the outlet member to hold it in the ready position prior to inhalation, a breath actuatable flap (61) carried on the junction member and arranged for action of inhalation breath on it, the flap having: a latch complementary to the sear and the flap being arranged: to latch the pivoted outlet member for kinked closure of the flexible tube via action of the latch and the sear and to release the pivoted outlet member for unkinking of the tube, and substance release, on inhalation by release of the sear by the latch and movement to its release position of the outlet member, characterised in that the source is a pressurized medicament container with a metered dose valve held in the body and in that the junction member is slidably mounted in the body for movement towards the container and dispensing of a dose to the valve via the junction member.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

SAFETY RAZORS

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

19.02.2004 0303865 ]32[ 19.02.2003 Int. Cl.(2008.04) B26B 19/38, 21/40 THE GILLETTE COMPANY, U.S.A. WO/2004/073936 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

[57] A safety razor comprising a blade unit (2) carried on a handle (1), an electrical arrangement including an electrically operated device, and an indicator (28), wherein the electrically operated device is actuable by the

September 22, 2009

–‫ד' בתשרי התש"ע‬

169961 ‫סכיני גילוח בטיחותיים‬

]33[

GB

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

electrical arrangement during shaving, and the indicator produces a signal for indicating to a razor user that the electrical arrangement is connected to a source of electrical power and ready for actuation of the device.

403

__________ ]11[]21[

170025 ‫תולדות גואדין פולימרי בתצורת תרופה‬ ‫סיטוסטתית‬

]54[

POLYMERIC GUANIDINE DERIVATIVES AS A CYTOSTATIC MEDICAMENT

]22[ ]31[ ]51[ ]71[

22.01.2004 A 174/2003 ]32[ 04.02.2003 ]33[ AT Int. Cl.(2008.04) A61K 311/55, A61P 35/00, C08G 73/02 GEOPHARMA PRODUCKTIONSGMBH, AUSTRIA WO/2004/069898 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

]87[ ]74[

[57] The use of a polymeric guanidine derivative based on a diamine containing oxyalkylene chains between two amino groups, with the guanidine derivative representing a product of polycondensation between a guanidine acid addition salt and

a diamine containing polyoxyalkylene chains between two amino groups, as well as the pharmaceutically acceptable salts thereof, for the preparation of a cytostatically active drug composition.

__________ 404

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

170095 ‫שיטה לשינוי מזהם הנמצא בתוך נוזל‬

]54[

METHOD OF ALTERING A FLUID-BORNE CONTAMINANT

]22[ ]31[

27.01.2004 60/445979 ]32[ 07.02.2003 ]33[ US 60/486507 11.07.2003 US Int. Cl.(2008.04) A61L 2/00, 9/16, A62D 3/00 THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, U.S.A. WO/2005/038428 DR. SHLOMO COHEN & CO., ,'‫ד"ר שלמה כהן ושות‬ 124 IBN GABIROL ST., ‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬ P.O.B. 11490, TEL AVIV 62038

]51[ ]71[ ]87[ ]74[

[57] A method for killing at least 99.9% of the anthrax spores in a fluid, comprising the steps of: (a) passing fluid containing anthrax spores through one positive-displacement pump or through multiple positive-displacement pumps connected in series; and, (b) operating the one positivedisplacement pump or multiple positive-

displacement pumps connected in series at a pressure ratio or pressure ratios such that the passage of the fluid containing anthrax spores through the one positivedisplacement pump or through the multiple positive-displacement pumps connected in series kills at least 99.9% of the anthrax spores in the fluid.

,197052

The applications for division from this application have not yet been published

‫בקשות חלוקה מבקשה זו‬ .‫שטרם פורסמו‬

_________

September 22, 2009

–‫ד' בתשרי התש"ע‬

405

]11[]21[

170215 ‫שיטה ומבנה למסננים וקדם מסננים‬ ‫להארכת מחזור החיים של גופי המסננים‬ ‫בתוכו‬

]54[

METHOD AND CONSTRUCTION OF FILTERS AND PRE-FILTERS FOR EXTENDING THE LIFE CYCLE OF THE FILTER BODIES THEREIN

]22[ ]31[ ]51[ ]71[

04.02.2004 60/446440 ]32[ 12.02.2003 ]33[ US Int. Cl.(2008.04) B01D 35/06, 43/00, B03C 3/12 GIDEON ROSENBERG ‫ קרית טבעון‬,‫גדעון רוזנברג‬ INNOVATIVE DEFENSE TECHNOLOGIES LTD., U.S.A. GIDEON ROSENBERG ‫גדעון רוזנברג‬ WO/2004/071613 G.E. EHRLICH (1995) LTD., ,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬ AYALON TOWER, 15TH FLOOR, ,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬ 11 MENACHEM BEGIN ST., ‫רמת גן‬ RAMAT GAN 52521

]72[ ]87[ ]74[

[57] A method of operating a filter (10) to remove solid particles from a fluid by passing the fluid through a filter body (11) having an upstream side and a downstream side, characterized in applying to the fluid, solely at the upstream side of the filter body, an AC electrical field (15) of a frequency and intensity to agglomerate

solid particles in the fluid before reaching the upstream side of the filter body, such as to reduce the number of small particles in the fluid tending to clog the filter body and thereby to extend the life cycle of the filter body before cleaning or replacement thereof is required.

__________ 406

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[ ]54[

AUTOMATED COVERING FOR AN AUTOMOBILE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

30.01.2004 10/386914 ]32[ 12.03.2003 Int. Cl.(2008.04) B60J 7/20 THOMAS C. RHEA, U.S.A. WO/2004/080741 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] An automated device (10) for covering the windows of a vehicle (14), comprising: a collection container; a plurality of extensions attached to the collection container and positioned to be substantially retained within and extended from the collection container; a motor attached to the collection container to rotate the collection container, whereby

170346 ‫כיסוי אוטומטי עבור כלי רכב‬

]33[

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, rotation of the collection container extends and retracts the plurality of extensions; a covering (16) attached to the plurality of extensions and sized to cover the windows of the automobile; and a top (28) attached to the collection container and positioned to retain the covering when the plurality of extensions are retracted.

__________

]11[]21[ September 22, 2009

–‫ד' בתשרי התש"ע‬

170493

407

‫תוית‬

]54[

LABEL

]22[ ]31[ ]51[ ]71[

27.02.2004 2003900886 ]32[ 27.02.2003 Int. Cl.(2009.01) G09F 03//10 GLOBAL APEEL LIMITED, UNITED KINGDOM WO/2004/077385 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520

]87[ ]74[

[57] A label for affixing to a container of produce, the label including:- a front portion (16) for carrying labeling indicia; an adhesive backing (18) substantially covering one side of the front portion; a non-stick backing sheet (17, 19) affixed to the adhesive backing, and a token (14); a portion of the front portion constituting the token and being readily severable from the front portion when the label is affixed to the container, a portion (24) of the backing sheet being removable from the adhesive

]33[

AU

,‫ד"ר מרק פרידמן בע"מ‬ ,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬ ‫ גן‬-‫רמת‬

backing such that another portion (22) of the backing sheet remains attached to the token; wherein perforations (20) in the front portion defining the token do not extend into the backing sheet, and wherein the backing sheet is cut through such that the other portion of the backing sheet which remains attached to the token is smaller than the token, the adhesive extending beyond the smaller other portion of the backing sheet.

__________

]11[]21[

408

170497

September 22, 2009

–‫ד' בתשרי התש"ע‬

]54[

AIRPORT NAVIGATION LIGHT UNIT AND SYSTEM

]22[ ]31[ ]51[ ]71[

19.03.2004 03006362.2 ]32[ 20.03.2003 Int. Cl.(2008.04) G08G 5/06 ADB AIRFIELD SOLUTIONS GMBH & CO. KG, GERMANY WO/2004/084154 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

[57] Airport navigation light unit (2) comprising a base body in which connection elements (8) are arranged for connecting supply lines (3), a lighting device (9), a sensor device (10), a switching device (11) and a communication device (12), wherein the switching device and the communication device are connected to the connection elements, wherein the switching device can be switched by the communication device according to control signals (S) which are transmitted via the supply lines to the communication device so that the

‫מערכת ויחידת תאורה לניווט בשדה‬ ‫תעופה‬

]33[

EP

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

lighting device can be switched on to the connection elements by means of the switching device, wherein a state prevailing outside the airport navigation light unit can be detected by means of the sensor device and transmitted as a raw signal (R) to the communication device, wherein the raw signal (R) can be evaluated by the communication device and a useful signal (N) determined therefrom fed to the supply lines, wherein the control signals (S) and the useful signal (N) can be transmitted as OFDM signals via the supply lines.

__________ September 22, 2009

–‫ד' בתשרי התש"ע‬

409

]11[]21[

170575 ‫שיטה להפסקת פעולת וחידוש פעולת‬ ‫מודולות אבטחה‬

]54[

METHOD FOR DEACTIVATING AND REACTIVATING SECURITY MODULES

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

02.03.2004 00325/03 ]32[ 03.03.2003 ]33[ Int. Cl.(2008.04) G07F 7/10, H04N 7/16 NAGRACARD S.A., SWITZERLAND WO/2004/079672 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] Method for deactivating and reactivating security modules particularly intended for access control to conditional access data, the security module including a plurality of registers containing values, this process including a step of sending, by an operator, at least one management message (RUN-EMM) containing an

CH

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,

executable code, said executable code being loaded into a memory of the security module and then executed, this method being characterized in that its execution modifies in a reversible way said values contained in the registers, the content of the registers after modification rendering the module unusable.

__________

]11[]21[ ]54[

PROCESS FOR THE PRODUCTION OF AN ELECTROLYTIC ELECTRODE WITH A PLATINUM GROUP METAL OXIDE COATING AND ELECTRODES MADE THEREFROM

]22[ ]31[ ]51[ ]71[

10.12.2003 10/395939 ]32[ 24.03.2003 Int. Cl.(2008.04) C25B 11/06 ELTECH SYSTEMS CORPORATION, U.S.A. WO/2004/094698 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352,

]87[ ]74[

410

170874 ‫תהליך להכנת אלקטרודה אלקטרוליטית‬ ‫עם צפוי אקסיד מתכתי של קבוצת פלטינה‬ ‫ואלקטרודים המיוצרים המנו‬

]33[

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, September 22, 2009

–‫ד' בתשרי התש"ע‬

JERUSALEM 91013 [57] A process for the production of an electrolytic electrode having an electrocatalytic coating thereon, said electrocatalytic coating having reduced amounts of platinum group metal oxides while maintaining coating durability, said process comprising the steps of: providing a valve metal electrode base; coating said valve metal electrode base with a coating layer of an electrochemically active coating on said valve metal base, said coating comprising a uniform mixture of platinum group metal oxides, and optionally, a valve metal oxide in an amount not greater than 25 mole percent, basis 100 mole percent of the metal

content of the coating, said mixture of platinum group metal oxides consisting essentially of ruthenium oxide and iridium oxide in a proportion providing from at least about 5 mole percent up to about 50 mole percent ruthenium, and at least about 50 mole percent up to about 95 mole percent iridium, basis 100 mole percent of these metals present in the coating, wherein said ruthenium oxide and iridium oxide are present in a molar proportion from about 1:1 to about 1:4 and, wherein said electrochemically active coating is applied in an amount from about 0.2 g/m2 to about 1.0 g/m2, basis said iridium, as metal, per a side of said electrode base.

__________

]11[]21[

171287 ‫שיטות ומערכות להצפנת אודיו‬ ‫המשתמשות במרכיב מצמד ספקטרלי‬ ‫ובמרכיב רגנרציה ספקטרלי‬

]54[

AUDIO CODING SYSTEMS AND METHODS USING SPECTRAL COMPONENT COUPLING AND SPECTRAL COMPONENT REGENERATION

]22[ ]31[ ]51[ ]71[

30.04.2004 10/434449 ]32[ 08.05.2003 ]33[ US Int. Cl.(2008.04) G10L 21/02, H03M 1/00 DOLBY LABORATORIES LICENSING CORPORATION, U.S.A. WO/2004/102532 SANFORD T.COLB & CO., ,'‫ קולב ושות‬.‫סנפורד ט‬ P.O.B. 2273, ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ REHOVOT 76122

]87[ ]74[

[57] A method for encoding a plurality of input audio signals, wherein the method comprises: receiving the plurality of input September 22, 2009

–‫ד' בתשרי התש"ע‬

audio signals and obtaining therefrom one or more baseband signals and one or more residual signals, wherein spectral

411

components of a baseband signal represent spectral components of a respective input audio signal in a first set of frequency subbands and spectral components in an associated residual signal in a second set of frequency subbands that are not represented by the baseband signal; obtaining energy measures of at least some spectral components of one or more synthesized signals to be generated during decoding, wherein the one or more synthesized signals have spectral components within the second set of frequency subbands; obtaining energy measures of at least some spectral components of each residual signal; obtaining from the plurality of input audio signals a coupled-channel signal having spectral components representing a composite of spectral components of two or more of the input audio signals in a third set of frequency subbands; obtaining energy measures of at least some spectral components of the coupled-channel signal; obtaining energy measures of at least some of the spectral components of the two or more input audio signals represented by the coupled-channel signal in the third set of frequency subbands; calculating coupling scale factors by obtaining square roots of ratios of the energy measures of spectral components in the two or more input audio signals to the energy in the coupled-channel signal, square roots of ratios of the energy measures of spectral energy in the coupled-channel signal to the energy measures of spectral components in the two or more input audio signals, ratios of square roots of the energy measures of spectral components in the two or more input audio signals to square roots of the energy measures of spectral energy in the

coupled-channel signal, or ratios of square roots of the energy measures of spectral energy in the coupled-channel signal to square roots of the energy measures of spectral components in the two or more input audio signals; calculating scale factors by obtaining square roots of ratios of the energy measures of spectral components in the residual signals to the energy measures of spectral energy in the coupled-channel signal to square roots of the energy measures of spectral components in the two or more input audio signals; calculating scale factors by obtaining square roots of ratios of the energy measures of spectral components in the residual signals to the energy measures of spectral components in the one or more synthesized signals, square roots of ratios of the energy measures of spectral components in the one or more synthesized signals to the energy measures of spectral components in the residual signals, ratios of square roots of the energy measures of spectral components in the residual signals to square roots of the energy measures of spectral components in the one or more synthesized signals, or ratios of square roots of the energy measures of spectral components in the one or more synthesized signals to square roots of the energy measures of spectral components in the residual signals; and assembling signal information and scaling information into an encoded signal, wherein the signal information represents the spectral components in the one or more baseband signals and the spectral components in the coupled-channel signal, and wherein the scaling information represents the scale factors and the coupling scale factors.

__________ ]11[]21[ ]54[

412

PROCESS TO PREPARE A SKIN SOFTENING COMPOSITION

171317 ‫תהליך להכנת תכשיר לריכוך העור‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

14.04.2004 60/468302 ]32[ 14.04.2003 ]33[ US Int. Cl.(2008.04) A61K 08/31, 08/34, 08/368, 6/00 TARO PHARMACEUTICALS U.S.A., INC., U.S.A. WO/2004/091554 PEARL COHEN ZEDEK LATZER, ,‫פרל כהן צדק לצר‬ 5 SHENKAR ST., ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ P.O.B. 12704, ‫הרצליה‬ HERZLIYA 46733

[57] A method of making a skin softening ointment, comprising the steps of: (a) heating and mixing a humectant and a non-aqueous thickener under vacuum in a first vessel; (b) introducing urea under vacuum into the mixture of step (a); (c) heating and mixing the contents of step (b) under vacuum, at a temperature sufficient to dissolve the urea; (d) heating and mixing a non-aqueous base and at least one emulsifier in a second vessel, whereby the non-aqueous base liquefies;

(e) drawing by vacuum the mixture from step (d) into the mixture in the first vessel; (f) mixing, heating and homogenizing the contents of step (e) under vacuum; (g) cooling, mixing and homogenizing the mixture of step (f) to a congealing temperature under vacuum; (h) cooling the mixture of step (g); (i) drawing by vacuum salicylic acid into the mixture of step (h); (j) recirculating the mixture of step (i) under vacuum; and, (k) cooling the mixture of step (j) under vacuum.

__________ ]11[]21[ ]54[

FLUID CONTROLLER

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

07.12.2005 2003-408975 ]32[ 08.12.2003 Int. Cl.(2008.04) F16K 7/16 FUJIKIN INCORPORATED, JAPAN WO/2005/054729 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013

[57] A fluid controller (21) comprising: a block-like main body (22) having a fluid inflow passage (23), a fluid outflow passage (24) and a concave portion (25) open upward; and diaphragm (28) pressed against or moved apart from an annular valve seat (27) arranged within the September 22, 2009

–‫ד' בתשרי התש"ע‬

171506 ‫בקר ניגרים‬

]33[

JP

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, concave portion of the main body so as to open and close the fluid passages, wherein the concave portion is formed into a shape including a large-diameter portion (25a) close to the opening and a small-diameter portion (25c) connected to a lower side of the large-diameter portion via a step

413

portion (25b), and the fluid controller is further provided with a flow path forming disk (26) fitted to the concave portion, the flow path forming disk includes a largediameter cylinder portion (31) fitted to the large-diameter portion of the concave portion in a fluid tight manner, a smalldiameter cylinder portion (33) having an outer diameter smaller than an inner diameter of the small-diameter portion of the concave portion and having a lower end received by a bottom surface of the concave portion, and a coupling portion (32) coupling a lower end portion of the large-diameter cylinder portion and an upper end portion of the small-diameter cylinder portion and received by the step portion of the concave portion, and a peripheral edge portion of the diaphragm is fixed to an upper end portion of the largediameter cylinder portion of the flow path forming disk, a valve seat is provided in the upper end portion of the smalldiameter cylinder portion of the flow path

forming disk, an inner annular space (52) of the large-diameter cylinder portion is formed by an inner periphery of the largediameter cylinder portion of the flow path forming disk, the diaphragm, the valve seat and a top surface of the coupling portion of the flow path forming disk, a plurality of through holes communicating an outer annular space (51) of the small-diameter cylinder portion formed between the smalldiameter cylinder portion of the flow path forming disk and a peripheral surface of the small-diameter portion of the concave portion with an inner annular space of the large-diameter cylinder portion are formed in a coupling portion of the flow path forming disk, any one of the fluid inflow passage and the fluid outflow passage is communicated with a lower end of the small-diameter cylinder portion of the flow path forming disk, and the other is formed so as to be communicated with the outer annular space of the small-diameter cylinder portion.

__________ ]11[]21[ ]54[

CERVICAL DILATION MONITOR

]22[ ]31[ ]51[ ]71[

04.05.2004 10/430297 ]32[ 07.05.2003 Int. Cl.(2008.04) A61B 51/03 ILAN HALEVI

414

171571 ‫מכשיר ניטור התרחבות צוואר הרחם‬

]33[

US

‫ פתח תקוה‬,‫אילן הלוי‬ September 22, 2009 –‫ד' בתשרי התש"ע‬

MIKI BEN-CNAAN BARAK HALEVI ]87[ ]74[

WO/2004/098375 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520

[57] A system (10) for measuring dilation of a cervix of a uterus of a female during the first stage of labor, comprising: (a) an expandable gripping arrangement (12) having two oppositely facing gripping members (14) each resiliently biased to gripping configuration for non-penetrating engagement of the cervix and an outwardly biased restoring member (16), said gripping arrangement being configured, such that, said restoring member pushes said gripping members apart to that said gripping arrangement grips the cervix while the cervix dilates; (b) a first elongated element (20) having a calibrated scale (22) disposed thereon; (c) a second elongated element (30), a part of said second elongated element being disposed along said calibrated scale, said part of said second elongated element having an indicator (32) disposed thereon,

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ תל אביב‬,‫כנען‬-‫מיקי בן‬ ‫ציונה‬-‫ נס‬,‫ברק הלוי‬ ,‫ד"ר מרק פרידמן בע"מ‬ ,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬ ‫ גן‬-‫רמת‬

said first elongated element and said second elongated element being mechanically connected to said gripping arrangement, in a manner such that, as said gripping arrangement expands with the dilating cervix, relative linear movement is generated between said first elongated element and said part of said second elongated element, thereby moving said indicator with respect to said calibrated scale so as to give a measurement of dilation of the cervix; and (d) an insertion arrangement (40) configured to temporarily retain said gripping members in an open configuration during fitting of said gripping arrangement on the cervix and to simultaneously release said gripping members so as to allow said gripping members to return to said gripping configuration for non-penetrating engagement of the cervix.

415

__________ ]11[]21[ ]54[ ]22[ ]31[ ]51[ ]71[

‫מזרק סיבובי‬

ROTARY INJECTOR

21.05.2004 10/249967 ]32[ 22.05.2003 Int. Cl.(2008.04) F02C 7/22 WILLIAMS INTERNATIONAL CO., L.L.C., U.S.A. ]87[ WO/2005/028843 ]74[ WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [57] A rotary injector, comprising: (a) at least one arm (48) adapted to rotate about an axis of rotation, wherein said at least one arm extends in a radial direction with respect to said axis of rotation, said at least one arm is adapted to rotate within a stream of a first fluid adapted to flow

416

171935

]33[

US

,‫ ברגמן וגולר‬,‫וולף‬ ‫ ירושלים‬,1352 .‫ד‬.‫ ת‬, across said at least one arm, and at least one said arm comprises a plurality of lands (52), wherein said plurality of lands are adapted so that said stream of first fluid can flow across said plurality of lands and at least two of said plurality of lands are located at different radial distances from September 22, 2009

–‫ד' בתשרי התש"ע‬

said plurality of lands are located at different radial distances from said axis of rotation; and (b) at least one port (58) located on each of said plurality of lands, wherein said at least

one port is operatively coupled by an associated fluid passage to a source of a second fluid.

__________ ]11[]21[ ]54[

METHOD FOR FORMING A SUPERHARD AMORPHOUS CARBON COATING IN VACUUM

]22[ ]31[ ]51[ ]71[ ]72[

21.04.2004 2003115309 ]32[ 22.05.2003 Int. Cl.(2008.04) C23C 14/22 ARGOR ALJBA AG, SWITZERLAND ALEXANDER YAKOVLEVICH KOLPAKOV, VITALY NIKOLAEVICH INKIN, SERGEI IVANOVICH UKHANOV ]87[ WO/2004/104263 ]74[ DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [57] A method for forming a superhard wear-resistant carbon coating in vacuum, comprising the steps of: placing an article into a vacuum chamber that is subsequently vacuumed; treating a surface of the article with accelerated ions; applying a layer of a material to the September 22, 2009

–‫ד' בתשרי התש"ע‬

172000 –‫שיטה ליצירת ציפוי פחמן אמורפי קשה‬ ‫ביותר בתוך ריק‬

]33[

RU

,‫ד"ר מרק פרידמן בע"מ‬ ,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬ ‫ גן‬-‫רמת‬ surface, said material providing adhesion of subsequent layers; and initializing a pulse electric arc discharge at a graphite cathode, and producing a pulse stream of carbon plasma from a plurality of cathode spots that move along a cathode surface; condensing the cathode plasma within a

417

predetermined area on the surface of the article to produce a superhard amorphous carbon coating, wherein a temperature of the article is maintained within the range of from 200 to 450 K by adjusting a pulse repetition rate of the electric arc discharge, the method characterized by using a pulse stream of the carbon plasma having an average energy of ions 25 to 35 eV and an

ion concentration of 1012 to 1013 cm-3, wherein an axis of said carbon plasma stream is positioned at an angle of from 15o to 45o to a predetermined surface of the article, and an article temperature variation ∆ t is maintained in a range of from 50 to 100 K during application of the coating.

__________ ]11[]21[

172717 ‫ ושיטה לאבטחת כלי טיס‬,‫ מערכת‬, ‫מתקן‬

]54[

APPARATUS, SYSTEM AND METHOD FOR AIRCRAFT SECURITY

]22[ ]31[

30.12.2003 60/482807 ]32[ 26.06.2003 ]33[ US 10/643101 18.08.2003 US Int. Cl.(2008.04) B64D 45/00, G08B 29/00 MICHAEL ARNOUSE, U.S.A. WO/2005/016747 EITAN MEHULAL LAW GROUP, ‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ 10 ABBA EBEN BLVD., ,‫פטנטים‬ P.O. B. 2081, ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬ HERZLIYA 46120

]51[ ]71[ ]87[ ]74[

[57] A security mechanism for identifying authorized users and reacting to detection of unauthorized users during all phases of an aircraft flight, the system comprising: a controller (112) operable by a user, a security device (114) to read information associated with the user attempting to operate the controller, the security device being located so as to be able to read the information at any time while the user is attempting to operate the controller; and one or more monitoring devices (116) storing information as to all users authorized to operate the controller and comparing the information of the user attempting to operate the controller against

418

the stored information as to all authorized users to determine whether the user is authorized to operate the controller, the stored information having been loaded into the monitoring device prior to flight; the one or more monitoring devices being operable to disable the controller and engage an autopilot if an unauthorized user is detected at the controller at any time during all phases of an aircraft flight, comprising starting up of the aircraft, movement of the aircraft from a fixed position, take-off or landing of the aircraft, taxiing of the aircraft as well as in the air flight.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

HIGH STRENGTH FABRIC STRUCTURE AND SEAM THEREFOR WITH UNIFORM THICKNESS AND A METHOD OF MAKING SAME

]22[ ]31[ ]51[ ]71[ ]72[

08.06.2004 10/620888 ]32[ 16.07.2003 Int. Cl.(2008.04) B32B 3/00, 5/12 RAYTHEON COMPANY, U.S.A. WILLIAM H. FOSSEY, SHARON A. ELSWORTH WO/2005/014905 JMB, FACTOR & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450

]87[ ]74[

[57] A high strength flexible fabric structure comprising: a plurality of flexible fabric sections (42, 44), each section including a plurality of plies (46, 48, 50, 52, 54, 56) of alternating fiber orientation;

September 22, 2009

–‫ד' בתשרי התש"ע‬

173118 ‫מבנה בד בעל חוזק גבוה ותפר עבורו בעל‬ ‫עובי אחיד ושיטה לייצורו‬

]33[

US

,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬ ,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬ ‫ירושלים‬ and a joint between adjacent sections wherein the plies of each section are offset to form a uniform thickness seam between the two sections without any overlap of plies of like fiber orientation.

419

__________ ]11[]21[ ]54[

PORTABLE TELEPHONE AND TERMINAL EQUIPMENT

]22[ ]31[ ]51[ ]62[ ]71[ ]72[

07.12.2000 349460/99 ]32[ 08.12.1999 Int. Cl.(2008.04) H04M 12/47, 17/25 DIVISION FROM 144790 NTT DOCOMO, INC., JAPAN MASAAKI YAMAMOTO, MASAHARU NAKATSUCHI WO/2001/043403 JMB, FACTOR & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450

]87[ ]74[

[57] A method for automatically switching a mode for a wireless communication terminal, the wireless communication terminal having a communication terminal control and a browser, the wireless communication terminal being configurable to a telephone mode, a video play mode and a music play mode, the method comprising: configuring the communication terminal control to the telephone mode; using the communication

420

174055 ‫טלפון נייד וציוד למסוף‬

]33[

JP

,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬ ,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬ ‫ירושלים‬ terminal control to activate the browser; using functionality of the browser to selectively access a content comprising at least one of audio data and visual data; and automatically switching, based on the accessed content, the wireless communication terminal from the telephone mode to at least one of the video play mode or music play mode for play functionality on the output device.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[

174322 ‫קולר תומך‬

]54[

SUPPORTING COLLAR

]22[ ]31[ ]51[ ]71[ ]74[

15.03.2006 05/02695 ]32[ 18.03.2005 Int. Cl.(2008.04) F16L 3/00 HISPANO-SUIZA, FRANCE EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120

[57] Supporting collar (10) for an element (8) such as a cable or a pipe, comprising a strap (18) capable of being fixed to a support (12), said collar being characterized in that it comprises an outer sleeve (16) encircled by this strap, an inner sleeve (14) through which said element

]33[

FR

‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬ ,‫פטנטים‬ ‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬ can pass, and a deformable web (15) connecting said sleeves and allowing the inner sleeve to move relative to the outer sleeve, and in that the web is formed by two annular membranes that come together at the outer sleeve and diverge with distance from the latter.

__________

]11[]21[

September 22, 2009

–‫ד' בתשרי התש"ע‬

174394

421

]54[

LOCK AND KEY SYSTEM WITH EXTRA CODE COMBINATIONS

]22[ ]31[

13.09.2004 60/504202 ]32[ 22.09.2003 10/913519 09.08.2004 Int. Cl.(2008.04) E05B 27/00 WINLOC AG, SWITZERLAND BO WIDEN WO/2005/028789 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

]51[ ]71[ ]72[ ]87[ ]74[

[57] A lock and key system including locks of the kind comprising: a housing (204) having a cylindrical bore, a cylindrical key plug (202) being rotatably journalled in said cylindrical bore, said key plug having a longitudinal key slot (201) and, at a side of said key slot, a number of side locking tumblers (206) in a row cooperating with a side locking means (213) for locking the key plug against rotation in the cylindrical bore, at least one of said side locking tumblers having a transversely projecting finger and being mounted in an associated chamber for elevational and rotational movement therein, said elevational movement being performed against the action of a force exerted along said chamber, and said rotational movement of the side locking tumbler corresponding to the associated finger performing a pivotal motion, the rotational movement of the side locking tumbler being limited between two angular positions corresponding to a respective pivotal end position of the finger, and including keys (100) of the kind comprising: a longitudinally extending key blade (102), which is insertable into said key slot of the key plug of an associated lock, said key blade having a side material region at one side of said key blade

422

‫מערכת של מנעול ומפתח עם תוספת‬ ‫צירופי קוד‬

]33[

US US

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ defined upwardly by a longitudinally extending shelf surface, which is at least partially interrupted by a side code pattern cut into said material region so as to form a wave-like guiding surface (105) including a ramp surface portion (106) at the free end portion (107) of the key blade, said wave-like guiding surface engaging with said finger of said at least one side locking tumbler and making the latter follow said wave-like guiding surface, while the side locking tumbler is moved elevationally against the action of said force and the finger being caused to pivot sideways between said pivotal end positions, when the key blade is inserted into the key slot, said wave-like guiding surface including at least one side code portion associated with said side locking tumbler and guiding the finger thereof, upon fully inserting the key blade into the key slot, into a specific position causing the locking tumbler to allow said side locking means to rotationally release the key plug relative to said housing, said at least one side code portion being located at a selected one of a predetermined number of vertical code levels and at a selected one of a predetermined number of longitudinal positions corresponding to a specific pivotal position of said finger, September 22, 2009

–‫ד' בתשרי התש"ע‬

characterized in that in addition to said number of vertical code levels for said at least one side code portion, there is an extra top code level located at said shelf surface, any side code top segment located

at this extra top code level representing an extra code for the corresponding side locking tumbler of the associated lock, whereby the number of possible code combinations is increased.

__________ ]11[]21[ ]54[

CONSTRUCTIONAL PANELS

]22[ ]31[ ]51[ ]71[

04.10.2004 0323314.5 ]32[ 04.10.2003 Int. Cl.(2008.04) E01C 5/20, 5/22, 9/08 FERGUS JONATHAN ARDERN, UNITED KINGDOM WO/2005/035874 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

]87[ ]74[

[57] A constructional panel (10) comprising: a central section (13) and two opposed end sections (14, 15), said central section being of generally rectangular form with two parallel external side edges and two parallel end edges, each said end section having an isosceles trapezoid part (16, 17) conjoined to a rectangular part (18, 19), said trapezoid part having parallel long (28) and short (27) edges and a pair of external oblique edges (29, 30) and said rectangular part having a pair of parallel first edges (33, 34) and a pair of external second edges (35, 36), the short edge of September 22, 2009

–‫ד' בתשרי התש"ע‬

174754 ‫לוחות מבניים‬

]33[

GB

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ the trapezoid part conjoining an end edge of the central section and the long edge conjoining a first edge of the rectangular part, the other first edge of the rectangular part being external, and the length of the external side edges of the central part being substantially twice the length of the each second edge of the rectangular parts, whereby one said panel (50) may be interengaged with other like panels (51) by an oblique edge of an end section of said one panel being engageable with an oblique edge of an end section of a second panel, a second edge of the rectangular

423

part of the interenchangeable end sections of each of the two panels being engageable with the respective side edge of the central section of the other panel, and a third panel way be interengaged with said two panels in a similar manner whereby an end section thereof is engageable with an end section of said one panel and the external first edge of said end section of the third panel (52) is engageable with the

corresponding external first edge of said second panel, characterized by the feature that at least some of the external edges of the one panel are configured for connection to the corresponding edges of the second like panel by providing on one of the edges which interengages the other edge, one or more projections (31), and on that other edge corresponding one or more recesses (30) for receiving each projection.

__________ ]11[]21[ ]54[

BORON CARBIDE COMPOSITE BODIES AND METHODS FOR MAKING SAME

]22[ ]31[

20.11.2001 60/252489 ]32[ 21.11.2000 60/329358 15.10.2001 Int. Cl.(2008.04) C04B 355/63 DIVISION FROM 155729 M CUBED TECHNOLOGIES, INC., U.S.A. WO/2002/068373 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122

]51[ ]62[ ]71[ ]87[ ]74[

[57] A composite material, comprising: a matrix comprising silicon carbide; an at least partially interconnected material distributed throughout said matrix, said

424

174808 ‫ ושיטות להכנתם‬,‫גופי קרביד–בורון מרוכב‬

]33[

US US

,'‫ קולב ושות‬.‫סנפורד ט‬ ‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬ material consisting essentially of elemental silicon and at least one substance comprising boron; and at least one reinforcement material comprising boron carbide, said reinforcement material also September 22, 2009

–‫ד' בתשרי התש"ע‬

distributed throughout said matrix, said reinforcement material comprising at least one morphology selected from the group consisting of particulate, flakes,

microspheres and aggregate, said boron carbide being substantially unaffected by said silicon.

__________ ]11[]21[ ]54[

CAPSULE LOADING DEVICE FOR FEEDING A CAPSULE DISPENSING MACHINE

]22[ ]31[ ]51[ ]71[ ]87[ ]74[

22.04.2005 04010644.5 ]32[ 05.05.2004 Int. Cl.(2008.04) A47F 1/08 NESTEC S.A., SWITZERLAND WO/2005/104910 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063

[57] Capsule loading device to form a reserve of stacked capsules (8) comprising: a detachable tube (2) containing stacked capsules furnished with an opening (24) for the capsules to pass through the tube, means of aligning the tube allowing the tube to be aligned with a capsule receiving zone for the capsules to descend by gravity

178260 ‫מתקן הטענת כמוסה עבור הזנת מכונת‬ ‫חלקות כמוסות‬

]33[

EP

,‫ד"ר יצחק הס ושותפיו‬ ‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬

into this zone, characterized in that the alignment means comprise means for retaining the capsules in their stack when the tube is moved with its opening oriented downwards, in the direction of the position in which the tube is aligned with the reception zone.

__________ ]11[]21[ ]54[

KEY COMBINATION ELEMENT

September 22, 2009

–‫ד' בתשרי התש"ע‬

178364 ‫אלמנט צירוף מפתח בתוך גלם מפתח‬

425

‫ומפתח‬

IN KEY BLANK AND KEY ]22[ ]31[ ]51[ ]71[ ]72[ ]87[ ]74[

28.03.2005 0407196.5 ]32[ 30.03.2004 ]33[ Int. Cl.(2008.04) E05B 19/08, 27/00, 35/00 MUL-T-LOCK TECHNOLOGIES LTD. DANI MARKBREIT, EFFI BENAHARON WO/2005/095738 DEKEL PATENT LTD., 18 MENUHA VENAHALA ST., REHOVOT 76209

[57] A key blank comprising: a generally elongate shaft portion (12) defining first and second generally flat oppositely directed side surfaces (14, 16) joined by edge surfaces (18), at least one of said first and second side surfaces cuttable to form key cuts (20) that define a key combination surface; and at least one key combination element (26) movably disposed in the elongate shaft portion and adapted for touching a lock combination element (54) disposed in a cylinder lock plug (46)

426

GB ‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬ ‫ אפי בן אהרון‬,‫דני מרקברייט‬ ,‫דקל פטנט בע"מ‬ ‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬

wherein said at least one key combination element has inherent energy for applying an urging force against the lock combination element, and wherein said at least one key combination element comprises a resilient arm (28) disposed in a recess (34) formed in said elongate shaft portion and capable of resiliently protruding outwards from the recess beyond both of said first and second side surfaces.

September 22, 2009

–‫ד' בתשרי התש"ע‬

__________ ]11[]21[ ]54[

METHOD, DEVICE AND CARRIER FOR ENCODING MULTIWORD INFORMATION

]22[ ]31[ ]51[ ]62[ ]71[

22.04.1999 98201395.5 ]32[ 29.04.1998 Int. Cl.(2008.04) H03M 1/22 DIVISION FROM 133735 KONINKLIJKE PHILIPS ELECTRONICS N.V., THE NETHERLANDS WO/1999/060706 REINHOLD COHN AND PARTNERS, 26A HABARZEL ST., RAMAT HACHAYAL 69710

]87[ ]74[

September 22, 2009

–‫ד' בתשרי התש"ע‬

183567 ‫ התקן ונשא להצפנת מידע רב‬,‫שיטה‬ ‫מילים‬

]33[

EP

,‫ריינהולד כהן ושותפיו‬ ‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬

427

[57] A method for encoding multiword information that is based on multibit symbols disposed between synchronizing bit groups and in relative contiguity with respect to a medium, whilst providing wordwise interleaving and wordwise error protection code facilities and

synchronizing bit groups and furthermore error locative clues in clue words arranged in columns of clue words, across words of a multiword group, characterized in that the clue columns are locally scarcer disposed around columns of synchronizing bit groups.

__________ ]11[]21[

185867 ‫בנזופיראנים מותמרים כאגוניסטים לקולטן‬ ‫ביתא סלקטיבי לאסטרוגן‬

]54[

SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS

]22[ ]31[

07.11.2002 60/332766 ]32[ 19.11.2001 ]33[ US 60/363622 11.03.2002 US Int. Cl.(2008.04) A61K 313/53, A61P 1/04, 11/00, 13/00, 19/00, 25/00, 35/00, 43/00, 9/00, C07D 311/00, 311/94 DIVISION FROM 161325 ELI LILLY AND COMPANY, U.S.A. WO/2003/044006 LUZZATTO & LUZZATTO, ,‫לוצאטו את לוצאטו‬ INDUSTRIAL PARK, OMER, ‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬ P.O.B. 5352, BEER-SHEVA 84152

]51[ ]62[ ]71[ ]87[ ]74[

[57] A compound of the formula

wherein R1b is amido or hydroxy; R2b is –H, or C1-C6 alkyl; R3b is –H or C1-C6 alkyl; R4b is amido or hydroxy;

G is –CH2-, -CH2CH2-, -CH2CH2CH2-; and with the proviso that at least one of R1b and R4b is amido; or a pharmaceutically acceptable salt thereof.

__________

428

September 22, 2009

–‫ד' בתשרי התש"ע‬

]11[]21[

186305 ‫מלואה שעוצב בצד הנגדי‬

]54[

REVERSE MOLDED PANEL

]22[ ]31[

09.01.2001 60/198709 ]32[ 20.04.2000 ]33[ US 09/742840 21.12.2000 US Int. Cl.(2008.04) B27N 3/08, 5/00, E04F 13/10 DIVISION FROM 152283 MASONITE CORPORATION, U.S.A. WO/2001/081055 DR. SHLOMO COHEN & CO., ,'‫ד"ר שלמה כהן ושות‬ 124 IBN GABIROL ST., ‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬ P.O.B. 11490, TEL AVIV 62038

]51[ ]62[ ]71[ ]87[ ]74[

[57] A wood composite article (10) reverse molded from a mat of refined cellulosic fibers and sufficient binder to adhere the cellulosic fibers together into a structurally sound article having a specific gravity in the range of about 0.96 to about 1.08, said article formed from at least 80% by weight fibrillated cellulosic fibers refined from wood chips, based on the total dry weight of the fibers in the article

and including planar surface portions (13) surrounding an outwardly protruding contoured panel (14), having a plurality of exterior corners (15), that simulates natural wood millwork, back surface portions of said article being coplanar for adhering said back surface to a planar surface of a substrate, said contoured panel extending outwardly from said planar substrate surface.

152283

The parent application from which this application has been divided has not yet been published

‫בקשת הורה לבקשה זו שטרם‬ ‫פורסמה‬

________

]11[]21[

September 22, 2009

–‫ד' בתשרי התש"ע‬

187834

429

]54[

SYSTEM AND METHOD FOR DISPLAYING A DRIVING PROFILE

]22[ ]31[ ]51[ ]71[

08.06.2006 60/688696 ]32[ 09.06.2005 Int. Cl.(2008.04) G09B 19/16 GREENROAD DRIVING TECHNOLOGIES LTD.

]87[ ]74[

WO/2006/131926 ALEF GIMEL - INTELLECTUAL PROPERTY CONSULTING LTD., P.O.B. 2079, REHOVOT 76120

[57] A system for displaying real time evaluations of driving sessions to a driver, the system comprising: a vehicle sensor utility operative to monitor the state of the vehicle and to output a raw data stream corresponding thereto; a driving event handler operative to receive the raw data stream detect driving events based thereon and to output a driving event string containing at least one driving event representation corresponding thereto; a maneuver detector operative to receive said at least one driving event representation, recognize patterns of

430

‫מערכת ושיטה להצגת פרופיל נהיגה‬

]33[

US ‫ אור‬,‫גרינרואד טכנולוגיות נהיגה בע"מ‬ ‫יהודה‬ ,‫ ייעוץ לקניין רוחני בע"מ‬- .‫ג‬.‫א‬ ‫ רחובות‬,2079 .‫ד‬.‫ ת‬,

driving maneuvers and to construct and output a driving maneuver representation corresponding thereto, said driving maneuver representation containing a representation of at least one driving maneuver; and a processor configured to evaluate a driving session based upon rating each of a plurality of driving maneuvers comprised in said driving session and to display the evaluation of said driving session and/or the rating of said plurality of driving maneuvers on a display; and the display.

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬ 1968 – ‫ תשכ"ח‬,‫הפטנטים‬

This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

________ ]11[]21[ ]54[

AREAL METAL ELEMENT AND PROFILE ELEMENT

]22[ ]31[ ]51[ ]62[ ]71[

25.11.2003 10259307.8 ]32[ 18.12.2002 Int. Cl.(2008.04) E04C 2/08, 2/42, 3/08 DIVISION FROM 168923 PROTEKTORWERK FLORENZ MAISCH GMBH & CO. KG, GERMANY WO/2004/055289 PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733

]87[ ]74[

[57] An areal metal element having a surface (13) which extends from a first outside edge (8) to a second outside edge (9) lying opposite the first outside edge, with the region of the metal element adjoining the first outside edge forming a first side region (26) and the region of the September 22, 2009

–‫ד' בתשרי התש"ע‬

187854 ‫אלמנט מתכת אזורי ופרופיל אלמנט‬

]33[

DE

,‫פרל כהן צדק לצר‬ ,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬ ‫הרצליה‬ metal element adjoining the second outer edge forming a second side region (27), both said side regions being connected to one another by a central region (28) lying between them, and with at least one completely bordered aperture (22, 23) being formed in at least one of the side

431

regions, with its border being formed in one part by said side region and in the other part by the central region, with the central region including at least two sections (29, 30) which each consist of two outwardly disposed part sections (31, 33, 34, 36) and a central part section (32, 35) lying between them, with the outwardly disposed part sections being folded over with respect to the central part section for the production of the aperture, with the sections forming part of the border of the aperture, and with the central region, including the sections being made in one

piece with the two side regions of the metal element, characterized in that two folding edges (16, 17; 18, 19) are provided which are formed by the folding over of the outwardly disposed part sections with respect to the central part section and of which the folding edge (17; 19) disposed more closely to the first outer edge of the metal element faces in the direction of the first outer edge (8) and the folding edge, disposed more closely to the second outer edge of the metal element faces in the opposite way thereto in the direction of the second outer edge.

________

432

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫פטנטים‬

PATENTS ‫פטנטים שניתנו‬ PATENTS GRANTED 115880 152327 153085 154120 154551 155047 155705 156123 156661 163438 164768 166908 138818 141920 147506 148595 149636 151343 172412 143160 144852 146544 137053 158196 159262 160347 161916

117422 152364 153128 154134 154572 155150 155709 156212 156948 163881 165045 167053 139364 142088 147651 148685 149843 151397 174376 143591 144891 180435 157254 158446 159593 160704 161987

September 22, 2009

130829 152431 153163 154236 154652 155165 155734 156226 157021 163897 165830 168225 139569 142170 147735 148796 149956 151399 175296 143604 145412 184144 157559 158816 159672 160977 162435

130954 152704 153221 154238 154731 155224 155792 156239 157070 164025 166229 168684 140001 142179 148134 148907 150215 151573 178782 143862 145866 134202 157637 158892 159753 161008 162450

–‫ד' בתשרי התש"ע‬

132661 152783 153503 154256 154755 155226 155883 156337 157150 164123 166509 168861 140721 142328 148154 149291 150371 151644 110669 143900 145908 134796 157817 158928 159893 161319 162561

133311 152834 153655 154332 154866 155477 155923 156474 157169 164134 166567 169680 140732 142366 148246 149358 150461 151903 127216 144518 146208 135587 157873 158940 160103 161396 162579

152120 152844 153699 154450 154896 155513 156086 156560 163124 164393 166697 169715 141769 142596 148371 149582 150866 151954 142699 144675 146255 135983 158068 159113 160223 161548 162753

152172 153049 153883 154480 154905 155538 156091 156615 163373 164486 166744 108276 141775 147416 148484 149592 150934 171405 142766 144681 146421 136127 158183 159261 160309 161870

433

‫פטנטים שחודשו‬ PATENTS RENEWED 97585 97646 97720 97779 110943 112969 113061 113137 113177 113239 113298 113412 128838 129084 129225 129297 133141 133706 137648 138080 138221 138289 138353 138424 138527 138599 138645 138717 138805 138935 139017 139364 141373 143862 148079 150215 152172 153085 154238 154755 155095 155477 156474 158183

434

97592 97658 97723 97800 112842 112995 113062 113138 113179 113245 113316 113448 128876 129097 129230 129310 133247 133707 137872 138090 138247 138291 138369 138438 138533 138605 138647 138719 138818 138953 139027 139569 141766 143900 148134 150371 152431 153221 154256 154773 155165 155538 156615 158196

97620 97674 97727 97837 112851 113010 113104 113143 113193 113248 113343 113449 128883 129119 129244 129317 133260 134796 137896 138092 138249 138306 138378 138439 138547 138606 138657 138723 138830 138961 139113 139725 141769 144852 148154 151168 152497 153503 154332 154808 155197 155705 156723 158226

97631 97690 97730 97892 112873 113021 113108 113153 113194 113255 113344 113465 128885 129120 129257 129375 133374 135344 138018 138118 138263 138333 138392 138458 138548 138613 138660 138733 138835 138970 139119 139834 141775 145126 148907 151321 152703 153655 154551 154835 155226 155709 157021 158816

97632 97693 97740 97904 112916 113023 113121 113156 113195 113259 113367 115560 128890 129163 129273 130829 133469 135721 138019 138127 138284 138337 138399 138466 138549 138614 138669 138745 138841 139005 139127 139857 141920 145838 149358 151732 152704 153834 154572 154866 155286 155734 157150 158928

97633 97695 97741 97910 112921 113034 113122 113162 113209 113271 113388 122675 128966 129172 129274 130954 133700 135893 138034 138137 138285 138345 138406 138467 138555 138620 138670 138746 138845 139008 139159 140258 142088 145866 149582 151903 152783 154109 154606 154894 155290 155792 157169 159113

September 22, 2009

97635 97701 97744 97915 112930 113036 113131 113165 113221 113278 113403 127216 129003 129218 129278 132750 133704 137138 138060 138142 138286 138346 138414 138476 138556 138623 138711 138765 138863 139009 139315 140711 142170 147506 149843 151954 152834 154120 154630 155012 155314 155883 157817 159201

97644 97709 97746 97935 112963 113037 113134 113172 113230 113289 113409 128837 129071 129223 129281 132835 133705 137549 138078 138153 138288 138352 138416 138497 138559 138640 138712 138767 138934 139013 139348 140721 142596 147735 149956 152089 153003 154236 154731 155025 155323 156337 158068 159261

–‫ד' בתשרי התש"ע‬

‫‪161319‬‬ ‫‪163373‬‬ ‫‪164123‬‬ ‫‪164412‬‬ ‫‪165045‬‬ ‫‪166744‬‬ ‫‪168861‬‬ ‫‪174376‬‬

‫‪435‬‬

‫‪160943‬‬ ‫‪163227‬‬ ‫‪164113‬‬ ‫‪164393‬‬ ‫‪164997‬‬ ‫‪166567‬‬ ‫‪168684‬‬ ‫‪174357‬‬ ‫‪184144‬‬

‫‪160704‬‬ ‫‪162915‬‬ ‫‪164084‬‬ ‫‪164303‬‬ ‫‪164969‬‬ ‫‪166509‬‬ ‫‪167838‬‬ ‫‪172465‬‬ ‫‪180435‬‬

‫‪160347‬‬ ‫‪162858‬‬ ‫‪164076‬‬ ‫‪164253‬‬ ‫‪164768‬‬ ‫‪166384‬‬ ‫‪167294‬‬ ‫‪172412‬‬ ‫‪179036‬‬

‫‪160309‬‬ ‫‪162579‬‬ ‫‪163936‬‬ ‫‪164206‬‬ ‫‪164561‬‬ ‫‪166223‬‬ ‫‪167053‬‬ ‫‪171814‬‬ ‫‪178910‬‬

‫‪159672‬‬ ‫‪162450‬‬ ‫‪163881‬‬ ‫‪164175‬‬ ‫‪164486‬‬ ‫‪165201‬‬ ‫‪167034‬‬ ‫‪169803‬‬ ‫‪178782‬‬

‫‪159335‬‬ ‫‪161870‬‬ ‫‪163871‬‬ ‫‪164170‬‬ ‫‪164475‬‬ ‫‪165135‬‬ ‫‪166828‬‬ ‫‪169715‬‬ ‫‪176365‬‬

‫ד' בתשרי התש"ע–‬

‫‪159262‬‬ ‫‪161813‬‬ ‫‪163438‬‬ ‫‪164134‬‬ ‫‪164456‬‬ ‫‪165071‬‬ ‫‪166775‬‬ ‫‪169680‬‬ ‫‪175296‬‬

‫‪September 22, 2009‬‬

‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬ PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL FEES 110468 110553 110657 110748 110831 125791 125946 126066 171559 119415 95262 95429 95559 134538 134846

436

110470 110577 110683 110753 110832 125809 125965 147787 108276 129812 95267 95433 95576 134613 134894

110471 110588 110684 110759 110845 125854 125972 150640 138450 132882 95268 95472 95578 134688 135006

110475 110591 110704 110767 111688 125885 126017 151090 138451 133172 95296 95473 95582 134698 135735

110493 110602 110708 110769 125681 125906 126034 151307 138689 145491 95297 95507 133962 134716 136622

110506 110606 110721 110777 125698 125908 126035 151504 155578 95208 95298 95508 134377 134718 157339

September 22, 2009

110522 110617 110722 110784 125713 125913 126049 151511 179842 95243 95334 95525 134413 134733 159557

110549 110632 110740 110808 125731 125922 126051 151582 119162 95251 95425 95542 134491 134837 159655

–‫ד' בתשרי התש"ע‬

‫פטנטים שחודשו לעשרים שנה‬ PATENTS RENEWED FOR 20 YEARS 151754

159663

September 22, 2009

166310

–‫ד' בתשרי התש"ע‬

437

Patents for which applications have been filed for extension of the patent term under chapter 4, part B1 of the Patents Law 105048

438

112081

‫פטנטים שלגביהם הוגשו בקשות‬ ‫להארכת תקופת ההגנה על פי פרק‬ ‫ לחוק הפטנטים‬1'‫ד' סימן ב‬

143091

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫הודעה‬

NOTICE

‫ לחוק‬60 ‫לפי סעיף‬ 1967-‫ תשכ"ז‬,‫הפטנטים‬ ‫הוגשה בקשה להחזר‬ ‫תוקפו של הפטנט המפורט‬ ‫ שתוקפו פקע מחמת‬,‫מטה‬ ‫אי תשלום אגרות החידוש‬ :‫הקבועות‬

Under section 60 of the Patent Law, 5727-1967 Application has been filed for the restoration of the patent recorded below, which has lapsed through non-payment of the prescribed renewal fees: No. of Patent Acceptance published in journal no: Proprietors:

101460 8/1995

‫מס' הפטנט‬ :'‫קיבול פורסם ביומן מס‬ :‫שם בעל הפטנט‬

‫נ התקנים בע"מ‬.‫מ‬.‫ת‬ T.M.N. DEVICES LTD. Title of invention: :‫שם האמצאה‬ ‫מכונית והתקן להכנסה והוצאה של כסא גלגלים מתא המטען‬ CAR AND DEVICE FOR INSERTING AND REMOVING A WHEELCHAIR FROM A LUGGAGE COMPARTMENT Any person may oppose the ‫כל אדם רשאי להתנגד‬ said application within three ‫לבקשה האמורה תוך‬ months from the date of this ‫שלושה חודשים מתאריך‬ Patents Journal, as ‫שנקבע‬ ‫ כפי‬,‫יומן פטנטים זה‬ prescribed by section 61 of 92 ‫ובתקנה‬ ‫ לחוק‬61 ‫בסעיף‬ the law and by regulation 92 -‫ תשכ"ח‬,‫לתקנות הפטנטים‬ of the Patent Regulations, 5728-1968 1968

September 22, 2009

–‫ד' בתשרי התש"ע‬

439

‫הודעה‬

NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.

440

164768 7/2008

,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬ 1967-‫תשכ"ז‬ ‫מודע בזאת כי ניתנה רשות‬ '‫לבעלת בקשת הפטנט מס‬ ‫דבר הקיבול פורסם ביומן‬ ‫לתקן את הפירוט של בקשת‬ ‫הפטנט האמורה‬ ‫כל אדם רשאי להתנגד למתן‬ ‫הרשות תוך שלושה חודשים‬ ‫ כפי‬,‫מתאריך יומן פטנטים זה‬ ‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬ -‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99 .1968

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫הודעה‬

NOTICE Under section 66 of the Patents Law, 5727-1967 This is to notify that permission has been granted to the owner of Patent Application No. Acceptance published in journal To amend the specification of the said Patent Application. Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.

September 22, 2009

–‫ד' בתשרי התש"ע‬

167402 3/2007

,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬ 1967-‫תשכ"ז‬ ‫מודע בזאת כי ניתנה רשות‬ '‫לבעלת בקשת הפטנט מס‬ ‫דבר הקיבול פורסם ביומן‬ ‫לתקן את הפירוט של בקשת‬ ‫הפטנט האמורה‬ ‫כל אדם רשאי להתנגד למתן‬ ‫הרשות תוך שלושה חודשים‬ ‫ כפי‬,‫מתאריך יומן פטנטים זה‬ ‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬ -‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99 .1968

441

‫שינויים בפרטים רשומים בפנקס‬ CHANGES IN PARTICULARS ENTERED IN REGISTER

‫שינוי בעלות‬ CHANGES IN PROPRIETORSHIP No. of Patent: Previous Proprietors:

:‫מס' פטנט‬ :‫הבעלים הקודמים‬

127907 NOVARTIS AG

:‫הבעלים החדשים‬

New Proprietors: NESTEC S.A.

No. of Patent: Previous Proprietors:

:‫מס' פטנט‬ :‫הבעלים הקודמים‬

137103 NOVARTIS AG

:‫הבעלים החדשים‬

New Proprietors: NESTEC S.A.

No. of Patent: Previous Proprietors:

:‫מס' פטנט‬ :‫הבעלים הקודמים‬

139170 NOVARTIS AG

:‫הבעלים החדשים‬

New Proprietors: NESTEC S.A.

No. of Patent: Previous Proprietors:

:‫מס' פטנט‬ :‫הבעלים הקודמים‬

167389 NOVARTIS AG

:‫הבעלים החדשים‬

New Proprietors: NESTEC S.A.

442

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫תיקון טעות‬ CORRIGENDUM Journal P. 4270 Patent application No. 144324 Correct name of applicant to -

10/2008

‫יומן‬ 144324 '‫ בקשת פטנט מס‬4270 '‫ע‬ -‫תקן שם המבקשת ל‬

OVESCO ENDOSCOPY GMBH

September 22, 2009

–‫ד' בתשרי התש"ע‬

443

‫קודים למדינת המופיעים ביומן‬ COUNTRY CODES APPEARING IN THIS JOURNAL Code AR AT AU BA BE BR CA CH CN CU CZ DE DK EC EP ES FI FR GB GE GR GT HR HU IE IL IN IT JP KR LK LU LV MX

Country or Organization Argentina Austria Australia Herzegovina Belgium Brazil Canada Switzerland China Cuba Czech Republic Germany Denmark Ecuador European Patent Office Spain Finland France United Kingdom Georgia Greece Guatemala Croatia Hungary Ireland Israel India Italy Japan Republic of Korea Sri Lanka Luxembourg Latvia Mexico

MY

Malaysia

444

September 22, 2009

–‫ד' בתשרי התש"ע‬

NL NO NZ PL PT RU SE SG SI SK TH TR TW UA US UY UZ WO ZA

The Netherlands Norway New Zealand Poland Portugal Russian Federation Sweden Singapore Slovenia Slovakia Thailand Turkey Taiwan Ukraine United States of America Uruguay Uzbekistan World Intellectual Property Organization (W.I.P.O.) South Africa

September 22, 2009

–‫ד' בתשרי התש"ע‬

445

‫מדגמים‬

DESIGNS ‫מדגמים שנרשמו‬ DESIGNS REGISTERED

Class

43335 6(01) 19. 11.2006

‫סוג‬

‫ אריכא ובניו בע"מ‬.‫שחם י‬

SHAHAM Y. ARICHA AND SONS LTD.

‫ספסל‬

Bench 43611 3(01) 9. 1.2007

Class

‫סוג‬

‫שוגון מוצרי עור בע"מ‬

SHUGON LEATHER GOODS LTD.

‫תיק גב‬

Bagpack 43935 9(03) 11. 3.2007

Class

‫סוג‬

‫פק תעשיות בע"מ‬-‫ואקו‬

VACO PAK INDUSTRIES LTD.

‫קופסא‬

Box

Class

44000 4(02) 27. 3.2007

‫סוג‬

UNILEVER PLC Cleansing implement Convention date (U.S.A.)

Class

10.10.2006 44159 7(07) 9. 5.2007

‫כלי ניקוי‬ )‫הברית‬ )‫(ארצותהברית‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬

‫סוג‬

MARLA WOLFSON Paper roll dispenser Convention date (U.S.A.)

446

27.3.2007

‫מתקן לגלילי נייר‬ )‫הברית‬ )‫(ארצותהברית‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬ September 22, 2009

–‫ד' בתשרי התש"ע‬

Class

44202 1(04) 17. 5.2007

‫סוג‬

‫אורלי הרוני‬

ORLY HARONI

‫פריט מזון‬

Food article

Class

44229, 47251 12(16) 27. 5.2007

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫מערכת מיגוני סף‬

Set of side protectors

Class

44230 12(16) 27. 5.2007

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫מערכת מיגונים תחתיים‬

Set of skid plates

Class

44259 2(03) 30. 5.2007

‫סוג‬

‫מרדכי פרוש‬

MORDECHAI PORUSH

‫כיפה‬

Kipa

Class

44462 3(01) 5. 7.2007

‫סוג‬

‫ידור פרוייקטים בע"מ‬

YIDOR PROJECTS LTD.

‫תיק למוצרי בישול‬

Bag for cooking goods

Class

44666 11(01) 20. 8.2007

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

September 22, 2009

–‫ד' בתשרי התש"ע‬

447

44768 11(01) 9. 9.2007

Class

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel 44789 6(09) 16. 9.2007

Class

‫סוג‬

ORIT EZRACH AND MEIR ASSA ‫משטח פעילות שהפך לקופסת‬ ‫צעצועים‬ )‫הברית‬ )‫(ארצותהברית‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬

Play mat converting into bag 30.3.2007

Convention date (U.S.A.)

44858 11(01) 8. 10.2007

Class

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

44888 21(03) 15. 10.2007

‫סוג‬

‫חמוטל וייס ועופר זיק‬

HAMUTAL WEISZ AND OFER ZICK

‫סייע מין לנשים‬

Female sex aid

Class

45000 26(04) 7. 11.2007

‫סוג‬

‫יגאל און‬

YIGAL ONN

‫נורה‬

Lamp

Class

PASCALE BENCHIMOL AND MURIEL BENICHOU

45024, 45026 2 (03) 12. 11.2007

‫סוג‬

‫פסקל בן שימול ומוריאל בנישו‬ ‫בסיס למטפחת‬

Basis for kerchief

448

September 22, 2009

–‫ד' בתשרי התש"ע‬

Class

45044, 46169, 46170 11(01) 13. 11.2007

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

45072, 45073 25(01) 15. 11.2007

ALUMA ALUMINUM SOLUTIONS LTD.

‫סוג‬

‫אלומה פתרונות באלומיניום‬ ‫בע"מ‬ ‫פרופיל‬

Profile

Class

45121 11(01) 2. 12.2007

‫סוג‬

‫יהלומי לילי‬

LILI DIAMONDS

‫אבן חן‬

Gemstone

Class

45179 9(01) 11. 12.2007

‫סוג‬

MICRO FINANCE INVESTMENT AG ‫בקבוק‬

Bottle

Class

45309 12(16) 27. 5.2007

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫פגוש‬

Bumper Class

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫התקן גרירה לרכב‬

Towing device

September 22, 2009

45310 12(16) 27. 5.2007

–‫ד' בתשרי התש"ע‬

449

Class

45477 14(02) 7. 2.2008

‫סוג‬

SKYCROSS, INC. Antenna Convention date (U.S.A.)

Class

‫אנטנה‬ )‫הברית‬ )‫(ארצותהברית‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬

17.8.2007 45760 9(03) 31. 3.2008

‫סוג‬

‫דרפק בע"מ‬

DARPACK LTD.

‫מיכל‬

Container

Class

45766 11(01) 31. 3.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

45828, 45833 11(01) 14. 4.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

45882 11(01) 27. 4.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

45994 11(01) 22. 5.2008

‫סוג‬

‫ראובן גרש‬

RUVEN GERSH

‫יהלום‬

Diamond

450

September 22, 2009

–‫ד' בתשרי התש"ע‬

46002, 46003 9(03) 26. 5.2008

Class

‫סוג‬

‫מנשה רוגוטנר‬

MENASHE ROGOTNER

‫מגש‬

Tray 46022, 46023 11(01) 29. 5.2008

Class

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

46030, 46031, 46032 11(01) 2. 6.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel 46051 24(02) 12. 6.2008

Class

‫סוג‬

SCALPAL LLC ‫איזמל‬

Scalpel

Class

46120, 46121 25(02) 24. 6.2008

‫סוג‬

‫) בע"מ‬1986 ‫פלסטוקיט (ייצור‬

PLASTOKIT (MANUFACTURING 1986) LTD.

‫מחסום‬

Barrier

Class

46135 9(03) 25. 6.2008

PLASGAD PLASTIC PRODUCTS AGSHACH LTD.

‫פלסגד מוצרים פלסטיים אגש"ח‬ ‫בע"מ‬ ‫ארגז מתקפל‬

Foldable box

September 22, 2009

‫סוג‬

–‫ד' בתשרי התש"ע‬

451

Class

46142 11(01) 29. 6.2008

‫סוג‬

‫ראובן גרש‬

RUVEN GERSH

‫יהלום‬

Diamond

Class

46228 23(04) 9. 7.2008

‫סוג‬

‫טוויטופלסט בע"מ‬

TWITOPLAST LTD.

‫תעלה למערכת מיזוג אוויר‬

Air conditioning system duct

Class

46229 23(04) 9. 7.2008

‫סוג‬

‫טוויטופלסט בע"מ‬

TWITOPLAST LTD.

‫יחידה למערכת מיזוג‬

Air conditioning system unit

Class

46235 11(01) 10. 7.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

46292, 46293, 46294, 46295 20(03)

‫סוג‬

JCDECAUX SA ‫לוח פרסום‬

Advertising panel

Class

46302 14(03) 24. 7.2008

LOOL INDUSTRIAL DESIGN LTD. Identification tag holder

452

‫סוג‬

‫לול עיצוב תעשייתי בע"מ‬ ‫מחזיק לדיסקית זיהוי‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

Class

46313 6(04) 27. 7.2008

‫סוג‬

‫טקסטורה רהיטים בע"מ‬

TEXTURA FURNITURE LTD.

‫שידה‬

Chest

Class

46493 28(03) 14. 8.2008

‫סוג‬

HENKEL AG & CO.KGAA Deodorant dispenser Convention date (OHIM)

Class

27.3.2008 46500 11(01) 14. 8.2008

‫מנפק דאודורנט‬ )‫הברית‬ )‫(אוהיים‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬

‫סוג‬

‫ראובן גרש‬

RUVEN GERSH

‫יהלום‬

Diamond

Class

46527 11(01) 21. 8.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

46582 6(01) 3. 9.2008

‫סוג‬

‫קיט אגודה שיתופית בע"מ‬-‫קידס‬

KIDS-KIT COOPERATIVE SOCIETY LTD.

‫מושב לתינוק‬

Baby seat

Class

46619 6(01) 10. 9.2008

SHAHAM Y. ARICHA AND SONS LTD.

‫אריכא ובניו בע"מ‬.‫שחם י‬ ‫ספסל‬

Bench

September 22, 2009

‫סוג‬

–‫ד' בתשרי התש"ע‬

453

Class

46642, 46643 14(03) 15. 9.2008

‫סוג‬

ZEM CO LTD.

‫צמח זם בע"מ‬

Remote control for air conditioner

‫שלט למיזוג אוויר‬

Class

46687 10(06) 25. 9.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫התקן לאיתות‬ )‫(ברזיל)הברית‬ ‫האמנה(ארצות‬ ‫תאריך אמנה‬

Signaling device Convention date (Brazil)

Class

4.7.2008 46703, 46704 25(01) 2. 10.2008

‫סוג‬

‫שוקת אלומיניום בע"מ‬

SHOKET ALUMINIUM LTD.

‫פרופיל‬

Profile

Class

46726, 47276 11(01) 12. 10.2008

‫סוג‬

‫יעקב דהאן‬

YAACOV DAHAN

‫תליון‬

Pendant

Class

46736, 46737 12(16) 12. 10.2008

‫סוג‬

‫שלמה שמול‬

SHLOMO SHMUL

‫כיסוי רכב‬

Car cover

454

September 22, 2009

–‫ד' בתשרי התש"ע‬

Class

46745, 46746, 46747, 46748, 46750, 46751, 46752, 46753, 46754, 46755, 46756, 46757, 46758, 46760, 46761, 46762, 46763, 46764 11(01) 22. 10.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel 46796 6(04) 29. 10.2008

Class

ALUMA ALUMINUM SOLUTIONS LTD.

‫סוג‬

‫אלומה פתרונות באלומיניום‬ ‫בע"מ‬ ‫פרופיל מעמד לבקבוקי יין‬

Profile for bottle stand

Class

46800, 46801, 46802, 46803, 46804, 46806, 46807, 46808, 46809, 46810, 46811 11(01) 29. 10.2008

‫סוג‬

H. STERN COMERCIO E INDUSTRIA S.A. ‫תכשיט‬

Jewel

Class

46826 9(03) 11. 11.2008

I.M.A. 1990 – ITZUR MUTZAREI ARIZA

‫סוג‬

‫ – ייצור מוצרי אריזה‬1990 .‫א‬.‫מ‬.‫י‬ ‫מגש‬

Tray

Class

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫התקן גרירה‬

Towing device

September 22, 2009

47249 12(16) 27. 5.2007

–‫ד' בתשרי התש"ע‬

455

Class

47250 12(16) 27. 5.2007

‫סוג‬

ASFIR LTD.

‫אספיר בע"מ‬

Fuel tank skid plate

‫מיגון מיכל דלק‬

Class

47251 12(16) 27. 5.2007

‫סוג‬

‫אספיר בע"מ‬

ASFIR LTD.

‫מערכת מיגוני סף‬

Set of side protectors

456

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫מדגמים שחודשו‬ DESIGNS RENEWED 29939 35228 39095 39225

31194 37349 39099 39240

September 22, 2009

31224 38495 39168 39246

31242 39003 39169 39247

–‫ד' בתשרי התש"ע‬

31293 39047 39170 39385

31338 39073 39171 39410

31514 39083 39203 42119

35227 39086 39217

457

‫מדגמים שבוטלו‬ DESIGNS VOID 22256 30399 30454 38373 38403 38433

22307 30400 30485 38375 38404 38435

30355 30410 38354 38385 38420 38436

Dr. Meir Noam Commissioner of Patents, Designs and Trade Marks

458

30356 30420 38359 38395 38421 38439

30359 30423 38364 38396 38425 38443

30395 30424 38370 38399 38426 38444

30396 30433 38371 38401 38427 38454

30398 30434 38372 38402 38428

‫ד"ר מאיר נועם‬ ‫ המדגמים‬,‫רשם הפטנטים‬ ‫וסימני מסחר‬

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫מפתחות לבקשות שקובלו‬ ‫‪INDICES OF APPLICATIONS ACCEPTED‬‬ ‫מפתח שמי‬ ‫אברהם כהן ‪120066‬‬ ‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬ ‫ופיתוח ‪164122‬‬ ‫אוניברסיטת תל‪-‬אביב פיתוח טכנולוגיות‬ ‫עתידיות‪ ,‬שותפות מוגבלת ‪159878‬‬ ‫אי‪.‬אי‪.‬אר החברה למשאבי סביבה ואנרגיה‬ ‫(ישראל) בע"מ ‪168286‬‬ ‫איל רובוטיקה והנדסה בע"מ ‪164709‬‬ ‫אילן הלוי ‪171571‬‬ ‫איתן‪ ,‬פרל‪ ,‬לצר וכהן צדק ‪164231‬‬ ‫אל‪-‬אופ תעשיות אלקטרו‪-‬אופטיקה בע"מ‬ ‫‪158937‬‬ ‫אפרת ביופולימריים בע"מ ‪140017‬‬ ‫בוריס ורשיצקי ‪134127‬‬ ‫ברק הלוי ‪171571‬‬ ‫גבי‪-‬לי אבגנים ‪154194‬‬ ‫גדעון רוזנברג ‪170215‬‬ ‫גיא טל ‪153990‬‬ ‫גיא טל ‪160729‬‬ ‫גיוון אימג'ינג בע"מ ‪159450‬‬ ‫גרין ויז'ן מערכות בע"מ ‪156325‬‬ ‫גרינרואד טכנולוגיות נהיגה בע"מ ‪187834‬‬ ‫היסנס בע"מ ‪167726‬‬ ‫התקני מצב מוצק ‪ -‬שותפות אלביט מערכות ‪-‬‬ ‫רפא"ל ‪167637‬‬ ‫חיים שטלריד ‪167726‬‬ ‫חניתה מפעלי מתכת בע"מ ‪159639‬‬ ‫טבת טכנולוגיות לבקרת תהליך בע"מ ‪162102‬‬ ‫טראנספארמה מדיקל בע"מ ‪152574‬‬ ‫ידע חברה למחקר ופיתוח בע"מ ‪154429‬‬

‫‪i‬‬

‫‪NAME INDEX‬‬ ‫יורי בנדרסקי ‪150933‬‬ ‫יישום חברה לפיתוח המחקר של‬ ‫האוניברסיטה העברית בירושלים ‪133540‬‬ ‫ישקר בע"מ ‪160935‬‬ ‫ישקר בע"מ ‪160935‬‬ ‫כרמלי אדהאן ‪165132‬‬ ‫מאיר אבגנים ‪154194‬‬ ‫מולטילוק טכנולוגיות בע"מ ‪149876‬‬ ‫מולטילוק טכנולוגיות בע"מ ‪169371‬‬ ‫מולטילוק טכנולוגיות בע"מ ‪178364‬‬ ‫מיסטרל דטקשון בע"מ ‪160989‬‬ ‫מיקי בן‪-‬כנען ‪171571‬‬ ‫מירבל מדיקל סיסטמס בע"מ ‪115525‬‬ ‫נאנומטריקס‪-‬ישראל בע"מ ‪162102‬‬ ‫נומד אקסס בע"מ (בפירוק) ‪153420‬‬ ‫נחום בוריבקר ‪134127‬‬ ‫סידרום אקס בע"מ ‪133540‬‬ ‫פלסן סאסא ‪149591‬‬ ‫רן טל ‪160729 ,153990‬‬ ‫רפאל מערכות לחימה מתקדמות בע"מ‬ ‫‪154871‬‬ ‫רפאל מערכות לחימה מתקדמות בע"מ‬ ‫‪156868‬‬ ‫& ‪ADB AIRFIELD SOLUTIONS GMBH‬‬ ‫‪CO. KG 170497‬‬ ‫‪ADC TELECOMMUNICATIONS, INC.‬‬ ‫‪148039‬‬ ‫‪AERO-HYDRO ASSOCIATES 154454‬‬ ‫‪AETERNA ZENTARIS GMBH 144739‬‬ ‫‪AKZO NOBEL N.V. 149173‬‬ ‫‪ALBERTO A. CALDERON 154454‬‬

‫ד' בתשרי התש"ע–‬

‫‪September 22, 2009‬‬

CHRISTIAN HUGUES 158327 CLINICAL DESIGNS LIMITED 169921 CONSTRUCTION RESEARCH & TECHNOLOGY GMBH 153588 CORDIS CORPORATION 162047 CURIS, INC. 136137 DABULAMANZI HOLDINGS, LLC 153172 DART INDUSTRIES INC. 162882 DELAVAL HOLDING AB 152960 DESIGN BLUE LTD. 162679 DIGITAL ENVOY INC. 164237 DISENO DE SISTEMAS EN SILICIO, S.A. 156440 DOLBY LABORATORIES LICENSING CORPORATION 169442, 171287 DOW AGROSCIENCES LLC 154764 DRK BLUTSPENDEDIENST BADENWURTTEMBERG-HESSEN GEMEINNUTZIGE GMBH 137424 DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG 152795 E.E.R. ENVIRONMENTAL ENERGY RESOURCES (ISRAEL) LTD. 168286 EDWARD H. RUEDIGER 150222 EFRAT BIOPOLYMERS LTD. 140017 EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH 139452 EITAN, PEARL, LATZER AND COHEN ZEDEK 164231 ELEMENT SIX LIMITED 162354 ELI LILLY & CO. 154840, 155812 ELI LILLY AND COMPANY 185867 EL-OP ELECTRO-OPTICS INDUSTRIES LTD. 158937 ELTECH SYSTEMS CORPORATION 170874 ESSELTE CORPORATION 166369 ETAT FRANCAIS REPRESENTE PAR LE DELEGUE GENERAL POUR L'ARMEMENT 159805 EUREON AG 159770 EXPRESSIVE RESEARCH B.V. 161773 FABIO PERINI S.P.A. 169898 FABRE-KRAMER PHARMACEUTICALS, INC. 150222

ii

ALBIREO AB 156341 ALSTOM TECHNOLOGY LTD. 168162 ALTAREX MEDICAL CORP. 148165 ANATOLIJS BIRMANS 160734 ANSELL HEALTHCARE PRODUCTS LLC 168841 ARC LEICHTMETALLKOMPETENZZENTRUM RANSHOFEN GMBH 159805 ARGOR ALJBA AG 172000 ARM LIMITED 167671 ASTRAZENECA AB 156341 ATHENA TECHNOLOGIES, INC. 153172 ATOFINA CHEMICALS, INC. 145673 AUBURN UNIVERSITY 157030 AVRAHAM COHEN 120066 AYAL ROBOTICS AND ENGINEERING LTD. 164709 BARAK HALEVI 171571 BAXTER HEALTHCARE S.A. 154170 BAYER AKTIENGESELLSCHAFT 151794 BAYER CROPSCIENCE AG 158180 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 164122 BERLIN-CHEMIE AG 157573 BIDACHEM S.P.A. 159151 BILTON-CONSULTADORIA E MARKETING LDA. 159770 BIOCON LIMITED 161079 BIOGEN IDEC MA INC. 136137 BIOLOGICAL TARGETS, INC. 149294 BIONEST LTD., 159770 BOMBARDIER TRANSPORTATION GMBH 160014 BORIS VARSHITSKY 134127 BRISTOL-MYERS SQUIBB COMPANY 149755 BUKWANG PHARMACEUTICAL CO., LTD. 158185 CABOT CORPORATION 157610 CABOT SUPER METALS K.K. 150851 CARMELI ADAHAN 165132 CELGENE CORPORATION 156646 CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) 156480 September 22, 2009

–‫ד' בתשרי התש"ע‬

INTERVET INTERNATIONAL B.V. 149173 ISCAR LTD. 160935 ISCAR LTD. 160935 IVARS KALVINSH 160734 JOHANN ANDERL 169432 JOHN LARRY SANDERS 157695 JOSEPH P. YEVICH 150222 KONINKLIJKE PHILIPS ELECTRONICS N.V. 161350, 183567 LAM RESEARCH CORPORATION 159935 LEE A. BULLA JR. 149294 LIFESCAN, INC. 170497 LOHMANN GMBH & CO. KG 152269 LTS-LOHMANN THERAPIE-SYSTEME AG 160515 M CUBED TECHNOLOGIES, INC. 174808 MAGNESIUM ELEKTRON LIMITED 168557 MAGNOLIA BROADBAND, INC. 158986 MANNKIND CORPORATION 147724 MARIS VEVERIS 160734 MASONITE CORPORATION 186305 MAXIMUM AVAILABILITY LIMITED 155217 MBT HOLDING AG 153588 MEDLIS CORP. 129586 MEHMET CANDAS 149294 MEIJI SEIKA KAISHA, LTD. 155990 MEIR AVGANIM 154194 MENARINI RICERCHE S.P.A. 157573 MERCK PATENT GMBH 141516 MICHAEL ARNOUSE 172717 MICHAEL HOFFMANN 144912 MICROSOFT CORPORATION 160352 MIKI BEN-CNAAN 171571 MIRABEL MEDICAL SYSTEMS LTD. 115525 MISTRAL DETECTION LTD. 160989 MITSUBISHI TANABE PHARMA CORPORATION 160700 MOTOROLA, INC. 160235 MUL-T-LOCK TECHNOLOGIES LTD. 149876 MUL-T-LOCK TECHNOLOGIES LTD. September 22, 2009

–‫ד' בתשרי התש"ע‬

FAZAN COMMUNICATIONS LLC 153420 FERGUS JONATHAN ARDERN 174754 FERRING B.V. 164519 FUJIKIN INCORPORATED 166866, 169611 FUJIKIN INCORPORATED 171506 GABI-LEE AVGANIM 154194 GE HEALTHCARE LIMITED 159260 GENENTECH, INC. 136216, 146954, 156435 GENETICS INSTITUTE, LLC 147599 GEOPHARMA PRODUCKTIONSGMBH 170025 GIDEON ROSENBERG 170215 GILEAD SCIENCES, INC. 158185 GIVEN IMAGING LTD. 159450 GLOBAL APEEL LIMITED 170493 GOYEN CONTROLS CO. PTY. LTD. 162015 GREEN VISION SYSTEMS LTD. 156325 GREENROAD DRIVING TECHNOLOGIES LTD. 187834 GRUNENTHAL GMBH 152352 GUY TAL 153990 GUY TAL 160729 H.C. STARCK GMBH 166739 HAIM SHTALRYD 167726 HAMMERSMITH IMANET LIMITED 159260 HANITA METAL WORKS LTD. 159639 HARRIS CORPORATION 163915 HISENSE LIMITED 167726 HISPANO-SUIZA 174322 IHARA CHEMICAL INDUSTRY CO., LTD. 155486 ILAN HALEVI 171571 INDENA S.P.A. 160232, 165081, 165122 INDRANET TECHNOLOGIES LIMITED 139927 INNOGENETICS N.V. 140217 INNOVATIVE DEFENSE TECHNOLOGIES LTD. 170215 INTERDIGITAL TECHNOLOGY CORPORATION 158884, 160251, 160331, 160526 INTERGRAPH HARDWARE TECHNOLOGIES COMPANY 146161

iii

QUALCOMM INCORPORATED 159298, 159510, 159806, 161882, 162809, 163252 QUANTUM DESIGN, INC. 165981 QUARK PHARMACEUTICALS, INC. 139637 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. 156868 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. 154871 RAN TAL 153990, 160729 RAYTHEON COMPANY 159323 RAYTHEON COMPANY 168657 RAYTHEON COMPANY 173118 RENISHAW PLC 138995 ROLAND HORRES 144912 S2 TECHNOLOGIES, INC. 158007 SAFRAN 152200 SAGEM DEFENSE SECURITE 152200 SAGEM SECURITE 152200 SAINT-GOBAIN CERAMICS & PLASTICS, INC. 164231 SAMSUNG ELECTRONICS CO., LTD. 158102 SANDVIK AB 168169 SANDVIK INTELLECTUAL PROPERTY AB 168169 SANOFI AVENTIS 146928 SANOFI AVENTIS 160700 SANOFI-AVENTIS DEUTSCHLAND GMBH 152287 SANOFI-AVENTIS DEUTSCHLAND GMBH 151695 SANOFI-AVENTIS DEUTSCHLAND GMBH 157208, 167781 SAZKA, A.S. 163671 SEMI-CONDUCTOR DEVICES - AN ELBIT SYSTEMS - RAFAEL PARTNERSHIP 167637 SIEMENS AKTIENGESELLSCHAFT 170497 SILVERBROOK RESEARCH PTY. LTD. 162277, 168609 SINCLAIR PHARMACEUTICALS LIMITED 164434 SNECMA 162830 SNECMA SERVICES 162830

iv

169371 MUL-T-LOCK TECHNOLOGIES LTD. 178364 NACHUM BORIVKER 134127 NAGRACARD S.A. 163031, 170575 NAGRAVISION S.A. 163890 NANOMETRICS- ISRAEL LTD. 162102 NESTEC S.A. 165297, 178260 N-GENE RESEARCH LABORATORIES INC. 159412 NICOX S.A. 147639 NIPRO CORPORATION 157945 NISSAN CHEMICAL INDUSTRIES LTD. 158151 NOF CORPORATION 168238 NOKIA CORPORATION 164378 NOKIA, INC. 164378 NOMAD ACCESS LTD 153420 NORTHCOAST TECHNOLOGIES 165667 NORTHFIELD LABORATORIES, INC. 126376 NOVARA TECHNOLOGY S.R.L. 166212 NOVARTIS AG 150481, 155029 NOVO NORDISK A/S 157945 NOVOZYMES A/S 158915, 161769 NTT DOCOMO, INC. 174055 ONO PHARMACEUTICAL CO., LTD. 156505 ORTHO-MCNEIL PHARMACEUTICAL, INC. 157589, 159698 ORTHO-TAIN, INC. 164886 OTSUKA CHEMICAL CO., LTD. 150293 PDL BIOPHARMA, INC. 139571 PFIZER PRODUCTS, INC. 142566 PHARMAPRODUCTS UK LIMITED 159770 PLASAN SASA 149591 POLYMER GROUP, INC. 156862 PRAXAIR S.T. TECHNOLOGY, INC. 161750 PROTEKTORWERK FLORENZ MAISCH GMBH & CO. KG 168923, 187854 QUALCOMM INCORPORATED 156801, 156947, 163833, 164481 September 22, 2009

–‫ד' בתשרי התש"ע‬

UNIVERSITE PIERRE ET MARIE CURIE 156480 UNIVERSITY OF DAYTON 167479 UNIVERSITY OF MASSACHUSETTS 150065 UNIVERSITY OF OTTAWA 153570 VALTION TEKNILLINEN TUTKIMUSKESKUS 145337 VIASAT, INC. 160140 VICURON PHARMACEUTICALS INC. 166212 VLIESSTOFF-TECHNOLOGIE IN 3. DIMENSION KG 152269 WALDEMAR LINK GMBH & CO. KG 169353 WARNER-LAMBERT COMPANY LLC 142225 WARNER-LAMBERT COMPANY LLC 168345 WELLSTAT BIOLOGICS CORPORATION 153570 WILLIAMS INTERNATIONAL CO., L.L.C. 171935 WINLOC AG 174394 YEDA RESEARCH AND DEVELOPMENT CO. LTD. 154429 YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 133540 YURY BENDERSKY 150933 ZYMOGENETICS INC. 142164 ZYSTOR THERAPEUTICS, INC. 158623

September 22, 2009

–‫ד' בתשרי התש"ע‬

SOCIETE DES PRODUITS NESTLE S.A. 152694, 160054 SOLVAY PHARMACEUTICALS B.V. 158728 SPECIALTY FERTILIZER PRODUCTS, LLC 157695 STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN 161773 STRATATECH CORPORATION 157667 SUNESIS PHARMACEUTICALS, INC. 166892 SYMBIONTICS, INC. 158623 SYNDROME X LTD. 133540 TADAHIRO OHMI 156116 TADAHIRO OHMI 156116 TADAHIRO OHMI 169611 TARO PHARMACEUTICALS U.S.A., INC. 171317 TEIJIN LIMITED 139571 TEL-AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P. 159878 TELECHEM INTERNATIONAL, INC. 153848 TEVET PROCESS CONTROL TECHNOLOGIES LTD. 162102 THE GILLETTE COMPANY 169961 THE PROCTER & GAMBLE COMPANY 159924, 162053 THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK 170095 THE ROCKEFELLER UNIVERSITY 160305 THOMAS C. RHEA 170346 TOKYO ELECTRON LTD 156116 TRANSPHARMA MEDICAL LTD. 152574 TREK 2000 INTERNATIONAL LTD. 159391

v

‫מפתח ענייני‬ SUBJECT MATTER INDEX A01J – 152960

B26B – 169961

A01N – 158180, 168841

B27N – 186305

A23G – 160054

B30B – 169432

A41D – 162679

B32B – 152269, 157030, 173118

A47F – 178260

B41J – 168609

A47J – 165297

B42F – 166369

A61B – 152200, 156868, 157945, 159450, 162830, 171571

B60J – 170346 B61F – 160014

A61F – 159924, 169353 B62B – 120066 A61J – 164886, 167726 B63B – 154454 A61K – 133540, 142225, 142566, 144739, 146928, 147599, 148165, 150222, 151695, 154170, 155029, 157208, 158623, 159412, 159770, 160232, 160305, 160515, 160734, 164434, 164519, 165081, 165122, 168238, 171317

B64C – 158327 B64D – 165667, 172717 B65D – 162882 B65B – 169898 B81N – 148039

A61L – 144912, 170095 C01B – 166212 A61M – 129586, 134127, 147724, 152694, 162047, 169921

C01G – 157610

A61N – 152574

C04B – 153588, 174808

B01D– 162015, 164122, 170215

C07B – 159260

B21C – 168169

C07C – 147639, 157589, 167781

B23B– 160935

C07D – 149755, 150293, 150481, 152352, 152795, 154764, 154840, 155486, 155990, 156341, 156505, 156646,

B23C – 159639

vi

September 22, 2009

–‫ד' בתשרי התש"ע‬

158151, 158728, 159151, 159698, 160700, 168345, 185867

F02C – 171935 F04D – 165132

C07F – 162053 F16K – 166866, 169611, 171506 C07H – 157573, 158185 F16L – 174322 C07K – 126376, 136137, 139452, 139571, 141516, 142164, 146954, 152287, 155812, 156435, 161769

F23D – 168162 F23G – 168286

C08F – 145673, 157695

F41A – 153990, 160729

C08G – 140017, 170025

F41H – 149591, 159805

C08L – 166739

G01B – 138995, 162102

C09G – 151794

G01J – 167637

C12N – 136216, 137424, 140217, 145337, 149173, 149294, 150065, 153570, 154429, 157667, 158915, 161773

G01K – 168657

C12P – 161079

G01P – 154871

C12Q – 139637, 153848

G01R – 167671

C22C – 150851

G01S – 158937, 159323, 159806

C23C – 161750, 164231, 172000

G05B – 153172

C23F – 168557

G06C – 162277

C25B – 170874

G06F – 146161, 150933, 155217, 158007, 159391

G01N – 115525, 156480, 160989, 165981, 166892, 167479

C30B – 162354 G06K – 156325 D04H – 156862 G06N – 139927 E01C – 174754 G06T – 159298 E04C – 168923, 187854 G07F – 163671, 170575 E05B – 149876, 154194, 169371, 174394, 178364 September 22, 2009

–‫ד' בתשרי התש"ע‬

G08G – 170497

vii

G09B – 187834 G09F – 170493 G10L – 158102, 169442 G11B – 161350 H01J – 159935 H01L – 156116 H01M – 159878 H01Q – 163915 H03M – 171287, 183567 H04B – 156801, 158986, 160140, 160235, 160526, 161882, 163833, 164481 H04J – 160251, 163252, 164378 H04L – 156440, 156947, 160331, 160352, 163890, 164237 H04M – 174055 H04N – 163031 H04Q – 153420, 158884, 159510, 162809

viii

September 22, 2009

–‫ד' בתשרי התש"ע‬

‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬ ‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER